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Guide to This Book
This book contains the Program Book, New Research 
Program Book, and Exhibits Guide. Located within the 
Program Book you will find a topic index in addition to 
program tracks (color-coded) that will assist you in finding 
scientific sessions of interest. The individual program for each 
day of the meeting is also color-coded so that you can easily 
find the day(s) of the meeting that interest you. The program 
is listed by start time with the formats listed alphabetically 
under those times. To make it even easier to plan your day 
a separate Days-at-a-Glance has been included with your 
registration materials. The New Research Program Book lists 
the titles of the Posters that will be presented at this meeting, 
organized numerically by session/day. There is a topic index 
for the Posters only, at the end of the New Research Program 
Book. The Exhibits Guide contains a list of the exhibitors and 
a floor plan of the exhibit hall, along with information about 
the Product Theaters.
If you have any questions about this book or the scientific 
program, please feel free to stop by the Scientific Programs 
Office, Room 712, South Building, Level 7, Toronto Convention 
Centre, and an APA staff person will be happy to assist you. 
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Welcome from the Scientific Program Committee
Sitting Left to Right: Steve H. Koh, M.D., Anna Dickerman, M.D., Saul Levin, M.D., Linda L.M. Worley, M.D., Phi l ip R. Muskin, M.D.,  
Laura K. Kent, M.D., Nyapati R. Rao, M.D., Lucy A. Hutner, M.D. Standing Left to Right: Donald C. Goff, M.D., Julio Licinio, M.D., Iqbal 
Ahmed, M.D., Elisabeth B. Guthrie, M.D., Kenneth R. Silk, M.D., Michael F. Myers, M.D., Robert Boland, M.D., Edmond H.T. Pi, M.D., 
Catherine Crone, M.D., Charles S. Price, M.D., Barry D. Sarvet, M.D., Cameron S. Carter, M.D., Stephen A. McLeod-Bryant, M.D., Barton 
J. Bl inder, M.D. Not Shown: Josepha Cheong, M.D., Richard D’All i, M.D., Kel l i J. Harding, M.D., John Luo, M.D., Arnaldo Moreno, M.D., 
Godfrey Pearlson, M.D., Daniel Pine, M.D., Jerrold F. Rosenbaum, M.D., Alan F. Schatzberg, M.D.
Dear Colleagues and Guests,
Welcome to Toronto and to the 168th Annual Meeting of the 
American Psychiatric Association. Both the city and the meet-
ing offer an incredibly broad range of exciting experiences 
and educational opportunities for all who attend. The annual 
APA meeting is truly a global meeting with presenters and 
attendees from around the world.
Under the leadership of APA President Paul Summergrad, 
M.D., the Scientific Program Committee has planned a diverse 
educational program reflecting the presidential theme, “Psychi-
atry: Integrating Body and Mind, Heart and Soul.” Please plan 
to attend the Annual Business meeting on Sunday 12:30 p.m. 
to 1:30 p.m. at in Room 106 of the Toronto Convention Centre.
The meeting offers a series of “tracks” on specialty areas includ-
ing addiction psychiatry, child & adolescent psychiatry, forensic 
psychiatry, geriatric psychiatry, and psychosomatic medicine. 
Additional “tracks” will focus on diversity and cultural psychia-
try, ethics, integrated care, and military mental health. You 
can search by topic area in the online Itinerary Planner (www.
psychiatry.org/annualmeeting) and in the APA Meetings app.
There will be a special Saturday evening performance by Dr. 
Richard Kogan taking place at 5:30 p.m. in the theatre (Room 
102). Dr. Kogan will speak about and play the music of Chopin, 
in the session “The Mind and Music of Chopin.” Distinguished 
Psychiatrist lectures will be given by Julio Licinio, M.D., Scott 
L. Rauch, M.D., Jerrold F. Rosenbaum, M.D., Barbara Milrod, 
M.D., and Anne Becker, M.D., Ph.D. Frontiers of Science 
lectures will be presented by Fred “Rusty” Gage, M.S., Ph.D., 
George Koob, Ph.D., Moshe Szyf, Ph.D., Barbara J. Mason, 
PhD., Philip G. Haydon, Bsc., Ph.D. Special Guests will include 
Ellen M. Zane, M.A., and Jonathan Moreno, Ph.D.
As always the meeting has a fantastic array of Advances ses-
sions. Advances in Research, chaired by Herbert Pardes, M.D. 
and Jack Barchas, M.D., will look at research directions and 
clinical approaches in some of the most frequent psychiatric 
disorders like anxiety, depression, and personality disorders. 
I am particularly looking forward to co-chairing, with Anna 
Dickerman, M.D., an interactive Advances session, “Test Your 
Knowledge with The Experts: An Interactive Advances In Series 
On Personality Disorders, Mentalizing and Network Therapy.” 
This session will be Tuesday, 2 p.m. to 5 p.m.
The meeting offers 16 sessions in the popular interactive 
format, in which attendees can engage directly with experts. 
Among the interactive session leaders are Dr. Summergrad, 
Dr. Mayberg, Dr. Nemeroff, Melissa Arbuckle, M.D., Barbara 
Coffey, M.D., Glen Gabbard, M.D., Otto Kernberg, M.D., Rus-
sell Lim, M.D., John Oldham, M.D., Alan Schatzberg, M.D., 
Nora Volkow, M.D., and Stuart Yudofsky, M.D. Please check 
the session listing in this book for further information as 
several of these sessions are for residents only.
Among the media workshops at this year’s meeting are:
 X Screening and Discussion of the Film “The Anonymous 
People”
 X “Ida”: A Viewing and Discussion of the Film
 X “Unicorn” and “Alone With People”—A Double Feature on 
Young Gay/Lesbian Identities: Exploring Sexual Orientation
 X What’s Wrong With Lisbeth Salander? Psychopathology of 
“The Girl With the Dragon Tattoo”
 X Power, Gender, and “The Devil Wears Prada”
With so much to offer, the 168th APA Annual Meeting prom-
ises to be an outstanding event. Enjoy your time in Toronto!






































Welcome from the APA President
Dear Colleagues and Guests,
The American Psychiatric Association’s 
2015 annual meeting in vibrant Toronto 
promises to be an exceptional educa-
tional experience. You will have many 
outstanding sessions to choose from 
as we bring together some of the best 
minds in psychiatry to present compelling 
research, clinical, and practice-related 
sessions in one dynamic meeting.
This year’s theme is “Psychiatry: Integrating Body and Mind, 
Heart and Soul.” Psychiatry’s position at the intersection of 
neuroscience and general medicine is reflected in the focus 
on advances in neuroscience, genetics and the integration of 
psychiatric and general medical care. Many sessions address 
the experience of illness: the heart and soul of the work we do.
Our Opening Session will be a lively and thought-provoking 
discussion with Helen S. Mayberg, M.D., the Hon. Patrick 
Kennedy and I discussing neuroscience research, advocacy, 
and the language of mental health. National Institutes of Drug 
Abuse Director Nora Volkow, M.D. will deliver the William Men-
ninger Memorial Lecture at the Convocation of Distinguished 
Fellows, on Monday at 5:30 p.m. Kennedy will also deliver the 
Patient Advocacy Award lecture, titled “The Open Warmth of 
Community Concern and Capability: Achieving President Ken-
nedy’s Vision,” on Tuesday at 9 a.m.
Several events will highlight the important role of psychiatry 
health care system transformation. On Monday at 9 a.m. I will 
chair a guest lecture by Ellen Zane, the Former CEO of Tufts 
Medical Center in Boston and a compelling speaker who will 
present on “Navigating Psychiatry and Health Care Reform.” 
I will also moderate a forum on psychiatrists as leaders with 
Herb Pardes, M.D., Darrell Kirch, M.D., Robert Golden, M.D., 
and Peter Buckley, M.D.
On Monday at 11 a.m. Karl Deisseroth, M.D., Ph.D. will 
receive the Adolph Meyer award for his outstanding work in 
optogenetics and the recently developed CLARITY system and 
present the Meyer lecture on “Illuminating the Brain.”
Each year we work with one of the NIH institutes at the meeting, 
this year will focus on the National Institute on Alcohol Abuse 
and Alcoholism (NIAAA), under its director George Koob, Ph.D.
On Tuesday at 11 a.m. in a unique video event, we’ll show 
highlights of my in-depth interview with Ram Dass, a renowned 
American spiritual teacher, on meditation, healing, and aging.
The international lectures will showcase psychiatric experts 
and leaders from around the world, including Sir Simon Wes-
sely, M.D., president of the Royal College of Psychiatrists and 
Florian Holsboer, M.D., director of the Max Planck Institute of 
Psychiatry in Munich among many others.
Presidential symposia include a session with Charles Nem-
eroff, M.D., Ph.D., Daniel Weinberger, M.D., Karl Deisseroth, 
M.D., Ph.D., and David Rubinow, M.D. on “21st-Century Psy-
chiatry at the Interface of Genetics, Neurobiology, and Clinical 
Science.” Other presidential symposia focus on mood disorders 
and neuroinflammation among other topics.
My deepest thanks to the Scientific Program Committee, under 
the leadership of chair Philip R. Muskin, M.D., for its outstand-
ing work.
This meeting provides hundreds of sessions to learn the latest 
science, sharpen your clinical skills, and inform you about new 
models of care delivery, along with plentiful networking and 
social opportunities.
We look forward to sharing with you all the education and ex-
citement which the APA’s Annual Meeting, the year’s premier 
psychiatric event, has to offer.
















Welcome from the APA CEO and Medical Director
Welcome from the Canadian Psychiatric 
Association and Ontario District Branch of APA
Dear Colleagues and Guests,
On behalf of the Canadian Psychiatric 
Association and the Ontario District 
Branch of the American Psychiat-
ric Association, we are delighted to 
welcome you to Canada and the host 
city of Toronto! In addition to renewing 
acquaintances, meeting new colleagues, 
and adding to your clinical knowledge 
at the APA’s 168th Annual Meeting, we 
hope that you will take in the sights and 
sounds of Canada’s largest metropolis 
and the provincial capital of Ontario. With 
a population of 5.5 million, Toronto was 
recently ranked by The Economist as the 
world’s best city to live in.
Named in 1834, Toronto is a world-class 
city with a wide variety of nightlife, the-
atre and performing arts, museums, and over 7,000 restau-
rants—you’ll never be at a loss for choice. From an academic 
standpoint, the University of Toronto is ranked as a top 20 
university globally and is home to a Department of Psychiatry 
with over 800 faculty members. Toronto is also Canada’s 
financial epicenter, home to the Toronto Stock Exchange, and 
headquarters to Canada’s five largest banks and many other 
leading organizations.
The city has one of the world’s most diverse populations—
close to 1 in 2 Toronto residents are born outside of Canada—
providing a deep cultural experience. Altogether the city offers 
a unique experience that blends Canada’s historic ties to 
the United Kingdom with an outward looking view toward an 
increasingly interconnected and innovative world.
We sincerely hope that your stay is memorable and one where 
you have an opportunity to listen, learn and enjoy.
Padraic Carr, M.D.
President, Canadian Psychiatric Association
Frank Sommers, M.D.
President, Ontario District Branch,  
American Psychiatric Association
Dear Colleagues and Guests,
Welcome to beautiful multicultural To-
ronto and the 168th APA Annual Meeting. 
The meeting offers the latest scientific 
research and new advances in clinical 
practice along with numerous special 
events and networking opportunities.
Please join us in honoring APA dis-
tinguished fellows, distinguished life 
fellows, international fellows, winners of 
several awards and others at the Convocation of Distinguished 
Fellows. We are honored to have National Institute on Drug 
Abuse Director Nora D. Volkow, M.D., presenting the William 
C. Menninger Memorial Convocation Lecture. The Convocation 
will be held Monday, May 18, 5:30 p.m.-6:30 p.m. in Exhibit 
Hall A, Toronto Convention Centre.
Among the many other award lectures being presented at the 
meeting are:
 X George Tarjan Award Lecture Marie–Claude Rigaud, M.D.
 X Simon Bolivar Award Lecture Carlos Zarate, M.D.
 X Alexandra Symonds Award Lecture Carol A. Bernstein, M.D.
 X Solomon Carter Fuller Award Lecture Dorothy E. Roberts, J.D.
 X Kun–Po Soo Award Lecture Russell F. Lim, M.D., M.Ed.
 X Adolf Meyer Award Lecture Karl Deisseroth, M.D., Ph.D. 
 X Patient Advocacy Award Patrick J. Kennedy
This year’s American Psychiatric Foundation annual benefit 
to support its public-education and research initiatives will be 
held on Saturday, May 16, 7 p.m. to 10 p.m. at Toronto’s fa-
mous CN Tower. This special event at the Horizons restaurant 
on the LookOut level promises spectacular views of the city 
along with a program honoring recipients of the 2015 Awards 
for Advancing Minority Mental Health. (Ticket required.)
A special series of scientific sessions and events have 
been developed for residents. The always popular national 
Jeopardy-like competition for residents, MindGames, will 
be held Tuesday, May 19, 5:15 p.m.-6:15 p.m., Room 106, 
Toronto Convention Centre.
Of course, the city of Toronto has numerous choices to add 
excitement and entertainment to your visit. Tour an elegant 98-
room castle, Casa Loma; visit the international exhibits of the 
Royal Ontario Museum; stroll the Art Gallery of Ontario; visit 
the Hockey Hall of Fame; or take in a Toronto Blue Jays game.
If you haven’t already, be sure to download the APA Meetings 
app for easy access to program information and the latest 
update alerts during the meeting.
Follow and share your thoughts on Twitter, #APAAM2015.
Saul Levin, M.D., MPA,  
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You are cordially invited to attend 
a Disease-State Theater supported by 
FORUM Pharmaceuticals
Monday, May 18, 2015
1:00 pm–2:00 pm 
Registration begins at 12:30 pm  |  Boxed lunch will be provided
APA Exhibit Hall, Product Theater
Metro Toronto Convention Centre, South Building  |  Toronto, Canada
Philip D. Harvey, Ph.D.
Leonard M. Miller Professor of Psychiatry
 and Behavioral Sciences
Director, Division of Psychology
University of Miami Miller School of Medicine
Miami, FL 
Anil K. Malhotra, M.D.
Professor of Psychiatry and Molecular Medicine
Hofstra North Shore-LIJ School of Medicine
Hempstead, NY
Director, Division of Psychiatry Research
The Zucker Hillside Hospital
Glen Oaks, NY
PRESENTED BY:
Please join us for a book signing
by Philip D. Harvey, Ph.D.
Sunday, May 17, 2015  |  2:00 pm–3:00 pm
COG
For more information on cognitive impairment in schizophrenia, visit 
www.NeedRecognition.com and www.CurrentPsychiatry.com/Cognition.
The industry product theater’s content and the views expressed therein are those of the 
supporting company and not of APA or APF. This program does not provide CME credits.
Please visit FORUM Pharmaceuticals at Booth #1539
Cognitive Impairment and
Poor Functioning in Schizophrenia
Relationship and Neurobiology
Key Locations in the Toronto 
Convention Centre
APA Annual Meeting on Demand Sales. . . . . . . . . . .  
Exhibit Halls D-E, South Building, Level 800 
Pre-Function, South Building, Level 700
APA Art Association Exhibit  . . . . . . . . . . . . . . . . . . .  
Registration Area, South Building, Level 600
APA Cafés  . . . . . . Exhibit Halls D–E, South Building, 
Level 800
APA Education Center  . . . . . . . . . . . . Pre-Function, 
South Building, Level 700
APA JobCentral  . . . . . . . . . . . . . . .Exhibit Halls D-E, 
South Building, Level 800 
APA Member Center . . . . . . . . . . . .Exhibit Halls D-E, 
South Building, Level 800
APA Newsroom  . . . . . . . . . Room 501, Park View A, 
South Building, Level 500
APA Psychiatric News  . . . . Room 501, Park View B, 
South Building, Level 500
Audiovisual Preview Rooms . . . . . . . . . . Room 710, 
South Building, Level 700 
Norfolk Room, Mezzanine, Sheraton Centre Hotel
Connection Café . . . . . . . . . . . . . . . . . Pre-Function, 
South Building, Level 800
CME Certificate of Attendance and Evaluation  . . . . .
Pre-Function, South Building, Level 700
Daily Bulletin . . . . . . . . . . . Room 401, Terrace View, 
South Building, Level 400
Exhibitor Registration . . . . . . . . . . .Exhibit Halls D-E, 
South Building, Level 800
Exhibits/Publishers’ Book Fair . . . . .Exhibit Halls D-E, 
South Building, Level 800
First Aid Room I . . . . . . . . . . . . . Across from Hall D, 
South Building, Level 800
First Aid Room II . . . . . . . . . . . . . Behind Room 204, 
North Building, Level 200
Housing Desk . . . . . . . . . . . . . . . . Registration Area, 
South Building, Level 600
Information Center . . . . . . . . Lobby, South Building, 
Level 500
Lactation Room . . . . . . . Room 702, South Building, 
Level 700
Lost and Found  . . . . . . . Room 707, South Building, 
Level 700
Meetings and Conventions Office  . . . . . Room 707, 
South Building, Level 700
Registration/Course Enrollment  . . .Exhibit Halls D-E, 
South Building, Level 800 
and Concourse Level, Sheraton Centre Hotel 
Scientific Program Office . . . . . . . . . . . . . Room 712, 
South Building, Level 700
















APA Annual Meeting on Demand Sales
Exhibit Halls D-E, South Building, Level 800
Sunday– Tuesday  10:00 a.m. – 4:00 p.m.
Pre-Function, South Building, Level 700
Saturday – Wednesday  7:30 a.m. – 5:30 p.m.
APA Annual Meeting on Demand includes over 300 
hours of educational content from the Annual Meeting. 
Content is available online within 24 hours, on USB 
Drive and mobile streaming. Additional CME available. 
APA Art Association Exhibit
Registration Area, South Building, Level 600
Sunday  10:00 a.m. – 4:00 p.m.
Monday – Tuesday  10:00 a.m. – 5:00 p.m.
Wednesday  10:00 a.m. – 2:00 p.m.
This exhibit includes paintings, photography, 
ceramics, and crafts created by APA members and/
or their significant others. Stop by for information on 
joining the APA Art Association.
APA JobCentral
Exhibit Halls D-E, South Building, Level 800
Saturday  9:00 a.m. – 4:00 p.m.
Sunday – Tuesday  10:00 a.m. – 4:00 p.m.
Visit the APA JobCentral booth located in the APA 
Member Center in the Exhibit Hall. A representative will 
be available to demonstrate JobCentral’s user-friendly 
system as well as assist you in posting your available 
position or resume. Using the Event Connection tool, 
candidates and employers can flag their resume and/
or posting to show attendance at this year’s meeting. 
For more information, visit APA JobCentral online.
APA Member Center
Exhibit Halls D-E, South Building, Level 800
Saturday  9:00 a.m. – 4:00 p.m.
Sunday – Tuesday  10:00 a.m. – 4:00 p.m.
A few of the many APA activities exhibited include: 
Membership; American Psychiatric Foundation, 
Diversity and Health Equity; Awards and Fellowships; 
Quality Improvement; Clinical Resources; Advocacy 
Tools; Career Development; Practice Management; 
Ontario DB activities; and International Meet Ups.
American Psychiatric Publishing (APP)
Exhibit Halls D-E, South Building, Level 800
Saturday  9:00 a.m. – 4:00 p.m.
Sunday – Tuesday  10:00 a.m. – 4:00 p.m.
Stop by the APP Bookstore to see the latest 
books, journals, and online content. You’ll find new 
bestselling titles and classic reference works in 
every area of psychiatry, including the DSM-5! APA 
members can take advantage of a 20% discount 
and APA Resident-Fellow Members receive a 25% 
discount on all book purchases. Special member 
prices are available on subscription products.
Members of the administration will be on hand 
to demonstrate online access for subscribers. 
Administration from APA’s CME journal Focus will 
also be available at booth 1605 to answer questions 
about this publication. Visitors can also purchase 
or renew subscriptions to all APA/APP journals at 
the Bookstore. Complimentary copies of Psychiatric 
News will be available at stands located throughout 
the Toronto Convention Centre. Persons who 
wish to contact editors or reporters of Psychiatric 
News are asked to go to Room 501 Park View 
B, South Building, Level 500, Toronto Convention 
Centre. Written announcements, suggestions for 
articles, letters to the editor, or other material for the 
newspaper’s consideration may also be left there.
Audiovisual Preview Rooms
For presentations in the Toronto Convention Centre, 
Room 710, South Building, Level 700
Friday  12:00 p.m. – 6:00 p.m.
Saturday – Tuesday  7:00 a.m. – 5:00 p.m.
Wednesday 7:00 a.m. – 3:00 p.m.
For presentations at the Sheraton Centre Hotel, 
Norfolk Room, Mezzanine
Friday  12:00 p.m. – 6:00 p.m. 
Saturday – Monday  7:00 a.m. – 5:00 p.m. 
Tuesday  7:00 a.m. – 3:00 p.m.
The Scientific Program Committee expects all 
presenters to preview their audiovisual materials 
prior to their sessions to familiarize themselves with 
the equipment. For your convenience, an audiovisual 







































CME Certificate of Attendance 
and Evaluation
The Scientific Program Committee needs your feed-
back to assess the effectiveness of the program and 
for planning next year’s Annual Meeting. The general 
evaluation and certificate can be obtained by visiting 
the CME Certificate of Attendance booth located in 
the Education Center, South Building, or online at 
www.psychiatry.org/annualmeetingcme. The website 
will be available during the meeting and for three 
months afterward. You will need your badge number 
to access the evaluation and obtain your certificate.
Education Center Hours and Location:
Pre-Function, South Building, Level 700
Saturday – Wednesday  8:00 a.m. – 5:30 p.m.
Continuing Medical Education
Educational Objectives
At the conclusion of this meeting the participant will 
be able to:
1. Review new research findings in the fields of 
psychiatry and neuroscience and address gaps in 
knowledge;
2. Acquire new knowledge and skills in clinical 
psychiatry, which can be utilized to improve 
patient care;
3. Identify and remove barriers to the transfer of 
new knowledge for your practice, including 
provision of culturally competent care for diverse 
populations;
4. Assess a variety of treatment choices, including 
psychotherapeutic and pharmacological options; 
and
5. Recognize mental health service delivery issues, 
including barriers to care.
The APA is accredited by the Accreditation Council 
for Continuing Medical Education (ACCME) to 
provide continuing medical education for physicians. 
The APA designates this live activity for a maximum 
of 50 AMA PRA Category 1 Credits™. Physicians 
should only claim credit commensurate with the 
extent of their participation in the activity.
Please note: Canadian physicians may record 
this group learning activity for Royal College of 
Canada MOC Section 1 credits.
The scientific sessions on the official Annual 
Meeting program, with some exceptions, meet 
the criteria for AMA PRA Category 1 Credit™. 
Sessions in the following program formats are 
designated as Category 1: Advances in… Series; 
Case Conferences; Courses; Focus Live; 
Forums; Lectures; Master Courses; Presidential 
Symposia; Scientific and Clinical Reports; 
Seminars; Small Interactive Sessions; Symposia; 
and Workshops. 
New Research Poster Sessions are NOT 
designated for AMA PRA Category 1 Credit™. 
Scientific sessions are open to all Annual Meeting 
registrants with the exception of Case Conferences, 
which are open to APA members only. Courses and 
Master Courses require a ticket and an additional fee.
To document CME credit earned at the Annual 
Meeting, participants should maintain a list of 
sessions they attended. Credit is earned on an hour–
for–hour basis. A daily attendance log is provided in 
this book for listing your sessions and credits.
Daily Bulletin
Room 401, Terrace View South Building, Level 400
The Daily Bulletin accepts written requests from APA 
members for publicity of component, committee, 
and allied group events as space allows. Three 
issues are published. The issue for Saturday/Sunday 
is published in advance. Copy for the Monday and 
Tuesday issues can be dropped off in Room 401, 
Terrace View South, Level 400, by 12:00 p.m. the 
day before the publication date.
Exhibitor Registration
Exhibit Halls D-E, South Building, Level 800
Friday 12:00 p.m. – 6:00 p.m.
Saturday – Tuesday 7:30 a.m. – 5:00 p.m.
Registered exhibitors will receive red badges that 
will permit access only to his/her exhibit booth in 
the Exhibit Hall and to ride the APA shuttle bus. If 
an exhibitor wants to attend sessions, he/she must 

















Exhibit Halls D-E, South Building, Level 800
Sunday – Tuesday 10:00 a.m. – 4:00 p.m.
Commercial and educational exhibits. All exhibits in 
the exhibit hall close at 4:00 p.m. on Tuesday.
First Aid
First Aid Room I, Across from Hall D,  
South Building, Level 800
Tuesday (May 12) –  
Wednesday (May 20) 7:00 a.m. – 6:00 p.m.
First Aid Room II, Behind Room 204, 
North Building, Level 200 
Friday – Wednesday 7:00 a.m. – 6:00 p.m.
International Meetings Pavilion
Exhibit Halls D-E, South Building, Level 800
Sunday – Tuesday 10:00 a.m. – 4:00 p.m.
Lost and Found
Room 707, South Building, Level 700
Friday 8:30 a.m. – 5:00 p.m.
Saturday 6:30 a.m. – 5:30 p.m.
Sunday – Wednesday 7:00 a.m. – 5:30 p.m. 
Meetings and Conventions Office
Room 707, South Building, Level 700
Friday 8:30 a.m. – 5:00 p.m.
Saturday 6:30 a.m. – 5:30 p.m.
Sunday – Wednesday 7:00 a.m. – 5:30 p.m.
Members of the administration located in the 
Meetings and Conventions Office are in charge of 
the logistics for the meeting.
Newsroom and Communications Office
Room 501, Park View A, South Building, Level 500
Friday  3:00 p.m. – 5:00 p.m.
Saturday – Tuesday 8:00 a.m. – 5:00 p.m.
Wednesday  8:00 a.m. – 3:00 p.m. 
This room is for the use of registered press and 
credentialed public relations representatives only.
Publishers’ Book Fair/Career Fair
Exhibit Halls D-E, South Building, Level 800
Saturday  9:00 a.m. – 4:00 p.m.
Sunday – Tuesday 10:00 a.m. – 4:00 p.m.
Registration/Course Enrollment 
Admission to all sessions is by registration 
badge only. A separate fee and ticket purchase is 
required for all courses.
Exhibit Halls D-E, South Building, Level 800
Friday 12:00 p.m. – 6:00 p.m.
Saturday – Wednesday* 7:30 a.m. – 5:00 p.m.
*Pre-Function, South Building, Level 700
Sheraton Centre Hotel, Concourse Level
Friday 12:00 p.m. – 6:00 p.m.
Saturday – Tuesday 7:30 a.m. – 5:00 p.m.
The registration fee covers admission to all sessions 
(except courses) and shuttle buses, and includes 
a badge, $10.00 food voucher (for paid registrants 
only), and copy of the Guide to the Annual Meeting. 
The Syllabus, the Guide and poster abstracts will 
be published online for downloading. Registration 
badges are required for all sessions and the Exhibit 
Hall. Only an APA member badge will admit you 
to the Business Meeting. Badge Color Codes: 
Blue=Members; Yellow=Nonmembers; Silver=Press; 
Red=Exhibitors; Green=APA Administration; and 
Clear=Temporary Personnel.
Course tickets not sold in advance will be available 
on site at Registration/Course Enrollment beginning 
at 12:00 p.m. on Friday. You must be registered for 
the meeting before you can enroll in courses.
Scientific Programs Office
Room 712, South Building, Level 700
Friday 12:00 p.m. – 6:00 p.m.
Saturday – Wednesday 7:30 a.m. – 5:00 p.m. 
Come to this office if you have questions about: 
1.) Scientific sessions listed in the Program Book 
or Syllabus; 2.) Adding audiovisual equipment to 
scientific sessions; 3.) Scientific program changes; 
4.) Submitting a scientific session for the 2016 







































Scientific Session Capacity Guidelines
If overcrowding occurs in a scientific session we ask 
your assistance so that all in attendance can benefit. 
Please abide by the following guidelines if you are in 
a crowded room.
1. Take a seat as close to the front of the room as 
possible;
2. Move to the center of the row and fill all seats, 
so that chairs are available on the aisles for 
additional attendees;
3. Don’t stand or sit in the aisles or lean against 
walls. Overcrowding of meeting rooms may 
subject the session to shut down by the Fire 
Marshall; therefore, please either find a seat or 
attend another session.
Shuttle Bus Desk and Service
Curbside, South Building
Pick up at hotels
Saturday May 16 – Wednesday May 20 7:00 a.m.
Last departure from Toronto Convention Centre
Saturday May 16 5:30 p.m.
Sunday May 17 7:30 p.m.
Monday May 18 7:30 p.m.
Tuesday May 19 5:30 p.m.*
Wednesday May 20 5:30 p.m.
A 2015 meeting badge is required to ride on the 
courtesy shuttle bus. The Toronto Convention Centre 
will serve as the “hub” for all shuttle bus routes. A 
continuous shuttle will run between the North and 
South buildings Saturday–Wednesday. A detailed 
shuttle bus schedule will be available on site and will 
be posted in the lobbies of participating hotels.
*After the regular shuttle departures end at 5:30 p.m., 
there will be one departure only for all routes at 6:30 
p.m. from the North Building for those attending 
Mind Games.
Smoking Policy
Smoking is not allowed anywhere in the Toronto 
Convention Centre. 
Audio and Visual Reproduction Policies 
Registrants are not permitted to photograph or video 
any session as the intrusive nature of recording may 
be disruptive. This includes photographs taken with 
cell phone cameras. Audio recording is permitted for 
personal use, only. Registrants are welcome to use 
their own small, portable audio recorders to record 
any session except case conferences or unless 
prohibited by the presenters. Larger professional 
tape recorders are not permitted except for use 
by registered members of the working press in 
accordance with APA Press Policies. Media will be 
identified with appropriate badges and approved 
equipment will be identified with APA Newsroom 
stickers. APA has authorized a professional taping 
firm, who will be clearly identified, to record sessions.
Wi-Fi
Attendees will have free wireless access in all public 
spaces, meeting rooms, and the Connection Café 
(Pre-Function, South Building, Level 800) which is 
supported by Janssen Pharmaceuticals Inc.
There is also free wireless in the two APA Cafés 
(Exhibit Halls D-E, South Building, Level 800, open 
during exhibit hours) which also include free coffee 
and charging stations for laptops, cell phones, and 
other devices. These are supported by Takeda 
Pharmaceuticals USA Inc. and Lundbeck Inc.
Future APA Meetings
APA Annual Meetings
May 14 – 18, 2016  Atlanta, GA
May 20 – 24, 2017  San Diego, CA
May 5 – 9, 2018 New York, NY
Institutes on Psychiatric Services
October 8 – 11, 2015 New York, NY
October 6 – 9, 2016  Washington, DC
October 19 – 22, 2017 New Orleans, LA
The Preliminary Program for the 2015 Institute on 
Psychiatric Services, which includes registration, 
housing, air travel, and program information, will be 
















The Toronto Convention Centre will operate as the “hub” of the APA shuttle bus 
system.  All routes will begin and end there.  The shuttle will operate during the 
following days and times:
Route 1 – Blue
Hilton Toronto At Sheraton Centre
Sheraton Centre  Curbside on Richmond Street West
Route 2 – Red
Courtyard by Marriott Toronto Curbside on Yonge Street
DoubleTree Toronto Downtown At Toronto Marriott Eaton Centre
Eaton Chelsea Toronto Curbside on Gerrard Street West
Pantages Hotel At Toronto Marriott Eaton Centre
Toronto Marriott Eaton Centre Curbside on Bay Street
Route 3 – Green
Radisson Plaza Hotel Admiral Curbside on Queens Quay West
Westin Harbour Castle Curbside on Queens Quay West
Route 4 – Orange
Cosmopolitan Hotel At Omni King Edward Hotel
Novotel Toronto Centre Curbside on the Esplanade,  
across the street
Omni King Edward Hotel Curbside on King Street East
One King West Hotel At Omni King Edward Hotel
Shuttle information signs will be posted in the lobby of each shuttle hotel. 
Check the sign in your hotel lobby for additional information and changes. 
For questions regarding the shuttle or to make an advance reservation for a 
wheelchair accessible shuttle, please see the shuttle supervisor at the Toronto 
Convention Centre during shuttle hours.
Hours of Operation:
Saturday, May 16, 2015 
7:00 a.m. – 5:30 p.m.
Sunday, May 17, 2015 
7:00 a.m. – 7:30 p.m.
Monday, May 18, 2015 
7:00 a.m. – 7:30 p.m.
Tuesday, May 19, 2015 
7:00 a.m. – 5:30 p.m.
One final shuttle departure 
only at 6:30 p.m. from the 
North Building for those 
attending Mind Games.
Wednesday, May 20, 2015 
7:00 a.m. – 5:30 p.m.
Walking Distance 
Hotels, NOT on 
shuttle bus routes: 
Delta Toronto
Fairmont Royal York
Hilton Garden Inn Toronto 
Downtown
Hotel le Germain Maple 
Leaf Square















































Hotel Names and Locations
1. Toronto Convention Centre, 255 Front Street West
2. Cosmopolitan Hotel, 8 Colborne Street
3. Courtyard by Marriott Toronto, 475 Yong Street
4. DoubleTree Toronto Downtown, 108 Chestnut Street
5. Eaton Chelsea Toronto, 33 Gerrard Street West
6. Fairmont Royal York, 100 Front Street West
7. Hilton Garden Inn Toronto Downtown, 92 Peter Street
8. Hilton Toronto, 145 Richmond Street West
9. Hotel le Germain Maple Leaf Square, 75 Bremner Boulevard
10. Hotel le Germain Toronto, 30 Mercer Street
11. Hyatt Regency Toronto, 370 King Street West
12. InterContinental, 225 Front Street West
13. Novotel Toronto Centre, 45 The Esplande
14. Omni King Edward Hotel, 37 King Street East
15. One King West Hotel, 1 King Street West
16. Pantages Hotel, 200 Victoria Street
17. Radisson Plaza Hotel Admiral, 249 Queens Quay West
18. Renaissance Toronto Downtown, 1 Blue Jays Way
19. Residence Inn by Marriott Toronto, 255 Wellington Street
20. Ritz-Carlton Toronto, 181 Wellington Street West
21. Sheraton Centre, 123 Queen Street West
22. Strathcona Hotel Downtown, 60 York Street
23. Toronto Marriott Eaton Centre, 525 Bay Street
24. Westin Harbour Castle, 1 Harbour Square
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 42 DOMINION BALLROOM N.  
 43 DOMINION BALLROOM S.  
42-43 DOMINION BALLROOM 
 44 ROOSEVELT  
 45 MACKENZIE 
 46 CHURCHILL  
 47 CITY HALL   
 48 PROVINCIAL BALLROOM N. 
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    50 ELGIN  
 51 WENTWORTH 
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 55 SIMCOE 
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Presidents/Representatives of U.S. Allied Organizations
Academy of Organizational and Occupational Psychiatry
Andrew O. Brown, M.D.
Academy of Cognitive Therapy
John P. Williams, M.D.
Academy of Psychosomatic Medicine
Catherine C. Crone, M.D.
ACMHA: The College for Behavioral Health Leadership
Leigh Steiner, M.D.
American Academy of Addiction Psychiatry
Laurence M. Westreich, M.D.
American Academy of Child and Adolescent Psychiatry
Paramjit T. Joshi, M.D.
American Academy of Family Physicians
Robert Wergin, M.D.
American Academy of Neurology
Terrence L. Cascino, M.D.
American Academy of Psychiatry and the Law
Graham D. Glancy, M.D.
American Academy of Psychoanalysis and Dynamic 
Psychiatry
David L. Lopez, M.D.
American Association for Emergency Psychiatry
Kimberly D. Nordstrom, M.D.
American Association for Social Psychiatry
Andres J. Pumariega, M.D.
American Association for the Advancement of Science
Dr. Geraldine Richmond
American Association of Chairs of Departments of 
Psychiatry
Carlos N. Pato, M.D.
American Association of Community Psychiatrists
Anita S. Everett, M.D.
American Association of Directors of Psychiatric 
Residency Training
Robert J. Boland, M.D.
American Association of Practicing Psychiatrists
Janis G. Chester, M.D.
American Association of Psychiatric Administrators
Thomas S. Newmark, M.D.
American Board of Psychiatry and Neurology, Inc
Larry R. Faulkner, M.D.
American College of Emergency Physicians
Michael J. Gerardi, M.D.
American College of Obstetricians and Gynecologists
Mark S. DeFrancesco, M.D.
American College of Physicians
Wayne J. Riley, M.D.
American College of Psychiatrists
Francisco Fernandez, M.D.
American College of Psychoanalysts
Jerome S. Blackman, M.D.
American College of Surgeons
Andrew L. Warshaw, M.D.
American Group Psychotherapy Association
Les R. Greene, M.D.
American Medical Association
David O. Barbe, M.D.
American Medical Women’s Association
Theresa Rohr-Kirchgrater, M.D.
American Neurological Association
Robert H. Brown, Jr., M.D.
American Neuropsychiatric Association






Barry S. Anton, M.D.
American Psychosomatic Society
Mustafa al’Absi, M.D.
American Society for Adolescent Psychiatry
Gregory Barclay, M.D.
American Society of Addiction Medicine
R. Jeffrey Goldsmith, M.D.
American Society of Clinical Psychopharmacology, Inc
Maurizio Fava, M.D.
American Society of Hispanic Psychiatry
Mauricio Tohen, M.D.
Arab American Psychiatric Association
Abdel F. Amin, M.D.
















Presidents/Representatives of U.S. Allied Organizations
Association for Behavioral and Cognitive Therapies
Jonathan Abramowitz, M.D.
Association of American Medical Colleges
Darrell G. Kirch, M.D.
Association of Chinese American Psychiatrists
Edmond H. Pi, M.D.
Association of Directors of Medical Student Education 
in Psychiatry
Nutan Atre-Vaidya, M.D.
Association of Gay and Lesbian Psychiatrists
Eric Yarbrough, M.D.
Association of Women Psychiatrists
Stacy S. Drury, M.D.
Council of Medical Specialty Societies
Allen Lichter, M.D.
Depression and Bipolar Support Alliance
Allen Doederlein, M.D.
Group for the Advancement of Psychiatry
Steven S. Sharfstein, M.D.
Indo-American Psychiatric Association
Vani A. Rao, M.D.
Mental Health America
Paul Gionfriddo, M.D.
National Alliance on Mental Illness
Jim Payne, M.D.
National Association of County Behavioral Health and 
Developmental Disability Directors
Cherryle-May. Ramirez, M.D.
National Association of Psychiatric Health Systems
Lisa B. Shea, M.D.
National Association of Social Workers, Inc
Darrell P. Wheeler, M.D.
National Council for Community Behavioral Healthcare
Linda Rosenberg, M.D.
National Institute of Mental Health (NIMH)
Thomas R. Insel, M.D.
National Institute on Alcohol Abuse and Alcoholism 
(NIAAA)
George Koob, M.D.
National Institute on Drug Abuse, (NIDA)
Nora D. Volkow, M.D.
Philippine Psychiatrists in America
Maria I. Lapid, M.D.











































Argentinean Association of Psychiatrists
Dr. Nestor Feliciano Marchant
Argentinean Psychiatrists Association
Dr. Horacio Vommaro
Foundation for Interdisciplinary Investigation of 
Communication (Argentina)
Dr. Miguel Angel Materazzi
Armenian Psychiatric Association
Dr. Armen Soghoyan
The Royal Australian & New Zealand College of 
Psychiatrists
Dr. Murray Patton




Arab Gulf Psychiatric Association
Dr. Mohamed Al-Haddad
Bangladesh Association of Psychiatrists
Dr. Md. Golam Rabbani
Barbados Association of Psychiatrists
Dr. Sharon Harvey
Royal Society of Mental Medicine of Belgium
Dr. William Pitchot
Flemish Psychiatric Association (Belguim)
Dr. Jürgen De Fruyt
Bolivian Society of Psychiatry
Dr. Fernando Garitano-Zavala B.
Psychiatric Association of Bosnia-Herzegovina
Dr. Abdulah Kuc˘ukalic´
Brazilian Association of Psychiatry
Dr. Antonio Geraldo da Silva
Psychiatric Association of Rio de Janeiro State (Brazil)
Dr. Paulo Cesar Geraldes









Society of Neurology, Psychiatry, and Neurosurgery 
(Chile)
Dr. José Luis Castillo
Chinese Society of Psychiatry
Dr. Xin Yu
Hong Kong College of Psychiatrists
Dr. Eric Yu-hai Chen
Colombian Society of Psychiatry
Dr. Iván A. Jiménez R.
Costa Rican Psychiatric Association
Dr. Francisco Gólcher Valverde
Croatian Psychiatric Association
Dr. Vlado Jukic
Cuban Society of Psychiatry







Dominican Society of Psychiatry





Salvadorean Association of Psychiatry (El Salvador)





















Presidents of International Allied Organizations
French Association of Psychiatrists in Private Practice
Dr. Patrice Charbit
French Association of Psychiatry
Dr. Jean-Yves Cozic
French Psychiatric Information Society
Dr. Nicole Garret-Gloanec
International Society of Psychopathology of Expression 
(France)
Dr. Lauren Schmitt
Medical Psychologic Society (France)
Dr. Aimé Charles-Nicolas
The Psychiatric Evolution (France)
Dr. Eric Marcel
Society of Georgian Psychiatrists
Dr. Eka Chkonia




Hellenic Psychiatric Association (Greece)
Dr. Dimitrios Ploumpidis
Hellenic Society of Neurology and Psychiatry (Greece)
Dr. Costas Stefanis
Guatamalan Psychiatric Association
Dr. Nery Adolfo Ortiz Alvarez
Honduran Society of Psychiatry





Indian Association for Social Psychiatry







Iraqi Society of Psychiatrists
Dr. Qassim Hadi Al-Awadi









Dr. Geoffrey Omar Walcott
Japanese Society of Psychiatry and Neurology
Dr. Masatoshi Takeda
Jordanian Association of Psychiatrists
Dr. Walid Moh’d Shnaigat
Kazakh Association of Psychiatrists and Narcologists
Professor Saltanat Nurmagambetova
Kenya Psychiatric Association











Luxembourguese Society of Psychiatry, Neurology and 
Psychotherapy
Dr. Chretien Jacoby




Dr. Teck Hoe Yen
Mauritius Psychiatric Association
Dr. Jagessur Arye Kumar
Mexican Psychiatric Association (Asociación 
Psiquiátrica Mexicana A.C.)





































Presidents of International Allied Organizations
Mexican Society of Neurology and Psychiatry
Dr. Juan Ignacio Rosales




Moroccan Society of Psychiatry
Dr. Fatima-Zahra Sekkat
Mozambican Association of Psychiatry and Mental 
Health
Dr. Maria Lídia Chaúque Gouveia
Psychiatrists’ Association of Nepal




Dr. Elda Yessenia Jiron Gonzalez
Association of Psychiatrists in Nigeria
Dr. Joseph D. Adeyemi
Norwegian Psychiatric Association
Dr. Ketil Joachim Ødegaard
Pakistan Psychiatric Society
Dr. Syed Muhammad Sultan
Palestinian Psychiatric Association
Dr. Ziad Naji Arandi
Panamanian Society of Psychiatry
Dr. Lexma Magalis Ruiz Martez
Papua New Guinea Psychiatric Association
Dr. Umadevi Ambihaipahar
Paraguayan Society of Psychiatry
Dr. Martin Moreno
Peruvian Psychiatric Association
Dr. Juan Manue Yori
Philippine Psychiatric Association
Dr. Edgardo Juan Tolentino, Jr.
Polish Psychiatric Association
Dr. Andrzej Rajewski
Portuguese Association of Psychiatry
Dr. Jose C. Dias Cordeiro
Portuguese Society of Psychiatry and Mental Health
Dr. Maria Luisa Figueira
Puerto Rican Society of Psychiatry
Dr. Jesús M. Saavedra Caballero
Belarusian Psychiatric Association
Dr. Oleg  Skugarevsky
League for Mental Health from Republic of Moldova
Dr. Mihail Hotineanu
Myanmar Medico-Psychological Society
Dr. Win Aung Myint
Association of Free Psychiatrists of Romania
Dr. Aurel Romila
Romanian Association of Psychiatry and Psychotherapy
Dr. Aurel Nirestean
Independent Psychiatric Association of Russia
Dr. Yuri Savenko
Russian Society of Psychiatrists
Dr. Nikolay Neznanov
Saudi Psychiatric Association
Dr. Mahdi S. Abumadini Al-Qahtani








Psychiatric Association of Slovenia
Dr. Peter Pregelj
South African Society of Psychiatrists
Dr. Mvuyiso Talatala
Korean Neuropsychiatric Association (South Korea)
Dr. Byoung-Hoon Oh
Spanish Association of Neuropsychiatry
Dr. Eudoxia Gay Pamos
Spanish Society of Psychiatry
Dr. Miguel Gutiérrez
Sri Lanka College of Psychiatrists
Dr. Samudra Kathriarachchi
Sudanese Association of Psychiatrists

















Presidents of International Allied Organizations
Swiss Society of Psychiatry (Schweiz Gesellschaft für 
Psychiatrie und Psychotherapie - SGPP)
Dr. Pierre Vallon
Syrian Arab Association of Psychiatrists
Dr. Pierre Chiniara
Taiwanese Society of Psychiatry
Dr. Frank Huang-Chih Chou
Psychiatric Association of Thailand
Dr. Yongyud Wongpiromsarn
Tunisian Society of Psychiatry
Dr. Rym Ghacherm Attia





Dr. David Kyemba Basangwa
Ukraine Scientific Society of Neurologists, Psychiatrists 
and Narcologists
Dr. Petro V. Voloshyn
Ukrainian Psychiatric Association
Dr. Viktor Shumlyansky
Emirates Psychiatric Society (United Arab Emirates) 
Dr. Adel Karrani
The Royal College of Psychiatrists
Dr. Simon Wessely
Society of Psychiatry of Uruguay
Dr. Cecillia Idiarte Borda
Association of Psychiatrists of Uzbekistan
Dr. Ulugbek Alimov
Venezuelan Society of Psychiatry
Dr. Yolanda P. Alvarado
Yemen Psychiatrists and Neurologists Association
Dr. Abdelmagid S. Al-Khulaidi
Officers reported to the American Psychiatric Association 






































American Association of Chairs of 
Departments of Psychiatry: support of the 
APA/AACDP Research Mentorship Award.
American Psychiatric Foundation: support 
of the APA Child and Adolescent Psychiatry 
Fellowship; Public Psychiatry Fellowship; 
Diversity Leadership Fellowship and Jeanne 
Spurlock Congressional Fellowship.
Association of Women Psychiatrists: co-support 
of the Alexandra Symonds Award Lecture.
Bristol-Myers Squibb Company: support of 
the APA Fellowship on Public Psychiatry.
Estate of Agnes Purcell McGavin: support 
of the Agnes Purcell McGavin Awards for 
Distinguished Career Achievement in Child and 
Adolescent Psychiatry, and for Prevention.
Estate of Dorothy C Kempf: support of APA/
Kempf Fund Award for Research Development 
in Psychobiological Psychiatry Awards.
Estate of Kun-Po Soo, MD PhD: 
support of the Kun-Po Soo Award.
Helen Johnson-Leipold and  Assurex Health: 
principal support of the Mrazek Memorial Lecture.
Janssen Pharmaceuticals, Inc: support of the 
APF Resident Psychiatric Research Scholars.
Lilly USA LLC: support of the APF Psychiatric 
Research Fellowship; and the APA/Lilly 
Resident Research Awards., and Co-
support of the Simon Bolivar Award.
National Institute of Minority Health 
and Health Disparities: the Research 
Colloquium for Junior Investigators.
Penn/Scattergood Ethics Program: 
recognized for its collaboration with the 2015 
Scientific Program Committee and APA Ethics 
Committee chairperson in the development of 
an ethics track for the 2015 Annual Meeting.
Substance Abuse and Mental Health Services 
Administration (CMHS, CSAP, CSAT): 
sponsorship of the APA/SAMHSA Minority 
Fellowship Program and support of the APA’s 
HIV-related education programs and materials.
The Ittleson Foundation: support of the Blanche 
F. Ittleson Award for Research in Child Psychiatry.
University of Nebraska: support of 
the Frank J. Menolascino Award for 


























































American Psychiatric Association Continuing Medical Education Policy on Full Disclosure
The American Psychiatric Association requires 
disclosure by all program planners and presenters 
at CME activities of any financial or other affiliation 
with commercial organization(s) that may have a 
direct or indirect interest in the subject matter of 
the educational activity. A “financial interest” may 
include, but is not limited to: being an employee 
and/or being a shareholder in the organization; being 
on retainer with the organization; or having research 
or honoraria paid by the organization. An “affiliation” 
may include holding a position on an advisory 
committee, speakers’ bureau or some other role or 
benefit to a supporting organization. 
In compliance with the ACCME’s Standards for 
Commercial Support, the APA has a management 
of conflict (MCI) process for all CME activities. 
This process ensures that all conflicts of interest 
are identified, managed and resolved prior to the 
educational activity. Additionally, the prospective 
audience must be informed of the presenters’ 
or program planners’ affiliations with every 
commercial interest by an acknowledgement in the 
printed program and verbal or visual disclosure to 
participants at the session (disclosure by slide or 
overhead is required if audiovisual equipment is 
used for the presentation). Disclosing to learners the 
relevant financial relationships that were present and 
resolved, assists learners in assessing the potential 
for bias in the information that is presented. The 
APA also requires verbal disclosure of discussion 
of unlabeled uses of a commercial product or 
investigational use of a product not yet approved for 
this purpose. 
The presenters and planners on the following pages 
indicated that either they or a spouse/partner have a 
financial interest or other affiliation with a commercial 
entity producing, marketing, re-selling, or distributing 
health care goods or services consumed by or used 
on patients; the company name and affiliation is also 
listed. Providers of clinical service directly to patients 
are not considered to be commercial interests. The 
second group of presenters and planners indicated 
neither they nor a spouse/partner have any 
significant relationship to disclose. 
All presenters and planners must complete a 
disclosure in order to participate in an APA CME 
activity. This disclosure listing includes the presenters 

































Honoraria Employee Grant/Research Support
Stock/Other Financial 
Relationship Other Disclosure
Aaronson, Scott T. Genomind | Neuronetics Inc. | Gerson Lerman Takeda | Sunovion | Lundbeck
Ahmed, Mohsin Genentech




Bahn, Sabine Myriad Genetics, Inc.
Barchas, Jack D. Eli Lilly
Barkil-Oteo, Andres Gilead Sciences
Baune, Bernhard T. Lundbeck
Benjamin, Sheldon Brain Educators, LLC  1/3 owner
Benson, Carmela J. Janssen JNJ
Beresford, Thomas Otsuka
Berwaerts, Joris (Spouse/Partner)J&J (Spouse/Partner)
J&J
Biederman, Joseph Alcobra |  Forest Res Inst |  Ironshore |  Lundbeck |  Magceu-
tics |  Merck |  PamLab |  Pfizer |  Enzymotec
Prophase |  Shire |  Bracket Global U.S. Patent pending (MGH Corp licensing) for a 
method to prevent stimulant abuse. Royalties: 
Rating scale used for ADHD dx/ Pmt: Ingenix
Blier, Pierre AbbVie | Boehringer Ingelheim | Forest | Genentech | 
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Blumberger, Daniel M. Brainsway Inc | Magventure
Bowie, Christopher AbbVie | Lundbeck Lundbeck
Brams, Matthew N. AstraZeneca | Otsuka | Sunovion | Takeda 
| Lundbeck
Brown, Richard P. Humanetics Humanetics
Brown, Thomas E. Lundbeck Shire Eli Lilly | Shire
Buckley, Peter F. Ameritox | Posit Science Sunovion
Bush, Ashley I. Collaborative Medicinal Development LLC | Brighton 
Biotechnology LLC
Servier Collaborative Medicinal Development LLC Prana Biotechnology Ltd. | Brighton 
Biotechnology LLC | Cogstate Ltd. | 
Mesoblast Ltd.
Chang, Kiki GSK | Actavis | BristolMyersSquibb | Sunovion Merck GSK
Childress, Ann C. Ironshore | Pfizer | Rhodes | Neos | 
Shionogi Inc | Shire | Novartis 
Shire | Novartis | NextWave | Eli Lilly | Forest | J&J | Otsuka 
|  Sunovion | Pfizer | Shionogi Inc | Noven | Theravance | Pur-
due Pharma | Sepracor | Rhodes | Ironshore |  Neurovance | 
Neos | Arbor | Tris
Ciraulo, Domenic A. Merck
Citrome, Leslie Alexza, Alkermes, AstraZeneca, Avanir, BMS, Eli Lilly, 
Envivo, Forest, Genentech, Janssen, Lundbeck, Merck, 
Mylan, Novartis, Noven, Otsuka, Pfizer, Reckitt Benckiser, 
Reviva, Shire, Sunovion, Takeda, Valeant
Alexza |  Alkermes |  AstraZeneca |  
Avanir | BMS |  Eli Lilly |  Envivo |  Forest |  
Genentech |  Janssen |  Lundbeck | Merck 
|  Mylan | Novartis |  Noven | Otsuka | 
Pfizer |  Reckitt Benckiser |  Reviva |  
Shire |  Sunovion |  Takeda | Valeant
Alexza |  Alkermes |  AstraZeneca |  Avanir |  BMS |  Eli Lilly |  
Envivo |  Forest |  Genentech |  Janssen |  Lundbeck |  Merck 
|  Mylan |  Novartis |  Noven |  Otsuka | Pfizer |  Reckitt 
Benckiser |  Reviva |  Shire | Sunovion | Takeda | Valeant
BMS | Eli Lilly | J&J | Merck | Pfizer
Clayton, Anita H. Arbor Scientia | Euthymics Bioscience | Forest | Lundbeck 
| Palatin Technologies | Roche | S1 Biopharmaceuticals | 
Sprout | Takeda
Forest | Pfizer | Takeda | Trimel Euthymics Bioscience | S1 Biopharma-
ceuticals Inc
Clemow, David Eli Lilly
Coffey, Barbara Quintiles | Geneco Sciences AstraZeneca | Catalyst | Otsuka | Shire
Compton, Wilson M. Pfizer
Correll, Christoph U. BMS | Eli Lilly | Genentech | Intracellular Therapies | 
Janssen | Lundbeck | Medavante | Otsuka | Pfizer | Roche 
| Sunovion | Supernus | Takeda | Gerson Lehrman Group | 
Medscape | ProPhase
BMS | Janssen | Lundbeck | Otsuka | 
Pfizer
BMS | Janssen | Otsuka
Cutler, Andrew J. Abbott | AstraZeneca | BMS | Forest | GSK | Lilly | Merck 
| Novartis | Ortho-McNeil Janssen | Otsuka | Pam Lab | 
Pfizer | Shire | Sunovion | Takeda | Vanda
Abbott | AstraZeneca | BMS | Forest | GSK 
| Lilly | Merck | Novartis | Ortho-McNeil 
Janssen | Otsuka | Pam Lab | Pfizer | 
Shire | Sunovion | Takeda | Vanda
Abbott | AstraZeneca | BMS | Forest | GSK | Lilly | Merck | 
Novartis | Ortho-McNeil Janssen | Otsuka | Pam Lab | Pfizer 
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Aaronson, Scott T. Genomind | Neuronetics Inc. | Gerson Lerman Takeda | Sunovion | Lundbeck
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Relationship Other Disclosure
Daly, John P. Avanir
Daniel, David G. Pharmastar Pharmastar, 
Bracket Global
Daskalakis, Z.J. Hoffman-LaRoche | Merck Eli Lilly | Sunovion Brainsway Inc
Datto, Catherine J. AstraZeneca
Davine, Jon S. Lundbeck Lundbeck
Davis, Lori Bracket | Otsuka | Lundbeck | Quintiles | Tonix Merck | Forest | Tonix
Davis, Robert E. Intracellular Therapies 3D Pharmaceuti-
cal Consultants
DeBattista, Charles Pfizer | Genentech St. Jude | Brain Resources | Takeda | Astra Zeneca | Roche | 
CNS Response | Assurerex | NIMH
De Faria, Ludmila Otsuka | Sunovion
D'Mello, Dale J&J
Doghramji, Karl Merck | Jazz | UCB Pharma | Aptalis | Teva | Pfizer Merck
Douaihy, Antoine Orexo
Durgam, Suresh Forest





El-Hage, Wissam AstraZeneca | BMS | Eli Lilly | Janssen-
Cilag | Lundbeck | Otsuka
Erder, Haim M. Shire Shire
Ernst, Carrie L. (Spouse/Partner) Frontline Medical Communications (Spouse/Partner)AstraZeneca | Takeda | 
Sunovion | Lundbeck
(Spouse) Consultant: WebMD and MedScape
Fineberg, Naomi A. GSK | Lundbeck | Transcept | Novartis AstraZeneca | BMS | Janssen-Cilag | 
Lundbeck | Jazz
Cephalon Inc. | GSK | Lundbeck | Servier | AstraZeneca Support to attend scientific  meetings: Jans-




Fong, Timothy W. Reckitt Benckiser
Forester, Brent Sunovion
Frank, Ellen Servier
Frasch, Karel J. Merz Lundbeck Stada | Rhoen Kliniken
Freudenreich, Oliver Psychogenics
Frick, Glenn Shire, GSK, Pfiser
Fridman, Moshe Shire | Vertex | Forest
Gaebel, Wolfgang Lundbeck Symposia support: Janssen-Cilag | GmbH | Neuss 
| Lilly Deutschland GmbH | Bad Homburg | Servier
Gerbarg, Patricia L. (Spouse/Partner)Humanetics (Spouse/Partner)Humanetics
Ghaemi, S. Nassir Takeda
Gobbi, Gabriella AstraZeneca | Merck Glaxo
Goldberg, Joseph F. Frontline Medical Communications | MedScape | webMD AstraZeneca | Merck | Takeda | Lundbeck 
| Sunovion
Goodwin, Frederick K. Merck
Gopal, Srihari Janssen Janssen
Grant, Jon Roche
Green, Alan I. Alkermes | Otsuka Novartis
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Grigoriadis, Sophie Eli Lilly
Hamarman, Stephanie Sunovion | Forest | Actavis
Harvey, Philip Boehringer Ingelheim | Dainippon Sumitomo | Genentech | 
Hoffman-LaRoche | Lundbeck | Otsuka | Takeda
Haydon, Philip G. Gliacure Inc. Gliacure Inc.
Henderson, David Otsuka En vivo | Novartis
Herman, Barry K. Shire Shire
Herrmann, Nathan AbbVie | Eli Lilly Pfizer Lundbeck | Elan Pharmaceuticals | Roche
Hollander, Eric Roche | Coranado Bioscience Shire Roche | Coranado Bioscience
Hu, Rona Sunovion
Hundt, Carla Forest Forest
Huremovic, Damir Abbott
Huss, Michael Novartis Novartis
Iosifescu, Dan V. Avanir Corporation | CNS Response | Lundbeck | Otsuka | 
Servier | Sunovion | INSYS Therapeutics
Alkermes | AstraZeneca | Brainsway Inc | Euthymics Biosci-
ence Inc. | NeoSync | Roche | Shire
Ismail, Zahinoor Janssen | Lundbeck | Eli Lilly | Otsuka | BMS | Pfizer | 
Sunovion | Merck Frosst
Jacobs, Karen Takeda
Jacobson, William Takeda Pfizer
Janicak, Philip G. J&J | Neuronetics Inc. | Otsuka
Johnson, Bankole D&A Pharma, Adial, PEPCo. Du Pont, Parke Davis, Scheer Janssen |  GlaxoSK | Ortho-McNeil | Oy Contral |  Quintiles 




Kahn, RenÃ© Janssen | Roche | Otsuka | Sunovion | Gedeon Richter AstraZeneca | Eli Lilly
Kalin, Ned Corcept Therapeutics, Inc.
Kane, John M. Alkermes | BMS | Eli Lilly | En vivo | Forum Pharmaceu-
ticals | Genentech | Lundbeck | Intracellular Therapies | 
Janssen | J&J | Otsuka | Roche | Reviva Pharmaceuticals
BMS | Janssen | Genentech | Otsuka Medavante
Karnik, Niranjan Hoffman-LaRoche
Katzman, Martin A. GSK | Lundbeck | Eli Lilly | AstraZeneca | Janssen-Ortho | 
Shire | BMS | Pfizer | Biovail Laboratories, Inc. | Boehring-
er Ingelheim | Solvay | Wyeth | Organon, Genuine Health
GSK | Lundbeck | Eli Lilly | AstraZeneca 
| Janssen-Ortho | Shire | BMS | Pfizer | 
Biovail Laboratories, Inc. | Boehringer 
Ingelheim | Solvay
GSK | Lundbeck | Eli Lilly | AstraZeneca | Janssen-Ortho 
| Solvay | Shire | BMS | Takeda | Pfizer | Roche | Purdue 
Pharma | Wyeth | Organnon
Keefe, Richard AbbVie | Amgen | Astellas Pharma US, Inc. | Akebia, 
Asubio, AviNeuro/ChemRar | Helicon | Minerva | Bioline | 
Biogen | BioMarin | Boehringer Ingelheim | Eli Lilly | Forum 
| G W Pharmaceutical | Lundbeck | Merck | Mitsubishi 
| Novartis | Otsuka | Pfizer | Roche | Shire | Sunovion | 
Takeda | Targacept
GSK | Novartis | PsychoGenetics
Kennedy, James L. Assure RX | Crestar | Optimise | Optimise Exec and Gen-
eral Assb Bds | Crestar General Assb Bd
Novartis
Ketter, Terence A. Sunovion | ProPhase LLC | Teva Pfizer (Spouse/Partner)
Janssen
Sunovion (Spouse/Partner)Janssen
Klassen, Larry J. Shire | Janssen-Ortho | Otsuka | Lundbeck | Sunovion | 
Valeant
Eli Lilly | Janssen-Ortho | Lundbeck | 
Otsuka | Shire | Sunovion | Valeant
Kleber, Herbert D. Grunenthal GmBH
Koblan, Kenneth S. Sunovion
Kolli, Venkata B. Janssen
Kornstein, Susan G. Allergan | Forest | Eli Lilly | Naurex | Pfizer | Shire | Takeda BMS | Forest | Roche | Pfizer
Kratochvil, Christopher Pfizer | Otsuka Eli Lilly | Shire | Forest Data Safety Monitoring Board for Neuren
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Relationship Other Disclosure
Krystal, Andrew Merck | Roche | Eisai Inc. | Jazz | Neurocrine Biosciences 
Inc. | Novartis | Somaxon | Teva | TransOral Pharmaceuti-
cals, Inc. | AstraZeneca | Lundbeck | Otsuka | Sunovion
Abbott | Astellas Pharma US, Inc. | Brainsway Inc | Janssen | 
NeoSync | Novartis | Sunovion | Teva
Kupfer, David J. Servier | (Spouse/Partner)Servier (Spouse/Partner)Lundbeck AliphCom | Psychiatric Assessments 
Inc. (spouse) Psychiatric Assessments 
Inc. 
Joint Ownership of Copyright to Pittsburgh Sleep 
Quality Index (PSQI) 
Lam, Raymond W. BMS | Eli Lilly | J&J | Lundbeck | Mochida | Pfizer | Takeda AstraZeneca | Lundbeck | Otsuka BMS | Lundbeck | Pfizer | St. Jude Medical Inc
Lauterbach, Margo D. Brain Educators, LLC, publishers of the Brain 
Card; 1/3 owner
Lavretsky, Helen Forest
Lefebvre, Patrick Janssen Employee: Groupe d’analyse Consulting Co., which 
received research grants from Janssen. 
Lenze, Eric Roche | Lundbeck
Lerdrup, Linda Lundbeck
Leventhal, Bennett L. Janssen Roche
Levin, Frances R. G W Pharmaceutical US World Med
Levine, Stephen B. S1 Biopharmaceuticals Inc
Lewis-Fernandez, Roberto Eli Lilly
Lewy, Alfred J. Servier Co-inventor on several melatonin process patents 
owned by my university and currently not licensed 
to any company.
Li, Yan Lundbeck





Lisanby, Sarah H. Brainsway Inc | Magstim | Magventure | NeoSync | Nexstim
Llorca, Pierre Michel Servier | Janssen | Lundbeck Servier | Lundbeck | AstraZeneca | Biogen AstraZeneca
Loebel, Antony Sunovion




Lorenz, Raymond A. Assure RX
Lozano, Andres M. Medtronic, Inc. | St. Jude Medical Inc | Celgene Corpora-
tion | Boston Scientific | Functional Neuromodulation Ltd
Functional Neuromodulation Ltd
Lucas, Phillipe Tilray Tilray
Lusskin, Shari I. Pfizer Pfizer
Madaan, Vishal Sunovion | Pfizer | Otsuka | Merck | Shire | Forest
Mago, Rajnish Forest | Otsuka Forest | Alkermes | Genomind
Mahableshwarkar, Atul R. Takeda J&J | Pfizer | GSK
Malhotra, Anil Genomind | Forum Pharmaceuticals
Mao, Alice R. Otsuka AstraZeneca | Otsuka | Novartis | Pfizer 
| Sunovion
Marder, Stephen R. Abbott | Takeda | Boehringer Ingelheim | En vivo | Genen-
tech | Jazz | Lundbeck | Roche
Genentech | Sunovion | Synchroneuron Medavante
Massoumi, Lila E. BMS
Mates, Sharon Intracellular 
Therapies
Mathew, Sanjay J. Genentech | Naurex | Cerecor, Inc. Janssen
Mayberg, Helen Eli Lilly | St. Jude Medical Inc St. Jude Medical Inc | Medtronic, Inc.
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Mayberg, Helen Eli Lilly | St. Jude Medical Inc St. Jude Medical Inc | Medtronic, Inc.































Honoraria Employee Grant/Research Support
Stock/Other Financial 
Relationship Other Disclosure
McDonald, William M. Neuronetics Inc. | Cervel Neurotech, Inc. Soterix provides tDCS machines (no cost) to a 
multicenter trial sponsored Stanley FND (I am PI.)  
Employee: Emory Univ which holds a patent for an 
rTMS stimulator used by Neuronetics.  
McDonnell, Mary Ann A. Ironshore Pharmacueticals Ironshore Pharmacueticals
McInerney, Shane J. Pfizer
McIntyre, Roger S. AstraZeneca | BMS | Eli Lilly | Lundbeck | Merck | Pfizer | 
Shire | GSK | Janssen-Ortho | Organon
AstraZeneca | Eli Lilly | Janssen-Ortho | 
Lundbeck | Merck | Pfizer
AstraZeneca | Eli Lilly | Janssen-Ortho | Lundbeck | Pfizer | 
Shire
Mech, Arnold W. Genomind | Vaya Genomind | JayMac  | Orexo | Vaya JayMac | Vaya
Miday, Karen K. (Spouse/Partner)
AstraZeneca
Mischoulon, David Pam Lab Fisher Wallace | Methylation Sciences | Nordic Naturals | 
PharmoRx Therapeutics
Misri, Shaila Pfizer | Sunovion | Lundbeck | Otsuka Lundbeck | Pfizer | Otsuka Pfizer
Mullen, Jamie A. AstraZeneca
Mulsant, Benoit BMS | Pfizer
Murray, Robin Dainippon Sumitomo Janssen-Cilag
Najim, Hellme Otsuka
Nakamura, Tadakatsu Mitsubishi 
Tanabe Pharma 
Corporation
Nasrallah, Henry A. Boehringer Ingelheim | Genentech | Janssen | Merck | 
Otsuka | Sunovion | Teva | Alkermes | Lundbeck
Genentech | Janssen | Otsuka | Sunovion 
| Alkermes
Genentech | Forum Pharmaceuticals
Nelson, J. Craig BMS | Corcept Therapeutics, Inc. | Eli Lilly | Genentech | 
Lundbeck | Otsuka | Pfizer
BMS | Otsuka Avid Atossa  | Atossa (Spouse)
Nemeroff, Charles B. Xhale | Takeda | SK Corporation | Shire | Roche | Allergan 
| Eli Lilly | Mitsubishi Pharma | Taisho Toyama | Lundbeck 
| Gerson Lerman | Prismic | Clintara | (Spouse/Partner) 
Takeda
Xhale | Celgene Corporation | AbbVie | 
Titan | Seattle Genetics
New, Antonia Azevan Pharmaceuticals
Newcomer, John American Physician Institute | CME Out-
fitters | CMEology | American Psychiatric 
Association
National Institutes of Health Jones and Bartlett Publishing | Bristol-Myers 
Squibb | Merck | Vivus
Nguyen, Charles T. Eisai Inc. | Otsuka Eisai Inc. | Otsuka Forest Orexigen
Nierenberg, Andrew A. Lundbeck | Sunovion | Pam Lab | Pfizer | AstraZeneca | 
Medavante | Brain Cells Inc | BMS | Corcept Therapeutics, 
Inc. | Eli Lilly | Forest | Genentech | GSK | Hoffman-
LaRoche | Merck | Methylation Sciences | Naurex | Ridge 
Diagnostics | Shire | Takeda | Teva
Forest | Pam Lab | Pfizer | Shire | Takeda | Lundbeck Medavante | Brain Cells Inc
Nunes, Edward V. Alkermes Alkermes/Cephalon, Inc., Reckitt-Benckiser, Duramed, 
Brainsway
Research Support reflects medications for 
research studies. 
Nylander, Anna-Greta Lundbeck
Olds, Jacqueline Partner in small start up company GoodLux 
Technology





Patterson, Robert D. Genelex Corpora-
tion
Genelex Corporation
Pawaskar, Manjiri Shire Shire
Perez, Vanessa R. Takeda Takeda | Lundbeck
Pesa, Jacqueline Janssen Janssen










































































Honoraria Employee Grant/Research Support
Stock/Other Financial 
Relationship Other Disclosure
McDonald, William M. Neuronetics Inc. | Cervel Neurotech, Inc. Soterix provides tDCS machines (no cost) to a 
multicenter trial sponsored Stanley FND (I am PI.)  
Employee: Emory Univ which holds a patent for an 
rTMS stimulator used by Neuronetics.  
McDonnell, Mary Ann A. Ironshore Pharmacueticals Ironshore Pharmacueticals
McInerney, Shane J. Pfizer
McIntyre, Roger S. AstraZeneca | BMS | Eli Lilly | Lundbeck | Merck | Pfizer | 
Shire | GSK | Janssen-Ortho | Organon
AstraZeneca | Eli Lilly | Janssen-Ortho | 
Lundbeck | Merck | Pfizer
AstraZeneca | Eli Lilly | Janssen-Ortho | Lundbeck | Pfizer | 
Shire
Mech, Arnold W. Genomind | Vaya Genomind | JayMac  | Orexo | Vaya JayMac | Vaya
Miday, Karen K. (Spouse/Partner)
AstraZeneca
Mischoulon, David Pam Lab Fisher Wallace | Methylation Sciences | Nordic Naturals | 
PharmoRx Therapeutics
Misri, Shaila Pfizer | Sunovion | Lundbeck | Otsuka Lundbeck | Pfizer | Otsuka Pfizer
Mullen, Jamie A. AstraZeneca
Mulsant, Benoit BMS | Pfizer
Murray, Robin Dainippon Sumitomo Janssen-Cilag
Najim, Hellme Otsuka
Nakamura, Tadakatsu Mitsubishi 
Tanabe Pharma 
Corporation
Nasrallah, Henry A. Boehringer Ingelheim | Genentech | Janssen | Merck | 
Otsuka | Sunovion | Teva | Alkermes | Lundbeck
Genentech | Janssen | Otsuka | Sunovion 
| Alkermes
Genentech | Forum Pharmaceuticals
Nelson, J. Craig BMS | Corcept Therapeutics, Inc. | Eli Lilly | Genentech | 
Lundbeck | Otsuka | Pfizer
BMS | Otsuka Avid Atossa  | Atossa (Spouse)
Nemeroff, Charles B. Xhale | Takeda | SK Corporation | Shire | Roche | Allergan 
| Eli Lilly | Mitsubishi Pharma | Taisho Toyama | Lundbeck 
| Gerson Lerman | Prismic | Clintara | (Spouse/Partner) 
Takeda
Xhale | Celgene Corporation | AbbVie | 
Titan | Seattle Genetics
New, Antonia Azevan Pharmaceuticals
Newcomer, John American Physician Institute | CME Out-
fitters | CMEology | American Psychiatric 
Association
National Institutes of Health Jones and Bartlett Publishing | Bristol-Myers 
Squibb | Merck | Vivus
Nguyen, Charles T. Eisai Inc. | Otsuka Eisai Inc. | Otsuka Forest Orexigen
Nierenberg, Andrew A. Lundbeck | Sunovion | Pam Lab | Pfizer | AstraZeneca | 
Medavante | Brain Cells Inc | BMS | Corcept Therapeutics, 
Inc. | Eli Lilly | Forest | Genentech | GSK | Hoffman-
LaRoche | Merck | Methylation Sciences | Naurex | Ridge 
Diagnostics | Shire | Takeda | Teva
Forest | Pam Lab | Pfizer | Shire | Takeda | Lundbeck Medavante | Brain Cells Inc
Nunes, Edward V. Alkermes Alkermes/Cephalon, Inc., Reckitt-Benckiser, Duramed, 
Brainsway
Research Support reflects medications for 
research studies. 
Nylander, Anna-Greta Lundbeck
Olds, Jacqueline Partner in small start up company GoodLux 
Technology





Patterson, Robert D. Genelex Corpora-
tion
Genelex Corporation
Pawaskar, Manjiri Shire Shire
Perez, Vanessa R. Takeda Takeda | Lundbeck
Pesa, Jacqueline Janssen Janssen































Honoraria Employee Grant/Research Support
Stock/Other Financial 
Relationship Other Disclosure
Peterchev, Angel Rogue Research Inc. Tal Medical - Travel Support MagVenture - Equip-
ment loan
Phillips, Katharine A. Abbott | AstraZeneca
Pi, Edmund Bracket
Plakun, Eric Abbott | Amgen | Eli Lilly | Novartis | 
(Spouse/Partner)Amgen
Pottorf, William AstraZeneca
Price, Charles S. Avanir | Forest | Takeda | Lundbeck | 
Sunovion | Pam Labs
Rado, Jeffrey T. Genentech | Alkermes | Neuronetics Inc.
Raison, Charles Pam Lab | Lundbeck | Sunovion | Otsuka Pam Lab | Lundbeck | Sunovion | Otsuka
Raj, Y. Pritham AstraZeneca | Forest
Ramirez, Luis F. Sunovion | Otsuka
Rasgon, Natalie L. Shire | Sunovion | Takeda Magceutics | Corcept
Rauch, Scott L. Cyberonics Inc. | Medtronic, Inc.
Renner, John, A. Johnson & Johnson | General Electric
Reynisdottir, Signy (Spouse/Partner)
Otsuka
Reynolds, Charles F. BMS | Forest | Pfizer | Eli Lilly The pharmaceutical companies listed provide sup-
plies and play no role in the design, analysis, or 
reporting of my data in peer reviewed journals.
Richter, Margaret A. Lundbeck
Rintell, David Novartis | Teva | Biogen
Rizvi, Muhammad Janssen
Robinson, David J. Lundbeck | Pfizer | Janssen AstraZeneca | Biovail Laboratories, Inc. 





Rosenbaum, Jerrold F. Medavante | PsyBrain Adult Son is VP of JDS Thearapeutics
Ruano, Gualberto Genomas Inc
Rubinow, David R. Sage Therapeutics Inc.
Ryan, Deirdre Pfizer
Sachs, Gary S. Astellas Pharma US, Inc. | AstraZeneca | BMS | Dainippon 
Sumitomo | Otsuka | Pfizer | Takeda
Astellas Pharma US, Inc. | BMS | GSK | 
Otsuka | Pfizer | Sanofi Pharmaceuticals, 
Inc. | Sunovion | Takeda
Bracket Repligen
Sajatovic, Martha Bracket | Pfizer | Amgen | Otsuka | ProPhase LLC Pfizer | Merck | Janssen | Ortho-McNeil Janssen
Salloum, Ihasan M. Orexigen
Sambunaris, Angelo Mylan | Forest | Takeda Forest | Mylan | Takeda Alkermes | AstraZeneca | Boehringer Ingelheim | BMS | Brain 
Cells Inc | Cenerx | Cephalon Inc. | Forest | GSK | Jazz | J&J 
| Labopharm Inc | Eli Lilly | Lundbeck | Merck | Neurocrine 
Biosciences Inc. | Novartis | Otsuka | Pfizer | Roche | Sanofi 
Aventis | Sunovion | Shire | Takeda
Samtani, Mahesh N. Janssen Janssen
San Román, Alberto Otsuka | Lundbeck | Janssen-Cilag | Eli Lilly
Sanacora, Gerard AstraZeneca | Avanir Corporation | BMS | Eli Lilly | Merck | 
Janssen | Naurex | Roche | Servier | Takeda
AstraZeneca | BMS | Eli Lilly | Merck | Janssen | Naurex | 
Roche | Servier
Biohaven Pharmaceutical











































































Honoraria Employee Grant/Research Support
Stock/Other Financial 
Relationship Other Disclosure
Peterchev, Angel Rogue Research Inc. Tal Medical - Travel Support MagVenture - Equip-
ment loan
Phillips, Katharine A. Abbott | AstraZeneca
Pi, Edmund Bracket
Plakun, Eric Abbott | Amgen | Eli Lilly | Novartis | 
(Spouse/Partner)Amgen
Pottorf, William AstraZeneca
Price, Charles S. Avanir | Forest | Takeda | Lundbeck | 
Sunovion | Pam Labs
Rado, Jeffrey T. Genentech | Alkermes | Neuronetics Inc.
Raison, Charles Pam Lab | Lundbeck | Sunovion | Otsuka Pam Lab | Lundbeck | Sunovion | Otsuka
Raj, Y. Pritham AstraZeneca | Forest
Ramirez, Luis F. Sunovion | Otsuka
Rasgon, Natalie L. Shire | Sunovion | Takeda Magceutics | Corcept
Rauch, Scott L. Cyberonics Inc. | Medtronic, Inc.
Renner, John, A. Johnson & Johnson | General Electric
Reynisdottir, Signy (Spouse/Partner)
Otsuka
Reynolds, Charles F. BMS | Forest | Pfizer | Eli Lilly The pharmaceutical companies listed provide sup-
plies and play no role in the design, analysis, or 
reporting of my data in peer reviewed journals.
Richter, Margaret A. Lundbeck
Rintell, David Novartis | Teva | Biogen
Rizvi, Muhammad Janssen
Robinson, David J. Lundbeck | Pfizer | Janssen AstraZeneca | Biovail Laboratories, Inc. 





Rosenbaum, Jerrold F. Medavante | PsyBrain Adult Son is VP of JDS Thearapeutics
Ruano, Gualberto Genomas Inc
Rubinow, David R. Sage Therapeutics Inc.
Ryan, Deirdre Pfizer
Sachs, Gary S. Astellas Pharma US, Inc. | AstraZeneca | BMS | Dainippon 
Sumitomo | Otsuka | Pfizer | Takeda
Astellas Pharma US, Inc. | BMS | GSK | 
Otsuka | Pfizer | Sanofi Pharmaceuticals, 
Inc. | Sunovion | Takeda
Bracket Repligen
Sajatovic, Martha Bracket | Pfizer | Amgen | Otsuka | ProPhase LLC Pfizer | Merck | Janssen | Ortho-McNeil Janssen
Salloum, Ihasan M. Orexigen
Sambunaris, Angelo Mylan | Forest | Takeda Forest | Mylan | Takeda Alkermes | AstraZeneca | Boehringer Ingelheim | BMS | Brain 
Cells Inc | Cenerx | Cephalon Inc. | Forest | GSK | Jazz | J&J 
| Labopharm Inc | Eli Lilly | Lundbeck | Merck | Neurocrine 
Biosciences Inc. | Novartis | Otsuka | Pfizer | Roche | Sanofi 
Aventis | Sunovion | Shire | Takeda
Samtani, Mahesh N. Janssen Janssen
San Román, Alberto Otsuka | Lundbeck | Janssen-Cilag | Eli Lilly
Sanacora, Gerard AstraZeneca | Avanir Corporation | BMS | Eli Lilly | Merck | 
Janssen | Naurex | Roche | Servier | Takeda
AstraZeneca | BMS | Eli Lilly | Merck | Janssen | Naurex | 
Roche | Servier
Biohaven Pharmaceutical
































Honoraria Employee Grant/Research Support
Stock/Other Financial 
Relationship Other Disclosure
Schatzberg, Alan F. Pfizer | Lundbeck | Takeda | Gilead Sciences | Genentech 
| Neuronetics Inc. | Eli Lilly | Merck | Naurex | Forum 
Pharmaceuticals | Xhale
Sunovion Cervel Neurotech, Inc. | Merck | Pfizer 
| Forest | Neurocrine Biosciences Inc. 
| Amnestix Inc | Corcept Therapeu-
tics, Inc. | Delpor Technology | Titan 
Pharmaceuticals Inc. | Xhale
Named inventor on pharmacogenetic and 
antiglucocorticoid use patents on prediction of 
antidepressant response.
Schooler, Nina R. Forum Pharmaceuticals | Sunovion | Roche Neurocrine Biosciences Inc. | Otsuka | Genentech
Schultz, Susan Eli Lilly | Toyama Eli-Lilly relationship is in partnership with them 
in an Alzheimers Disease Cooperative Study ‘A4 
Trial.’  Toyoma Chemical Co., is in partnership with 
the Alzheimers Disease Coopeative Study ‘Noble 
Trial.’
Schulz, S. Charles Eli Lilly | Genentech | Forum Pharmaceuticals AstraZeneca | Myriad Pharmaceuticals | Otsuka
Shear, Neil H. AbbVie | Amgen | Roche | Janssen | Novartis | Actellion | 
Leo Pharmaceuticals
AbbVie | Amgen | Roche | Janssen | Vale-
ant | Actellion
Sheehan, David Abbott | Actavis | Alexza | Alza | AstraZeneca | Avera 
Pharm | BioMarin | BMS | Cephalon Inc. | Cortex Phar-
maceutical | Cypress Bioscience | Eisai Inc. | Eli Lilly | 
Forest | GSK | Janssen | Jazz | Labopharm Inc | Lundbeck 
| Neuronetics Inc. | Nova Del Pharma Inc. | Novartis | 
Orion | Parexel International Corporation | Otsuka | Pfizer | 
Pharmacia & Upjohn Company, Inc. | PharmaNeuroBoo
Abbott | AstraZeneca | Boehringer 
Ingelheim | Boots Pharmaceuticals | 
Burroughs-Wellcome Pharmaceutical 
Company | BMS | Ciba Geigy Corporation, 
Pharmaceutical Division | Dista Products | 
Eli Lilly | Glaxo | GSK | Humana | Janssen 
| Kali-Duphar Laboratories, Inc. | Labo-
pharm Inc | Lundbeck | Marion-Merrell 
Dow | McNeil Pharmaceuticals | Meade 
Johnson | Merck | Parke-Davis, Division 
of Warner-Lambert Company | Pfizer | 
Pharmacia & Up
Abbott | AstraZeneca | Avera Pharm | BMS | Burroughs-Well-
come Pharmaceutical Company | Cephalon Inc. | Eisai Inc. | 
Eli Lilly | Forest | GSK | Janssen | Jazz | Kali-Duphar Labo-
ratories, Inc. | Labopharm Inc | Lundbeck | Meade Johnson | 
Merck | Novartis | Parke-Davis, Division of Warner-Lambert 
Company | Pfizer | Quintiles | Sandoz Pharmaceuticals Cor-
poration | Sanofi Aventis | Sanofi-Synthelabo Pharmaceu
Simon, Naomi (Spouse/Partner)Dandreon | (Spouse/
Partner)Elan Pharmaceuticals | 
(Spouse/Partner)Gatekeeper | 
(Spouse/Partner)Gzero
Simpson, H. Blair Janssen-Ortho | Transcept
Siu, Cynthia Sunovion
Skuban, Aleksandar Otsuka
Sledge, William H. (Spouse/Partner)Pfizer | J&J
Spencer, Thomas Alcobra | Heptares | Impax | Ironshore | Lundbeck | Shire | 
Sunovion | Enzymotec Ltd.
US Patent Pending (Provisional # 61/233,686) 
through MGH Corporate Sponsored Licensing, on 
a method to prevent stimulant abuse 
Stankovic, Srdjan Alkermes
Starr, H. Lynn Janssen J&J
Stewart, Donna Eli Lilly
Strauss, Gordon Allergan | Baxter Healthcare Corp | 
Boston Scientific | BMS | Eli Lilly | 
GSK | Humana | J&J | Medco Health 
| Merck | Pfizer | Proctor & Gamble | 
Repligen | Wyeth-Ayerst
Sullivan, Maria A. Alkermes Alkermes has provided medication for a NIDA-
funded trial that I serve as Principal Investigator.
Summers, Richard F. Eli Lilly | BMS | Biogen | Sangamo Bio 
Science
Sun, Shawn X. Actavis Actavis
Suppes, Trisha AstraZeneca | Pfizer
Surman, Craig Pfizer Alcobra | Janssen-Ortho | Shire Magceutics | Pam Lab
Tamminga, Carol A. Astellas Pharma US, Inc. | Autifony | Eli Lilly | Intracellular 
Therapies | Lundbeck | Pfizer
Sunovion
Thase, Michael E. Alkermes | Allergan | AstraZeneca | BMS | Cerecor, Inc. | 
Eli Lilly | Forest | Gerson Lerman | Guidepoint Global | GSK 
| Lundbeck | Medavante | Merck | Moksha | Neuronetics 
Inc. | Novartis | Otsuka | Ortho McNeil Pharmaceuticals | 
Pam Lab | Shire | Sunovion | Takeda










































































Honoraria Employee Grant/Research Support
Stock/Other Financial 
Relationship Other Disclosure
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antiglucocorticoid use patents on prediction of 
antidepressant response.
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Trial.’
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Eli Lilly | Glaxo | GSK | Humana | Janssen 
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pharm Inc | Lundbeck | Marion-Merrell 
Dow | McNeil Pharmaceuticals | Meade 
Johnson | Merck | Parke-Davis, Division 
of Warner-Lambert Company | Pfizer | 
Pharmacia & Up
Abbott | AstraZeneca | Avera Pharm | BMS | Burroughs-Well-
come Pharmaceutical Company | Cephalon Inc. | Eisai Inc. | 
Eli Lilly | Forest | GSK | Janssen | Jazz | Kali-Duphar Labo-
ratories, Inc. | Labopharm Inc | Lundbeck | Meade Johnson | 
Merck | Novartis | Parke-Davis, Division of Warner-Lambert 
Company | Pfizer | Quintiles | Sandoz Pharmaceuticals Cor-
poration | Sanofi Aventis | Sanofi-Synthelabo Pharmaceu
Simon, Naomi (Spouse/Partner)Dandreon | (Spouse/
Partner)Elan Pharmaceuticals | 
(Spouse/Partner)Gatekeeper | 
(Spouse/Partner)Gzero
Simpson, H. Blair Janssen-Ortho | Transcept
Siu, Cynthia Sunovion
Skuban, Aleksandar Otsuka
Sledge, William H. (Spouse/Partner)Pfizer | J&J
Spencer, Thomas Alcobra | Heptares | Impax | Ironshore | Lundbeck | Shire | 
Sunovion | Enzymotec Ltd.
US Patent Pending (Provisional # 61/233,686) 
through MGH Corporate Sponsored Licensing, on 
a method to prevent stimulant abuse 
Stankovic, Srdjan Alkermes
Starr, H. Lynn Janssen J&J
Stewart, Donna Eli Lilly
Strauss, Gordon Allergan | Baxter Healthcare Corp | 
Boston Scientific | BMS | Eli Lilly | 
GSK | Humana | J&J | Medco Health 
| Merck | Pfizer | Proctor & Gamble | 
Repligen | Wyeth-Ayerst
Sullivan, Maria A. Alkermes Alkermes has provided medication for a NIDA-
funded trial that I serve as Principal Investigator.
Summers, Richard F. Eli Lilly | BMS | Biogen | Sangamo Bio 
Science
Sun, Shawn X. Actavis Actavis
Suppes, Trisha AstraZeneca | Pfizer
Surman, Craig Pfizer Alcobra | Janssen-Ortho | Shire Magceutics | Pam Lab
Tamminga, Carol A. Astellas Pharma US, Inc. | Autifony | Eli Lilly | Intracellular 
Therapies | Lundbeck | Pfizer
Sunovion
Thase, Michael E. Alkermes | Allergan | AstraZeneca | BMS | Cerecor, Inc. | 
Eli Lilly | Forest | Gerson Lerman | Guidepoint Global | GSK 
| Lundbeck | Medavante | Merck | Moksha | Neuronetics 
Inc. | Novartis | Otsuka | Ortho McNeil Pharmaceuticals | 
Pam Lab | Shire | Sunovion | Takeda































Honoraria Employee Grant/Research Support
Stock/Other Financial 
Relationship Other Disclosure
Trivedi, Madhukar Abbot | Abdi | Akzo [Organon] | Alkermes | AstraZeneca 
| Bristol-Meyer Squibb | Cephalon | Cerecor | Concert | 
Eli Lilly | Evotec | Fabre Kramer | Forest | GSK | Janssen 
| J&J | Libby | Lundbeck | Meade Johnson | MedAvante 
| Medtronic | Merck | Mitsubishi | Tanabe | Naurex | 
Neuronetics | Otsuka | Pamlab | Parke-Davis | Pfizer | Pgx-
Health | Rexahn | Ridge Diag | Roche | Sepracor | Shire | 
SK Life & Sci | Sunovion | Takeda | Tal Medical | Targacept 
| Transcept | VantagePoint | Vivus | Wyeth
AHRQ | Corcept | Cyberonics | Merck
Ungar, Thomas E. BMS | Eli Lilly | Janssen | Lundbeck | Otsuka | Sunovion BMS | Eli Lilly | Janssen | Lundbeck | 
Otsuka | Sunovion
Van Ameringen, Michael Forest | Janssen | Labopharm Inc | Lundbeck | Pfizer | 
Servier | Shire | Sunovion | Valeant
Janssen | Lundbeck | Pfizer | Shire Forest | Janssen | Pfizer | Roche | Servier
van den Heuvel, Odile A. Lundbeck GE Healthcare Inc. | PhotoPharmics Inc.




SynapDx SynapDx | Novartis | Roche | Sunovion | Forest | Seaside 
Therapeutics
Verduin, Marcy J&J
Vieta, Eduard BMS | AstraZeneca | Elan Pharmaceuticals | Eli Lilly | 
Ferrer International | Forest | Glaxo | Janssen-Cilag | Jazz 
| Lundbeck | Merck | Novartis | Otsuka | Pfizer | Roche | 
Servier | Shire | Schering Corporation | Sunovion | Takeda 
| Teva | United BioSource
Almirall | Astra-Zeneca | BMS | Elan | Eli Lilly | Ferrer | Forest 
| Gedeon Richter |  GSK | Janssen-Cilag | Jazz | Lundbeck | 
Merck | Novartis |  Otsuka | Pfizer | Roche | Sanofi | Servier |  
Schering-Plough | Shire | Sunovion |  Takeda | Teva | United 
Biosource
Vigod, Simone (Spouse/Partner)Brainsway Inc | (Spouse/Partner)Magven-
ture
Wagner, Karen D. Lundbeck UBM Medica
Wang, Rosa Evidera Forest Inc.
Weiss, Roger D. Reckitt Benckiser
Wietecha, Linda Eli Lilly
Woodruff, Kimberly Janssen Pfizer
Wright, Jesse H. Empower Interactive | Mindstreet
Xie, Lin Eisai Inc. STATinMED 
Research
Yatham, Lakshmi N. Forest | AstraZeneca | BMS | GSK | J&J | Novartis | Pfizer | 
Abbott | Servier | Wyeth-Ayerst
AstraZeneca | BMS | GSK | J&J | Novartis | Pfizer | Abbott | 
Servier | Wyeth-Ayerst
Zane, Ellen M. Parexel International Corporation Brooks Automation: May use their automated 
compound and biological sample storage manage-
ment; Haemonetics Corp: May use their devices, 
information mgmt and consulting svcs of blood 
mgmt.
Zeller, Scott L. Teva | Alexza Teva
Zipursky, Robert Otsuka | Lundbeck Roche
Zukin, Stephen R. Forest










































































Honoraria Employee Grant/Research Support
Stock/Other Financial 
Relationship Other Disclosure
Trivedi, Madhukar Abbot | Abdi | Akzo [Organon] | Alkermes | AstraZeneca 
| Bristol-Meyer Squibb | Cephalon | Cerecor | Concert | 
Eli Lilly | Evotec | Fabre Kramer | Forest | GSK | Janssen 
| J&J | Libby | Lundbeck | Meade Johnson | MedAvante 
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Van Ameringen, Michael Forest | Janssen | Labopharm Inc | Lundbeck | Pfizer | 
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van den Heuvel, Odile A. Lundbeck GE Healthcare Inc. | PhotoPharmics Inc.




SynapDx SynapDx | Novartis | Roche | Sunovion | Forest | Seaside 
Therapeutics
Verduin, Marcy J&J
Vieta, Eduard BMS | AstraZeneca | Elan Pharmaceuticals | Eli Lilly | 
Ferrer International | Forest | Glaxo | Janssen-Cilag | Jazz 
| Lundbeck | Merck | Novartis | Otsuka | Pfizer | Roche | 
Servier | Shire | Schering Corporation | Sunovion | Takeda 
| Teva | United BioSource
Almirall | Astra-Zeneca | BMS | Elan | Eli Lilly | Ferrer | Forest 
| Gedeon Richter |  GSK | Janssen-Cilag | Jazz | Lundbeck | 
Merck | Novartis |  Otsuka | Pfizer | Roche | Sanofi | Servier |  
Schering-Plough | Shire | Sunovion |  Takeda | Teva | United 
Biosource
Vigod, Simone (Spouse/Partner)Brainsway Inc | (Spouse/Partner)Magven-
ture
Wagner, Karen D. Lundbeck UBM Medica
Wang, Rosa Evidera Forest Inc.
Weiss, Roger D. Reckitt Benckiser
Wietecha, Linda Eli Lilly
Woodruff, Kimberly Janssen Pfizer
Wright, Jesse H. Empower Interactive | Mindstreet
Xie, Lin Eisai Inc. STATinMED 
Research
Yatham, Lakshmi N. Forest | AstraZeneca | BMS | GSK | J&J | Novartis | Pfizer | 
Abbott | Servier | Wyeth-Ayerst
AstraZeneca | BMS | GSK | J&J | Novartis | Pfizer | Abbott | 
Servier | Wyeth-Ayerst
Zane, Ellen M. Parexel International Corporation Brooks Automation: May use their automated 
compound and biological sample storage manage-
ment; Haemonetics Corp: May use their devices, 
information mgmt and consulting svcs of blood 
mgmt.
Zeller, Scott L. Teva | Alexza Teva
Zipursky, Robert Otsuka | Lundbeck Roche
Zukin, Stephen R. Forest
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These sessions are intended to highlight important 
new advances occurring in the field of psychiatry 
involving selected disorders or treatments. Some of 
these sessions are chaired by editors of recent text-
books published by American Psychiatric Publishing, 
(APP), and feature selected chapter authors from 
these texts. The books discussed at these sessions 
may be purchased at the APP bookstore or online. 
During the Advances in Research Session, leading 
clinical researchers present the latest developments 
in research. Other types of advances in sessions 
include topics designed to provide psychiatrists with 
the latest in clinical developments in other areas of 
medicine. The intent is to give the audience an up-
date from a physician in a particular specialty. These 
sessions will help attendees keep pace with the 
rapidly expanding knowledge base and technology 
in various branches of medicine.
Case Conferences
During these 90-minute sessions, clinical material is 
presented by videotape or the treating therapist. One 
or more experts then discuss the case.
Courses/Master Courses
Courses are designed to emphasize learning 
experiences that actively involve participants and 
include the opportunity for informal exchange with 
the faculty. Offered in four-hour (half-day), six-
hour (full-day), and eight-hour (full-day) sessions, 
courses either review basic concepts in a special 
subject area or present advanced material on a 
circumscribed topic. Attendees must be registered 
for the meeting and purchase tickets to attend.
Focus Live!
These 90-minute sessions allow attendees to test 
their knowledge using an interactive Audience Re-
sponse System (ARS), offering a new and entertain-
ing way to learn. By using the ARS, attendees will 
feel like they are involved in a small group consulta-
tion with an expert clinician, even though the session 
is being attended by a large number of people. 
Experts, who served as guest editors of FOCUS, will 
lead lively multiple choice question-based discus-
sions, and the audience will enter their answers 
using hand-held devices. The results are instantly 
tallied and projected on the screen.
Forums
These are flexible presentations that afford an 
opportunity to highlight and select topics that are 
of timely interest to psychiatrists and other mental 
health professionals. Speakers and panel members 
are chosen by the Scientific Program Committee for 







































Lectures feature a small number of distinguished 
speakers discussing scientific and cultural topics, 
many of which will extend our understanding beyond 
the usual limits of clinical psychiatry. The Scientific 
Program Committee invites the lecturers. Award 
lectures are selected by the various APA Award 
Boards and/or Councils. All award lecturers are 
approved by the Board of Trustees.
New Research
This format allows for presentation of very recent 
findings. Posters, which are visual, are self-
explanatory presentations. Two poster sessions on 
Monday will be designated as Young Investigators’ 
Poster Sessions, which will contain poster 
presentations from young investigators, residents, 
medical students, and research or clinical fellows.
Scientific And Clinical Reports
Scientific and Clinical Reports are oral presentations 
of papers prepared for submission before 
publication. In this 90-minute format, reports are 
grouped by topic, with discussion from the audience 
following the presentation of each paper. There is no 
formal discussant.
Seminars
Seminars are designed to emphasize in-depth 
learning experiences that actively involve participants 
and include the opportunity for informal exchange 
with the presenters. Offered in four-hour (half-day) 
sessions, seminars either review basic concepts in a 
special subject area or present advanced material on 
a circumscribed topic.
Interactive Sessions
This 90-minute format allows small groups to meet 
informally with either selected experts in psychiatry 
to discuss topics chosen by the expert; to obtain 
consultations for problems in research from senior 
researchers; or utilize clinical material offered by 
the attendee and hear clinically-based seminars 
presented by outstanding educators.
Symposia/ Presidential
Symposia are two or three-hour sessions consist-
ing of four to six presentations that are thematically 
linked and focus on a specific topic relevant to clini-
cal psychiatry. They are designed to provide com-
prehensive treatment on a topic or discussion of the 
topic from several points of view by the participants 
and stimulate discussion with the audience.
Workshops/ Media
Workshops are 90-minute sessions, which typi-
cally involve brief presentations from individual panel 
members, followed by the opportunity for lively and 
informative discussion. This format provides for sub-
stantial audience participation and should be highly 
interactive. Media Workshops are three-hour sessions 















Daily Log for Attendance at CME Sessions
Date / Time Title of Session # of Hours
Total
This form is for your records and not for submission. Use this page to keep track of your attendance. 
Reporting is on an honor basis, claim one credit for each hour of participation.
All scientific sessions listed in the Annual Meeting Program Book are designated for AMA PRA Category 1 
Credits™, except for Poster Sessions.
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Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Conversion Disorder: Update on 
Evaluation and Management
5
8:00 a.m. - 12:00 p.m.
Grand Ballroom West, Lower Concourse
Sheraton Centre Toronto Hotel
Directors:
Gaston Baslet, M.D.
John J. Barry, M.D.
Faculty:
Andres Kanner, M.D.
W. Curt LaFrance Jr., M.D., M.P.H.
Adriana Bermeo-Ovalle, M.D.
Attention-Deficit/Hyperactivity 
Disorder in Adults: From Clinical 
Science to Clinical Practice
8:00 a.m. - 12:00 p.m.
Grand Ballroom Center, Lower Concourse






8:00 a.m. - 12:00 p.m.
Sheraton Hall E, Lower Concourse
Sheraton Centre Toronto Hotel
Director:
John C. Markowitz, M.D.
Updates in Geriatric Psychiatry
American Association for Geriatric 
Psychiatry
4
8:00 a.m. - 12:00 p.m.
Dominion Ballroom North, 2nd Floor
Sheraton Centre Toronto Hotel
Director:
Rajesh R. Tampi, M.D.
Faculty:
I lse Wiechers, M.D., M.H.S., M.P.P.




An Update on the Management of 
Psychiatric Disorders in Pregnant and 
Postpartum Women
8:00 a.m. - 12:00 p.m.
Dominion Ballroom South, 2nd Floor






Shari I. Lusskin, M.D.
Tricia Bowering, M.D.
Courses
Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Buprenorphine and Office-Based 
Treatment of Opioid Use Disorder
APA Council on Addiction Psychiatry
1
8:00 a.m. - 5:00 p.m.
Chestnut East-West, Mezzanine
Sheraton Centre Toronto Hotel
Directors:
Petros Levounis, M.D.
John A. Renner, M.D.
Faculty:
Andrew J. Saxon, M.D.
9:00 a.m. Sessions
Case Conference
These sessions are open to 
APA members only. A blue 
registration badge or an APA 
membership card are required for 
admittance.
!
Ketamine Treatment of Mood 
Disorders: Promising New Clinical 
Avenue or Dead-End Road?
9:00 a.m. - 10:30 a.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Gerard Sanacora, M.D., Ph.D.
Speakers:
Robert B. Ostroff, M.D.
Sanjay J. Mathew, M.D.
Steven Garlow, M.D., Ph.D.
Complexity, Comorbidity, and 
Challenges to Treatment
9:00 a.m. - 10:30 a.m.
Room 715 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:




Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
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 APA Meeting on Demand
!
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 













All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 




Psychiatry Under National Socialism: 
Remembrance and Responsibility
APA International Psychiatrist Lecture 
Series
9:00 a.m. - 10:30 a.m.
Room 102 (Theatre), Level 100, North 
Building
Metro Toronto Convention Centre
Lecture Chairs:
Paul Summergrad, M.D.
Barton J. Blinder, M.D., Ph.D.
Lecturer:
Frank Schneider, M.D., Ph.D.
Scientific and Clinical 
Reports
Studies in Geriatric Psychiatry and 
Dementia
 4
9:00 a.m. - 10:30 a.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Arnaldo Moreno, M.D.
1. Attitudes Toward Dementia, 
Awareness of Dementia Services, 
and Impact of a Short Film on 
Dementia Stigma in a Chinese-
American Community
Benjamin K.P. Woo, M.D.
4
2. Increasing Usage of Sedative 
Antidepressants in Long-Term 
Care Homes Among Elderly With 
Dementia: A Population-Based Time-
Series Analysis
Akshya Vasudev, M.B.B.S., M.D.
4
3. Self-Perceived Need for Mental 
Health Care and Successful 
Treatment of Depressive Symptoms 
in the Elderly: Findings From an 
Implementation Study
Eric Van Exel, M.D., Ph.D.
4
4. Altered Default Mode Network 







9:00 a.m. - 10:30 a.m.
Rooms 202 C-D, Level 200, North 
Building
Metro Toronto Convention Centre
Chairs:
Michelle Riba, M.D.
Leah J. Dickstein, M.A., M.D.
Models of Mental Health 
Collaboration in Pediatric Primary 
Care
APA Council on Children, Adolescents 
and Their Families
2
9:00 a.m. - 10:30 a.m.
Room 204 (Summit), Level 200, North 
Building





Marian F. Earls, M.D.
Katherine E. Grimes, M.D., M.P.H.
Amy Cheung, M.D., M.Sc.
EEG in Psychiatric Practice
World Psychiatric Association
9:00 a.m. - 10:30 a.m.
Room 205 C, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Oliver Pogarell, M.D.
Nashaat N. Boutros, M.D.
Speakers:
Oliver Pogarell, M.D.
Nashaat N. Boutros, M.D.
Use of Social Media and the Internet 
to Educate the Masses: Increasing 
Awareness and Decreasing the 
Stigma of Psychiatry Amongst 
Minority Populations
APA/SAMHSA Minority Fellows
9:00 a.m. - 10:30 a.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Wilsa M.S. Charles Malveaux, M.A., M.D.
Speakers:
Jeffrey A. Borenstein, M.D.
Racquel Reid, M.D.
Chuan Mei Lee, M.D.
Vandai Le, M.D.
Tiffani Bell, M.D.
Frank Schneider, MD, PhD Studies in Psychology and Medicine. Specialist in Psychiatry 
and Psychotherapy. Following positions in Tübingen, Philadelphia and Duesseldorf since 
2003 head of the Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH 
Aachen University. Past President of the German Associon for Psychiatry, Psychotherapy 
ans Psychosomatics, Adjunct Professor of Psychiatry, School of Medicine, University of 
Pennsylvania, Managing Director of the Jülich Aachen Research Alliance (JARA), Vice 
Dean at the School of Medicine, RWTH Aachen University, and speaker of the International 
Research Training Group Schizophrenia and Autism (funded by DFG). Member of APA since 
1993. Since several years he is annually listed as a Top-Physician in the sections Psychiatry, 










U.S. and Low- and Middle-Income 
Countries Models of Education and 
Training on Global Mental Health
APA Caucus on Global Mental Health and 
Psychiatry
9:00 a.m. - 10:30 a.m.
Room 802 A-B, Level 800, South Building





Donald R. Banik, D.O., M.P.H.
Muhammad Irfan, M.B.B.S., M.S.
Roy A. Kallivayalil, M.D.
Carla Marienfeld, M.D.
Maintenance of Certification Part 4 
- Performance in Practice: Making It 
Work in Your Practice
9:00 a.m. - 10:30 a.m.
Room 803 A-B, Level 800, South Building







Margo D. Lauterbach, M.D.
Empathy: To Teach, to Learn, to 
Practice
9:00 a.m. - 10:30 a.m.







Second Generation Collaborations: 
Curing the Ailment of Politics in 
Psychiatric Treatment
2
9:00 a.m. - 10:30 a.m.










Advances in Substance Abuse 
Treatment
 1
9:00 a.m. - 12:00 p.m.
Exhibit Hall G, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Marc Galanter, M.D.
Herbert D. Kleber, M.D.
Discussant:
Kathleen Brady, M.D., Ph.D.
1. Assessment of Patients With 
Substance Use Disorders
Shelly Greenfield, M.D., M.P.H.
2. Treatment Strategies for Cannabis 
Use Disorders
Frances R. Levin, M.D.
3. Buprenorphine in the Treatment of 
Addiction: Past, Present, Future
Herbert D. Kleber, M.D.
4. Women and Addiction: Gender-
Specific Issues
Kathleen Brady, M.D., Ph.D.
5. Alcoholics Anonymous and 
Spirituality in Long-Term Recovery
Marc Galanter, M.D.
Media Workshops
“The Way He Looks”: A Brazilian Film 
About Being Young, Gay, and Blind
American Academy of Child and 
Adolescent Psychiatry
2
9:00 a.m. - 12:00 p.m.
Ballroom A-B, Lower Level
InterContinental Toronto Centre
Chairs:
Richard R. Pleak, M.D.
Jose Vito, M.D.
Speakers:




Current Developments in Forensic 
Psychiatry
American Academy of Psychiatry and the 
Law
 3
9:00 a.m. - 12:00 p.m.
Room 718 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Robert Weinstock, M.D.
Jeffrey S. Janofsky, M.D.
1. Stalking: Overview and Clinical Risk 
Management
Debra Pinals, M.D.
2. The Detection of Malingered 
Hallucinations
Phillip Resnick, M.D.
3. Psychiatry and the Death Penalty: 
Duties, Dilemmas, and Death
Charles Scott, M.D.
4. The Challenges of Practicing at the 
Interface of Psychiatry and Law
Robert Weinstock, M.D.
5. Reducing Inpatient Suicide Risk: 
Improving Observation Practices
Jeffrey S. Janofsky, M.D.
6. Assessment of Juvenile Violence: 
From Prediction to Prevention
Charles Scott, M.D.
All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
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 APA Meeting on Demand
!
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 














Drugs, Drinking, and Disordered 
Eating: Managing Psychiatric 
Complications Associated With 
Bariatric Surgery
9:00 a.m. - 12:00 p.m.
Rooms 201 A-F, Level 200, North Building





1. New Insights Into Alcohol Use 
Disorders After Bariatric Surgery
Sanjeev Sockalingam, M.D.
2. Psychopharmacology in Severe 
Obesity: Surgery and Beyond
Raed Hawa, M.D.
3. Disordered Eating After Bariatric 
Surgery: Detection and Treatment
Susan M. Wnuk, Ph.D.
4. Smartphone Apps and Online 
Psychosocial Resources for Weight 
Loss: The Psychiatrist’s Toolkit
Melvyn W.B. Zhang, M.B.B.S.
5. Motivational Interviewing for 
Massive Weight Loss: Office-Based 
Interventions
Stephanie E. Cassin, Ph.D.
Multiple Sclerosis and Mental Health: 
An Interdisciplinary Care Model
 5
9:00 a.m. - 12:00 p.m.
Rooms 202 A-B, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Laura Safar, M.D.
1. Multiple Sclerosis (MS) Services 
and Access to Care: Building an 
Interdisciplinary Team
Sarah L. Minden, M.D.
2. Neuropsychiatric Assessment and 
Management in Multiple Sclerosis
Laura Safar, M.D.
3. Cognitive Deficits in MS: Assessment 
and Rehabilitation Therapies
Lindsay Barker, Ph.D.
4. Psychosocial Adaptation in MS
David Rintell, Ed.D.
5. An Eight-Year Telephone Support 
Group for Homebound People With 
Multiple Sclerosis
Audrey H. Cecil, M.S.W.
Can Better Understanding of the 
Mechanisms Underlying Obsessive 
Compulsive Disorder Impact on 
Treatment?
9:00 a.m. - 12:00 p.m.
Rooms 203 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Margaret A. Richter, M.D.
Discussant:
H. Blair Simpson, M.D., Ph.D.
1. Clinical Correlates of Treatment 
Outcome in OCD
Margaret A. Richter, M.D.
2. The Examination of Five- Factor 
Model Personality Traits and 
Cognitive Dimensions in Cognitive 
Behavioral Therapy Treatment for 
OCD
Neil Rector, Ph.D.
3. Understanding the Role of Habit in 
OCD
Naomi A. Fineberg, M.B.B.S.
4. Brain Circuit Structure and Function 
in OCD
Odile A. van den Heuvel, M.D., Ph.D.
5. Pharmacogenetic Markers of 
Treatment Response in OCD
Gwyneth Zai, M.D., M.Sc.
Shame: The Missing Factor in 
Conceptualizing and Treating 
Borderline Personality Disorder: 
Shame’s Powerful Impact on the 
Lives of Those With Borderline 
Personality Disorder (BPD)
9:00 a.m. - 12:00 p.m.
Room 206 C-D, Level 200, North Building





1. Cutting to the Core of BPD- TARA 
Method Techniques for Coping With 
Shame in the Family
Valerie Porr, M.A.
2. Development of an Evidence-Based, 
Cognitive-Behavioral Treatment 
for Shame: Self-Acceptance Group 
Therapy
Michelle Schoenleber, Ph.D.
3. Treating Shame With Transference 
Focused Therapy Methadology
Peter Freed, M.D.
4. Shame From the Inside Out: How 
Shame Is Experienced When Coping 
With BPD
Kristie Tse, B.A.
The Role of Addictions in the HIV 
Treatment Cascade
 1
9:00 a.m. - 12:00 p.m.
Rooms 206 E-F, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Lawrence M. McGlynn, M.D.
1. The Addiction Circuitry in HIV/AIDS
Harinder Rai, B.A.
2. Alcohol Use Disorders and HIV
Yelizaveta I. Sher, M.D.
3. Heroin Use and HIV/AIDS: An Update
Rusty Baik
4. The Role of Methamphetamine 
and Party Drugs in the HIV/AIDS 
Treatment Cascade
Lawrence M. McGlynn, M.D.
5. The Role of Motivational Interviewing 
in the HIV Treatment Cascade
Antoine Douaihy, M.D.
Advances in Medications 
Development to Treat Alcohol 
Use Disorder and Co-Occurring 
Psychiatric Disorders
U.S. National Institute on Alcohol Abuse 
and Alcoholism
 6
9:00 a.m. - 12:00 p.m.
Room 701 B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Raye Z. Litten, Ph.D.
Discussant:
Raye Z. Litten, Ph.D.
1. Medications Development for Alcohol 
Use Disorder: Why Human Laboratory 
Models Are a Good Idea
Raye Z. Litten, Ph.D.
2. A Double-Blind, Placebo-Controlled 
Trial Assessing the Efficacy and 
Safety of Varenicline Tartrate for 
Alcohol Dependence
Daniel E. Falk, Ph.D.
3. Treatment of Alcohol Use Disorder 
With Co-Occurring Bipolar Disorder: 
Efficacy and Prediction of Treatment 
Response









4. Alcohol Use Disorder and 
Schizophrenia: Approaches to 
Pharmacologic Interventions
Alan I. Green, M.D.
Meaning and Dignity in End-of-Life 
Care: Psychotherapeutic Innovations
 4
9:00 a.m. - 12:00 p.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Harvey M. Chochinov, M.D., Ph.D.
Discussant:
Molyn Leszcz, M.D.
1. Dignity Therapy: Evidence and 
Practice in Palliative Care
Harvey M. Chochinov, M.D., Ph.D.
2. Managing Cancer and Living 
Meaningfully: From the Practical to 
the Profound
Gary Rodin, M.D.




Algorithms to Guide Clinical 
Decisions for Treating Bipolar 
Disorder
9:00 a.m. - 12:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Dana Wang, M.D.
David N. Osser, M.D.
Discussant:
R.H. Belmaker, M.D.
1. Bipolar Depression Algorithm Part 
1: Introduction and Discussion of 
Important Comorbidity and Initial 
Treatment Options
Dana Wang, M.D.
2. Bipolar Depression Part 2: 
Treatment - Resistance, The Roles 
of Antidepressants, Treatment 
Combinations, and Less Evidenced 
Options
Arash Ansari, M.D.
3. Bipolar Mania Algorithm Part 1: 
Introduction and Discussion of 
Important Comorbidity, and Initial 
Treatment Options.
David N. Osser, M.D.
4. Bipolar Mania Part 2: Further 
Explanation of the Roles of 
Haloperidol, Olanzapine, and 
Valproate in This Algorithm: 
Treatment-Resistant Mania
Othman Mohammad, M.D.
Novel Philosophies in Mental Health 
Education
Royal College of Psychiatrists
 5
9:00 a.m. - 12:00 p.m.
Room 717 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Zainab Jabur, M.D., M.P.H.
Norman Sartorius, M.A., M.D.
Discussant:
Simon C. Wessley, M.D., M.H.Sc.
1. Simulation Training, Where We’ve 
Come From, Where We Are, and 
Where We’re Going.
Sean Cross, M.B.B.S.
2. Mock Behavioral Codes: Case 
Simulation to Teach 4th Year 
Medical Students How to Approach 
and Contain Angry, Agitated and 
Potentially Violent Patients
Argyro Caminis, M.D., M.P.H.
3. Longitudinal Integrated Clerkship: A 
Year-long Third-Year Medical School 
Experience in the Acute Psychiatric 
Services and Outpatient Clinics
Lior Givon, M.D., Ph.D.
4. Curiosity and Simulation: A Mental 
Health Approach for First-Year 
Medicine Students
Victor H.O. Otani, M.D.
5. Exploring the Nontechnical Skill 
of Personal and Cognitive Bias to 
Improve Clinical Skills, Including Risk 
Assessments
Zainab Jabur, M.D., M.P.H.
Personalized Medicine in Mood and 
Anxiety Disorders: The Future is 
Bright
9:00 a.m. - 12:00 p.m.
Room 718 B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Charles B. Nemeroff, M.D., Ph.D.
Alan F. Schatzberg, M.D.
1. Child Abuse and Neglect Predict 
Disease Vulnerability and Treatment 
Response: Neurobiological 
Mechanisms
Charles B. Nemeroff, M.D., Ph.D.
2. Understanding Genetic and 
Epigenetic Risk Factors That 
Differentiate Risk and Resilience in 
the Aftermath of Child Abuse and 
Neglect
Kerry Ressler, M.D., Ph.D.
3. A Personalized Medicine Approach to 
Psychotic Major Depression
Alan F. Schatzberg, M.D.
4. Everyday Functioning in Mood 
Disorders: Treatment Implications of 
Variability in Outcomes
Philip Harvey, Ph.D.
5. Precision Medicine: The Evolving 
Role for Imaging in Optimizing 
Treatment for Depression
Helen S. Mayberg, M.D.
6. Insights Into Novel Early 
Interventions From Nonhuman 
Primate Translational Studies of 
Anxious Temperament
Ned Kalin, M.D.
The Emerging Field of Computational 
Psychiatry
9:00 a.m. - 12:00 p.m.
Room 801 B, Level 800, South Building




1. The Emerging Field of Computational 
Psychiatry
Read Montague, Ph.D.
2. A Computational Framework for 
Psychopathology
Peter Fonagy, Ph.D.
3. A Computational Psychiatry 
Approach to Mentalizing Deficits in 
Borderline Personality Disorder
Tobias Nolte, M.D.
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Psychiatric Consultation to the Army 
Patient-Centered Medical Home 
(PCMH)
5
9:00 a.m. - 12:00 p.m.
Niagara/Ontario Rooms, Lower Level
InterContinental Toronto Centre
Chair:
Charles S. Milliken, M.D.
1. Screening, Brief Intervention, 
and Referral to Treatment and 
Pharmacologic Consultation to the 
PCMH
John R. Magera, M.D.
2. Consulting to Primary Care Clinics
Shannon Ford, M.D.
3. Confidential Alcohol Treatment for 
Soldiers: A Necessity for Effective 
Primary Care Alcohol Screening and 
Brief Intervention
Charles S. Milliken, M.D.
Courses
Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Evidence Based Psychodynamic 
Therapy: A Clinician’s Workshop
9:00 a.m. - 4:00 p.m.
Sheraton Hall A, Lower Concourse
Sheraton Centre Toronto Hotel
Directors:
Richard F. Summers, M.D.
Jacques P. Barber, Ph.D.
Integrating Behavioral Health and 
Primary Care: Practical Skills for the 
Consulting Psychiatrist
5
9:00 a.m. - 4:00 p.m.
Sheraton Hall C, Lower Concourse
Sheraton Centre Toronto Hotel
Directors:
Anna Ratzliff, M.D., Ph.D.
Lori E. Raney, M.D.
Faculty:
Robert J. Hilt, M.D.
John Kern, M.D.
Jurgen Unutzer, M.D., M.P.H.
Treatment of Schizophrenia
9:00 a.m. - 4:00 p.m.
Birchwood Ballroom, Mezzanine
Sheraton Centre Toronto Hotel
Directors:
Philip G. Janicak, M.D.




Essentials of Assessing and Treating 
Attention-Deficit/Hyperactivity 
Disorder in Adults and Children
9:00 a.m. - 4:00 p.m.
Civic Ballroom South, 2nd Floor
Sheraton Centre Toronto Hotel
Director:









10:00 a.m. - 12:00 p.m.
Exhibit Halls D-F, Level 800, South 
Building
Metro Toronto Convention Centre
11:00 a.m. Sessions
Case Conference
These sessions are open to 
APA members only. A blue 
registration badge or an APA 
membership card are required for 
admittance.
!
Cognitive-Behavior Therapy for 
Mood and Anxiety Disorders: Case 
Conference
11:00 a.m. - 12:30 p.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Jesse H. Wright, M.D., Ph.D.
Speakers:
Jesse H. Wright, M.D., Ph.D.
Ario Hosseini, M.D.
APA Case Conference: Anorexia 
Nervosa With Co-Occurring Mental 
Illnesses
5
11:00 a.m. - 12:30 p.m.
Room 715 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:




Challenges and Controversies 
in Personality Disorders and 
Psychoanalysis
11:00 a.m. - 12:30 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Otto F. Kernberg, M.D.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
!
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 














11:00 a.m. - 12:30 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Gaurav Mehta, M.B.B.S.
1. Inflammatory and Immunologic 
Cytokines: Relationships With 
Hurricane Exposure, Ethnicity, 
Gender and Psychiatric Diagnoses
Phebe M. Tucker, M.D.
5
2. Genomewide Association Study 
Implicates Protein Kinase N2 as a 
Risk Factor in Persistent Drug Abuse 
in Intravenous Drug Users
Shaocheng Wang, M.D., Ph.D.
1
3. Association of Brain-Derived 
Neurotrophic Factor Polymorphisms, 
Traumatic Stress, Mild Traumatic 
Brain Injury, and Combat Exposure 
With Posttraumatic Stress Disorder 
in U.S. Soldiers Returning From 
Deployment
Michael Dretsch, Ph.D.
4. Elevated Cholesterol and Triglyc-
erides Are Associated With Better 
Cognitive Functioning in Schizophre-
nia Data From the CATIE Study
Henry A. Nasrallah, M.D.
1
Workshops
Advocacy 101: How to Successfully 
Advocate for Your Patients and Your 
Practice
APA Council on Advocacy and 
Government Relations
11:00 a.m. - 12:30 p.m.
Rooms 202 C-D, Level 200, North 
Building




Robert P. Cabaj, M.D.
Jerry Halverson, M.D.
Christina J. Arredondo, M.D.
Resiliency’s Role in Force Health 
Protection: Determining the Effective-
ness of International Military Efforts
11:00 a.m. - 12:30 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chair:
Christopher H. Warner, M.D.
Speakers:
Stephanie Belanger, Ph.D.
Carl A. Castro, Ph.D.
Rakesh Jetly, M.D.
Dennis McGurk, M.D.
Cultural Psychiatry in Integrated 
Care: The Asian-American/Canadian 
Experience
APA Caucus of Asian-American 
Psychiatrists
11:00 a.m. - 12:30 p.m.
Room 205 C, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Sharat P. Iyer, M.D., M.S.
Speakers:
Sharat P. Iyer, M.D., M.S.
Albert Yeung, M.D.
Francis G. Lu, M.D.
Russell F. Lim, M.D., M.Ed.
Yu-Heng Guo, M.D.
Kenneth Fung, M.D., M.S.
Sexual Assault Response Behaviors: 
Scientific, Procedural, and Ethical 
Challenges
3
11:00 a.m. - 12:30 p.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
David E. Johnson, M.D.
Philip J. Candilis, M.D.
Speaker:
Scott C. Moran, M.D.
Professionalism in Social Networking: 
Do’s and Don’ts for Psychiatrists
11:00 a.m. - 12:30 p.m.
Room 802 A-B, Level 800, South Building




Michelle Chaney, M.D., M.S., M.Sc.
Wesley Hill, M.D.
Administrative Psychiatry in the U.S.: 
Current Perspectives
American Association of Psychiatric 
Administrators
11:00 a.m. - 12:30 p.m.
Humber Room, Main Level
InterContinental Toronto Centre
Chairs:
Geetha Jayaram, M.B.A., M.B.B.S., M.D.
Victor J.A. Buwalda, M.D., Ph.D.
Speakers:
Geetha Jayaram, M.B.A., M.B.B.S., M.D.
Victor J.A. Buwalda, M.D., Ph.D.
Advancing Public Service Psychiatry to 
Meet Unmet Needs: The National Health 
Service Corps and the Idea of the 
American Psychiatric Service Corps
11:00 a.m. - 12:30 p.m.





Robert J. Ronis, M.D., M.P.H.
Annelle Primm, M.D., M.P.H.
Kenneth Thompson, M.D.
Forum
Gun Violence, Human Rights, and the 
Need for More Physician Participation 
in Civic Engagement
American Association for Social 
Psychiatry
5
11:00 a.m. - 1:00 p.m.
Room 101, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
John H. Halpern, M.D.
Andres J. Pumariega, M.D.
Speakers:
Vivek Murthy, M.B.A., M.D.
Nada L. Stotland, M.D., M.P.H.
Steven Sharfstein, M.D., M.P.A.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
















Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Mentalization Based Treatment for 
Borderline Personality Disorder
1:00 p.m. - 5:00 p.m.
Grand Ballroom West, Lower Concourse




Melatonin and Light Treatment of 
Seasonal Affective Disorder, Sleep 
and Other Body-Clock Disorders
APA Caucus on Complementary and 
Alternative Medicine
1:00 p.m. - 5:00 p.m.
Grand Ballroom Center, Lower Concourse
Sheraton Centre Toronto Hotel
Director:
Alfred J. Lewy, M.D., Ph.D.
Late-Life Mood Disorders: Achieving 
Accurate Diagnosis and Effective 
Treatment
American Association for Geriatric 
Psychiatry
4
1:00 p.m. - 5:00 p.m.
Sheraton Hall E, Lower Concourse
Sheraton Centre Toronto Hotel
Director:
James M. Ellison, M.D., M.P.H.
Faculty:
Donald A. Davidoff, Ph.D.
Brent Forester, M.D., M.Sc.
Grace C. Niu, Ph.D.
A Psychiatrist’s Guide to Patients 
With Severe Obesity: Assessment and 
Beyond
5
1:00 p.m. - 5:00 p.m.
Dominion Ballroom North, 2nd Floor




Stephanie E. Cassin, Ph.D.
Timothy D. Jackson, M.D., M.P.H.





How to Give More Effective Lectures: 
Punch, Passion, and Polish
3
1:00 p.m. - 5:00 p.m.
Dominion Ballroom South, 2nd Floor





These sessions are open to 
APA members only. A blue 
registration badge or an APA 
membership card are required for 
admittance.
!
Emergency Psychiatry Case 
Conference: The Psychiatrist is 
Assaulted
1:30 p.m. - 3:00 p.m.
Room 701 A, Level 700, South Building




Michael H. Allen, M.D.
Interactive Sessions
Challenges in Cognitive-Behavior 
Therapy: Overcoming Barriers to 
Effective Treatment
1:30 p.m. - 3:00 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Jesse H. Wright, M.D., Ph.D.
Judith Beck, Ph.D.
Scientific and Clinical 
Reports
Suicide: Epidemiology, Risk, 
Competency, and History of 
Prevention Techniques
 5
1:30 p.m. - 3:00 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Gaurav Mehta, M.B.B.S.
1. Completed Suicides: Psychiatric 





2. The VISN 22 High Risk for Suicide 
Opioid Dashboard: An Information 
Technology Solution to Monitor 
Suicide Risk in Veterans Prescribed 
High-Dose Opioid Medications
Peter Hauser, M.D.
3. Last Wills and Testaments in Suicide 
Notes in Toronto: A Novel Issue With 
Implications for Testamentary Capacity
Mark Sinyor, M.D.
4. Suicide Prevention: A Centennial 
Review
Roger Peele, M.D.
All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
!
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Prescribing Food: Can Diet 
Interventions Reduce Symptoms in 
Children With Mental Illness?
APA Council on Children, Adolescents 
and Their Families
2
1:30 p.m. - 3:00 p.m.
Room 204 (Summit), Level 200, North 
Building







Alice R. Mao, M.D.
The Future of Military Psychiatry: 
Integrating Advances and Lessons 
Learned Onto the Battlefield
1:30 p.m. - 3:00 p.m.
Room 205 C, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Christopher H. Warner, M.D.
Speakers:
Rakesh Jetly, M.D.
Eric Vermetten, M.D., Ph.D.
Monica Lovasz, M.D.
Christopher Ivany, M.D.
Hand-Offs in Psychiatry: A HAND to 
Improve Transitions of Care
APA Council on Quality Care
1:30 p.m. - 3:00 p.m.
Room 206 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Mary Kimmel, M.D.
Geetha Jayaram, M.B.A., M.B.B.S., 
M.D.
Speakers:
Yad M. Jabbarpour, M.D.
Sunil Khushalani, M.D.
Coercive and Noncoercive Elements 
of Mandated Outpatient Treatment: 
What Promotes Recovery? A 
Presentation, Debate and Discussion
3
1:30 p.m. - 3:00 p.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Serena Y. Volpp, M.D., M.P.H.
Speakers:
Louis F. Cuoco, D.S.W., L.C.S.W.
Daniel Garza, M.D.
Scott Soloway, M.D.
The Role of Peer Supports in 
Recovery to Practice
1:30 p.m. - 3:00 p.m.




Octavio N. Martinez Jr., M.D., M.P.H.
Speaker:
Michele R. Guzmán, Ph.D.
Psychopharmacology Algorithm for 
Management of Generalized Anxiety 
Disorder
1
1:30 p.m. - 3:00 p.m.
Caledon and Oakville, Main Level
InterContinental Toronto Centre
Chairs:
Harmony R. Abejuela, M.D.
David N. Osser, M.D.
Speakers:
Harmony R. Abejuela, M.D.
David N. Osser, M.D.







2:00 p.m. - 4:00 p.m.
Exhibit Halls D-F, Level 800, South 
Building
Metro Toronto Convention Centre
Media Workshops
Therapeutic Uses of Music/Sound in 
Psychiatric Practice
2:00 p.m. - 5:00 p.m.
Ballroom A-B, Lower Level
InterContinental Toronto Centre
Chair:
David M. Perez-Martinez, M.D.
Presidential Symposia
Marijuana in 2015: State of the Policy 
and Treatment
American Academy of Addiction 
Psychiatry
1
2:00 p.m. - 5:00 p.m.
Room 718 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Laurence Westreich, M.D.
Kevin P. Hill, M.D.
Discussant:
Herbert D. Kleber, M.D.
1. Medical Marijuana: What a 
Psychiatrist Needs to Know
Kevin P. Hill, M.D.
2. Legalization of the Recreational Use 
of Marijuana: Are We Ready?
Andrew J. Saxon, M.D.
3. Diagnosing and Treating Cannabis 
Use Disorders
Frances R. Levin, M.D.
How the Mind Affects the Body 
and the Body Affects the Mind: 
Inflammation, Depression, Drugs, and 
Disease
5
2:00 p.m. - 5:00 p.m.
Room 718 B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
S. Nassir Ghaemi, M.D., M.P.H.
1. Anti-Inflammatory Agents as 
Antidepressants: Truth or Dare
Charles Raison
2. Integrating Inflammation With Other 
Disease Models in Mood Disorders
Roger S. McIntyre, M.D.
3. Death, Depression and Heart Disease
Steven Roose, M.D.
4. Lithium for Prevention of Dementias 
and Reduction of Mortality
S. Nassir Ghaemi, M.D., M.P.H.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 















Between Temperament and Mental 
Disorders: Assessing the Continuum
5
2:00 p.m. - 5:00 p.m.
Room 101, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Irina Trofimova, M.Sc., Ph.D.
1. Coupling of Temperament Traits With 
Depression in Different Age Groups
William Sulis, M.D., Ph.D.
2. Psychophysiology of Temperament 
Traits and Its Links to Mental Illness
Irina Trofimova, M.Sc., Ph.D.
3. Comparison of Measures of 
Temperament and Personality 
Disorders
Julie Christiansen, M.Sc.
4. Coupling of Temperament Traits With 
Anxiety in Different Age Groups
William Sulis, M.D., Ph.D.
Psychiatric/Psychological Input Into 
National Plans to Counter-Terrorism
 3
2:00 p.m. - 5:00 p.m.
Room 105, Level 100, North Building






1. Canada’s Counter-Terrorism 
Plan Is Developing Psychological 
Components
Howard E. Book, M.D.
2. Australia’s Counter-Terrorism Plan 




3. A Psychiatric Perspective on U.K. 
Approaches to Counter-Terrorism
Rachel Jenkins, M.D.
4. Psychological Input Into Pakistan’s 
Counter-Terrorism Efforts
Feriha Peracha, Ph.D.
Khalid A. Mufti, M.D.
5. Psychological Dimensions of the U.S. 
Counter-Terrorism Plan
Jerrold Post, M.D.
The War on Women
APA Womens Caucus
2:00 p.m. - 5:00 p.m.
Rooms 201 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Gail E. Robinson, M.D.
Gisele Apter, M.D., Ph.D.
Discussant:
Carol C. Nadelson, M.D.
1. Peripartum Mental Health: Access 
and Care Are Still an Issue
Gisele Apter, M.D., Ph.D.
2. Understanding the Social 
Determinants of Women’s Mental 
Health
Helen Herrman, M.B.B.S., M.D.
3. Abortion and Our Patients: Science in 
Clinical Care
Nada L. Stotland, M.D., M.P.H.
4. Current Rape Culture: Blame the Victim
Gail E. Robinson, M.D.
5. The Disappearance of Women
Malkah T. Notman, M.D.
Improving the Effectiveness of 
Cognitive Behavioral Therapy (CBT) 
Across Cultures
2:00 p.m. - 5:00 p.m.
Rooms 202 A-B, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Muhammad Irfan, M.B.B.S., M.S.
Discussant:
Farooq Naeem, M.B.B.S., M.Sc., Ph.D.
1. Developing a Model for Cultural 
Adaptation of CBT for English 
Speaking Caribbean Origin Group
Kwame J. McKenzie, M.D.
2. Cultural Issues on the Use of CBT 
and Acceptance and Commitment 
Therapy (ACT)
Kenneth Fung, M.D., M.S.
3. Cultural Adaptation of CBT: Process, 
Methods and Finding
Farooq Naeem, M.B.B.S., M.Sc., Ph.D.
4. Cultural Adaptation of CBT for 
Psychotic Disorders
Shanaya Rathod, M.D.
5. Depressed British South Asian 
Mothers “Voices Within the Four 
Walls”: A Mixed-Methods Study
Nusrat Husain, D.P.H., M.B.B.S., 
M.D., M.P.H.
6. Evaluation of Culturally Adapted 
CBT (CaCBT) Through Randomized 
Controlled Trials in Pakistan: 
Developing the Evidence Base
Muhammad Irfan, M.B.B.S., M.S.
Implementation of Coordinated 
Specialty Care for First-Episode 
Psychosis in U.S. Community Mental 
Health Clinics
2:00 p.m. - 5:00 p.m.
Rooms 202 C-D, Level 200, North 
Building




1. Facilitators and Barriers to 
Implementation of Coordinated 
Specialty Care in U.S. Community 
Mental Health Clinics
Mary Brunette, M.D.
2. Individual Resiliency Training in 
NAVIGATE: Training, Supervision, 
and Fidelity Assessment to Support 
Implementation
Piper Meyer-Kalos, Ph.D.
3. The Role of the Family Intervention in 
NAVIGATE
Shirley Glynn, Ph.D.
4. Risk Factors for Medical 
Comorbidities at the Onset of 
Psychosis: Relevance for Improved 
Care Delivery in Patients Diagnosed 
With Schizophrenia
Christoph U. Correll, M.D.
5. Cost-Effectiveness of Coordinated 
Specialty Care for People With First-
Episode Psychosis
Robert Rosenheck, M.D.
S E S S I O N  T R A C K S
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Development, Implementation, and 
Efficacy of Innovative Behavioral Ac-
tivation Programs: Experiences From 
Two Acute Psychiatric Inpatient Units
2:00 p.m. - 5:00 p.m.
Rooms 203 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Marlene Taube-Schiff, Ph.D.
Jackie K. Gollan, Ph.D.
Discussant:
Christopher Martell, Ph.D.
1. Behavioral Activation Communication 
(BAC) Program for Acute Psychiatric 
Inpatients: Model, Techniques and 
Effectiveness
Jackie K. Gollan, Ph.D.
2. Adaptation of BAC to University 
Health Network-Toronto General 
Hospital: Development, Feasibility, 
Training and Research Developments
Marlene Taube-Schiff, Ph.D.
3. Implementation of BAC on a General 
Psychiatry Inpatient Unit: Feasibility, 
Integration and Staff Impressions
Jenna McLeod, C.T.R.S.
4. Innovative BAC Programming Within 
a Specialized Psychiatric Intensive 
Care Unit
Anna Skorzewska, M.D.
The Evolution of Mathematical 
Psychiatry: Implications for Bridging 
DSM-5 and Research Domain 
Criterias (RDoCs) Using Behavioral 
Game Theory
2:00 p.m. - 5:00 p.m.
Rooms 206 E-F, Level 200, North Building




Andrew J. Gerber, M.D., Ph.D.
1. Bridging DSM-5 and RDoCs Using 
Behavioral Game Theory: Modeling 
Obsessive-Compulsive Disorder as a 
Signaling Game
Lawrence Amsel, M.D.
2. Adapting Game Theory to Model 
Resource Management Behaviors: 
Clinical Implications
Robert Rogers, Ph.D.
3. Decision-Making and Suicidal 
Behavior
Fabrice Jollant, M.D., Ph.D.
4. Modeling the Grief Process Using 
Game Theory and Information 
Processing
Erica Griffith, B.S.
5. Intertemporal Bargaining in Self-
Control
George Ainslie, M.D.
Alcohol Use Disorders and PTSD: New 
Findings, New Challenges
U.S. National Institute on Alcohol Abuse 
and Alcoholism
 6
2:00 p.m. - 5:00 p.m.
Room 701 B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Anita Bechtholt, Ph.D.
1. Update on Translational Research: 
Neurobiology of Appetitive and 
Aversive Behaviors in Mice and 
Alcohol Use Disorders and PTSD in 
Humans
Kerry Ressler, M.D., Ph.D.
2. New Developments in the Treatment 
of Co-occurring PTSD and Alcohol 
Use Disorders
Kathleen Brady, M.D., Ph.D.
3. The Alpha-1 Adrenoreceptor 
Antagonist Prazosin for Alcohol Use 
Disorder in Combat Veterans (and 
Civilians) With PTSD
Murray A. Raskind, M.D.
4. An Update on the Seeking Safety 
Model: Empirical and Clinical 
Developments
Lisa Najavits, Ph.D.
Reduce Duration of Untreated 
Psychosis (DUP) and Then Treat Well
2:00 p.m. - 5:00 p.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
S. Charles Schulz, M.D.
1. High-Quality Psychiatric Care to 
Reduce Time of Active Psychosis
Oliver Freudenreich, M.D.
2. Recovery After an Initial 
Schizophrenia Episode: Early 
Treatment Program
John M. Kane, M.D.
3. The Reduction of the Duration of 
Untreated Psychosis in Australia and 
Ireland
Brian O’Donoghue
4. Recovery in Schizophrenia: What’s 
DUP Got to Do With It?
Robert Zipursky, M.D.
Society Unfair, Society Unwell: 
Addressing the Social Determinants 
of Mental Health
2:00 p.m. - 5:00 p.m.
Room 715 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Ruth Shim, M.D., M.P.H.
Michael T. Compton, M.D., M.P.H.
Discussant:
David A. Pollack, M.D.
1. An Introduction to the Social 
Determinants of Mental Health
Ruth Shim, M.D., M.P.H.
2. Food Insecurity as a Social 
Determinant of Mental Health
Michael T. Compton, M.D., M.P.H.
3. Poverty and Income Inequality as 
Social Determinants of Mental Health
Marc W. Manseau, M.D., M.P.H.
4. Adverse Features of the Built 
Environment as Social Determinants 
of Mental Health
Lynn Todman, Ph.D.
The Place of Benzodiazepines in 
Treatment of Anxiety Disorders: Are 
We Ignoring the Evidence?
2:00 p.m. - 5:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Edward K. Silberman, M.D.
Discussant:
Edward K. Silberman, M.D.
1. How an Age of Anxiety Became an 
Age of Depression
Allan V. Horwitz, Ph.D.
2. Abuse Potential of Benzodiazepines: 
What Is the Evidence?
Richard Balon, M.D.
3. Benzodiazepine Prescription for 
Patients With Substance Abuse: Is It 
Ever Appropriate?
Domenic A. Ciraulo, M.D.
4. Fear-Driven Reluctance to Prescribe 














Physical Health in Bipolar Disorder: 
Scientific, Clinical, and Public Health 
Implications
 5
2:00 p.m. - 5:00 p.m.
Room 717 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Benjamin Goldstein, M.D., Ph.D.
1. Oxidative Stress in Bipolar Disorder 
and Other Psychiatric Illnesses
Ana Andreazza, Ph.D.
2. Adolescent Bipolar Disorder as a 
Vascular Disease
Benjamin Goldstein, M.D., Ph.D.
3. Metabolic-Inflammatory Disturbance 
in Bipolar Disorder: Implications for 
Disease Pathogenesis and Cognitive 
Impairment
Roger S. McIntyre, M.D.
4. Staging in Bipolar Disorder and Its 
Relationship to Physical Health
David J. Kupfer, M.D.
Mindfulness: In the Brain and in 
Clinical Practice
2:00 p.m. - 5:00 p.m.
Room 801 A, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Frank Sommers, M.D.
1. Neural Mechanisms of Mindfulness 
Training - How Does it Change the 
Brain and Whom Can It Help?
Norman A. S. Farb, Ph.D.
2. Identifying Therapeutic Factors in an 
Eight-Week (30-hour) Mindfulness-
Based-Stress Reduction Program
Katalin J. Margittai, M.D.
3. Mindfulness in Love and Love Making
Frank Sommers, M.D.
4. Every Moment Is an Opportunity 
to Practice (OTP): Integrating 
Mindfulness and Mindfulness 
Meditation
Michele C. G. Chaban, D.Phil., 
M.S.W., Ph.D.
Compulsivity as a New Trans-
Diagnostic Research Domain for the 
RDoC
International College of Obsessive-
Compulsive Spectrum Disorders
2:00 p.m. - 5:00 p.m.
Room 801 B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Michael Van Ameringen, M.D.
1. Cognition as a Treatment Target in 
Obsessive-Compulsive Disorders 
(OCD)
Naomi A. Fineberg, M.B.B.S.
2. Oxytocin/Vasopressin and Immune-
Inflammatory Interventions for 
the Repetitive Behavior Domain in 
Autism and Obsessive-Compulsive 
Spectrum Disorders
Eric Hollander, M.D.
3. The Use of Compulsivity as a 
Phenotype in Genetic Studies of OCD
Margaret A. Richter, M.D.
4. Pharmacological Treatment of 
Compulsivity Across Disorders
Jon Grant, M.D.
5. dTMS in OCD-State of the Art
Lior Carmi, M.Psy.
Training Experiences in Psychiatry: 
Then, Now and How to Create the 
Best Future
APA/SAMHSA Minority Fellows
2:00 p.m. - 5:00 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Andrea M. Brownridge, J.D., M.D., M.H.A.
Stacia E. Mills, M.D.
1. Introduction to Training Experiences 
in Psychiatry: Then, Now and How to 
Create the Best Future
Stacia E. Mills, M.D.
2. Paving the Way: A Look Into the 
History of Psychiatric Training 
Programs
Frank Clark, M.D.
3. Are We There Yet: Current 
Perspectives of Residents and 
Fellows in Training
Tiffani Bell, M.D.
D. Anton Bland, M.D.
Roberto Montenegro, M.D., Ph.D.
4. Building the Road We Envision: Tools 
to Address the Problems of the Past 
and Present
Ranna Parekh, M.D., M.P.H.
Preparing Residents for War: How 
Military Graduate Medical Education 
Prepares Early Career Psychiatrists 
for Overseas Deployments
2:00 p.m. - 5:00 p.m.
Niagara/Ontario Rooms, Lower Level
InterContinental Toronto Centre
Chair:
Vincent F. Capaldi I I, M.D.
1. Approaching the Breech: Measures 
for Preparing Residents for 
Deployment
Hanna Zembrzuska, M.D.
2. Navy Combat Psychiatry After 
Residency: The Experience of an 
Early Career Psychiatrist Embedded 
With the U.S. Marine Corps
Dennis A. White, M.D.
3. Resources for Early Career 
Psychiatrists in Combat
Vincent F. Capaldi I I, M.D.
3:30 p.m. Sessions
Advances in Medicine
Top 10 Medical Stories 2014: A 
Comprehensive and Practical Review 
of What We Need to Know
3:30 p.m. - 5:00 p.m.
Room 701 A, Level 700, South Building




Monique V. Yohanan, M.D., M.P.H.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
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Youth Alcohol and Marijuana Use and 
Substance Use Policy
U.S. National Institute on Alcohol Abuse 
and Alcoholism
6
3:30 p.m. - 5:00 p.m.
Room 206 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Sharon Levy, M.P.H., Ph.D.
Speaker:
Sharon Levy, M.P.H., Ph.D.
Lectures
Innovative Pharmacological Strate-
gies to Treat Alcohol Use Disorder
U.S. National Institute on Alcohol Abuse 
and Alcoholism
APA Frontiers of Science Lecture Series
3:30 p.m. - 5:00 p.m.
Exhibit Hall A, Level 300, North Building
Metro Toronto Convention Centre
Lecturer:
Barbara J. Mason, Ph.D.
Scientific and Clinical 
Reports
Topics in Psychiatric Education and 
Training
 6
3:30 p.m. - 5:00 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Edmond Pi, M.D.
1. The Epidemic of Resident Physician 
Burnout: Contributors and Potential 
Interventions to Take Care of Our Own
Emily Holmes, M.D., M.P.H.
2. Developing a Diversified Psychiatric 
Workforce for the 21st Century: 
Research and Policy Considerations
Bernhard T. Baune, M.D., Ph.D.
3. Queer, Queering, and Questioning: 
Digital Narratives for Health Care 
Education
Tara La Rose, M.S.W., Ph.D.
4. What Is Psychodynamic Supervision?
Howard E. Book, M.D.
Workshops
From Riches to Rags: The Veteran and 
the Public Mental Health System
3:30 p.m. - 5:00 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chairs:
Elspeth C. Ritchie, M.D., M.P.H.
Harold S. Kudler, M.D.
Speakers:
Maria Llorente, M.D.
Elspeth C. Ritchie, M.D., M.P.H.
Harold S. Kudler, M.D.
Violence Toward Care Providers in 
the General Hospital: Strategies for 
Assessment, Treatment, Safety, and 
Risk Reduction
APA Ethics Committee and Penn-
Scattergood Ethics Program
5
3:30 p.m. - 5:00 p.m.
Room 205 C, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Rebecca W. Brendel, M.D.
Teresa Rummans, M.D.
Speakers:
Sean P. Heffernan, M.D.
James R. Rundell, M.D.
Lisa Seyfried, M.D.
Rebecca W. Brendel, M.D.
Teresa Rummans, M.D.
Improving Treatment Outcomes: How 
Can Clinicians Implement in Their 
Practice a Systematic Approach 
to Pharmacotherapy for Late-Life 
Depression?
4
3:30 p.m. - 5:00 p.m.
Room 711, Level 700, South Building






Daniel M. Blumberger, M.D.
Mark Rapoport, M.D.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
Barbara J Mason, PhD is the Pearson Family Professor, Director of the Laboratory of 
Clinical Psychopharmacology, and Acting Chair of the Committee on the Neurobiology 
of Addictive Disorders at The Scripps Research Institute, La Jolla, CA. Dr. Mason is an 
expert on medication development for treatment of Alcohol Use Disorder (AUD) and she 
has performed seminal work for two current AUD medications (acamprosate [Campral] and 
nalmefene [Selincro]). Her work has been recognized with a MERIT Award from NIH, the 
Dean’s Senior Clinical Research Award from the University of Miami School of Medicine, and 
the Andrew W. Mellon Foundation Teacher-Scientist Award from Cornell University Medical 
College.  Dr. Mason has served on NIAAA’s and NIDA’s National Advisory Councils and she is 
currently pursuing a program of NIH-funded research that includes human laboratory studies 














Effective And Safe Use of Psych 
Mobile Apps: Current Trends and the 
Future
3:30 p.m. - 5:00 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Steven Chan, M.B.A., M.D.
Donald M. Hilty, M.D.
Speakers:
Donald M. Hilty, M.D.
Steven Chan, M.B.A., M.D.
John Torous, M.D.
John Luo, M.D.
How I Chose Psychiatry: Reflections 
on Recruitment Strategies for 
Undergraduate-Level Medical 
Students
3:30 p.m. - 5:00 p.m.









Learning by Examples: Key 
Components/Developmental Steps 
That Led to Sustainable Collaborative 
Care Models in a U.S. Setting Versus 
a Canadian Setting
5
3:30 p.m. - 5:00 p.m.
Caledon and Oakville, Main Level
InterContinental Toronto Centre
Chairs:
Mark D. Williams, M.D.
Nick Kates, M.B.B.S.
Speakers:




The Mind and Music of Chopin
Chair: Richard Kogan, M.D.
5:30 p.m. - 7:00 p.m.
Room 102 (Theatre), Level 100, North 
Building





“I”: A Viewing and Discussion of the 
Film.
7:00 p.m. - 10:00 p.m.
Ballroom A-B, Lower Level
InterContinental Toronto Centre
Chairs:
Lloyd I. Sederer, M.D.
Alan A. Stone, M.D.
Speaker:
Gail E. Robinson, M.D.
Symposia
Spirituality and Religion in Global 
Mental Health
APA Caucus of Religion, Spirituality and 
Psychiatry
7:00 p.m. - 10:00 p.m.
Niagara/Ontario Rooms, Lower Level
InterContinental Toronto Centre
Chair:
Wai Lun Alan Fung, M.D., Sc.D.
Discussant:
Molyn Leszcz, M.D.
1. Spiritism and Mental Health: Theory 
and Practice
Alexander Moreira-Almeida, M.D., Ph.D.
2. Islamic Perspective in the Psychiatric 
Practice in Pakistan
Unaiza Niaz, M.D.
3. Hinduism and Principles of Mental 
Health
Dinesh Bhugra, M.D., Ph.D.
4. Expanding the Reach and Multiplying 
the Impact of Mental Health 
Prevention and Intervention Where 
Resources Are Scarce: Empowering 
Faith Communities to Deliver Mental 
Health Psychoeducation in a Spiritual 
Context
Tat-Ying Wong, M.D.
5. Psych and Spirit: The Role of Faith 
Communities in the Treatment of 
Mental Illness
Victor Shepherd, Ph.D.
The National Intrepid Center of 
Excellence (NICOE) Research Update 
and Model of Care for Traumatic 
Brain Injury and Psychological Health 
Conditions
5
7:00 p.m. - 10:00 p.m.




Elspeth C. Ritchie, M.D., M.P.H.
Discussants:
Robert L. Koffman, M.D., M.P.H.
Thomas DeGraba, M.D.
1. Care of Patients With Mild Traumatic 
Brain Injury and Co-Morbid 
Psychological Health Conditions
James Kelly, M.D.
2. The Role of the NICoE’s Integrated 
Practice Unit Model Within the 
Military Health System Pathway of 
Care
Sara M. Kass, M.D.
3. NICoE Research Infrastructure and 
Strategic Research Plan
Geoffrey Grammer, M.D.
4. Research Findings Update From the 
NICOE
Thomas DeGraba, M.D.
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Carol A Bernstein, MD is Associate Professor of Psychiatry, Vice Chair for Education in 
Psychiatry and Director of Residency Training in Psychiatry at the NYU School of Medicine. 
From 2001-2011, Dr. Bernstein also served as the Associate Dean for Graduate Medical 
Education and the Designated Institutional Official for ACGME accredited training programs 
at NYU. Dr. Bernstein is a Past-President of the American Psychiatric Association and has 
served the Association as Vice-President, Treasurer and Trustee-at-Large and as the chair 
of multiple committees. She has served as a spokesperson for the American Psychiatric As-
sociation on many occasions and received the 1997 exemplary psychiatrist award from the 
National Alliance for the Mentally Ill (NAMI). In 2014, she was the recipient of the APA/NIMH 
Vestermark Award in Psychiatric Education. Dr. Bernstein has devoted her entire career in 
medicine to the education and training of the next generation of psychiatrists.
Dr. Bernstein completed medical school at the Columbia University College of Physi-
cians and Surgeons. Following an internship in internal medicine at St. Luke’s/Roosevelt 
Medical Center in New York, she completed her psychiatric residency training at Colum-
bia University and the New York State Psychiatric Institute. Dr. Bernstein is active in many 
national psychiatric associations in addition to the APA - these include the American College 
of Psychiatrists (she was elected to the Board of Regents in February of 2012), the Group 
for the Advancement of Psychiatry and the American Board of Psychiatry and Neurology, 
among others. In 2003, Dr. Bernstein was selected as a Fellow in ELAM (Executive Leader-
ship in Academic Medicine) a national program, designed to promote leadership for women 
in medicine. In 2005, Dr. Bernstein completed the Physician Leadership Development 
Program at NYU as well as the Graduate Medical Education Leadership Program of the AC-
GME. In 2010, Dr. Bernstein was appointed to the Board of Directors of the ACGME – the 
body that accredits the more than 8000 residency and fellowship training programs in the 
United States. Dr. Bernstein has written numerous articles and chapters on psychiatric edu-
cation and has served as a peer reviewer for both the American Journal of Psychiatry and 
Academic Psychiatry. She has served on the editorial boards of Academic Psychiatry, the 
Journal of Psychiatric Services and Focus, has presented at more than 70 conferences and 
meetings and has been the recipient of a number of visiting professorships. Dr. Bernstein 
hosts a weekly call-in show for consumers on Sirius Radio’s Doctor Radio Channel which is 
sponsored by the NYU Langone Medical Center. Besides her academic responsibilities, Dr. 
Bernstein maintains a private practice in psychiatry in Manhattan, is married to a psychiatrist 
and the mother of a seventeen year old daughter.
Bio
Anne E Becker, MD, PhD is the Maude and Lillian Presley Professor of Global Health 
and Social Medicine at Harvard Medical School, where she also serves as Vice Chair of the 
Department of Global Health and Social Medicine. An anthropologist and psychiatrist, Dr. 
Becker was lead investigator on a series of studies demonstrating the relationship between 
media exposure and eating pathology in the small-scale indigenous population of Fiji. In 
addition, Dr. Becker’s NIMH-funded research has investigated the impact of rapid economic 
and social transition on eating pathology, suicide, and other youth health risk behaviors in 
Fiji. She and her co-PI, Pere Eddy Eustache, have just completed a school-based youth 
mental health pilot intervention in central Haiti with NIMH funding. Dr. Becker serves as 
vice chairperson of the APA’s Council on International Psychiatry, is founding and past 
Director of the Eating Disorders Clinical and Research Program at Massachusetts General 
Hospital, an associate editor of the International Journal of Eating Disorders, past president 
of the Academy for Eating Disorders, and served as a member of the APA’s DSM-5 Eating 
Disorders Work Group. She received the 2013 Price Family Award for Research Excellence 












Up the Down Staircase: Continuing 
Challenges for Women in Leadership
APF Alexandra Symonds Award Lecture
8:00 a.m. - 9:30 a.m.
Rooms 206 A-F, Level 200, North Building
Metro Toronto Convention Centre
Lecture Chairs:
Ludmila De Faria, M.D.
Mary E. Barber, M.D.
Lecturer:
Carol A. Bernstein, M.D.
Globalization, the Media, and Eating 
Disorders: What Can We Learn From 
Fiji?
APA Distinguished Psychiatrist Lecture 
Series
8:00 a.m. - 9:30 a.m.
Exhibit Hall G, Level 800, South Building
Metro Toronto Convention Centre
Lecture Chair:
Jerrold F. Rosenbaum, M.D.
Lecturer:
Anne E. Becker, M.D., Ph.D.
Lectures
An Update on the Treatment and 
Research of Treatment-Resistant 
Depression and Bipolar Disorder
APF Simon Bolivar Award Lecture
8:00 a.m. - 9:30 a.m.
Rooms 205 A-D, Level 200, North Building
Metro Toronto Convention Centre
Lecture Chairs:
Mauricio Tohen
Jose E. De La Gandara, M.D.
Christina Mangurian, M.D.
Lecturer:
Carlos A. Zarate Jr., M.D.
8:00 a.m. Sessions
Interactive Sessions
An Update on Antidepressant 
Treatment: Pharmacogenetics, Rapidly 
Acting Agents, and Brain Stimulation
8:00 a.m. - 9:30 a.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Alan F. Schatzberg, M.D.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
Carlos A Zarate, Jr, MD is Chief Experimental Therapeutics & Pathophysiology Branch 
and of the Section on Neurobiology and Treatment of Mood and Anxiety Disorders, Division 
Intramural Research Program, National Institute of Mental Health. Dr. Zarate completed his 
residency training in psychiatry at the Massachusetts Mental Health Center/Brockton VAMC 
division. He later completed a fellowship in Clinical Psychopharmacology at McLean Hospital 
of the Consolidated Department of Psychiatry, Harvard Medical School and remained on 
staff at McLean Hospital as the Director of the Bipolar and Psychotic Disorders Outpatient 
Services. From 1998 to 2000 Dr. Zarate was the Chief of the Bipolar and Psychotic Disor-
ders Program at the University of Massachusetts Medical School. In 2001, he joined the 
Mood and Anxiety Disorders Program at NIMH. His achievements and awards include the 
Ethel-DuPont Warren Award and Livingston Awards, Consolidated Department of Psychiatry, 
Harvard Medical School; Outstanding Psychiatrist Research Award, Massachusetts Psychi-
atric Association; Program for Minority Research Training in Psychiatry, APA; the National 
Alliance for Research on Schizophrenia and Depression Young Investigator Award; National 
Alliance for Research on Schizophrenia and Depression Independent Investigator Award; the 
National Institutes of Health Director’s Award Scientific/Medical, the 2011 Brain & Behavior 
Research Foundation Award for Bipolar Mood Disorder Research, and the 2013 National 
Institute of Health Director’s Award—Scientific/Medical Achievement and Mogens Schou 
Research Award: Bipolar Disorder. Dr. Zarate has been elected to membership to the Ameri-
can College of Neuropsychopharmacology, to the Board of Councilors for the International 
Society for Bipolar Disorders. He is also a member of the Society of Biological Psychiatry 
and the Society for Neuroscience. Dr. Zarate’s research focuses on the pathophysiology and 
development of novel therapeutics for treatment-resistant mood disorders as well as the 
study of biomarkers and neural correlates of treatment response.
Bio
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Promoting Mental Health of Refugees 
and Immigrants: North American and 
Global Perspectives
American Association for Social 
Psychiatry
8:00 a.m. - 9:30 a.m.
Humber Room, Main Level
InterContinental Toronto Centre
Chairs:
Aida Spahic-Mihajlovic, M.D., M.S.
Rama Rao Gogineni, M.D.
Speakers:
Morton Beiser, C.M., M.D.
Khalid A. Mufti, M.D.
Ali Mufti, M.B.B.S.
Kenneth Thompson, M.D.
Teaching Ego Defense Mechanisms 
With Media Clips
8:00 a.m. - 9:30 a.m.
Caledon and Oakville, Main Level
InterContinental Toronto Centre
Chairs:
Luis F. Ramirez, M.D.
David J. Robinson, M.D.
Advances in Series
The DSM-5 Cultural Formulation 
Interview: Implementing Cultural 
Assessment in Routine Clinical 
Practice
American Psychiatric Publishing Editorial 
Board
8:00 a.m. - 11:00 a.m.
Room 105, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Roberto Lewis-Fernandez, M.A., M.D.
1. Enhancing the Role of Culture 
in DSM-5: The Need for Cultural 
Assessment
Roberto Lewis-Fernandez, M.A., M.D.
2. The Core Cultural Formulation 
Interview and DSM-5 Field Trial 
Results
Neil K. Aggarwal, M.A., M.D.
3. The Future of Cultural Formulation 
in Psychiatry: Advancing Person-
Centered Care
Laurence J. Kirmayer, M.D.
4. The Supplementary Modules in 
DSM-5: Overview of the Modules and 
Examples of Clinical Utility
Devon E. Hinton, M.D., Ph.D.
Primary Care and Psychiatry in the 
Military
8:00 a.m. - 9:30 a.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chairs:





Association for Academic Psychiatry
8:00 a.m. - 9:30 a.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
John Teshima, M.D., M.Ed.
Speakers:
Marcy Verduin, M.D.
Sarah B. Johnson, M.D.
An Introduction to Neuroimaging in 
Dementia
4
8:00 a.m. - 9:30 a.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Vimal M. Aga, M.D.
Brief Primer to Acceptance and 
Commitment Therapy
8:00 a.m. - 9:30 a.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Kenneth Fung, M.D., M.S.
Mateusz Zurowski, M.D., M.Sc.
Speakers:
Kenneth Fung, M.D., M.S.
Mateusz Zurowski, M.D., M.Sc.
Scientific and Clinical 
Reports
Issues in the Care of Military 
Personnel and Veterans
 1
8:00 a.m. - 9:30 a.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Josepha A. Cheong, M.D.
1. Brief Interventions to Prevent Suicide 
Attempts in Military Personnel
Craig J. Bryan, Psy.D.
M. David Rudd, Ph.D.
2. Findings and Paths Forward From the 
Study “Cognitive Processing Therapy 
for Veterans Dually Diagnosed With 
Posttraumatic Stress Disorder (PTSD) 
and Substance Use Disorders”
Laura A. Bajor, D.O., M.A.
1
3. Comparing the DSM-5 PTSD Criteria 
in Soldiers Exposed to Combat: 
Problems With the New Definition and 
Clinical Implications
Charles Hoge, M.D.
4. Effect of Live Music on the Emotional 
State of Patients and Staff at a 
Military Treatment Facility (MTF)
Micah Sickel, M.D., Ph.D.
Workshops
Providing Mental Health Services in 
Areas With Restricted Human Rights
APA/SAMHSA Minority Fellows
3
8:00 a.m. - 9:30 a.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Obianuju “Uju” J. Obi, M.D., M.P.H.
Héctor Colón-Rivera
Speakers:
Neil Leibowitz, J.D., M.D.
Bipin Subedi, M.D.
Makeda N. Jones-Jacques, M.D.
Linda Piwowarczyk, M.D., M.P.H.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
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Optimizing Treatment of Complicated 
Grief: Results of a Multicenter Clinical 
Trial
8:00 a.m. - 11:00 a.m.
Rooms 201 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chair:
M. Katherine Shear, M.D.
Discussants:
Michael First, M.D.
Charles F. Reynolds III, M.D.
1. Complicated Grief: Clinical and 
Diagnostic Considerations
Sidney Zisook, M.D.
2. Diagnostic Performance of 
Several Proposed Criteria Sets for 
Complicated Grief
Christine Mauro, Ph.D.
3. Is there a Role for Pharmacotherapy 
in the Treatment of Complicated 
Grief? Available Data and Results 
of a Randomized Controlled Trial of 
Citalopram
Naomi Simon, M.D.
4. Psychotherapy for Complicated Grief: 
An Evidence-Based Approach
M. Katherine Shear, M.D.
Afterwar: Healing the Moral Wounds 
of Our Soldiers
APA Ethics Committee and Penn-
Scattergood Ethics Program
8:00 a.m. - 11:00 a.m.
Rooms 202 A-B, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Nancy Sherman, Ph.D.
Stephen N. Xenakis, M.D.
1. Treating Moral Injury in War Veterans
Victoria Bruner, L.C.S.W.
2. The Afterwar: Healing the Moral 
Wounds of Our Soldiers
Nancy Sherman, Ph.D.
3. Department of Defense and Veterans 
Administration Protocols for Treating 
Veterans With Traumatic Brain Injury 
and Posttraumatic Stress Disorder
Stephen N. Xenakis, M.D.
4. Report From the Ground on 
Psychological Trauma Cognitive 
Processing Therapy
Joshua Mantz, B.S.
Integrated and Shared Care in the 
U.S. and Canada: Learning From Our 
Neighbors
8:00 a.m. - 11:00 a.m.
Room 718 B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Lori E. Raney, M.D.
Nick Kates, M.B.B.S.
Discussants:
James R. Rundell, M.D.
Nick Kates, M.B.B.S.
1. Collaborative Care and Shared Care in 
the Primary Care Setting
Jurgen Unutzer, M.D., M.P.H.
2. Collaborative Mental Health Care in 
Canada
Roger C. Bland, C.M., M.B.
3. Premature Mortality in Patients With 
Mental Illnesses: The U.S. Experience
Benjamin Druss, M.D.
4. Integrating Care for High Risk and 
Disadvantaged Adults With Serious 
Mental Illness: Lessons Learned in a 
System of Universal Access to Health 
Care
Vicky Stergiopoulos, M.D., M.H.Sc.
Symposia
Variables in How Suicide Impacts 
Treating Professionals: Level of 
Training, Type of Suicide, Notoriety of 
the Victim, and Threat of Malpractice 
Suit
8:00 a.m. - 11:00 a.m.
Rooms 104 A-B , Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Kenneth R. Silk, M.D.
Michael F. Myers, M.D.
1. The Aftermath of Suicide for the 
Treating Professional
Michael F. Myers, M.D.
2. Perspective of the Psychiatrist-in-
Training
Rachel Caravella, M.D.
3. Always Expect the Unexpected
Philip R. Muskin, M.D.
4. Patient Suicide and the Threat of 
Malpractice
Kenneth R. Silk, M.D.
5. A View From the Wings: Treating the 
Famous and Infamous
Susan L. Donner, M.D.
6. Suicide and the Community
Robert Michels, M.D.
5. Cultural Assessment of Older Adults, 
Caregivers, and Other Specific 
Populations Using the Supplementary 
Modules
Ladson Hinton, M.D.
6. Cultural Formulation Interview: 
Technology And Training
Ravi DeSilva, M.A., M.D.
Media Workshops
“Can”: A Vietnamese-American’s 
First-Person Account of Bipolar 
Disorder and the Path Toward 
Recovery: Applying the DSM-5 Outline 
for Cultural Formulation
APA Council on Minority Mental Health 
and Health Disparities
8:00 a.m. - 11:00 a.m.
Ballroom A-B, Lower Level
InterContinental Toronto Centre
Chair:




Utilizing Psychodynamic Psychiatry in 
the Medical Setting
American Academy of Psychoanalysis 
and Dynamic Psychiatry
 5
8:00 a.m. - 11:00 a.m.
Room 718 A, Level 700, South Building





1. Psychodynamic Aspects of Liaison 
Psychiatry - Understanding 
Countertransference in 
Psychosomatic Medicine
Cesar A. Alfonso, M.D.
2. Psychodynamic Approaches to 
Nonadherence to HIV Medical Care
Mary Ann Cohen, M.D.
3. Medical Students, Clinical Experience, 
Psychodynamics
Nada L. Stotland, M.D., M.P.H.
4. Somatoform Disorders in Childhood 
and Adolescence
Clarice J. Kestenbaum, M.D.











An Update on Neurocognitive 
Disorders for the General Psychiatrist
 4
8:00 a.m. - 11:00 a.m.
Room 717 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Andrea Iaboni, D.Phil., M.D.
David Gold, Ph.D.
1. Depression and Cognitive Decline in 
Later Life: Cause, Consequence or 
Comorbidity?
Damien Gallagher
2. Dementia Presenting With Psychiatric 
Symptoms
Corinne E. Fischer, M.D.
3. An Approach to Diagnosing and 
Managing Cognitive Impairment 
in Psychiatric Practice: Cognitive 
Effects of Psychiatric Illness and 
Psychotropic Medications
Andrea Iaboni, D.Phil., M.D.
4. Neuropsychological Screening for 
Mild Cognitive Impairment and 
Dementia.
David Gold, Ph.D.
Advances in the Neurobiology of 
Attention Deficit Hyperactivity 
Disorder (ADHD)
8:00 a.m. - 11:00 a.m.
Room 801 A, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Joseph Biederman, M.D.
1. Dissociation of Working Memory and 
ADHD in the Brain
Joseph Biederman, M.D.
2. Evidence of a Pharmacological 
Dissociation Between the Robust 
Effects of Methylphenidate on ADHD 
Symptoms and Weaker Effects on 
Working Memory
Thomas Spencer, M.D.
3. Working Memory Deficits and 
Transgenerational Transmission 
of ADHD Phenotype in a Prenatal 
Nicotine Exposure Mouse Model
Pradeep G. Bhide, Ph.D.
4. A Functional Magnetic Resonance 
Imaging Study of Vulnerability for 
Posttraumatic Stress Disorder in Non-
Traumatized, Medication Naive Adults 
With ADHD
Andrea Spencer, M.D.
Brief Therapy: Practical Clinical Pearls
 5
8:00 a.m. - 11:00 a.m.
Room 715 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Mantosh Dewan, M.D.
1. Contribution of Common Versus 
Specific Factors (Therapy or 
Medication) to Successful Outcome
Mantosh Dewan, M.D.
2. Cognitive Therapy for Depression
Judith Beck, Ph.D.
3. Exposure Therapy for a Rape Survivor 
With Posttraumatic Stress Disorder
Seth J. Gillihan, Ph.D.
4. Premature Psychotherapy Termination
Roger P. Greenberg, Ph.D.
Quality Improvement Initiatives: 
International Perspectives
World Psychiatric Association
8:00 a.m. - 11:00 a.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
John S. McIntyre, M.D.
Wolfgang Gaebel, M.D., Ph.D.
1. Role of World Psychiatric Association 
in Promoting Quality Improvement 
Initiatives
John S. McIntyre, M.D.
2. Secondary Data Analysis in Quality 
Assurance: Pathways of Care in 
Depression, Anxiety and Somatoform 
Disorders
Wolfgang Gaebel, M.D., Ph.D.
3. Implementation of Quality Indicators 
in Routine Mental Health Care
Birgit Janssen, Ph.D.
4. Restraint-Related Deaths in Children 
and Adolescents
J. Richard Ciccone, M.D.
5. Use of an All-Payers Claim Database 
to Improve Quality of Psychiatric Care 
in Wisconsin
Jerry Halverson, M.D.
Healing the Broken Bough: Update 
on the Diagnosis, Prevention and 
Treatment of Fetal Alcohol Spectrum 
Disorders (FASD)
U.S. National Institute on Alcohol Abuse 
and Alcoholism
 6
8:00 a.m. - 11:00 a.m.
Room 701 B, Level 700, South Building





1. Overview of Fetal Alcohol Spectrum 
Disorders
Kenneth Warren, Ph.D.
2. Brain Development In Children and 
Adolescents With Prenatal Alcohol 
Exposure
Elizabeth R. Sowell, Ph.D.
3. Facial Clues to the Effects of Prenatal 
Alcohol Exposure on Brain and 
Behavior
Peter Hammond, Ph.D.
4. Developing a Neurobehavioral Profile 
of FASD
Sarah N. Mattson, Ph.D.
5. Neurobehavioral Disorder Associated 
With Prenatal Alcohol Exposure: 
Reliability and Validity of Diagnostic 
Criteria and Interventions for FASD
Julie Kable, Ph.D.
The Potential of Biomarkers to Assist 
in Clinical Care of Schizophrenia
8:00 a.m. - 11:00 a.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
S. Charles Schulz, M.D.
1. Efficacy of Biomarkers in Predicting 
Outcome of First Episode Psychosis
Robin Murray, M.D.
2. The Potential of Proteomics Biomark-
er Studies for Psychiatric Disorders
Sabine Bahn, M.D., Ph.D.
3. Pharmacogenetics: Using Genetic 
Information to Enhance Treatment
Anil Malhotra, M.D.
4. Biomarkers of Vulnerability and Pro-
gression in the Psychosis Prodrome
Tyrone D. Cannon, Ph.D.
5. Biomarkers of Vulnerability and Pro-
gression in the Psychosis Prodrome
Diana Perkins, M.D., M.P.H.
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 












Management of the Cognitive and 
Neuropsychiatric Symptoms of 
Dementia
4
8:00 a.m. - 12:00 p.m.
Birchwood Ballroom, Mezzanine





Andrew S. Wiens, M.D.
Tarek K. Rajji, M.D.
Dallas P. Seitz, M.D., Ph.D.
Zahinoor Ismail, M.D.
Evaluation and Treatment of 
Behavioral Emergencies
American Association for Emergency 
Psychiatry
5
8:00 a.m. - 12:00 p.m.
Civic Ballroom South, 2nd Floor
Sheraton Centre Toronto Hotel
Director:
Kimberly Nordstrom, J.D., M.D.
Faculty:
Kimberly Nordstrom, J.D., M.D.
Leslie Zun, M.B.A., M.D.
Jon S. Berlin, M.D.
Seth Powsner, M.D.
Scott L. Zeller, M.D.
Seminars
Training Practitioners to Use a 
Psychopathology Clinical Rating Scale
8:00 a.m. - 12:00 p.m.
Sheraton Hall E, Lower Concourse
Sheraton Centre Toronto Hotel
Director:
Ahmed Aboraya, Dr.P.H., M.D.
Faculty:
Daniel Elswick, M.D.
Henry A. Nasrallah, M.D.
Risk Assessment for Violence
3
8:00 a.m. - 12:00 p.m.
Chestnut East-West, Mezzanine




Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Good Psychiatric Management for 
Borderline Personality Disorder: What 
Every Psychiatrist Should Know
8:00 a.m. - 12:00 p.m.
Grand Ballroom Center, Lower Concourse
Sheraton Centre Toronto Hotel
Directors:
John G. Gunderson, M.D.
Paul Links, M.D.
Faculty:
Brian Palmer, M.D., M.P.H.
Street Drugs and Mental Disorders: 
Overview and Treatment of Dual 
Diagnosis Patients
1
8:00 a.m. - 12:00 p.m.
Sheraton Hall C, Lower Concourse
Sheraton Centre Toronto Hotel
Director:




Timothy W. Fong, M.D.
The Relevance of Circadian Rhythm 
Disturbances and Treatment to 
Psychiatric Practice
8:00 a.m. - 11:00 a.m.
Room 801 B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Richard S. Schwartz, M.D.
Jacqueline Olds, M.D.
1. Individual Differences in Light Sensitivity
Kathryn A. Roecklein, Ph.D.
2. Circadian Disruption in Delirium: 
The Role of Light, Melatonin, and 
Ramelteon
Mark Oldham, M.D.
3. Defining and Measuring Circadian Light
Mark S. Rea, Ph.D.
4. Applications and Practical 
Specifications for Light Treatment
Mariana Figueiro, Ph.D.
Integration of Spirituality in Health 
Care: Research and Clinical Reports
APA Caucus of Religion, Spirituality and 
Psychiatry
8:00 a.m. - 11:00 a.m.
Niagara/Ontario Rooms, Lower Level
InterContinental Toronto Centre
Chair:
Alexander Moreira-Almeida, M.D., Ph.D.
1. Controlled Clinical Trials for Spiritual 
and Religious Interventions: A 
Systematic Review and Meta-Analysis
Homero Vallada, M.D., Ph.D.
2. Clinical Implications of Spirituality to 
Mental Health: Review of Evidence 
and Practical Guidelines
Alexander Moreira-Almeida, M.D., Ph.D.
3. Interest in Spiritually Integrated 
Psychotherapy Among Acute 
Psychiatric Patients
David H. Rosmarin, Ph.D.
4. Depression and Spirituality: Clinical 
Implications
John R. Peteet, M.D.
5. Spirituality Groups With the 
Chronically Mentally ill
Nancy Kehoe, Ph.D.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
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Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Transference-Focused Psychotherapy 
for Borderline Personality Disorder
9:00 a.m. - 4:00 p.m.
Grand Ballroom East (Large), Lower 
Concourse
Sheraton Centre Toronto Hotel
Directors:
Frank E. Yeomans, M.D., Ph.D.
Otto F. Kernberg, M.D.
Faculty:
John F. Clarkin, Ph.D.
10:00 a.m. Sessions
Advances in Medicine
Rehabilitation of Complex Trauma: 
Implications for Mental Health 
Professionals
10:00 a.m. - 11:30 a.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Elspeth C. Ritchie, M.D., M.P.H.
Speaker:
Paul F. Pasquina, M.D.
Interactive Sessions
Let’s Talk About Marijuana
For Residents only
10:00 a.m. - 11:30 a.m.
Rooms 205 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Nora D. Volkow, M.D.
Radically Open Dialectical Behavior 
Therapy for Disorders of Overcontrol: 
Remembering Our Tribal Nature
9:00 a.m. - 4:00 p.m.
Pine, Mezzanine
Sheraton Centre Toronto Hotel
Director:
Thomas R. Lynch, Ph.D.
Practical Assessment and Treatment 
of Behavior Disturbance in Patients 
With Moderate to Severe Dementia
4
9:00 a.m. - 4:00 p.m.
Dominion Ballroom North, 2nd Floor
Sheraton Centre Toronto Hotel
Director:
Maureen Nash, M.D., M.S.
Faculty:
Sarah Foidel, O.T.R./L.
Maria L. Shindler, M.S.N., R.N.
Sleep Medicine - A Review and Update 
for Psychiatrists
9:00 a.m. - 4:00 p.m.
Dominion Ballroom South, 2nd Floor
Sheraton Centre Toronto Hotel
Directors:
Thomas D. Hurwitz, M.D.
Imran Khawaja, M.B.B.S.
Faculty:
Elliott K. Lee, M.D.
Max Hirshkowitz, Ph.D.
R. Robert Auger, M.D.
Yoga of the East and West Experiential 
for Stress, Anxiety, Posttraumatic 
Stress Disorder, Mass Disasters, 
Military, Schizophrenia, and Stress-
Related Medical Conditions
APA Caucus on Complementary and 
Alternative Medicine
5
9:00 a.m. - 4:00 p.m.
City Hall, 2nd Floor
Sheraton Centre Toronto Hotel
Director:
Patricia L. Gerbarg, M.D.
Faculty:
Richard P. Brown, M.D.
Patricia L. Gerbarg, M.D.
Beth P. Abrams, M.D.
Narrative Hypnosis With Special 
Reference to Pain
APA Caucus on Complementary and 
Alternative Medicine
5
8:00 a.m. - 12:00 p.m.
Civic Ballroom North, 2nd Floor
Sheraton Centre Toronto Hotel
Directors:
Lewis Mehl-Madrona, M.D., Ph.D.
Barbara Mainguy, M.A., M.F.A.
9:00 a.m. Sessions
Courses
Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Dialectical Behavior Therapy 
(DBT) for Psychiatrists: Using DBT 
Strategies in Your Psychotherapy and 
Psychopharmacological Practice
9:00 a.m. - 4:00 p.m.
Grand Ballroom West, Lower Concourse
Sheraton Centre Toronto Hotel
Directors:
Beth S. Brodsky, M.D., Ph.D.
Barbara Stanley, Ph.D.
Transgender and Intersex for the 
Practicing Psychiatrist
APA Council on Quality Care
2
9:00 a.m. - 4:00 p.m.
Sheraton Hall A, Lower Concourse
Sheraton Centre Toronto Hotel
Director:
William Byne, M.D., Ph.D.
Faculty:
Jack Pula, M.D.
Richard R. Pleak, M.D.
A. Evan Eyler, M.D., M.P.H.
Dan H. Karasic, M.D.
Heino F.L. Meyer-Bahlburg, Ph.D.











One Hundred Years of Shellshock: RIP 
or Alive and Kicking?
APA International Psychiatrist Lecture 
Series
10:00 a.m. - 11:30 a.m.
Exhibit Hall A, Level 300, North Building




Simon Wessely, M.A., M.D., M.Sc.
Lectures
DSM-IV-5 and Culture: Lessons 
Learned From 20 Years of Teaching 
Cultural Psychiatry-Applied Cultural 
Humility
APF Kun-Po Soo Award Lecture
10:00 a.m. - 11:30 a.m.
Rooms 206 A-F, Level 200, North Building
Metro Toronto Convention Centre
Lecturer:




10:00 a.m. - 11:30 a.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Petros Levounis, M.D.
Michael S. Ascher, M.D.
Simon Wessely, MA, MD, MSc is Professor and Head of the Department of Psychologi-
cal Medicine and Vice Dean for Academic Psychiatry at the Institute of Psychiatry (IoP), King’s 
College London. He is a clinical liaison psychiatrist, with a particular interest in unexplained 
symptoms and syndromes, and a clinical epidemiologist with an interest in military health.
Born and educated in Sheffield, he studied medical sciences and history of art at Trinity 
Hall, Cambridge, and then finished his medical training at University College Oxford, graduat-
ing in 1981. He obtained his medical membership in Newcastle, before moving to London’s 
Maudsley Hospital to train in psychiatry, where he also obtained a Master’s and Doctorate in 
epidemiology. His doctoral thesis was on crime and schizophrenia. Professor Wessely has 
been a consultant liaison psychiatrist at King’s College Hospital and the Maudsley Hospital 
since 1991, where he set up the first NHS service for sufferers from chronic fatigue syndrome.
His interest in military health dates back to his work on Gulf war related illness, after 
which he helped set up the King’s Centre for Military Health Research, a unique collaboration 
between the IoP and the KCL Department of War Studies. Its flagship project, a large-scale 
ongoing study of the health and wellbeing of the UK Armed Forces, has had a direct impact 
on public policy and on forms of treatment and help for Service personnel. He is Civilian 
Consultant Advisor in Psychiatry to the British Army and has visited services in Bosnia, Iraq 
and Afghanistan. He is a trustee of Combat Stress, the principal UK charity for veterans with 
mental health problems, and his contributions to veterans’ charities include cycling (slowly) 
seven times to Paris to raise funds for service personnel in need.
He established the first clinical trials unit in this country dedicated to mental health, and 
is a Foundation Senior Investigator of the National Institute for Health Research, and Fellow of 
the Academy of Medical Sciences. In 2012 he was awarded the first Nature “John Maddox 
Prize” for Standing Up for Science, and was knighted in the 2013 New Year’s Honours List.
Bio
Russell F Lim, MD, MEd is completed his Adult Psychiatric Residency at the University 
of California, San Francisco. Currently, he is a Health Sciences Clinical Professor at the Uni-
versity of California, Davis (UCD), where he has been for the last 17 years.
He is committed to providing mental health services to seriously persistently mentally ill 
adults in the community with an emphasis on culturally appropriate diagnosis and treatment.
He edited The Clinical Manual of Cultural Psychiatry, Second Edition for APPI in 
2015, and the first edition in 2006. In his role as Chair of the Diversity Advisory Committee 
(DAC), founded in 1999, he received the American College of Psychiatrists’ (ACP) Award for 
Creativity in Psychiatric Education in 2007. DAC’s four-year curriculum in cultural psychiatry 
was chosen as one of two model curriculums in Cultural Psychiatry by the American Asso-










Military Sexual Assault: Root Causes, 
Prevention Effectiveness, and 
Challenges in Treatment
10:00 a.m. - 11:30 a.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chair:
Christopher H. Warner, M.D.
Speakers:
Carl A. Castro, Ph.D.
Sara Kintzle, M.S.W., Ph.D.
But They’re Just Kids! Assessing the 
Risk of Violence in Youth
3
10:00 a.m. - 11:30 a.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Sandra K. Antoniak, M.D.
Speaker:
George David Annas, M.D., M.P.H.
3. Interactive Tools to Assess Common 
Mental Illnesses in Primary Care
Farah Ahmad, M.B.B.S., M.P.H., Ph.D.
4. Understanding Split-Treatment 
From the Patients’ Perspectives: 
Do Their Therapists and 
Psychopharmacologists Actually 
Communicate? Does It Matter?
Thomas Kalman, M.D., M.S.
Rachel L. Levine Baruch, M.A.
Workshops
The Teaching of Psychotherapy Inter-
ventions in the Psychiatric Emergency 
Center During Residency Training
10:00 a.m. - 11:30 a.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Anu A. Matorin, M.D.
Ye B. Du, M.D., M.P.H.
Speakers:
Natalie C. Pon, M.D.
Shirali S. Patel, M.D.
Gary Bryan Fillette, M.D.
Glilal Cells in Sleep and Depression
APA Frontiers of Science Lecture Series
10:00 a.m. - 11:30 a.m.
Exhibit Hall G, Level 800, South Building
Metro Toronto Convention Centre
Lecture Chair:
Godfrey D. Pearlson, M.D.
Lecturer:
Philip G. Haydon, Ph.D.
Scientific and Clinical 
Reports
Integrated Care: Some Tools of the Trade
10:00 a.m. - 11:30 a.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Britta Ostermeyer, M.D.
1. Patient Satisfaction With Shared 
Medical Appointments for Women 
With Depression Using the Patient 
Satisfaction Questionnaire-18 (PSQ-18)
Lilian Gonsalves, M.D.
2. Integrating Peer Staff Into Medication 
Management Visits to Support Recovery
Rachael Steimnitz, M.P.H.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
Philip G Haydon, PhD is the Annetta and Gustav Grisard Professor and Chair of Neuro-
science at Tufts University School of Medicine, Boston, USA. For the past twenty years his 
research has focused on roles played by astrocytes in the modulation of neuronal activity, 
synaptic transmission, behavior and more recently into the use of glial targets as therapeutic 
interventions for brain disorders. He graduated from the Department of Physiology, Univer-
sity of Leeds England with B.Sc (Hons) and Ph.D. in 1979 and 1982, respectively and then 
moved to the USA for postdoctoral studies and subsequent faculty positions. He obtained 
his first faculty position at Iowa State University where his studies of glial-neuron interac-
tions commenced in 1992. In 1994 he published the first paper demonstrating the regu-
lated release of gliotransmitters and demonstrated that astrocytes could modulate neuronal 
activity through the release of the excitatory transmitter glutamate. In 1999, together with 
colleagues in his laboratory, he coined the concept of “The Tripartite Synapse” to recognize 
the important role played by astrocytes in the modulation of synaptic transmission. Subse-
quently, while at the University of Pennsylvania School of Medicine, he integrated molecular 
genetics into his studies and demonstrated the role for astrocyte released ATP, that leads 
to adenosine accumulation, in the modulation of excitatory synaptic transmission and in the 
control of sleep. Because sleep disorders are co-morbid with numerous brain disorders, his 
recent research has turned to understanding how glia contribute to dysfunction of the brain 
in disorders including depression and Alzheimer’s disease.
He has received numerous prestigious awards including the McKnight Innovator Award 













These sessions are open to 
APA members only. A blue 
registration badge or an APA 




Psychiatric Care for a Pregnant 
Woman With Psychosis: A Unique 
Bridge to Alliance
3
12:30 p.m. - 2:00 p.m.
Room 701 A, Level 700, South Building




Laura M. Polania, M.D.
Paul S. Appelbaum, M.D.
Poster Sessions
International Poster Session 1
10:00 a.m. - 12:00 p.m.
Exhibit Halls D-F, Level 800, South Building
Metro Toronto Convention Centre
12:30 p.m. Sessions
Meeting
These sessions are open to 
APA members only. A blue 
registration badge or an APA 
membership card are required for 
admittance.
!
APA Annual Business Meeting
Voting APA Members Only
12:30 p.m. - 1:30 p.m.
Room 106, Level 100, North Building
Metro Toronto Convention Centre
Cultural Competence in Diverse 
Clinical Settings
10:00 a.m. - 11:30 a.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Kenneth Fung, M.D., M.S.
Lisa F. Andermann, M.D.
Speakers:
Kenneth Fung, M.D., M.S.
Lisa F. Andermann, M.D.
Hung Tat Lo, M.B.B.S.
Alpna Munshi, M.D.
Using the Cultural Formulation 
Interview With Refugees
10:00 a.m. - 11:30 a.m.
Humber Room, Main Level
InterContinental Toronto Centre
Chairs:




Ali A. Asghar-Ali, M.D.
Asim Shah, M.D.
An Dinh, D.O.
Opportunities for Health Care Reform 
to Impact Forensic Services Delivery: 
The New York Experience
3
10:00 a.m. - 11:30 a.m.






Ann Marie T. Sullivan, M.D.
Elizabeth Ford, M.D.
Fred C. Osher, M.D.
12:30 p.m. Meeting
APA Annual Business Meeting
12:30 p.m. – 1:30 p.m.
Voting members only
Room 106, North Level 100




Memorial to Deceased 
Members
Announcement of Election 
Results
Hind Benjelloun, M.D.
Chair, Committee of Tellers
Reports to the Membership
Saul Levin, M.D., M.P.A.
CEO and Medical Director
Frank Brown, M.D.
Treasurer
Maria A. Oquendo, M.D.
Secretary




Rebecca W. Brendel, M.D., J.D.
Chair, Committee on By-Laws








Resident-Fellow Member, General Mem-
bers, Distinguished Fellows, Fellows, 
Life Fellows, Distinguished Life Fellows, 
and Life Members. Registration badge 
and/or APA membership card neces-
sary for admission. No cameras or tape 
recorders are permitted in this meeting.
All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
!
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The American Journal of Psychiatry 
Residents’ Journal: How to Get 
Involved
12:30 p.m. - 2:00 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Misty Richards, M.D., M.S.
Robert Freedman, M.D.
Speakers:
Rajiv Radhakrishnan, M.B.B.S., M.D.
Tobias Wasser, M.D.
Holly Peek, M.D., M.P.H.
Kathleen M. Patchan, M.D.
Ijeoma Chukwu, M.D., M.P.H.
Why Did Alois Alzheimers Lose?
APA Ethics Committee and Penn-
Scattergood Ethics Program
12:30 p.m. - 2:00 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chair:
Jason Karlawish, M.D.
Addressing the Social Determinants of 
Latino Mental Health
APA Caucus of Hispanic Psychiatrists
12:30 p.m. - 2:00 p.m.
Room 711, Level 700, South Building





Guillermo Valdes, M.B.A., M.D.
Elena F. Garcia Aracena, M.D.
Helena Hansen, M.D., Ph.D.




12:30 p.m. - 2:00 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Svetlana Milenkovic, M.D.
1. Glycine Reuptake Inhibitors in the 
Treatment of Negative Symptoms of 
Schizophrenia
Rejish K. Thomas, M.D.
2. ITI-007 for the Treatment of 
Schizophrenia: Safety and Tolerability 
Analyses From the Randomized ITI-
007-005 Trial
Kimberly E. Vanover, Ph.D.
Sharon Mates, Ph.D.
Robert E. Davis, Ph.D.
4
3. Thirty-Day Hospital Readmission 
for Medicaid Enrollees With 
Schizophrenia: The Role of Patient 
Comorbidity and Local Health Care 
Systems
Alisa B. Busch, M.D., M.S.
5
4. Killer Cult Members and the Insanity 
Plea: Exploring the Line Between 
Belief and Delusion
Brian J. Holoyda, M.D., M.P.H.
3
Interactive Sessions
Sports Psychiatry: Overcoming 
Medical, Social, and Psychological 
Recovery Barriers From Serious 
Athletic Injury
5
12:30 p.m. - 2:00 p.m.
Room 801 B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
David R. McDuff, M.D.
Helping Kids in Crisis
Meet the Author
2
12:30 p.m. - 2:00 p.m.
Room 803 A-B, Level 800, South Building




The Future of Antidepressant Drug 
Discovery and Development
APA International Psychiatrist Lecture 
Series
12:30 p.m. - 2:00 p.m.
Room 102 (Theatre), Level 100, North 
Building
Metro Toronto Convention Centre
Lecture Chair:
Alan F. Schatzberg, M.D.
Lecturer:
Florian Holsboer, M.D., Ph.D.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
Florian Holsboer, MD, PhD was born in Munich, Germany and studied chemistry and 
medicine at the University of Munich where he completed his residency in psychiatry. His 
areas of study include: Affective disorders, depression, anxiety, central regulation of stress 
hormones, sleep physiology, molecular and clinical psychopharmacology, pharmacogenetics 
and personalized medicine.
In 1989 Professor Holsboer became Director of the Max-Planck Institute for Psychiatry. 
The institute is a research center for disorders of the central nervous system. Research is 
conducted by 28 different research groups in a broad range of areas from molecular biology 
to pharmacology, to human and mouse genetics, proteomics and chemical genomics.
His extensive knowledge and research of mental health issues will give attendees an 













Compliance: Abu Ghraib in a Fast-
Food Joint
3
1:00 p.m. - 4:00 p.m.






Kevin D. Moore, M.D.
Mark G. Frank, Ph.D.
Presidential Symposia
Geriatric Psychiatry: Treatment 
Updates and New Perspectives
American Association for Geriatric 
Psychiatry
 4
1:00 p.m. - 4:00 p.m.
Room 718 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Susan Schultz, M.D.
1. Older Patients Telling Stories to 
Doctors in a Technological Age
Dan G. Blazer II, M.D., M.P.H., Ph.D.
2. The Citalopram for Agitation in 
Alzheimer Disease Study: Effect of 
Citalopram on Agitation in Dementia
Bruce G. Pollock, M.D., Ph.D.
3. Antipsychotic Management in the 
Elderly: Guidelines and Goals of Care
Susan Schultz, M.D.
Understanding Resilience in the Face 
of Trauma: From Molecules to Circuits 
to Behaviors
1:00 p.m. - 4:00 p.m.
Room 718 B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Charles R. Marmar, M.D.
1. Psychosocial and Genetic Markers 
of Resilience Following Repeated 
Childhood Trauma Exposure
Kerry Ressler, M.D., Ph.D.
2. Trajectories of Posttraumatic Stress 
and Resilience: Identification of 
Phenotypic Patterns of Traumatic 
Stress Response Across Contexts and 
Species
Isaac R. Galatzer-Levy, Ph.D.
1:00 p.m. Sessions
Advances in Medicine
Medical Mysteries and Practical 
Med Psych Updates: Is It Medical, 
Psychiatric, or a Little of Both?
1:00 p.m. - 4:00 p.m.
Room 105, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Robert M. McCarron, D.O.
Speakers:
Y. Pritham Raj, M.D.
Jeffrey T. Rado, M.D., M.P.H.
Jaesu Han, M.D.
Advances in Series
Advances in Psychodynamic 
Psychiatry
1:00 p.m. - 4:00 p.m.
Rooms 206 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Elizabeth Auchincloss, M.D.
1. The Therapeutic Alliance in 
Contemporary Psychiatry: New 
Developments
Elizabeth Auchincloss, M.D.
2. Psychodynamic Treatment of 
Personality Disorders: Evolving 
Perspectives on Interpretation
Eve Caligor, M.D.
3. Transformations of the Developmental 
Process: Human Development in the 
Technocultural Era
Karen J. Gilmore, M.D.
4. The Classification of Personality 
Disorders: New Developments
Otto F. Kernberg, M.D.
Pearls of Psychosomatic Medicine: 
Stuff You Really Want to Know About 
Delirium, Torsades, Treatment of 
Pregnant Women, and Projective 
Identification
Academy of Psychosomatic Medicine
5
12:30 p.m. - 2:00 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Philip R. Muskin, M.D.
Speakers:
Joji Suzuki, M.D.
Margo C. Funk, M.A., M.D.
Christina L. Wichman, D.O.
Current Procedural Terminology Code 
Set: The Old, the New, and the Ugly!
12:30 p.m. - 2:00 p.m.
Humber Room, Main Level
InterContinental Toronto Centre
Chairs:
Vikram Shah, M.B.A., M.D.
Stuart L. Lustig, M.D., M.P.H.
Counties as Psychiatric Service 
Providers
12:30 p.m. - 2:00 p.m.
Caledon and Oakville, Main Level
InterContinental Toronto Centre
Chair:





Robert P. Cabaj, M.D.
Roderick Shaner, M.D.
Media Workshops
Screening and Discussion of the Film 
“Anonymous People”
U.S. National Institute on Alcohol Abuse 
and Alcoholism
6
12:30 p.m. - 2:30 p.m.
Exhibit Hall G, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
George Koob, Ph.D.
Nora D. Volkow, M.D.
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4. The Association Between BPD in 
Adolescents, Childhood Adversity, and 
Childhood Protective Experiences
Mary C. Zanarini, Ed.D.
Real-Life Consequences to Patients 
and Families of Misdiagnosis, 
Misunderstanding, Mistreatment 
and Stigmatization of Borderline 
Personality Disorder (BPD)
1:00 p.m. - 4:00 p.m.
Room 701 B, Level 700, South Building





John M. Oldham, M.D.
1. Is Research on BPD Underfunded by 
the National Institutes of Health?
Mark Zimmerman, M.D.
2. BPD Public Health and Treatment 
Crisis: Global Consequences of 
Misdiagnosis, Mistreatment and 
Stigmatization of BPD
Valerie Porr, M.A.
3. Evaluating Experiences of 300 
Participants With Diagnosis and 
Treatment of BPD: Results of a TARA 
On-Line Survey
Kristie Tse, B.A.
4. BPD, the Family and Psychiatry
Eric Manheimer, M.D.
Introducing the Structured Clinical 
Interview for DSM-5 – Clinician 
Version (SCID-5-CV)
American Psychiatric Publishing Editorial 
Board
1:00 p.m. - 4:00 p.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Michael First, M.D.
1. Introduction to SCID-CV
Michael First, M.D.
2. Diagnosing Mood and Psychotic 
Disorders Using the SCID-CV
Janet B.W. Williams, Ph.D.
3. Diagnosing Substance Use and 
Anxiety Disorders Using the SCID-CV
Rhonda Karg, Ph.D.
3. Psychiatric and Psychological Effects 
of Infertility and Infertility Treatments
Lucy Hutner, M.D.
4. Bipolar Disorder in the Perinatal 
Patient: Balancing the Risks of Illness 
and Treatment
Elizabeth Fitelson, M.D.
5. Anxiety Disorders in Pregnancy: What 
Every Clinician Needs to Know
Lauren M. Osborne, M.D.
6. Treatment of Depression in Perinatal 
Women
Laura Miller, M.D.
On-Call Update: Skills in Acute Care 
Psychiatry
1:00 p.m. - 4:00 p.m.
Rooms 202 A-B, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Jodi Lofchy, M.D.
1. On-Call Risk Assessment: Suicide
Jodi Lofchy, M.D.
2. Assessing Medical Stability in 
Psychiatric Emergencies
David Koczerginski, M.D.
3. Managing the Agitated Patient On-Call
Anna Skorzewska, M.D.
4. Managing Common Inpatient Issues
Andrea Waddell, M.D., M.Ed.
Childhood Precursors of Borderline 
Personality Disorder (BPD)
North American Association for the Study 
of Personality Disorders
2
1:00 p.m. - 4:00 p.m.
Rooms 205 A-D, Level 200, North Building




Andrew M. Chanen, M.B.B.S., Ph.D.
1. Why Are Childhood Precursors 
Important?
Joel Paris, M.D.
2. Hypermentalizing in Adolescent BPD 
Compared to Psychiatric and Healthy 
Controls: Introducing a New Measure
Carla Sharp, Ph.D.
3. Heightened Negative Emotional 
Reactivity as a Marker of Stress 
Sensitivity in the Development of BPD 
Symptoms
Stephanie Stepp, Ph.D.
3. Causal Paths from Genetic Influence 
to Resilience: Evidence from A 
Prospective Cohort Study of Highly 
Trauma Exposed Urban Police Officers
Charles R. Marmar, M.D.
4. Neurobiological Mechanisms of 
Recovery From Posttraumatic Stress
Amit Etkin, M.D., Ph.D.
Symposia
Primary Care and Assertive 
Community Treatment (ACT)Teams: 
New Frontiers in Team-Based Chronic 
Illness Management
1:00 p.m. - 4:00 p.m.
Rooms 104 A-B , Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Erik Vanderlip, M.D., M.P.H.
Maria Monroe-DeVita, Ph.D.
1. The Minnesota Approach to Integrated 
Care: Integrated Illness Management 




2. Embedded Primary Care Within Asser-
tive Community Treatment: Implemen-
tation and Outcomes in L.A. County
Benjamin Henwood, L.C.S.W., 
M.S.W., Ph.D.
3. From the Eyes of the PACT Staff: 
Barriers and Facilitators to Effective 
Physical Health Management
Maria Monroe-DeVita, Ph.D.
4. Sooner or Later: The Oklahoma 
Adoption of Health Homes and ACT 
Integration
Erik Vanderlip, M.D., M.P.H.
Perinatal Mental Health: Evaluation 
and Treatment Considerations for the 
General Psychiatrist
 5
1:00 p.m. - 4:00 p.m.
Rooms 201 A-F, Level 200, North Building




1. Antidepressants in Pregnancy: 
Knowledge Transfer and Translation of 
Scientific Evidence
Adrienne Einarson, R.N.
2. Approach to Substance Use Disorders 
in the Perinatal Period











All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
!
Comprehensive HIV Neuropsychiatry 
Update
 5
1:00 p.m. - 4:00 p.m.
Room 715 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Karl Goodkin, M.D., Ph.D.
1. Medical Update
Marshall Forstein, M.D.
2. Neurocognitive Decline in HIV/AIDS
Lawrence M. McGlynn, M.D.
3. Psychopharmacological Treatments in 
HIV Patients
Stephen J. Ferrando, M.D.
4. Discussing HIV Cognitive Disorder 
With Patients: Giving the Diagnosis 
and the Implications for Psychiatric 
Care
Marshall Forstein, M.D.
5. Diagnosis and Clinical Monitoring of 
HAND
Karl Goodkin, M.D., Ph.D.
The Schizophrenia Syndrome in 2015: 
New Facts and Emerging Insights
1:00 p.m. - 4:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Henry A. Nasrallah, M.D.
Rajiv Tandon, M.D.
Discussant:
Carol A. Tamminga, M.D.
1. Accelerating Genetic Discoveries in 
Schizophrenia
Anil Malhotra, M.D.
2. Pathophysiology of Schizophrenia: 
Emerging Insights
Matcheri Keshavan, M.D.
3. Advances in Diagnosis and 
Phenomenology
Rajiv Tandon, M.D.
4. Beyond Dopamine: The Evolving 
Therapeutics of Schizophrenia and Its 
Various Symptom Domains
Henry A. Nasrallah, M.D.
Spaces, Genes, Induced Pluripotent 
Stem Cells (IPSCs) and Neurocircuits: 
How Novel Approaches Are Informing 
Our Understanding of Etiology and 
Clinical Phenotype in Psychiatry
1:00 p.m. - 4:00 p.m.
Room 717 A-B, Level 700, South Building





Alan F. Schatzberg, M.D.
1. IPSCs: A Revolution in Understanding 
Psychiatric Disorders
Pasca Sergiu, M.D.
2. Neural Circuits as Substrates of 
Mental Illness and Targets for 
Therapeutics
Amit Etkin, M.D., Ph.D.
3. Neurocognitive Dimensions and 
Neurocircuits Subserving Psychiatric 
Disorders: A Developmental 
Perspective
Ruth O’Hara, Ph.D.
4. Integrating Genes, IPSCs and 
Neurocircuits Into a Clearer 
Understanding of the Etiology and 
Clinical Phenotypes in Psychiatric 
Disorders
Joachim Hallmayer, M.D.
Challenges and Opportunities for 
Global Mental Health
APA Council on International Psychiatry
1:00 p.m. - 4:00 p.m.
Room 801 A, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Samuel O. Okpaku, M.D., Ph.D.
1. Task Shifting and Sharing 
Opportunities and Caveats-
Perspectives of Stakeholders in a 
West African Nation
Vincent Agyapong, M.D.
2. Am I My Brother’s Keeper
Samuel O. Okpaku, M.D., Ph.D.
3. Global Mental Health: Is It Possible?
Clare Pain, M.D.
4. Bringing Ubuntu Back from Southern 
Africa
Mary Kay Smith, M.D.
5. The Burden and Treatment Gap of 
Mental Illness
Robert Kohn, M.D.
Anti-Lesbian Gay Bisexual 
Transgender (LGBT) Discrimination 
Abroad and Asylum-Seeking at Home: 
The Psychiatrist’s Role
Association of Gay and Lesbian 
Psychiatrists
3
1:00 p.m. - 4:00 p.m.





Dinesh Bhugra, M.D., Ph.D.
1. A Psychiatrist’s View of International 
Anti-Gay Policies
Miriam Shuchman, M.D.
2. My Experiences in Uganda and as an 
Asylum-Seeker
John A. Wambere
3. A View From Iran: Discrimination at 
Home and Mental Health Needs of 
Asylum Seekers
Shervin Shadianloo, M.D.





International Poster Session 2
2:00 p.m. - 4:00 p.m.
Exhibit Halls D-F, Level 800, South Building
Metro Toronto Convention Centre
2:30 p.m. Sessions
Advances in Medicine
Why Psychiatrists Should Care About 
Frontotemporal Dementia
2:30 p.m. - 4:00 p.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Catherine C. Crone, M.D.
Speaker:










Reflections on a Decade of Research 
Investigating Deep Brain Stimulation 
for Depression
2:30 p.m. - 4:00 p.m.
Room 801 B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Helen S. Mayberg, M.D.
Lectures
Metals and Oxidative Stress in 
Alzheimer’s Disease
APA International Psychiatrist Lecture 
Series
 4
2:30 p.m. - 4:00 p.m.
Room 102 (Theatre), Level 100, North 
Building
Metro Toronto Convention Centre
Lecture Chair:
Barton J. Blinder, M.D., Ph.D.
Lecturer:
Ashley I. Bush, M.D., Ph.D.
Scientific and Clinical 
Reports
Integrated Care Across Clinical 
Settings
 2 5
2:30 p.m. - 4:00 p.m.
Room 713 A-B, Level 700, South Building




1. Identifying Undiagnosed Pediatric 
Mental Illness in the Emergency 
Department
Leslie Zun, M.B.A., M.D.
2
2. Engagement in a Remotely-Delivered 
Behavioral Health Intervention 
Reduces Depression, Stress, and 
Anxiety in Medically High-Risk 
Populations
Reena L. Pande, M.D., M.Sc.
Aimee Peters, L.C.S.W.
Patrick L. Kerr, Ph.D.
5
3. A Physician-Health Plan Collaborative 
Solution for Achieving Primary Care 
Mental Health Integration
Judith A. Feld, M.D.
4. Integrating Mental Health and Primary 
Medical Care for Homeless Veterans 
in a Community Setting
Theddeus Iheanacho, M.D.
Workshops
Mild Traumatic Brain Injury: 
Assessment and Initial Management 
With Neuropharmacology
2:30 p.m. - 4:00 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
David B. FitzGerald, M.B.A., M.D.
Josepha A. Cheong, M.D.
Speakers:
David B. FitzGerald, M.B.A., M.D.
Josepha A. Cheong, M.D.
Physician Health and Physician as 
Patient
2:30 p.m. - 4:00 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chair:
Glen O. Gabbard, M.D.
Speakers:
Holly Crisp-Han, M.D.
Gabrielle S. Hobday, M.D.
Psychiatric, Orthopedic, and Ethical 
Concerns in Delayed Amputations 
Subsequent to Traumatic Injury in a 
Military Setting
5
2:30 p.m. - 4:00 p.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Edmund G. Howe III, J.D., M.D.
Speakers:
Benjamin K. Potter, M.D.
Harold J. Wain, Ph.D.
Edmund G. Howe III, J.D., M.D.
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!
Ashley Bush, MD PhD is professor of neuroscience at The University of Melbourne, Di-
rector of the Oxidation Biology Unit at The Florey Institute of Neuroscience & Mental Health, 
and a psychiatrist at the Massachusetts General Hospital, Boston. He is the recipient of 
numerous awards including the Beeson Award, the Senator John T. Hatfield Award from the 
Alzheimer’s Association, and the Potamkin Prize from the American Academy of Neurology. 
He is the most highly cited neuroscientist in Australia over the last 10 years, and in 2014 
was listed in the Thompson ISI list of The World’s Most Influential Scientific Minds. Professor 
Bush has authored over 310 publications, with over 21,000 citations, 23 patents and has 
founded 4 biotechnology companies. He discovered the interaction of beta-amyloid with zinc 
as a major factor in Alzheimer’s disease pathogenesis, and focuses on the neurobiology of 
metal ions and oxidative stress in neurodegenerative and psychiatric disorders.
Bio
This session will be captured 
as part of APA Annual 
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speaker permission. Visit the APA 
on Demand Sales Booths in 













Opening Session and Special Conversation
4:30 pm – 6:45 pm
Hall A, North, Level 300
Toronto Convention Centre
Call to Order
Paul Summergrad, M.D., President
Welcoming Remarks by the Canadian 
Psychiatric Association President
Padraic E. Carr, M.D.
Presentation of Check to 
Covenant House of Toronto
Paul Summergrad, M.D
Introduction of Stage Guests
Paul Summergrad, M.D.
Introduction of Dr. Philip R. Muskin
Paul Summergrad, M.D.
Report from the Scientific Program Committee
Philip R. Muskin, M.D., Chairperson
Introduction of Presidents and 
Representatives of United States and 
International Allied Organizations
Paul Summergrad, M.D.





Introduction of the President-Elect for the 
Response to the Presidential Address
Uyen-Khanh Quang-Dang, M.D.
Response of the President-Elect
Renee L. Binder, M.D.
Introduction of the Special Conversation Program
Paul Summergrad, M.D.
Adjournment
A Special Conversation on Science, Advocacy, and Talking About Mental Health 
with Paul Summergrad, MD, Helen S Mayberg, MD, and The Hon Patrick Kennedy
APA President Paul Summergrad, M.D., renowned researcher Helen S. Mayberg, M.D., and former U.S. 
Rep. Patrick Kennedy will engage in a thought-provoking conversation about neuroscience opportunities 
in psychiatry, the role of advocacy, and the unique challenges of talking about mental health and complex 
neuropsychiatric illness.
Paul Summergrad, MD, is president of the American Psychiatric Association. He is the 
Psychiatrist-in-Chief of Tufts Medical Center and the Dr. Frances S. Arkin Professor and 
Chairman of the Tufts Medical Center Physicians Organization. During his distinguished 
career, he has published extensively on the history and development of psychiatry, medical 
psychiatry, and strategic planning in academic psychiatry.
Helen S Mayberg, MD, is a professor of psychiatry, neurology, and radiology at 
Emory University School of Medicine. She heads a multidisciplinary depression research 
program dedicated to the study of brain circuits in depression and the effects of various 
antidepressant treatments measured using an array of functional and structural imaging 
tools. She was recently named Emory University’s “Game Changers” in recognition of her 
pioneering deep brain stimulation (DBS) research.
Patrick Kennedy spent 16 years in the U.S. House of Representatives and is 
predominately known as the author and lead sponsor of the Mental Health Parity and 
Addiction Equity Act of 2008. This legislation provides access to mental health care to tens 
of millions of Americans who were previously denied care. He has long been an outspoken 
advocate for mental health care. He is the co-founder of One Mind, a national coalition 
seeking new treatments and cures for neurologic and psychiatric diseases, and the founder 










Integrating Dialectical Behavioral 
Therapy, Mentalization-Based 
Treatment, and General Psychiatric 
Management Using an Interpersonal 
Focus
7:00 p.m. - 10:00 p.m.
Niagara/Ontario Rooms, Lower Level
InterContinental Toronto Centre
Chairs:





1. Integration of Multiple Evidence-
Based Treatments to Treat “the 
Need for Specialness” in Patient 
With Narcissistic and Borderline 
Personality Disorders (BPD)
Claire M. Brickell, M.D.
2. Integrated Treatment for BPD: 
A Career Patient With Extensive 
Comorbidity and Recurrent Ingestion
Karen Jacob, Ph.D.
3. Treatment of Somatic Symptoms in 
BPD: Is Therapy Possible?
Renee T. Witlen, M.D.
4. Good Psychiatric Management as a 
Foundation for Integrating Evidence-
Based Treatments for BPD
Brandon Unruh, M.D.
Intensive Short-Term Dynamic 
Psychotherapy (ISTDP): Evidence, 
Theory, and Technique
5
7:00 p.m. - 10:00 p.m.





1. ISTDP- Evidence, Theory, and 
Technique
Jeffrey Katzman, M.D.
2. ISTDP: The Experience of Training 
During a General Residency Program
Brandon Yarns, M.D.
3. ISTDP: Examples From Videotaped 
Patient Examples
Patricia Coughlin, Ph.D.
Women Psychiatrists: Roadblocks and 
Pathways to Success
2:30 p.m. - 4:00 p.m.






Donna M. Norris, M.D.
Laura Roberts, M.A., M.D.
4:30 p.m. Sessions
Session
Opening Session with a Special 
Conversation With Paul Summergrad, 
M.D, Helen Mayberg, M.D., and the 
Hon. Patrick Kennedy on Science, 
Advocacy, and Talking About Mental 
Health
4:30 p.m. - 6:30 p.m.
Exhibit Hall A, Level 300, North Building
Metro Toronto Convention Centre
7:00 p.m. Sessions
Media Workshops
Reviewing (Mental) Disorders With 
a Reverent Understanding of the 
Macabre (REDRUM)
1
7:00 p.m. - 10:00 p.m.






Tom E. Draschil, M.D.
Helping Patients Who Drink Too Much: 
Using the NIAAA’s Clinician’s Guide
U.S. National Institute on Alcohol Abuse 
and Alcoholism
6
2:30 p.m. - 4:00 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Mike Fleming, M.D., M.P.H.
Speakers:
Mike Fleming, M.D., M.P.H.
Robert Huebner, Ph.D.
Detection and Treatment of Bullying-
Related Morbidity: A Public Health 
Need
2
2:30 p.m. - 4:00 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Jorge C. Srabstein, M.D.
Speaker:
Jorge C. Srabstein, M.D.
Developing a Citywide System of 
Care in Acute Psychiatry: The Toronto 
Mental Health and Addictions Acute 
Care Alliance
2:30 p.m. - 4:00 p.m.







Vicky Stergiopoulos, M.D., M.H.Sc.
Paul V. Benassi, M.D.
Nicole Kozloff, M.D.
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The Psychiatrist as Expert Witness
3
8:00 a.m. - 12:00 p.m.
City Hall, 2nd Floor





These sessions are open to 
APA members only. A blue 
registration badge or an APA 
membership card are required for 
admittance.
!
A Complex Case of a Hispanic Male 
Patient With Depression and History of 
Sexual Trauma
9:00 a.m. - 10:30 a.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:




Steve Koh, M.D., M.P.H.
Focus Live
Focus Live! Psychopharmacology
9:00 a.m. - 10:30 a.m.
Room 105, Level 100, North Building
Metro Toronto Convention Centre
Moderator:
Mark H. Rapaport, M.D.
Tristan Gorrindo, M.D.
Speakers:
Carol A. Tamminga, M.D.
Ana Stan, M.D., Ph.D.
Exploring Technologies in Psychiatry
8:00 a.m. - 12:00 p.m.
Sheraton Hall E, Lower Concourse






Identifying and Helping Older Adults 
With Mild Neurocognitive Disorders
4
8:00 a.m. - 12:00 p.m.
Pine, Mezzanine
Sheraton Centre Toronto Hotel
Director:
James M. Ellison, M.D., M.P.H.
Faculty:
Courtney Carroll Spilker, Psy.D.
Donald A. Davidoff, Ph.D.
David C. Hsu, M.D.
ECT Practice Update for the General 
Psychiatrist
8:00 a.m. - 12:00 p.m.
Chestnut East-West, Mezzanine
Sheraton Centre Toronto Hotel
Director:
Peter B. Rosenquist, M.D.
Faculty:
Charles H. Kellner, M.D.
Donald Eknoyan, M.D.
Andrew Krystal, M.D., M.S.
W. Vaughn McCall, M.D., M.S.
8:00 a.m. Sessions
Courses
Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Advanced Assessment and Treatment 
of ADHD
8:00 a.m. - 12:00 p.m.
Grand Ballroom West, Lower Concourse
Sheraton Centre Toronto Hotel
Director:




for Narcissistic Personality Disorder
8:00 a.m. - 12:00 p.m.
Grand Ballroom Center, Lower Concourse
Sheraton Centre Toronto Hotel
Directors:
Frank E. Yeomans, M.D., Ph.D.




Teaching Psychotherapy? Let 
Hollywood (and Cable TV) Help!
8:00 a.m. - 12:00 p.m.
Sheraton Hall A, Lower Concourse
Sheraton Centre Toronto Hotel
Directors:




All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
!
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
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Navigating Psychiatry and Health Care 
Reform
APA Guest Lecture Series
9:00 a.m. - 10:30 a.m.
Room 102 (Theatre), Level 100, North 
Building




Ellen M. Zane, M.A.
Fatal Pauses: Stuck in Pleasing 
Others. An Introduction to 
Supermentalization
Meet the Author
9:00 a.m. - 10:30 a.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Stuart C. Yudofsky, M.D.
Interactive Sessions
The National Neuroscience 
Curriculum Initiative: Bringing 
Neuroscience Into the Clinical 
Practice of Psychiatry
For Residents only
9:00 a.m. - 10:30 a.m.
Room 101, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Melissa Arbuckle, M.D., Ph.D.
Michael J. Travis, M.D.
David A. Ross, M.D., Ph.D.
Ellen M Zane, MA is a nationally renowned health care leader who recently retired as 
President & Chief Executive Officer of Tufts Medical Center and the Floating Hospital for 
Children. She was the first woman to run the hospital in its 218-year history. The hospital 
employs more 5,000 doctors, nurses, researchers, and other healthcare workers, includes 
Floating Hospital for Children, and has 450 beds. Ellen remains involved at Tufts Medical 
Center as a vice chair of the Board of Trustees. Ellen holds two faculty appointments at Tufts 
University School of Medicine including: Assistant Professor in the Department of Medicine, 
Division of Clinical Care Research and Assistant Professor of Public Health & Community 
Medicine. Additionally, Ellen holds a faculty appointment as Adjunct Assistant Professor in 
the Health Policy and Management at the Harvard School of Public Health. For the period of 
2011 to 2013, Ellen was a Distinguished Guest Lecturer in Healthcare Administration at the 
Sawyer Business School at Suffolk University.
From 1994 to 2004, Ellen held the position of Network President for Partners Health-
Care System, Inc. In this capacity, she was responsible for the development of a provider 
network featuring the Massachusetts General Hospital and Brigham & Women’s Hospital. 
The network encompassed 5600 physicians and represented $800+ million of managed 
care revenue. Today, this entity represents one of the largest physician networks in America.
Prior to that, Ellen was the Chief Executive Officer at Quincy Hospital in Quincy, Massa-
chusetts. Ellen was an employee of HCA and then Quorum Health Resources in this capacity.
Ellen received her Professional Director Certification from the American College of Cor-
porate Directors in 2013, her Bachelor of Arts degree from the George Washington Univer-
sity in Washington, D.C. in 1973 and her Master of Arts degree in 1975 from the Catholic 
University of America in Washington. She holds the following honorary degrees: Doctorate 
of Commercial Science from Bentley University, Doctorate of Business Administration from 
Stonehill College; and Doctorate of Humane Letters from Curry College.
Ellen is currently a Director of Brooks Automation (NASDAQ-BRKS); a Director of Hae-
monetics Corporation (NYSE-HAE); and a Director of Parexel International (NASDAQ-PRXL). 
She is a Director of Press Ganey, a private company nationally known as the preeminent 
provider of patient satisfaction measurement and data in acute hospital settings; and the 
Vice Chair of the Board of Trustees at George Washington University, Washington DC.
Ellen is a former Director of Lincare Holdings, Inc. (NASDAQ-LNCR); a former Director 
of Variagenics, Inc. (NASDAQ-VGNX), a Cambridge, Massachusetts biotech public company 
focused on pharmacogenomics; a former member of the Board of Overseers at the Tufts 
University School of Medicine; a former Chair of the Board of the Massachusetts Hospital 
Association; a former Trustee of Northeastern University; and also a former Director of the 
John F. Kennedy Library Foundation. From 1996 to 2001, Ellen was a member of the Board 
of Governors at the Warren Grant Magnuson Clinical Center (national hospital) at the Na-










4. Lived Lost Lives: A Science/Arts 
Research Collaborative: Engaging 
Bereaved Families, the Public and 
Policy Makers With Young-Adult 
Suicide
Kevin M. Malone, M.D.




Ethics of Clinical Reasoning
APA Ethics Committee and Penn-
Scattergood Ethics Program
9:00 a.m. - 10:30 a.m.
Rooms 103 A-B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Nancy N. Potter, Ph.D.
Speakers:
Mona Gupta, M.D., Ph.D.
Nancy N. Potter, Ph.D.
Scientific and Clinical 
Reports
Suicide: Possible Comorbidities and 
Engaging Survivors
 2 5
9:00 a.m. - 10:30 a.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Britta Ostermeyer, M.D.
1. Marked Impact on Suicidal Ideation 
and Suicidology in a Military 
Population Following a Cervical 
Sympathetic Blockade
Eugene Lipov, M.D.
2. Disordered Sleep and Stress Among 
Private High School Students: 




3. Causes and Outcomes of 
Acetaminophen Overdoses: The Mayo 
Clinic Experience, 2004-2010
Nuria J. Thusius, M.D.
5
“But We Need the Eggs”: Perspectives 
on What Psychiatry Has Been, Can Do, 
and Must Become
APA Distinguished Psychiatrist Lecture 
Series
9:00 a.m. - 10:30 a.m.
Exhibit Hall A, Level 300, North Building
Metro Toronto Convention Centre
Lecture Chairs:
Philip R. Muskin, M.D.
Barton J. Blinder, M.D., Ph.D.
Lecturer:
Jerrold F. Rosenbaum, M.D.
Is Psychiatric Medication Selection 
via Genetic Testing Becoming the 
Preferred Practice
APA David A. Mrazek, M.D. Memorial 
Lecture on Psychiatric Pharmacogenomics
9:00 a.m. - 10:30 a.m.
Exhibit Hall G, Level 800, South Building
Metro Toronto Convention Centre
Lecturer:
James L. Kennedy, M.D.
Jerrold F Rosenbaum, MD is Psychiatrist-in-Chief at Massachusetts General Hospital 
(MGH) and Stanley Cobb Professor of Psychiatry at Harvard Medical School. Dr. Rosenbaum 
heads a department of more than 600 clinicians, researchers, and trainees, ranked in 2014 
by U.S. News and World Report as #1 for Psychiatry and for 17 of the last 19 years. He 
served as President and Chairman of the Board of the Anxiety and Depression Association 
of America (ADAA) and is Chair of the Scientific Council and on the Board of Directors for 
the American Foundation for Suicide Prevention (AFSP). He also serves on the MGH Board 
of Trustees. He has authored more than 400 original articles and reviews and authored or 
edited 20 books. Dr. Rosenbaum is a graduate of Yale College and Yale School of Medicine 
and Psychiatry residency at MGH, Harvard Medical School.
Bio
James L Kennedy, MD has training in three major areas: neuroscience, clinical psychia-
try, and molecular genetics. His main research interest over the past 20 years has been the 
identification of susceptibility genes for psychiatric disorders. His discoveries include: 1) the 
role of the DRD4 gene in ADHD, 2) the genetic predictors of antipsychotic response and 
side effects, 3) the 5HTTLPR genetic marker predicts risk for antidepressant induced mania. 
He has published pioneering findings relating gene variants in the dopamine, serotonin, and 
neurodevelopment systems to psychiatric disorders, neuroimaging (PET and MRI) and to 
treatment response. A major current project led by Dr. Kennedy is examining a large sample 
(N=20,000) of patients to determine the usefulness and cost-benefit of genetic testing ap-
plied to choice and dosage of psychiatric medications in clinical care. Dr. Kennedy has pub-
lished more than 540 scientific articles with over 25,000 citations, and he is an active lecturer 












The Challenge of Rechallenge: 
A Rational Approach to Treating 
Survivors of Major Adverse Effects of 
Clozapine
5
9:00 a.m. - 10:30 a.m.





The Latest Research and Clinical 
Information Regarding Major 
Psychiatric Disorders
9:00 a.m. - 12:00 p.m.
Room 106, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Herbert Pardes, M.D.
Jack D. Barchas, M.D.
1. Pathways to new treatments in 
Autism Spectrum Disorder
Jeremy Veenstra-VanderWeele
2. Schizophrenia 2014: From Genes to 
Mechanisms of Illness
Daniel R. Weinberger, M.D.
3. Understanding and Effectively 
Managing Anxiety in the Transition to 
Young Adulthood
Anne M. Albano, Ph.D.
4. Advances in Research in Mood 
Disorders: New Opportunities, New 
Treatments
Andrew A. Nierenberg, M.D.
5. New Research on Personality 
Disorders
John M. Oldham, M.D.
When a Psychiatrist Loses a Parent
9:00 a.m. - 10:30 a.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chair:
William H. Sledge, M.D.
Speakers:
Francine Cournos, M.D.
Mohsin Ahmed, M.D., Ph.D.
Richard F. Summers, M.D.
Rethinking the Long-Term Use of 
Antipsychotics in Schizophrenia: For 
Everyone, No one or Some?
9:00 a.m. - 10:30 a.m.
Room 711, Level 700, South Building





Joanna Moncrieff, M.B.B.S., M.D.
Hugh Middleton, M.D.
Sandra Steingard, M.D.
Stephen R. Marder, M.D.
Integrating Psychiatrists Within 
Primary Care Settings: Practical Tips 
and Tools
9:00 a.m. - 10:30 a.m.
Room 802 A-B, Level 800, South Building




Jon S. Davine, M.D.
Pharmacotherapy and Psychotherapy 
Treatment for Posttraumatic Stress 
Disorder: Using Meta-Analyses to 
Determine Which Treatments Are Most 
Effective
9:00 a.m. - 10:30 a.m.
Humber Room, Main Level
InterContinental Toronto Centre
Chairs:
Daniel J. Lee, M.D.
Charles Hoge, M.D.
Speakers:
Daniel J. Lee, M.D.
Jonathan P. Wolf, M.D.
Charles Hoge, M.D.
Carla W. Schnitzlein, D.O.
A User’s Guide to the Frontal Lobes: 
Bedside Assessment of Frontal 
Executive Function
9:00 a.m. - 10:30 a.m.
Room 104 A, Level 100, North Building





Margo D. Lauterbach, M.D.
Medications for the Treatment of 
Alcohol Use Disorders and Related 
Comorbidities: A Brief Guide
U.S. National Institute on Alcohol Abuse 
and Alcoholism
6
9:00 a.m. - 10:30 a.m.
Room 104 B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Domenic A. Ciraulo, M.D.
Speaker:
Domenic A. Ciraulo, M.D.
Food and the Brain
9:00 a.m. - 10:30 a.m.
Room 104 D, Level 100, North Building




Blogging, Linking, Liking & Following: 
A Psychiatrist’s Guide for Using Social 
Media and Blogging for Mental Health 
Education and Advocacy
APA Child and Adolescent Psychiatry 
Fellowship
9:00 a.m. - 10:30 a.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Holly Peek, M.D., M.P.H.
Clarice J. Kestenbaum, M.D.
Speakers:
Eugene V. Beresin, M.D.
Steve Schlozman, M.D.
Lara J. Cox, M.D.
Carlene MacMillan, M.D.
S E S S I O N  T R A C K S
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One Dream, Three Perspectives: The 
Place of the Dream and Dreaming in 
Clinical Practice and Training
American Psychoanalytic Association
9:00 a.m. - 12:00 p.m.
Room 718 B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Mark D. Smaller, L.C.S.W., Ph.D.
Harriet L. Wolfe, M.D.
1. A Dream Within an Analytic Session
Jan A. Seriff, Psy.D.
2. A Freudian Perspective on the 
Patient’s Dream
Harriet L. Wolfe, M.D.
3. A British School Perspective on the 
Patient’s Dream
Adam J. Goldyne, M.D.




Telepsychiatry’s Evidence Base 
Shows Effectiveness: New Models 
(Asynchronous), More Psychotherapy, 
and Innovations With Special 
Populations
9:00 a.m. - 12:00 p.m.
Room 104 C, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Donald M. Hilty, M.D.
Terry Rabinowitz, D.D.S., M.D.
Discussant:
Donald M. Hilty, M.D.
1. Effectiveness of Telepsychiatry: 
Feasibility and Outcomes for 
Synchronous/Video (STP), 
Asynchronous/Store and Forward 
(ATP), and Other Models
Donald M. Hilty, M.D.
2. Views and Misconceptions of 
Telepsychiatry: A Survey of Psychiatry 
Fellows, Residents and Training 
Directors
Cesar Cruz, M.D.
3. Special Considerations for 
Psychological Evaluations, Formal 
Assessments (e.g., cognitive testing), 




Unicorn and Alone With People - A 
Double Feature on Young Gay/
Lesbian Identities: Exploring Sexual 
Orientation
American Academy of Child and 
Adolescent Psychiatry
2
9:00 a.m. - 12:00 p.m.
Ballroom A-B, Lower Level
InterContinental Toronto Centre
Chairs:
Richard R. Pleak, M.D.





Updates in Women’s Health
Academy of Psychosomatic Medicine
 5
9:00 a.m. - 12:00 p.m.
Room 718 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Linda L.M. Worley, M.D.
Christina L. Wichman, D.O.
Discussant:
Michelle Riba, M.D.
1. Intimate Partner Violence and 
Psychosomatic Medicine
Donna Stewart, M.D.
2. Management and Assessment of 
Alcohol, Tobacco and Opioid Use 
Disorders During Pregnancy
Leena Mittal, M.D.
3. Infertility and Perinatal Loss: When 
the Bough Breaks
Nancy Byatt, D.O., M.B.A.
4. Psychotropic Medication Management 
in Pregnancy and Postpartum for 
Depression and Anxiety.
Madeleine Becker, M.D.
5. Psychopharmacologic Approaches in 
the Perinatal Period: Mood Stabilizers 
and Antipsychotics
Christina L. Wichman, D.O.
6. Promoting Sexual Health and Well-
Being
Linda L.M. Worley, M.D.
Advances in Series
Gun Violence and Mental Illness
3
9:00 a.m. - 12:00 p.m.
Room 107, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Liza Gold, M.D.
1. Gun Violence and Mental Illness: 
Public Health Crises
Liza Gold, M.D.
2. NICS, Mental Illness, and Firearms 
Legislation: What You Should Know
Marilyn Price, M.D.
3. Mass Distractions and Socio-Cultural 
Factors in Mass Shootings
James L. Knoll IV, M.D.
4. Firearms Risk Prevention: Considering 
Legal and Clinical Reforms
Debra Pinals, M.D.
5. Firearms and Suicide
Matthew Miller, M.D., M.P.H.
6. Reducing Risk of Suicide: Best 
Practices and Talking to Patients 
About Access to Firearms
Alan L. Berman, Ph.D.
Forum
A Preview of Breaking New Research 
on Adolescent Drinking, Schizophrenia 
and Suicide From the American 
Journal of Psychiatry and Molecular 
Psychiatry
American Psychiatric Publishing Editorial 
Board
9:00 a.m. - 12:00 p.m.
Room 801 B, Level 800, South Building










Program changes are printed 
each day in the Daily Bulletin 
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2. Behavioral and Psychological 
Symptoms of Dementia: Definition, 
Epidemiology and Neurobiology
Rabeea Mansoor, M.D.
3. Sexuality and Aging
Anil K. Bachu, M.D.
4. Behavioral and Psychological 
Symptoms of Dementia and 
Inappropriate Sexual Behaviors in 
Dementia
Rajesh R. Tampi, M.D.
The Biological and Symptom 
Relationships Between the Personality 
Disorders and the Anxiety, Mood and 
Psychotic Disorders
Association for Research in Personality 
Disorders
9:00 a.m. - 12:00 p.m.
Rooms 206 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chair:
James Reich, M.D., M.P.H.
Discussant:
Alan F. Schatzberg, M.D.
1. Borderline Personality Disorder 
and Bipolar Disorder-Dimensionally 
Similar and Categorically Different.
Terence A. Ketter, M.D.
2. Overlap of Psychotic Symptoms and 
Personality Pathology
Rona Hu, M.D.
3. Overlap Between Syndromal 
Psychiatric Disorders and Personality 
Disorders in Biomarkers
M. Mercedes Perez-Rodriguez, M.D., 
Ph.D.
4. Empirical Evidence on the 
Relationship of the Anxiety Disorders 
and Personality Pathology
James Reich, M.D., M.P.H.
3. Chaos versus Cohesion: Challenges 
Running Groups for Concurrent 
Disorders
Jan Malat, M.D.
4. Finding a Voice in Trauma and 
Addiction: Running a Stage Two 
Trauma and Addiction Group
Pamela A. Stewart, M.D.
5. Remembering the Forgotten: 
Psychotherapy Groups for Geriatric 
Patients
Ken Schwartz, M.D.
6. Kidney Disease as a Mental Disorder: 
Group Therapy Experiences With 
Patients Suffering From Chronic 
Kidney Disease
Marta Novak, M.D., Ph.D.
Updates in Neuropsychiatry
 5
9:00 a.m. - 12:00 p.m.
Rooms 203 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Yelizaveta I. Sher, M.D.
José R. Maldonado, M.D.
1. Posterior Reversible Encephalopathy 
Syndrome
Yelizaveta I. Sher, M.D.
2. Neuropsychiatric Complications of 
Multiple Sclerosis
Renee M. Garcia, M.D.
3. Neuropsychiatric Aspects of Hepatitis 
C and Its Treatments
Lawrence M. McGlynn, M.D.
4. Updates in Neuropsychiatry
Andrea Ament, M.D.
5. Electrophysiologic Correlates in 
Chronic Fatigue Syndrome
José R. Maldonado, M.D.
A Comprehensive Review: Dementias, 
Behavioral and Psychological 
Symptoms of Dementias (BPSD) and 
Inappropriate Sexual Behaviors in 
Dementia (ISBD)
American Association for Geriatric 
Psychiatry
 4
9:00 a.m. - 12:00 p.m.
Rooms 205 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Rajesh R. Tampi, M.D.
1. Dementias: An Update
Kristina Zdanys, M.D.
4. How to Adapt Clinical Approaches and 
Telepsychiatry to Child, Adolescent, 
and Family Work – Considerations 
Based on Treatments and Settings
Erica Shoemaker, M.D.
5. Special Populations and Models: TP 
to the Nursing Home, Issues With 
Culture and Diversity and Models
Terry Rabinowitz, D.D.S., M.D.
Choosing the Right Treatment for 
Substance Use Disorders
APA Council on Addiction Psychiatry
 1
9:00 a.m. - 12:00 p.m.
Rooms 201 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Herbert D. Kleber, M.D.
Edward V. Nunes, M.D.
1. Detecting and Managing Misuse of 
Prescription Stimulants and Sedative-
Hypnotics
John J. Mariani, M.D.
2. Treatment of Chronic Pain and Opioid 
Dependence: Role for Opioid Agonists 
and Antagonists
Maria A. Sullivan, M.D., Ph.D.




4. Choosing Treatment for Cannabis Use 
Disorders
Frances R. Levin, M.D.
5. Combining Medication and 
Psychosocial Interventions in the 
Treatment of Substance Use Disorders
Edward V. Nunes, M.D.
The Widening Scope of Group Therapy 
for Treating Complex Patients
9:00 a.m. - 12:00 p.m.
Rooms 202 A-B, Level 200, North Building





1. I’m Not Alone: A Group for People With 
Recurrent Suicide Attempts
Yvonne Bergmans, M.S.W.
2. I’m Not Alone: A Group for People With 
Recurrent Suicide Attempts
Nadiya Sunderji, M.D.
S E S S I O N  T R A C K S
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Psychiatric Care in Adolescent 
Obesity: Integrated Approaches to 
Challenging Transitions and Ongoing 
Psychosocial Stressors
 5
9:00 a.m. - 12:00 p.m.
Room 717 A-B, Level 700, South Building






1. Impact of Behavioral and Medication 
Adherence Issues for Obese Youth 
Transferred to an Adult-Centered 
Bariatric Surgery Center
Patti Kastanias, M.Sc., R.N.
2. Challenging Treatment Decisions in 
Presence of Psychosocial Stress and 
Psychiatric Comorbidity: Experiences 
From a Youth-Centered Obesity 
Program
Signy Reynisdottir, M.D., Ph.D.
3. Behavioral and Adherence Issues in 
Young Adults: Challenges for Adult 
Health Care Providers: Development 
of Transition Programs in Obesity 
Management
Marlene Taube-Schiff, Ph.D.
4. The Prominent Role of Psychosocial 
and Emotional Distress in Obesity 
Development and the Need for a 
Holistic Treatment Approach
Erik Hemmingsson, Ph.D.
Betrayed by the Body: PTSD in 
Medical Populations
 5
9:00 a.m. - 12:00 p.m.
Room 801 A, Level 800, South Building





1. The Trauma From Within: Predictors, 
Prevalence, and Palliation of 
Traumatic Stress Symptoms in Acute 
Leukemia
Peter Fitzgerald, M.D.
2. Posttraumatic Stress Phenomena 
in Critical Illness/Intensive Care 
Survivors
Oscar J. Bienvenu, M.D., Ph.D.
Interpersonal Psychotherapy in 2015: 
Looking Back and Forging Ahead
 5
9:00 a.m. - 12:00 p.m.
Room 715 A-B, Level 700, South Building





1. Interpersonal Counseling (IPC) for 
Depression in Primary Care
Myrna M. Weissman, Ph.D.
2. Sudden Gains in Cognitive Therapy 
and Interpersonal Psychotherapy for 
Adult Depression
Frenk Peeters, M.D., Ph.D.
3. Web-Based Training for Clinicians to 
Extend the Reach of Interpersonal and 
Social Rhythm Therapy
Holly Swartz, M.D.
4. Interpersonal Psychotherapy for PTSD
John C. Markowitz, M.D.
5. Forty Years of Interpersonal 
Psychotherapy
Paula Ravitz, M.D.
Understanding Borderline Personality 
Disorder (BPD): Thirty-Five Years of 
Progress Through Empirical Research
9:00 a.m. - 12:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Kenneth R. Silk, M.D.
Perry Hoffman, Ph.D.
Discussant:
John G. Gunderson, M.D.
1. Basic Facts About BPD
Joel Paris, M.D.
2. The Long-Term Course of BPD
Mary C. Zanarini, Ed.D.
3. Longitudinal Perspectives on Suicidal 
Behavior in BPD
Paul H. Soloff, M.D.
4. Pharmacologic Treatment of BPD
Kenneth R. Silk, M.D.
5. Evidence-Based Psychotherapies for 
Treatment in BPD
Donald Black, M.D.
Psychosis and Diabetes: Challenges 
and Strategies for Successful Co-
Management
 5
9:00 a.m. - 12:00 p.m.
Room 701 B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Niall P. Boyce, M.B.
Lydia Chwastiak, M.D., M.P.H.
1. Epidemiology of Diabetes in Psychosis
Martha Craig-Ward, M.D.
2. Closing the Treatment Gap for 
Diabetes in Psychosis
Benjamin Druss, M.D.
3. Pathways to Cardiometabolic Disease 
in Psychosis
David Henderson, M.D.
4. Clinical Management of Diabetes and 
Psychosis
Lydia Chwastiak, M.D., M.P.H.
Implementation and Evidence: 
Collaborative Primary Care for 
Posttraumatic Stress Disorder and 
Depression in the U.S. Military
 5
9:00 a.m. - 12:00 p.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:




1. Patient and Provider Perspectives of 
Collaborative Primary Care in the U.S. 
Military Health System
Terri Tanielian, M.A.
2. Randomized Effectiveness Trial 
of Collaborative Care in the U.S. 
Military: Effects on PTSD, Depression, 
Functioning, and Service Use
Michael C. Freed, Ph.D.
3. Collaborative Care for Anxiety and 
Depression: An Opportunity for the 
U.S. Military Health System
Jurgen Unutzer, M.D., M.P.H.
4. Scalable, Centrally Implemented 
Collaborative Primary Care Treatment 
Package for PTSD and Depression in 
the U.S. Military
Charles C. Engel, M.D., M.P.H. All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 














Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
DSM-5: What You Need to Know
American Psychiatric Institute for 
Research and Education
7
9:00 a.m. - 4:00 p.m.
Grand Ballroom East (Large), Lower 
Concourse
Sheraton Centre Toronto Hotel
Directors:
Darrel A. Regier, M.D., M.P.H.
William Narrow, M.D., M.P.H.
Faculty:
J. Raymond DePaulo Jr., M.D.
Wilson M. Compton, M.D.
Katharine A. Phillips, M.D.




9:00 a.m. - 4:00 p.m.
Osgood Ballroom, Lower Concourse
Sheraton Centre Toronto Hotel
Directors:
Robert Boland, M.D.
Arden D. Dingle, M.D.
Faculty:
Richard Balon, M.D.
Josepha A. Cheong, M.D.
Vishal Madaan, M.D.
Mark Servis, M.D.
Sandra M. DeJong, M.D., M.Sc.




Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Psychodynamic Psychopharmacology: 
Applying Practical Psychodynamics 
to Improve Pharmacologic 
OutcomesWith Treatment Resistant 
Patients
9:00 a.m. - 4:00 p.m.
Birchwood Ballroom, Mezzanine





David F. Flynn, M.D.
Samar Habl, M.D.
Barri A. Belnap, M.D.
Autism Spectrum Disorders: 
Diagnostic Considerations, Genetic 
Research, and Treatment Review
2
9:00 a.m. - 4:00 p.m.
Dominion Ballroom South, 2nd Floor
Sheraton Centre Toronto Hotel
Directors:
Alice R. Mao, M.D.
Jennifer Yen, M.D.
Faculty:
Matthew N. Brams, M.D.
Stephanie Hamarman, M.D.
Oscar Bukstein, M.D., M.P.H.
Julie A. Chilton, M.D.
Christian Marshall, Ph.D.
3. A Complex Systems Approach to 
Identify Risk Factors for PTSD in 
Children With Injuries and Burns
Glenn Saxe, M.D.
4. PTSD Related Health Risks and 
Mortality Among Vietnam Veterans
Charles R. Marmar, M.D.
LGBT and Differences of Sex 
Development Patient Care 
Competencies: Taking Psychiatry Into 
the Next Era of Sex, Sexuality, and 
Gender Sensitive Care
9:00 a.m. - 12:00 p.m.
Niagara/Ontario Rooms, Lower Level
InterContinental Toronto Centre
Chair:
Scott F. Leibowitz, M.D.
1. Overview of the AAMC LGBT/DSD-
Affected Patient Care Advisory Project 
and Competencies
Tiffani St.Cloud
2. LGBT and DSD-Affected Patient 
Care Competencies: Relevance to 
Behavioral Health
Andres F. Sciolla, M.D.
3. Bridging the LGBT and DSD-Affected 
Patient Care Competencies From 
Medical School into Psychiatry 
Residency Training
Kristen Eckstrand, M.D., Ph.D.
4. Integrating the Competencies by 
Modality: Guidance for Collaborative 
Efforts Among Residents, Faculty, and 
Administrators
Scott F. Leibowitz, M.D.
5. Enhancing Institutional Climate 
and Assessment to Promote Sex, 
Sexuality, and Gender Competence
Brian Hurley, M.B.A., M.D.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
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!
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 











Focus Live! Sleep Disorders
11:00 a.m. - 12:30 p.m.
Room 105, Level 100, North Building
Metro Toronto Convention Centre
Moderator:






APA Adolf Meyer Award Lecture
11:00 a.m. - 12:30 p.m.
Exhibit Hall A, Level 300, North Building
Metro Toronto Convention Centre
Lecture Chairs:
Paul Summergrad, M.D.
Jerrold F. Rosenbaum, M.D.
Lecturer:
Karl Deisseroth, M.D., Ph.D.
11:00 a.m. Sessions
Case Conference
These sessions are open to 
APA members only. A blue 
registration badge or an APA 
membership card are required for 
admittance.
!
Mis(sed) Diagnosis: Trauma, 
Dissociation and Psychosis Revisited
2
11:00 a.m. - 12:30 p.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Jeffrey A. Sugar, M.D.
David Spiegel, M.D.
Speakers:
Jeffrey A. Sugar, M.D.
John P. Daly, M.D.
David Spiegel, M.D.
Seminars
Primary Care Skills for Psychiatrists
9:00 a.m. - 4:00 p.m.
Dominion Ballroom North, 2nd Floor
Sheraton Centre Toronto Hotel
Directors:
Erik Vanderlip, M.D., M.P.H.
Lori E. Raney, M.D.
Faculty:




Young Investigator Poster Session 1
10:00 a.m. - 12:00 p.m.
Exhibit Halls D-F, Level 800, South Building
Metro Toronto Convention Centre
Karl Deisseroth, MD, PhD, is the D.H. Chen Professor in the Bioengineering and Psychiatry 
Departments at Stanford, and is a practicing inpatient and outpatient psychiatrist, employing 
medications and interventional brain stimulation techniques (VNS, TMS and others) to treat pa-
tients with psychiatric disease. He received his bachelor’s degree from Harvard in 1992, his PhD 
from Stanford in 1998, and his MD from Stanford in 2000. He completed postdoctoral training, 
medical internship, and adult psychiatry residency at Stanford, and he was board-certified in 
2006 by the American Board of Psychiatry and Neurology. Deisseroth led the development and 
application of optogenetics: the integration of genetics and optics to achieve gain- or loss-of-
function of well-defined events (such as action potential patterns) in defined cell types within 
intact biological systems. He also led the development of CLARITY, a chemical engineering-
based method for transforming biological systems by creating a tissue-hydrogel hybrid, to allow 
full transparency and accessibility to molecular labels without slicing or sectioning; CLARITY en-
ables high-throughput whole brain analysis of wiring and fine structure without disassembly. He 
has also led both basic science and disease-focused work employing optogenetics and CLARI-
TY, with investigations into aspects of Parkinsonism, anxiety, social dysfunction, depression, and 
other neuropsychiatric disease symptoms. Deisseroth also serves as Director of Undergraduate 
Education in Bioengineering at Stanford, teaches yearly courses in the graduate and under-
graduate curricula, and provides education and training in optogenetics and CLARITY as well 
as freely distributing and supporting tools and expertise to thousands of scientists worldwide. 
He was elected to the Institute of Medicine in 2010 and to the National Academy of Sciences in 
2012, and selected as a Howard Hughes Medical Institute Investigator in 2013. For developing 
and applying optogenetics and CLARITY, Deisseroth has received the NIH Director’s Pioneer 
Award (2005), the Zuelch Prize (2012), the BRAIN prize (2013), the Pasarow Prize (2013), and 
the Perl Prize (2012), and among other awards, is the sole recipient of the 2010 Koetser Prize, 
the 2010 Nakasone Prize, the 2011 Alden Spencer Prize, the 2013 Richard Lounsbery Prize, 












4. The VISN 22 Evidenced-Based 
Psychotherapy Telemental Health 




“I’ll Show You Mine, If You Show Me 
Yours:” The Impact of Underage Sexting
3
11:00 a.m. - 12:30 p.m.
Room 101, Level 100, North Building




Susan Hatters Friedman, M.D.
Sara Moore, M.A.
Scientific and Clinical 
Reports
Psychosomatic and Consultative 
Psychiatry
 5
11:00 a.m. - 12:30 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Kelli J. Harding, M.D.
1. Posttraumatic Stress Disorder Is 
Associated With Impaired Coronary 
Distensibility and Predicts Major 
Adverse Cardiovascular Events
Naser Ahmadi, M.D., Ph.D.
5
2. Reducing Psychiatric Symptom 
Severity in Patients With Epilepsy and 
Non-Epileptic Seizures
Jasper J. Chen, M.D., M.P.H.
5
3. Proactive Consultations in a General 
Hospital Using the Cedars-Sinai 
Psychiatric Consultation Identification 
Score (CS-PCI)
Waguih W. IsHak, M.D.
5
Epigenetic Processes Mediating the 
Impact of Social Environments on 
Mental Health and Disease
APA Frontiers of Science Lecture Series
11:00 a.m. - 12:30 p.m.
Exhibit Hall G, Level 800, South Building
Metro Toronto Convention Centre
Lecture Chair:
Steve Koh, M.D., M.P.H.
Lecturer:
Moshe Szyf, Ph.D.
From Efficacy to Biomarkers To 
Precision Medicine in Depression 
APA Research in Psychiatry Award Lecture
11:00 a.m. - 12:30 p.m.
Room 102 (Theatre) Level 100, North 
Building





Moshe Szyf, PhD received his Ph. D from the Hebrew University and did his postdoctoral 
fellowship in Genetics at Harvard Medical School, joined the department of Pharmacology 
and Therapeutics at McGill University in Montreal in 1989 and currently holds a James McGill 
Professorship and GlaxoSmithKline-CIHR Chair in Pharmacology and is a fellow of the Royal 
Society of Canada. He is the founding co-director of the Sackler Institute for Epigenetics and 
Psychobiology at McGill and is a Fellow of the Canadian Institute for Advanced Research 
Experience-based Brain and Biological Development program. Szyf has been the founder of 
the first “Pharma” to develop epigenetic pharmacology “Methylgene Inc.” and the first journal 
in epigenetics “Epigenetics”. Szyf lab has proposed two decades ago that DNA methylation 
is a prime therapeutic target in cancer and other diseases and has postulated and provided 
the first set of evidence that the “social environment” early in life can alter DNA methylation 
launching the emerging field of “social epigenetics”.
Bio
Madhukar H Trivedi, MD is Professor of Psychiatry, Chief of the Division of Mood Dis-
orders, and Director of the Comprehensive Center for Depression at the University of Texas 
Southwestern Medical Center. He holds the Betty Jo Hay Distinguished Chair in Mental Health. 
Dr. Trivedi is an established efficacy and translation researcher in Mood Disorders. Dr. Trivedi 
has focused his research on the neurobiology of depression as well as pharmacological, psy-
chosocial, and other nonpharmacological treatments for depression. Dr. Trivedi has published 
over 480 articles and chapters related to the Diagnosis and Treatment of Mood Disorders.
Bio
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 










An Introduction to Complementary, 
Alternative, and Integrative Medicine 
in Psychiatry
APA Caucus on Complementary and 
Alternative Medicine
11:00 a.m. - 12:30 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Lila E. Massoumi, M.D.
David London, M.D.
Speakers:
Lila E. Massoumi, M.D.
David London, M.D.
Personal Experiences of Psychiatrists 
in the Combat Zone
11:00 a.m. - 12:30 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Sebastian R. Schnellbacher, D.O.
Elspeth C. Ritchie, M.D., M.P.H.
Speakers:
Jason I. Dailey, M.D.
Kenneth E. Richter Jr., D.O.
Anna Makela, M.D.
Follow the Yellow Brick Road: The 
McMaster Competency-Based 
Framework for Residency Training in 
Psychiatry
11:00 a.m. - 12:30 p.m.
Humber Room, Main Level
InterContinental Toronto Centre
Chairs:
Sheila C. Harms, M.D.
Karen Saperson, M.B.B.S.
Dual Diagnosis Treatment on an 
Assertive Community Treatment Team: 
Psychiatrists as Group Leaders
American Association of Community 
Psychiatrists
1
11:00 a.m. - 12:30 p.m.






M. M. Naveen, M.D.
Marissa Flaherty, M.D.
Practical Guide to Preparing 
Psychiatric Trainees to Practice in 
Integrated Primary Care and Mental 
Health Settings
11:00 a.m. - 12:30 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Rachel Robitz, M.D.
Steve Koh, M.D., M.P.H.
Speakers:
Robert M. McCarron, D.O.
Jessica Thackaberry, M.D.
A Novel Educational Intervention to 
Increase Clinical Scholarship Among 
Faculty and Trainees
11:00 a.m. - 12:30 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chairs:







Changes in Psychiatry and Changing 
Styles of Practice: Views From Senior 
and Early Career Psychiatrists
3
11:00 a.m. - 12:30 p.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Malkah T. Notman, M.D.
Speakers:
Simha Ravven, M.D.
Elissa P. Benedek, M.D.
Olaya Solis, M.D.
Public Health Approaches to Campus 
Mental Health in Canada and the 
U.S.: McMaster University, Cornell 
University, and the JED Foundation
11:00 a.m. - 12:30 p.m.
Rooms 103 A-B, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Catharine Munn, M.D.
Leigh A. White, M.D.
Speakers:
Victor Schwartz, M.D.
Tim Marchell, M.P.H., Ph.D.
Mood Disorders in Neurological Illness
5
11:00 a.m. - 12:30 p.m.
Room 104 A, Level 100, North Building





John F. Sullivan, M.D.
Gaston Baslet, M.D.
Psychiatry in the Courts: APA 
Confronts Legal Issues of Concern to 
the Field
APA Committee on Judicial Action
3
11:00 a.m. - 12:30 p.m.
Room 104 B, Level 100, North Building




Paul S. Appelbaum, M.D.
Howard Zonana, M.D.
“It’s a Wonderful Life:” Psychiatry in 
Canada
11:00 a.m. - 12:30 p.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Leslie H. Gise, M.D.
Steven Sharfstein, M.D., M.P.A.
Speakers:
Jon S. Davine, M.D.
Randall F. White, M.D. Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 













All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 




Culturally Appropriate Assessment: 
Using the Cultural Formulation 
Interview as an Assessment Tool and 




1:30 p.m. - 3:00 p.m.
Room 801 B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Russell F. Lim, M.D., M.Ed.
A New DSM-5 “Alternative Model” for 
the Personality Disorders
For Residents only
1:30 p.m. - 3:00 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
John M. Oldham, M.D.
Andrew Skodol, M.D.
The Notorious Past and Bright Future 
of Psychiatry
1:30 p.m. - 3:00 p.m.
Room 106, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Jeffrey A. Leiberman, M.D.
The Expert Witness in Psychiatric 
Malpractice Cases
3
1:00 p.m. - 5:00 p.m.
City Hall, 2nd Floor





These sessions are open to 
APA members only. A blue 
registration badge or an APA 
membership card are required for 
admittance.
!
The N-BOMb Strikes Again. A Case of 
Self-Injurious Behavior While Under 
the Influence of a Novel Psychedelic 
Drug
1
1:30 p.m. - 3:00 p.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Petros Levounis, M.D.




Jennifer Hanner, M.D., M.P.H.
Forum
Ebola: Be Afraid but not That Afraid
1:30 p.m. - 3:00 p.m.
Rooms 206 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Mary Anne Badaracco, M.D.
Philip R. Muskin, M.D.
Speakers:
Mary Anne Badaracco, M.D.
Philip R. Muskin, M.D.
1:00 p.m. Sessions
Courses
Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Motivational Interviewing for the 
Routine Practice of Psychiatry
1
1:00 p.m. - 5:00 p.m.
Grand Ballroom West, Lower Concourse
Sheraton Centre Toronto Hotel
Director:
Steven Cole, M.D.
Evaluation and Treatment of Sexual 
Dysfunctions
1:00 p.m. - 5:00 p.m.
Sheraton Hall E, Lower Concourse
Sheraton Centre Toronto Hotel
Director:
Waguih W. IsHak, M.D.
Seminars
Neuroanatomy of Emotions
1:00 p.m. - 5:00 p.m.
Grand Ballroom Center, Lower Concourse
Sheraton Centre Toronto Hotel
Director:
Ricardo M. Vela, M.D.
Why Is Sex Important? A Seminar on 
the Impediments to Adult Love
5
1:00 p.m. - 5:00 p.m.
Chestnut East-West, Mezzanine
Sheraton Centre Toronto Hotel
Director:
Stephen B. Levine, M.D.
S E S S I O N  T R A C K S
1 Addiction Psychiatry

















Professionalism and Physician Health: 
Integrating Ethics and Self-Care
APA Ethics Committee and Penn-
Scattergood Ethics Program
1:30 p.m. - 3:00 p.m.
Rooms 103 A-B, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Philip J. Candilis, M.D.
Richard Martinez, M.D.
Speakers:
Philip J. Candilis, M.D.
Edmund G. Howe III, J.D., M.D.
Richard Martinez, M.D.
Practicing Cognitive Behavior 
Therapy: An Experiential Workshop
1:30 p.m. - 3:00 p.m.
Room 104 A, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Judith Beck, Ph.D.
What to Do While Waiting for 
Better Antidepressant Treatments: 
Antidepressant Efficacy and Options
1:30 p.m. - 3:00 p.m.
Room 104 B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Jerrold F. Rosenbaum, M.D.
2. The Australian and New Zealand 
College of Psychiatrists’ 
Posttraumatic Stress Disorder 
Guidelines Review
Malcolm Hopwood, M.B.B.S., M.D.
5
3. The Association Between Child 
Maltreatment and Adult Mental Health 
Problems in a Large Birth Cohort: 
More Complex Than Retrospective 
Data Suggest
Steve Kisely, M.D., Ph.D.
4. “Don’t Tell, Don’t Heal:” Sexual 
Violence Against Men in a Sample 
of Asylum-Seekers: A Report From 




How to Adapt In-Person to 
Telepsychiatric Practice for Clinicians 
and Residents
1:30 p.m. - 3:00 p.m.
Room 101, Level 100, North Building
Metro Toronto Convention Centre
Chairs:




Donald M. Hilty, M.D.
Patrick T. O’Neill, M.D.
John Teshima, M.D., M.Ed.
Lectures
Depression and Obesity: The Clinical 
and Research Interface of Two Modern 
Diseases
APA Distinguished Psychiatrist Lecture 
Series
1:30 p.m. - 3:00 p.m.
Exhibit Hall G, Level 800, South Building
Metro Toronto Convention Centre
Lecture Chairs:
Linda L.M. Worley, M.D.
Barton J. Blinder, M.D., Ph.D.
Lecturer:
Julio Licinio, M.D.
Scientific and Clinical 
Reports
Posttraumatic Stress Disorder and 
Abuse
 2 5
1:30 p.m. - 3:00 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Lynn Nguyen, M.D.
1. The STARTS Screening Tool: 
Advancing Culturally-Appropriate 
Trauma Screenings for Young Men of 




Julio Licinio, MD, FRANZCP, is Deputy Director for Translational Medicine and Head, 
Mind and Brain Theme at the South Australian Health and Medical Research Institute and 
Strategic Professor of Psychiatry, Flinders University in Adelaide, South Australia. He is also a 
Research Professor at the University of Southern California, in Los Angeles, Clinical Profes-
sor of Psychiatry at University of Adelaide, Visiting Professor of Psychiatry at University of 
Minho, in Braga, Portugal and Professeur Associé at Université de Paris – Descartes. He 
was previously Professor and Director, John Curtin School of Medical Research, The Aus-
tralian National University (ANU). Professor Licinio is originally from Brazil and lived for over 
25 years in the United States, where he had clinical and research training in endocrinology 
and psychiatry at University of Chicago, Albert Einstein College of Medicine and Cornell. He 
worked for over 20 years at Yale, NIH, UCLA, University of Miami and ANU, with leadership 
positions in those institutions. He is founding and Chief Editor of three Nature Publishing 
Group journals, Molecular Psychiatry (Impact Factor: 14.897 number 1 worldwide), The 
Pharmacogenomics Journal (Impact Factor 5.1) and Translational Psychiatry. Professor 
Licinio’s translational and genomics research spans the lab and clinic examining obesity, 












Update on Synthetic Cannabinoids
1
1:30 p.m. - 3:00 p.m.




Adriana de Julio, M.D.
Speakers:
Eileen Delaney, Ph.D.
Adriana de Julio, M.D.
2:00 p.m. Sessions
Poster Sessions
New Research Poster Session 1
2:00 p.m. - 4:00 p.m.
Exhibit Halls D-F, Level 800, South Building
Metro Toronto Convention Centre
Advances in Series
Care of Military Service Members, 
Veterans and Their Families
2:00 p.m. - 5:00 p.m.
Room 107, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Stephen J. Cozza, M.D.
Discussant:
Harold S. Kudler, M.D.
1. Combat Stress Reactions and 
Psychiatric Disorders After 
Deployment
David M. Benedek, M.D.
2. Health Consequences Of Military 
Service and Combat
Paula P. Schnurr, Ph.D.
3. Suicidal Thoughts and Behaviors 
in Military Service Members and 
Veterans
Matthew N. Goldenberg, M.D.
4. Collaborative Care: Mitigating Stigma 
and Other Barriers to Care
Charles C. Engel, M.D., M.P.H.
5. Risk and Resilience in Military 
Families
Stephen J. Cozza, M.D.
Morale and Mental Health in Vietnam, 
Highlights From U.S. Army Psychiatry 
in the Vietnam War: New Challenges 
in Extended Counterinsurgency 
Warfare
1:30 p.m. - 3:00 p.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Norman M. Camp, M.D.
Elspeth C. Ritchie, M.D., M.P.H.
Lessons From the Front: Applying 
Combat Stress Control Techniques 
to Everyday Psychiatric Practice in 
America
1:30 p.m. - 3:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Steven Pflanz, M.D.
Skills in Extreme Negotiation Within 
the Work Environment
1:30 p.m. - 3:00 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Ari E. Zaretsky, M.D.
Sanjeev Sockalingam, M.D.
Speaker:
Susan Lieff, M.D., M.Ed.
Development and Implementation 
of Interprofessional and Integrated 
Clinical Treatment and Training 
Programs at a VA Medical Center
1:30 p.m. - 3:00 p.m.
Humber Room, Main Level
InterContinental Toronto Centre
Chairs:





Clarence G. White Jr., M.D.
Update From the Council on 
Psychiatry and the Law
APA Council on Psychiatry and Law
3
1:30 p.m. - 3:00 p.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Steven Hoge, M.B.A., M.D.
Speakers:




Professional Boundaries in the Era of 
the Internet
3
1:30 p.m. - 3:00 p.m.
Room 105, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Glen O. Gabbard, M.D.
Gabrielle S. Hobday, M.D.
Speakers:
Glen O. Gabbard, M.D.
Gabrielle S. Hobday, M.D.
A Resident’s Guide to Borderline 
Personality Disorder: From the Experts 
(Part 1 of 2)
1:30 p.m. - 3:00 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Brian Palmer, M.D., M.P.H.
Speakers:
John G. Gunderson, M.D.
Kenneth R. Silk, M.D.
Perry Hoffman, Ph.D.
Evaluating Disability in Your Patient: 
The Long, Winding Road Involving 
Therapeutic Process, Employers, and 
Employees
APF Partnership Advisory Council
1:30 p.m. - 3:00 p.m.
Room 204 (Summit), Level 200, North 
Building




Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 











4. Treating LGBT Patients With Complex 
Trauma
Joan E. Storey, L.C.S.W., Ph.D.
5. Group Psychotherapy With Lesbian 
and Gay Asylum Seekers
Melba J. Sullivan, Ph.D.
Kelly J. Kleinert, M.D.
Novel Psychopharmacological 
Therapies for Psychiatric Disorders: 
MDMA and Psilocybin
2:00 p.m. - 5:00 p.m.
Rooms 202 A-B, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Michael C. Mithoefer, M.D.
Timothy D. Brewerton, M.D.
Discussant:
Timothy D. Brewerton, M.D.
1. Psilocybin, Mystical-Type Experiences, 
and the Treatment of Symptoms of 
Anxiety and Depression In Patients With 
a Life-Threatening Cancer Diagnosis
Roland Griffiths, Ph.D.
2. Psilocybin-Assisted Treatment for 
Alcohol Dependence
Michael P. Bogenschutz, M.D.
3. MDMA Treatment of Social Anxiety in 
Adults on the Autism Spectrum
Charles S. Grob, M.D.
4. Psilocybin as an Adjunct to Tobacco 
Smoking Cessation Treatment
Matthew W. Johnson, Ph.D.
5. MDMA-Assisted Psychotherapy: 
A Promising Treatment for 
Posttraumatic Stress Disorder
Michael C. Mithoefer, M.D.
Facing Death in Research and Clinical 
Care
 4
2:00 p.m. - 5:00 p.m.
Rooms 203 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Alexander Moreira-Almeida, M.D., Ph.D.
1. Self-Transcendence and Adaptation 
to Ultimate Situations: Clinical and 
Research Findings
C. Robert Cloninger, M.D., Ph.D.
2. William James and Scientific 
Investigation of Spiritual Experiences 
Related to Death
Alexandre Sech Jr., M.A.
4. The Future of Child and Adolescent 
Psychiatry Training and Research
Bennett L. Leventhal, M.D.
Symposia
From Neuron to Neighborhood: An 
Update on Contemporary Models 
for Disease Pathogenesis, Clinical 
Characterization, and Treatment of 
Bipolar Disorder
2:00 p.m. - 5:00 p.m.
Room 102 (Theatre), Level 100, North 
Building
Metro Toronto Convention Centre
Chairs:
Roger S. McIntyre, M.D.
Natalie L. Rasgon, M.D., Ph.D.
1. Bridging the Research Domain Criteria 
to Bipolar Disorder: Understanding 
the Role of Inflammation/Metabolism 
in Neurocircuit Asynchrony
Roger S. McIntyre, M.D.
2. Insulin Resistance or Type 2 Diabetes 
Mellitus: Modifiable Risk Factors for 
Brain Alterations in Bipolar Disorders
Tomas Hajek, D.Phil., Psy.D.
3. Irritability, Anxiety, and Mixed 
Depression in Bipolar Disorder
Terence A. Ketter, M.D.
4. Differential Effects of Weight Versus 
Insulin Resistance in Patients With 
Depressive Disorders
Natalie L. Rasgon, M.D., Ph.D.
Trauma and Resilience in Lesbian, 
Gay, Bisexual, and Transgender (LGBT) 
Populations
2:00 p.m. - 5:00 p.m.
Room 104 C, Level 100, North Building





Omar Fattal, M.D., M.P.H.
1. Suicide Risk and Resiliency Among 
Trans Youth
John Frank, B.A.
Arnold H. Grossman, Ph.D.








What’s Wrong With Lisbeth Salander? 
Psychopathology of “The Girl With the 
Dragon Tattoo”
3
2:00 p.m. - 5:00 p.m.





21st Century Psychiatry at the 
Interface of Genetics, Neurobiology 
and Clinical Science
2:00 p.m. - 5:00 p.m.
Rooms 201 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Charles B. Nemeroff, M.D., Ph.D.
Discussant:
Paul Summergrad, M.D.
1. Paradise Lost: The Persistent Biologi-
cal and Psychiatric Consequences of 
Child Abuse and Neglect
Charles B. Nemeroff, M.D., Ph.D.
2. The Simple Truth About the Genetic 
Complexity of Schizophrenia
Daniel R. Weinberger, M.D.
3. Illuminating Neural Circuitry
Karl Deisseroth, M.D., Ph.D.
4. Everything You Never Wanted to Know 
About Sex: This Is Your Brain on Steroids
David R. Rubinow, M.D.
The Practice of Child and Adolescent 
Psychiatry in the 21st Century
American Academy of Child and 
Adolescent Psychiatry
 2
2:00 p.m. - 5:00 p.m.
Room 718 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Paramjit T. Joshi, M.D.
1. Integrated Care: Unique Aspects of 
Child Mental Health
Gregory K. Fritz, M.D.
2. Working with Diverse Populations: HIV, 
Sexual, Ethnic, and Racial Minority Youth
Warren Y.K. Ng, M.D.
3. Children’s Mental Health: A Call to Action











Treating Psychiatric Disorders During 
Pregnancy
2:00 p.m. - 5:00 p.m.
Room 717 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Donna Stewart, M.D.
1. The Treatment of Unipolar Depression 
During Pregnancy
Donna Stewart, M.D.
2. Management of Women with Bipolar 
Disorder During Pregnancy
Marta B. Rondon, M.D.
3. Women With Schizophrenia During 
Pregnancy and Postpartum
Simone Vigod, M.D.
4. Treating Substance Use Disorders 
During Pregnancy and Postpartum
Leslie Buckley, M.D., M.P.H.
Positive Psychiatry Across the Lifespan
4
2:00 p.m. - 5:00 p.m.
Room 718 B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Dilip V. Jeste, M.D.
Samantha Boardman, M.D., M.Psy.
Discussant:
Richard F. Summers, M.D.
1. Positive Psychiatry of Late Life
Dilip V. Jeste, M.D.
2. Postive Child Psychiatry; Application 
for Practice and Education
David Rettew, M.D.
3. Neuroplasticity of Adulthood
Jennifer R. Gatchel, M.D., Ph.D.
4. Positive Psychotherapeutic and 
Behavioral Interventions
Piper Meyer, Ph.D.
5. Positive Psychiatry in Clinical Practice
Samantha Boardman, M.D., M.Psy.
Value in Mental Health Care: What 
Does It Mean, and Who Decides?
2:00 p.m. - 5:00 p.m.
Room 801 A, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Robert P. Roca, M.D., M.P.H.
Benjamin Liptzin, M.D.
Discussant:
Steven Sharfstein, M.D., M.P.A.
1. Value: Medicine’s Holy Grail?
Robert P. Roca, M.D., M.P.H.
3. Alcohol Screening and Brief Intervention: 
Using the NIAAA Youth Alcohol Screen-
ing Guide in Outpatient Psychiatry
Sharon Levy, M.P.H., Ph.D.
4. Using Development to Inform 
Adolescent Alcohol Intervention
Sandra Brown, Ph.D.
5. Alcohol’s Role in Sexual Assault on Col-
lege Campuses: What is the Evidence 
and What Research is Still Needed?
Antonia Abbey, Ph.D.
Advances in Therapeutic Interventions 
in Geriatric Psychiatry
 4
2:00 p.m. - 5:00 p.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Helen Lavretsky, M.D.
1. Late-life Bipolar Disorder: Emerging 
Research and Complexities of Care
Martha Sajatovic, M.D.
2. Thoughts, Trials and Tribulations: An 
Update on Treatment of Dementia
Krista L. Lanctot, Ph.D.
3. Neuromodulation in the Treatment of 
Geriatric Psychiatric Disorders
William M. McDonald, M.D.
4. Advances in the Treatment of Late 
Life Unipolar Depression.
Helen Lavretsky, M.D.
Evidence-Based Specialty Treatments 
for Obsessive Compulsive Disorder 
(OCD) and Related Disorders: Updates 
and Issues on Dissemination of 
Expertise
2:00 p.m. - 5:00 p.m.
Room 715 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Debbie Sookman, Ph.D.
1. Update on Pharmacotherapy and 
Cognitive Behavioral Therapy for Body 
Dysmorphic Disorder (BDD)
Katharine A. Phillips, M.D.
2. Specialty Cognitive Behavior Therapy 
for OCD
Debbie Sookman, Ph.D.
3. Optimizing Pharmacotherapy for OCD: 
New Treatments and Services
Naomi A. Fineberg, M.B.B.S.
4. Treating the OCD-Related Disorders: 
The Need for Specific Disorder-Based 
Strategies
Margaret A. Richter, M.D.
3. Anomalous Experiences Related 
to the Experience of the Departed 
(Mediumship) – Clinical and Research 
Implications
Alexander Moreira-Almeida, M.D., Ph.D.
4. Helping the Clinician Be Prepared 
for Anomalous Experiences During 
Treatment of Traumatic Loss
James Lomax, M.D.
The Mental Health and Faith 
Community Partnership: Where Should 
We Go From Here?
APA Caucus of Religion, Spirituality and 
Psychiatry
2:00 p.m. - 5:00 p.m.
Rooms 205 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
John R. Peteet, M.D.
Discussant:
Annelle Primm, M.D., M.P.H.
1. The Walking Together Conference and 
Initiative
Abraham M. Nussbaum, M.D.
2. Psychiatry and the Exploration of Faith
Nancy Kehoe, Ph.D.
3. Mental Health and Faith Community 
Partnership: An Asian Canadian 
Perspective
Wai Lun Alan Fung, M.D., Sc.D.
4. Project COPE- An Innovative Strategy 
Engaging the Clergy to Improve 
Mental Health in the Community
Tatiana Falcone, M.D.
5. Psychiatry as a Resource in Faith 
Communities
William C. Rennebohm, D.Min.
Youth Interrupted: Alcohol Use 
Disorders and Adolescents
U.S. National Institute on Alcohol Abuse 
and Alcoholism
 6
2:00 p.m. - 5:00 p.m.
Room 701 B, Level 700, South Building





1. Modeling Effects of Social Isolation on 
Alcohol Drinking in Adolescent Mice
Andrey Ryabinin, Ph.D.
2. Adolescence and Emerging Adulthood: 










Dorothy E Roberts, JD is the 14th Penn Integrates Knowledge Professor and George A. 
Weiss University Professor of Law & Sociology at the University of Pennsylvania, with joint 
appointments in the Departments of Africana Studies and Sociology and the Law School, 
where she is the inaugural Raymond Pace and Sadie Tanner Mossell Alexander Professor of 
Civil Rights. She is also Director of the Penn Program on Race, Science & Society. An inter-
nationally recognized scholar, public intellectual, and social justice advocate, she has written 
and lectured extensively on the interplay of gender, race, and class in legal issues and has 
been a leader in transforming thinking on reproductive health, child welfare, and bioethics. 
Professor Roberts is the author of the award-winning books Killing the Black Body: Race, 
Reproduction, and the Meaning of Liberty (Random House/Pantheon, 1997) and Shattered 
Bonds: The Color of Child Welfare (Basic Books/Civitas, 2002), as well as co-editor of 6 
books on constitutional law and gender. She has also published more than 90 articles and 
essays in books and scholarly journals, including Harvard Law Review, Yale Law Journal, 
and Stanford Law Review. Her latest book, Fatal Invention: How Science, Politics, and Big 
Business Re-create Race in the Twenty-First Century, was published by the New Press in 
July 2011. Among her many public interest positions, Roberts is Chair of the Board of Direc-
tors of the Black Women’s Health Imperative.
Bio
Jonathan Moreno, PhD is a philosopher and historian. As the David and Lyn Silfen Uni-
versity Professor at the University of Pennsylvania, Moreno is one of fifteen Penn Integrates 
Knowledge professors. At Penn he is also Professor of Medical Ethics and Health Policy, of 
History and Sociology of Science, and of Philosophy. Among his books are The Body Politic, 
which was named a Best Book of 2011 by Kirkus Reviews, Mind Wars (2012), and Undue 
Risk (2000).
His latest book, Impromptu Man: J.L. Moreno and the Origins of Psychodrama, En-
counter Culture, and the Social Network (2014), traces the life and influence of his father, the 
founder of role playing and social network analysis.
Moreno frequently contributes to such publications as The New York Times, The Wall 
Street Journal, The Huffington Post, and Psychology Today, and often appears on broad-
cast and online media. In 2008-09 he served as a member of President Barack Obama’s 
transition team. His work has been cited by Al Gore and was used in the development of the 
screenplay for “The Bourne Legacy.” His online neuroethics course drew more than 36,000 
registrants in fall 2013. The American Journal of Bioethics has called him “the most interest-
ing bioethicist of our time.”
Moreno is an elected member of the Institute of Medicine of the National Academy 
of Sciences and is the U.S. member of the UNESCO International Bioethics Committee. 
A Senior Fellow at the Center for American Progress in Washington, D.C., Moreno has 
served as an adviser to many governmental and non-governmental organizations, including 
three presidential commissions, the Department of Defense, the Department of Homeland 
Security, the Department of Health and Human Services, the Centers for Disease Control, 
the Federal Bureau of Investigation, the Howard Hughes Medical Institute, and the Bill and 
Melinda Gates Foundation.
Moreno holds a Ph.D. from Washington University in St. Louis, was an Andrew W. Mel-
lon post-doctoral fellow, was awarded an honorary doctorate by Hofstra University, and is a 
recipient of the Benjamin Rush Medal from the College of William and Mary Law School and 












Transforming Race in Medicine: Body 
and Mind, Heart and Soul
APF Solomon Carter Fuller Award Lecture
3:30 p.m. - 5:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Lecture Chair:
Donald H. Williams, M.D.
Lecturer:
Dorothy E. Roberts, J.D.
The Role of Psychodynamic 
Treatments in Anxiety Disorders: A 
Relatively Neglected Area
APA Distinguished Psychiatrist Lecture 
Series
3:30 p.m. - 5:00 p.m.
Exhibit Hall G, Level 800, South Building
Metro Toronto Convention Centre
Lecture Chairs:
Philip R. Muskin, M.D.





Ethical Perspectives on the 
Psychiatric Evaluation of Public 
Figures
APA Ethics Committee and Penn-
Scattergood Ethics Program
3:30 p.m. - 5:00 p.m.
Room 101, Level 100, North Building
Metro Toronto Convention Centre
Chair:




Paul S. Appelbaum, M.D.
Sagar Vijapura, M.D.
Lectures
Impromptu Man: J.L. Moreno and the 
Origins of Psychodrama, Encounter 
Culture, and the Social Network
APA Ethics Committee and Penn-
Scattergood Ethics Program
3:30 p.m. - 5:00 p.m.
Rooms 206 A-F, Level 200, North Building





2. Value: Perspectives on Outcomes and 
Costs
Benjamin Liptzin, M.D.
3. Measuring Outcomes Using 
Standardized Tools: Why It’s Important 
and How to Do It
Henry Harbin, M.D.
4. Value: What Matters to the People We 
Treat?
Dinah Miller, M.D.
5. Eliminiate Waste, Improve Value
Sunil Khushalani, M.D.
Early Life Adversities and Physicians’ 
Resilience and Risk for Negative 
Professional Outcomes
2:00 p.m. - 5:00 p.m.
Niagara/Ontario Rooms, Lower Level
InterContinental Toronto Centre
Chairs:
Andres F. Sciolla, M.D.
Alistair J.R. Finlayson, M.D.
1. Early Childhood Maltreatment: A 
Risk Factor for Physician Boundary 
Violations?
Kai MacDonald, M.D.
2. Physicians Sanctioned for Boundary 
Violations: Risk and Resiliency
William H. Swiggart, M.S.
3. Attachment and Belief System Findings 
in Physician Sexual Boundary Violators
Ron E. Neufeld, B.A., B.S.
4. Maladaptive Beliefs and Insecure 
Attachment as Possible Mediators 
Between Childhood Maltreatment 
and Physician Professional Boundary 
Violations
Andres F. Sciolla, M.D.
5. Physicians Who Cross Sexual 
Boundaries
Alistair J.R. Finlayson, M.D.
Barbara Milrod, MD is Professor of Psychiatry at Weill Cornell Medical College and is on 
the faculty of both the New York Psychoanalytic Institute and the Columbia Psychoanalytic 
Institute for Treatment and Research. She is an Associate Editor of The American Journal 
of Psychiatry, and serves on the Editorial Board of Psychoanalytic Psychology. She is an 
internationally-recognized expert in the area of clinical trials of psychotherapy outcome, 
particularly concerning anxiety disorders and psychoanalytic treatments, and has developed 
and tested an operationalized form of psychoanalytic psychotherapy for panic disorder, for 
which she has demonstrated efficacy. This continues to be the only psychoanalytic psycho-
therapy with demonstrated efficacy for an Axis I anxiety disorder. Dr. Milrod has received 
numerous awards and grants from a number of institutions, including the National Institute of 
Mental Health and the Brain and Behavior Research Foundation. She is currently developing 
and testing a psychoanalytic psychotherapy for non-responders with anxiety disorders and 
depression with her NARSAD Distinguished Investigator Award.
Bio
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Transitioning From Servicemember 
to Veteran: Impact, Assistance, and a 
Way Ahead
3:30 p.m. - 5:00 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chair:
Christopher H. Warner, M.D.
Speakers:
Carl A. Castro, Ph.D.
Charles Hoge, M.D.
Loree K. Sutton, M.D.
Computer-Assisted Cognitive Behavior 
Therapy for Depression
3:30 p.m. - 5:00 p.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Jesse H. Wright, M.D., Ph.D.
Speakers:
Jesse H. Wright, M.D., Ph.D.
Michael E. Thase, M.D.
Introduction to Media Writing: A 
Hands-On, Interactive Experience for 
Psychiatry Trainees and Early Career 
Psychiatrists
American Psychiatric Leadership 
Fellowship
3:30 p.m. - 5:00 p.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Smita Das, M.D., M.P.H., Ph.D.
Desiree Shapiro, M.D.
Speakers:
Deborah L. Cabaniss, M.D.
Lloyd I. Sederer, M.D.
Drew Ramsey, M.D.
Practicing in the Ninth Decade: 
Opportunities and Issues
Senior Psychiatrists
3:30 p.m. - 5:00 p.m.
Room 801 B, Level 800, South Building





Leah J. Dickstein, M.A., M.D.
Norman A. Clemens, M.D.
Brian Crowley, M.D.
Alan A. Stone, M.D.
Top 10 Geriatric Psychiatry Issues for 
the General Psychiatrist
4
3:30 p.m. - 5:00 p.m.
Room 104 A, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Josepha A. Cheong, M.D.
Iqbal Ahmed, M.D.
PTSD in Psychiatrists: A Hidden 
Epidemic
3:30 p.m. - 5:00 p.m.
Room 104 B, Level 100, North Building






Michael F. Myers, M.D.
Behavioral Health Services Within an 
Immigrant Community: A Population 
Health Perspective From a Student-
Run Free Clinic
3:30 p.m. - 5:00 p.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chair:





Michelle A. Silva, Psy.D.
A Resident’s Guide to Borderline 
Personality Disorder: From the Experts 
(Part 2 of 2)
3:30 p.m. - 5:00 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Brian Palmer, M.D., M.P.H.
Speakers:
John G. Gunderson, M.D.
Kenneth R. Silk, M.D.
Perry Hoffman, Ph.D.




3:30 p.m. - 5:00 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Lynn Nguyen, M.D.
1. A Randomized Controlled Trial of 
Internet-Based Psychoeducation for 
Patients With Borderline Personality 
Disorder
Mary C. Zanarini, Ed.D.
2. Online Dialectical Behavioral Therapy 
(DBT) Is Effective in Improving 
Symptoms in Patients With Borderline 
Personality Disorder
Nazanin Alavi, M.D.
3. A Comparative Study of the Psychoso-
cial Morbidity Associated With Bipolar 
Disorder and Borderline Personality 
Disorder in Psychiatric Outpatients
Mark Zimmerman, M.D.
Workshops
Medical Conditions Mimicking 
Psychiatric Disorders Versus 
Psychiatric Disorders Mimicking 
Medical Conditions: Diagnostic and 
Treatment Challenges
5
3:30 p.m. - 5:00 p.m.
Rooms 103 A-B, Level 100, North Building
Metro Toronto Convention Centre
Chairs:




Vanessa Torres Llenza, M.D.
Stephanie Cho, M.D., M.S.
All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
!
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 













59th Convocation of Distinguished Fellows
5:30 pm – 6:30 pm
Hall A, North, Level 300
Toronto Convention Centre
Introduction of Fellows and Life Fellows
Paul Summergrad, M.D., President
Introduction of Distinguished Life Fellows; 
Induction of Distinguished Fellows; and the 
Pledge of Distinguished Fellowship
Renee L. Binder, M.D., President-Elect
Introduction of Fellows and Life Fellows; 
Introduction of the 50-Year Distinguished 
Life Fellows, Life Fellows, and Life Members; 
Introduction of the International Distinguished 
Fellow; and Introduction of International Fellows
Paul Summergrad, M.D
Awards for 2015
All awards will be presented by Paul Summergrad, M.D.
Special Presidential Commendation
Dinesh Bhugra, M.D., Ph.D.
Grand Challenges Canada
The Iraq and Afghanistan Veterans of America
Joe Pantoliano
Chester M. Pierce, M.D.
Lori E. Raney, M.D.
Richard and Susan Selke
Howard Somers, M.D. and Jean Somers
Distinguished Service Award
Jack W. Bonner III, M.D.
Joseph T. English, M.D.
Dilip V. Jeste, M.D.
Wayne Jay Katon, M.D. (posthumously)
Helen S. Mayberg, M.D.
Organizational Distinguished Service Award





and Award Board 
Chairpersons
Paul Summergrad, M.D
APA Human Rights Award
Chester M. Pierce M.D.
APF Blanche F. Ittleson Award for Research 
in Child Adolescent Psychiatry
James T. McCracken, M.D.
APF/Kempf Fund Award for Research 
Development in Psychobiological Psychiatry
Savita Bhakta, M.D.
Neal Swerdlow, M.D., Ph.D.
APA/Lilly Resident Research Award
Kara S. Bagot, M.D.
Carrie Holmberg, M.D.
APF Agnes Purcell McGavin Award for a 
Distinguished Career in Child and Adolescent 
Psychiatry
James F. Leckman, M.D., Ph.D.
APF Agnes Purcell McGavin Award for 
Prevention
Charles H. Zeanah, Jr., M.D.
APF Isaac Ray Award
Marvin S. Swartz, M.D.
APA Jack Weinberg Memorial Award for 
Geriatric Psychiatry
Robert G. Robinson, M.D.
The William C Menninger 
Memorial Convocation Lecture
Nora D. Volkow, M.D. 
Director, National Institute on Drug Abuse
Established in 1972, this lecture honors the late William C. Menninger, 
M.D., president of APA 1948-49, who brought to the association a 
formalized Convocation of Distinguished Fellows, first held in 1956.
All Distinguished Life Fellows, 
Distinguished Fellows, Life 
Fellows, International Fellows, APA 
Members, and Registered Guests 












Power, Gender and “The Devil Wears 
Prada”
7:00 p.m. - 10:00 p.m.









The Evidence-Based Psychotherapist: 
Using Theories and Techniques From 
Attachment, Trauma and Mentalizing 
to Improve Outcomes
5
3:30 p.m. - 5:00 p.m.












5:30 p.m. - 6:30 p.m.
Exhibit Hall A, Level 300, North Building
Metro Toronto Convention Centre
Don’t Get Hit: How to Manage the 
Agitated Soldier or Patient
3:30 p.m. - 5:00 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Sebastian R. Schnellbacher, D.O.
Wendi M. Waits, M.D.
Psychiatric Interventions in Palliative 
or End-Stage Cancer
5
3:30 p.m. - 5:00 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Antolin Trinidad, M.D., Ph.D.
Speaker:
Cheryl Person, M.D.
From Temperament to Psychiatric 
Illness: Neuropsychology of 
Underlying Systems
5
3:30 p.m. - 5:00 p.m.
Humber Room, Main Level
InterContinental Toronto Centre
Chair:
Irina Trofimova, M.Sc., Ph.D.
Speakers:
William Sulis, M.D., Ph.D.
Julie Christiansen, M.Sc.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
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These sessions are open to 
APA members only. A blue 
registration badge or an APA 




A Clinical Conundrum That Is Still Not 
Going Away
9:00 a.m. - 10:30 a.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
S. Charles Schulz, M.D.
David R. Williams, M.D.
Speakers:
Peter F. Buckley, M.D.
S. Charles Schulz, M.D.
Focus Live
Focus Live! Understanding the 
Evidence for Off-Label Use of Atypical 
Antipsychotics
9:00 a.m. - 10:30 a.m.
Room 105, Level 100, North Building
Metro Toronto Convention Centre
Moderators:




David L. Fogelson, M.D.
Forum
Globalization of Psychiatry: APA and 
WPA Perspectives
World Psychiatric Association
9:00 a.m. - 10:30 a.m.
Room 101, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Rama Rao Gogineni, M.D.
Roy A. Kallivayalil, M.D.
Speakers:
Pedro Ruiz, M.D.
Dinesh Bhugra, M.D., Ph.D.
Anne E. Becker, M.D., Ph.D.
Paul Summergrad, M.D.
The Cultural Formulation Interview 
Illustrated: How to Approach 
Culturally-Appropriate Assessment 
Using DSM-5 - A Hands-On Course 
With Video Examples
8:00 a.m. - 12:00 p.m.
Pine, Mezzanine
Sheraton Centre Toronto Hotel
Directors:
Russell F. Lim, M.D., M.Ed.
Francis G. Lu, M.D.
Faculty:
Roberto Lewis-Fernandez, M.A., M.D.
Master Courses
Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 




8:00 a.m. - 5:00 p.m.
Osgood Ballroom, Lower Concourse
Sheraton Centre Toronto Hotel
Director:





Charles B. Nemeroff, M.D., Ph.D.
Terence A. Ketter, M.D.
8:00 a.m. Sessions
Courses
Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
The Clinical Assessment of Malingered 
Mental Illness
8:00 a.m. - 12:00 p.m.
Birchwood Ballroom, Mezzanine
Sheraton Centre Toronto Hotel
Director:
Phillip Resnick, M.D.
Restoring Professionalism: Integrating 
Body and Mind, Heart and Soul for 
Distressed Physicians.
1
8:00 a.m. - 12:00 p.m.
Chestnut East-West, Mezzanine
Sheraton Centre Toronto Hotel
Directors:
Alistair J.R. Finlayson, M.D.
Linda L.M. Worley, M.D.
Faculty:
William H. Swiggart, M.S.
Ron E. Neufeld, B.A., B.S.
Seminars
Current Procedural Terminology 
Coding and Documentation
APA Committee on RBRVS, Codes and 
Reimbursement
8:00 a.m. - 12:00 p.m.
Sheraton Hall A, Lower Concourse
Sheraton Centre Toronto Hotel
Directors:
Ronald Burd, M.D.
Jeremy S. Musher, M.D.
Faculty:
Junji Takeshita, M.D.
Allan A. Anderson, M.D.
Gregory G. Harris, M.D., M.P.H.
David Nace, M.D.
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2. Neurocognitive Predictors of 
Response in Treatment-Resistant 
Depression With Deep Brain 
Stimulation (DBS) Therapy
Shane J. McInerney, M.B., M.D., M.Sc.
3. Addressing Depression and Pain 
Together: The “ADAPT” Clinical Trial 
for Older Adults With Depression and 
Chronic Low Back Pain
Jordan F. Karp, M.D.
4
4. The 12-Item WHODAS 2.0 Disability 
Questionnaire Has Good Sensitivity 
Among Individuals With Recent 




The Interdisciplinary Team and Role 
of the Psychiatrist in Deep Brain 
Stimulation
9:00 a.m. - 10:30 a.m.
Rooms 103 A-B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Sarah M. Fayad, M.D.
Speakers:
Sarah M. Fayad, M.D.
Herbert Ward, M.D.
Modeling Neuropsychiatric Disorders 
Using Human Stem Cells
APA Frontiers of Science Lecture Series
9:00 a.m. - 10:30 a.m.
Room 102 (Theatre), Level 100, North 
Building
Metro Toronto Convention Centre
Lecture Chair:
Jeffrey A. Lieberman, M.D.
Lecturer:
Fred H. Gage, M.S., Ph.D.




9:00 a.m. - 10:30 a.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Shirwan Kukha-Mohamad, M.D.
1. A Randomized Clinical Trial of 
Mindfulness-Based Cognitive Therapy 
for Treatment-Resistant Depression 
and Functional Magnetic Resonance 
Imaging
Stuart J. Eisendrath, M.D.
5
Interactive Sessions
The Person With the Diagnosis
For Residents Only
9:00 a.m. - 10:30 a.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Glen O. Gabbard, M.D.
Lectures
The Open Warmth of Community 
Concern and Capability: Achieving 
President Kennedy’s Vision
APA Patient Advocacy Award Lecture
9:00 a.m. - 10:30 a.m.
Exhibit Hall A, Level 300 North Building




Patrick J. Kennedy, J.D.
Patrick J Kennedy, JD spent 16 years in the U.S. House of Representatives and is 
predominately known as the author and lead sponsor of the Mental Health Parity and 
Addiction Equity Act of 2008. This legislation provides access to mental health care to tens 
of millions of Americans who were previously denied care. He has long been an outspoken 
advocate for mental health care. He is the co-founder of One Mind, a national coalition 
seeking new treatments and cures for neurologic and psychiatric diseases, and the founder 
of the Kennedy Forum on Community Mental Health.
Bio
Fred H Gage, MS, PhD is an Adler Chair in the Laboratory of Genetics at the Salk In-
stitute. He received his Ph.D. in 1976 from The Johns Hopkins University. His work concen-
trates on the unexpected plasticity and adaptability the brain and genome of all mammals. 
He was President of the Society for Neuroscience and of the International Society for Stem 
Cell Research. He is a Fellow of the AAAS, a Member of the NAS and IOM, a Fellow of the 
American Academy of Arts and Sciences, an Associate Member of EMBO, and a member of 
the American Philosophical Society.
Bio
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 









Practical Strategies to Decrease 
Cognitive Bias in the Diagnosis 
of Medical Conditions Mimicking 
Psychiatric Disorders
5
9:00 a.m. - 10:30 a.m.
Caledon and Oakville, Main Level
InterContinental Toronto Centre
Chairs:




Adam L. Hunzeker, M.D.
Vincent F. Capaldi II, M.D.
Jarred A. Hagan, D.O.
Advances in Series
Managing the Side Effects of 
Psychotropic Medications: Balancing 
Risks and Benefits
American Psychiatric Publishing Editorial 
Board
9:00 a.m. - 12:00 p.m.
Room 107, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Joseph F. Goldberg, M.D.
Carrie L. Ernst, M.D.
1. Core Concepts in the Evaluation and 
Management of Adverse Drug Effects
Joseph F. Goldberg, M.D.
2. Identifying and Managing Cardiac 
Safety Risks of Psychotropic Drugs
Carrie L. Ernst, M.D.
3. Metabolic Comorbidity and Side 
Effects: How to Manage
Roger S. McIntyre, M.D.
4. How to Evaluate and Manage 
Suspected Drug Rashes
Neil H. Shear, M.D.
Advances in Integrated Care: Across 
the Collaboration Spectrum
9:00 a.m. - 12:00 p.m.
Rooms 205 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Lori E. Raney, M.D.
Robert M. McCarron, D.O.
Discussant:
Benjamin Druss, M.D.
1. The Dual Jeopardy of Serious Physical 
and Mental Disorders Mandates an 
Integrated and Collaborative Approach 
in Psychiatric Practice
Henry A. Nasrallah, M.D.
High Anxiety in the Resident Clinic: 
Challenges for Therapists-in-Training
9:00 a.m. - 10:30 a.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chairs:
Joan M. Anzia, M.D.
John Manring, M.D.
Speakers:
Priyanthy Weerasekera, M.D., M.Ed.
Megan Pirigyi, M.D.
Kara Brown, M.D.
Are You a Sitting Duck Online? What 
You Can (and Can’t, or Shouldn’t) Do 
About Negative Reviews Your Patients 
Post About You
American Association for Technology in 
Psychiatry
9:00 a.m. - 10:30 a.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Robert C. Hsiung, M.D.
Speakers:
Paul S. Appelbaum, M.D.
John Luo, M.D.
Dinah Miller, M.D.
Laura Roberts, M.A., M.D.
Working With the Gender-Variant 
Client/Clients With Gender Dysphoria
9:00 a.m. - 10:30 a.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
David Baker-Hargrove, Ph.D.
When Heart and Mind Conflict: Helping 
Cognitively Impaired Colleagues 
Transition Out of Clinical Practice but 
Preserve Their Personal Integrity
Senior Psychiatrists
4
9:00 a.m. - 10:30 a.m.






Nada L. Stotland, M.D., M.P.H.
James Lomax, M.D.
Luis T. Sanchez, M.D.
Breaking Down Barriers to Care: 
Stigma and Other Obstacles
2
9:00 a.m. - 10:30 a.m.
Room 104 A, Level 100, North Building




John V. Campo, M.D.
Eugene V. Beresin, M.D.
Gordon Strauss, M.D.
Patricia Lester, M.D.
Psychiatry of Pandemics: Mental 
Health Aspects of Pandemic Outbreaks 
of Infectious Diseases
5
9:00 a.m. - 10:30 a.m.
Room 104 B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Damir Huremovic, M.D., M.P.P.
Speakers:





Rajvee Vora, M.D., M.S.
Interactive Training and Dissemination 
of Tobacco Cessation in Psychiatry: An 
Rx for Change
APA Council on Addiction Psychiatry
1
9:00 a.m. - 10:30 a.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Smita Das, M.D., M.P.H., Ph.D.
Speakers:
Smita Das, M.D., M.P.H., Ph.D.
Andrew J. Saxon, M.D.
Douglas Ziedonis, M.D., M.P.H.
Moral Dilemmas, Mental Health, and 
Ethical Conduct on the Battlefield: The 
NATO Approach
9:00 a.m. - 10:30 a.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Christopher H. Warner, M.D.
Speakers:
Rakesh Jetly, M.D.










Nowhere to Go: The Crisis of 
Psychiatric Patients Boarding in 
Emergency Departments
APA Council Quality Care
9:00 a.m. - 12:00 p.m.
Rooms 202 A-B, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Yad M. Jabbarpour, M.D.
Marvin Swartz, M.D.
Discussant:
Steven Sharfstein, M.D., M.P.A.
1. Risks to Patient Safety and Quality 
of Care From Boarding of Psychiatric 
Patients in Emergency Departments
Anne C. Bauer, M.D.
2. The Legal Challenges and Responses 
to Shortages of Beds for Emergency 
Psychiatric Evaluation
Richard J. Bonnie, J.D.
3. Why is There a Psychiatric Bed Shortage?
Marvin Swartz, M.D.
4. Dealing With Psychiatric Boarders 
in the Emergency Department: An 
Emergency Physician’s Perspective
Leslie Zun, M.B.A., M.D.
Interacting With Demanding, Suicidal 
and Aggressive Patients: Avoiding 
Interpersonal Crash and Combustion
9:00 a.m. - 12:00 p.m.
Rooms 203 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Diana Kljenak, M.D.
1. Interacting With Suicidal Patients
Yvonne Bergmans, M.S.W.
2. Interacting With Demanding Patients
Shelley McMain, Ph.D.
3. Interacting With Aggressive Patients
Jodi Lofchy, M.D.
Maintenance of Certification (MOC): 
Why It Exists, What It is About, and 
How You Can Do It
9:00 a.m. - 12:00 p.m.
Rooms 206 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Philip R. Muskin, M.D.
1. American Board of Medical Specialties 
Continuing Certification: For our Pa-
tients, the Public, and our Profession
Lois M. Nora, J.D., M.B.A., M.D.
Symposia
Factors That Enhance Resilience in 
At-Risk Groups That Have Experienced 
Family Violence (FV)
9:00 a.m. - 12:00 p.m.
Room 104 C, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Donna Stewart, M.D.
1. A Systematic Review of Resilience in 
the Physically Ill
Donna Stewart, M.D.
2. Mental Health and Resilience in 
Women Facing Unwanted Pregnancy
Marta B. Rondon, M.D.
3. Resilience and Resources Among 
South Asian Immigrant Women as 
Survivors of Partner Violence
Farah Ahmad, M.B.B.S., M.P.H., Ph.D.
4. Promoting Resilience in Individuals 
Affected by Child Maltreatment and 
Intimate Partner Violence
Helen Herrman, M.B.B.S., M.D.
Seizure Therapy for Depression: 
Teaching an ‘Old Dog’ Some ‘New 
Tricks’
9:00 a.m. - 12:00 p.m.
Rooms 201 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Sarah H. Lisanby, M.D.
Matthew V. Rudorfer, M.D.
1. Dose for Seizure Therapy: Definitions 
and Implications for Practice
Angel Peterchev, Ph.D.
2. Safety and Efficacy of Right Unilateral 
Ultrabrief Pulse Electroconvulsive 
Therapy in Depressed Seniors: 
New Insights From the Prolonging 
Remission in Depressed Elders Trial
Mustafa M. Husain, M.D.
3. Translational Development of 
Magnetic Seizure Therapy (MST): 
Improving the Safety and Focality of 
Seizure Therapy
Sarah H. Lisanby, M.D.
4. Safety and Efficacy of Magnetic 
Seizure Therapy
Z.J. Daskalakis, M.D.
2. Preventing Medical Illness in 
Psychiatry: Just the Basics
Robert M. McCarron, D.O.
3. The Collaborative Care Model for 
the Treatment of Mental Illnesses in 
Primary Care
Jurgen Unutzer, M.D., M.P.H.
4. Preparing Psychiatrists to Work in the 
Collaborative Care Model
Lori E. Raney, M.D.
Media Workshops
Update: A Case of Xenoglossy and the 
Nature of Consciousness (First Present-
ed at the 2013 APA Annual Meeting)
9:00 a.m. - 12:00 p.m.
Ballroom A-B, Lower Level
InterContinental Toronto Centre
Chair:
Samuel H. Sandweiss, M.D.
Speakers:
Jonathan Lieff, B.S., M.D.
Sthaneshwar Timalsina, Ph.D.
Presidential Symposia
Talking About the Brain With 
Patients: Science, Metaphor, and 
Communication
American Association of Directors of 
Psychiatric Residency Training
9:00 a.m. - 12:00 p.m.
Room 718 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Adrienne L. Bentman, M.D.
Richard F. Summers, M.D.
Discussant:
Christopher K. Varley, M.D.
1. Talking About the Brain With Parents
Adrienne L. Bentman, M.D.
2. Neuroscience and Cognitive-Behavior 
Therapy: Integrating Knowledge and 
Practice
Jesse H. Wright, M.D., Ph.D.
3. Talking About the Brain in Combined 
Treatment
Art Walaszek, M.D.
4. Talking About the Brain in 
Psychodynamic Psychotherapy
Richard F. Summers, M.D.










“I Have Your Back!”: Meaningful 
Action to Address Vicarious Trauma in 
the Workplace
9:00 a.m. - 12:00 p.m.
Room 717 A-B, Level 700, South Building




Charles R. Figley, Ph.D.
1. A Case Presentation on Vicarious 
Trauma From Work With a 9/11 First 
Responder
Mark R. Evces, Ph.D.
2. A Case Presentation on Vicarious 
Trauma From Work With Delayed-
Onset Posttraumatic Stress Disorder 
After a Traumatic Birth
Danielle A. Kaplan, Ph.D.
3. A Case Presentation on Vicarious 
Trauma From Work With a Survivor of 
Military Trauma
Charles Nelson, Ph.D.
4. A Case Presentation on Vicarious 
Trauma From Work With a Boston 
Marathon Bombing Victim
April J. Naturale, Ph.D.
Addictions: Epidemiology and 
Treatment in France and in the United 
States: Vive la Difference!
APA Council on International Psychiatry
1
9:00 a.m. - 12:00 p.m.
Room 718 B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
John A. Talbott, M.D.
Francois Petitjean, M.D.
1. Addictions in France: An 
Epidemiological Overview
Florence Vorspan, M.D., Ph.D.
2. Baclofen for the Treatment of Alcohol 
Dependence
Renaud de Beaurepaire, M.D.
3. Alcohol and Other Drug Misuse by 
American Collegiate and Professional 
Athletes
David R. McDuff, M.D.
4. Personalized Medicine Treatment for 
Alcohol Use Disorders in the U.S.
Bankole Johnson, M.D.
5. Alcohol and Mental Disorders: Cause 
or Consequence?
Francois Petitjean, M.D.
Impact of Unrecognized Attention-
Deficit/Hyperactivity Disorder on 
Treatment of Anxiety and Depressive 
Disorders
9:00 a.m. - 12:00 p.m.
Room 715 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Thomas E. Brown, Ph.D.
1. Implications of New Understandings 
of ADHD for Treatment of Anxiety and 
Depression
Thomas E. Brown, Ph.D.
2. Incidence and Interventions for 
Patients With Depressive Disorder and 
Underlying ADHD
Martin A. Katzman, M.D.
3. Incidence and Interventions for 
Patients With Anxiety Disorders and 
Underlying ADHD
Larry J. Klassen, M.D.
Integrating Primary Care and 
Behavioral Health for Managing 
Memory Disorders
APA Caucus on Complementary and 
Alternative Medicine
4
9:00 a.m. - 12:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Lewis Mehl-Madrona, M.D., Ph.D.
1. Evidence-Based Practices to Improve 
Memory or Reduce the Rate of 
Decline
Lewis Mehl-Madrona, M.D., Ph.D.
2. Results of Implementing Group 
Medical Visits With Behavioral Health 
Into Primary Care
Barbara Mainguy, M.A., M.F.A.
3. Integrating Behavioral Health, 
Lifestyle Management, and General 
Medicine in a Primary Care Setting
Michael Ross, D.O.
4. The Role of Osteopathic Medicine 
in Preventing Frailty and Memory 
Decline
Magili Chapman-Quinn, D.O.
5. Integrating Neuromuscular Medicine 
Into Geriatric Group Visits and Nursing 
Home Care
Josephine Conte, D.O.
2. American Board of Psychiatry 
and Neurology Perspectives on 
Maintenance of Certification
Larry R. Faulkner, M.D.
3. How the APA Provides Everything You 
Need to Make MOC Easy for You
Tristan Gorrindo, M.D.
4. MOC: What Should I do?
Margo D. Lauterbach, M.D.
Attachment and Chronic Illness: 
Challenging Cases Across the Lifespan
 5
9:00 a.m. - 12:00 p.m.
Room 701 B, Level 700, South Building








2. Attachment and Medical Illness in the 
Child and Young Adolescent
Gabrielle H. Silver, M.D.
3. Attachment and Medical Illness in the 
Late Adolescent and Young Adult: The 
Emerging Adult
Jennifer Tanner, Ph.D.
4. Attachment and Medical Illness in the 
Adult of Middle Age
Francine Cournos, M.D.
Personality and Personality Disorders: 
Unresolved Puzzles
9:00 a.m. - 12:00 p.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
John F. Clarkin, Ph.D.
1. The Adolescent Brain and 
the Emergence and Peak of 
Psychopathology
BJ Casey, Ph.D.
2. The Nature and Scope of Disordered 
Personality
John Livesley, M.D., Ph.D.
3. Rigidity as the Key Deficit as We Label 
Personality Disorder
Peter Fonagy, Ph.D.
4. Controversies in the Classification of 
Personality Disorders












Young Investigator Poster Sessions 2
10:00 a.m. - 12:00 p.m.
Exhibit Halls D-F, Level 800, South Building
Metro Toronto Convention Centre
Moderator:
Chetana A Kulkarni, B.Sc., M.D.
11:00 a.m. Sessions
Case Conference
These sessions are open to 
APA members only. A blue 
registration badge or an APA 
membership card are required for 
admittance.
!
Neuropsychiatry Case Conference: 
Dementia With Visual System 
Deterioration
11:00 a.m. - 12:30 p.m.
Room 701 A, Level 700, South Building




Margaret C. Tuttle, M.D.
Interactive Sessions
Management of Treatment-Resistant 
Depression: The Art and the Science
11:00 a.m. - 12:30 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Charles B. Nemeroff, M.D., Ph.D.
Gender Dysphoria and Treatment in Mi-
nors: Legal and Ethical Considerations
3
9:00 a.m. - 12:00 p.m.
Niagara/Ontario Rooms, Lower Level
InterContinental Toronto Centre
Chairs:
Erik R. Frost, M.D.
Philip J. Candilis, M.D.
1. Case Presentation
Erik R. Frost, M.D.
2. Competency Evaluations in Minors
Philip J. Candilis, M.D.
3. Disclosure Elements and Discussion 
in the Treatment of Gender Dysphoria
Ricky D. Malone, M.D.
Courses
Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Neuropsychiatric Masquerades: Medi-
cal and Neurological Disorders That 
Present With Psychiatric Symptoms
5
9:00 a.m. - 4:00 p.m.
Grand Ballroom Center, Lower Concourse
Sheraton Centre Toronto Hotel
Director:
José R. Maldonado, M.D.
Faculty:
Yelizaveta I. Sher, M.D.
José R. Maldonado, M.D.
A Psychodynamic Approach to 
Treatment-Resistant Mood Disorders: 
Breaking Through Treatment 
Resistance by Focusing on Comorbid 
Personality Disorders
9:00 a.m. - 4:00 p.m.
Sheraton Hall E, Lower Concourse




Edward R. Shapiro, M.D.
David Mintz, M.D.
6. Screening and Treatment of 
Substance Abuse Disorders in 
Primary Care in the U.S.
David Oslin, M.D.
Administrative Psychiatry: A 
Worldwide Perspective
American Association of Psychiatric 
Administrators
 7
9:00 a.m. - 12:00 p.m.
Room 801 A, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Victor J.A. Buwalda, M.D., Ph.D.
Discussant:
Sy A. Saeed, M.D.
1. What is Administrative Psychiatry About?
Victor J.A. Buwalda, M.D., Ph.D.
2. Leadership, Management and 
Administrative Issues
Julian Beezhold, M.D.
3. The Benefits of an Master’s in 
Business Administration
Geetha Jayaram, M.B.A., M.B.B.S., M.D.
4. A Proposal for a Worldwide Survey on 
Administrative Psychiatry
Victor J.A. Buwalda, M.D., Ph.D.
Contemporary Clinical and Research 
Applications of the DSM-5 Alternative 
Model of Personality Disorders
7
9:00 a.m. - 12:00 p.m.
Room 801 B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Robert F. Krueger, Ph.D.
Andrew Skodol, M.D.
Discussant:
John M. Oldham, M.D.
1. Distinguishing Between Personality 
Disorder Style and Severity: 
Conceptual and Psychometric 
Considerations
Leonard J. Simms, Ph.D.
2. Linking Neural Intrinsic Connectivity 
Networks (ICNs) With DSM-5 
Pathological Personality Domains
Robert F. Krueger, Ph.D.
3. The Development of the Structured 
Clinical Interview for DSM-5 Alterna-
tive Model for Personality Disorders
Michael First, M.D.
4. Personality Disorder Classification: 
Stuck in Neutral, How to Move 
Forward?
Andrew Skodol, M.D.
S E S S I O N  T R A C K S
1 Addiction Psychiatry
















Ethical Dilemmas in Psychiatric 
Practice
APA Ethics Committee and Penn-
Scattergood Ethics Program
11:00 a.m. - 12:30 p.m.
Room 104 A, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Richard D. Milone, M.D.
Richard K. Harding, M.D.
Speakers:
Mark S. Komrad, M.D.
William Arroyo, M.D.
Stephen C. Scheiber, M.D.
Claire Zilber, M.D.
Elissa P. Benedek, M.D.
Wade C. Myers, M.D.
Qigong for Mental Health
11:00 a.m. - 12:30 p.m.
Room 104 B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Colleen T. Loehr, M.D.
Whose Communication Problem? 
Obstacles to Recovery in Persons With 
Intellectual Disability and Psychiatric 
Disorders
11:00 a.m. - 12:30 p.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Robert J. Pary, M.D.
Janice L. Forster, M.D.
Speakers:
Janice L. Forster, M.D.
Jeffrey I. Bennett, M.D.
Stephen Ruedrich, M.D.
4. Serotonin Syndrome Revisited: How 




Diagnosing, Disclosing, and 
Documenting Borderline Personality 
Disorder: Clinical and Ethical 
Dimensions
APA Ethics Committee and Penn-
Scattergood Ethics Program
11:00 a.m. - 12:30 p.m.
Room 101, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Dominic Sisti, Ph.D.
John G. Gunderson, M.D.
Speakers:
Andrea G. Segal, M.S.
Andrew M. Siegel, M.A., M.D.
Social Media: The Good, the Bad, and 
the Ugly
American Association for Technology in 
Psychiatry
11:00 a.m. - 12:30 p.m.
Rooms 103 A-B, Level 100, North Building




A Special Conversation With Ram Dass 
and Paul Summergrad (Prerecorded)
APA Guest Lecture Series
11:00 a.m. - 12:30 p.m.
Exhibit Hall A, Level 300, North Building





Scientific and Clinical 
Reports
Psychopharmacology
11:00 a.m. - 12:30 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderators:
Svetlana Milenkovic, M.D.
1. Improving Antipsychotic 
Pharmacotherapy Via Educational 
Outreach to Prescribers Across a 
State Mental Health System
Mary Brunette, M.D.
2. Genetic and Clinical Determinants of 
Weight Gain and/or Metabolic Syn-
drome in a Large Psychiatric Sample 
Treated With Psychotropic Drugs
Chin B. Eap, Ph.D.
3. N-Acetylcysteine Augmentation 
Lowers Clozapine Dose as Efficacy Is 
Maintained and Adverse Effects and 
Obsessive Symptoms Are Diminished: 
A Case Report
Richard H. McCarthy, C.M., M.D., Ph.D.
Ram Dass, PhD (Richard Alpert), one of America’s most beloved spiritual teachers, has 
made his mark on the world by teaching the path of the heart and promoting service in the 
areas of social consciousness and care for the dying. Richard Alpert, Ph.D., was a promi-
nent Harvard psychologist and psychedelic pioneer with Timothy Leary, Ph.D. before his first 
trip to India in 1967. In India, he met his guru, Neem Karoli Baba, who gave Ram Dass his 
name, which means “servant of God.” 
Ram Dass became a pivotal influence in our culture with the publication of Be Here Now 
in 1970. He published numerous other books including Still Here in 2004, Be Love Now 
in 2010, and with co-author Rameshwar Das, Polishing the Mirror: How to Live from Your 
Spiritual Heart in 2013. 
Ram Dass’ spirit has been a guiding light for four decades, carrying millions along the jour-
ney. He now makes his home in Maui and teaches worldwide through his website (RamDass.org) 













Women in Psychiatry: Career Ladder, 
Academics, Advocacy and Personal 
Life. Opportunities and Challenges.
1:00 p.m. - 5:00 p.m.
Sheraton Hall A, Lower Concourse




Margo C. Funk, M.A., M.D.
Karen Jacobs, D.O.
Tatiana Falcone, M.D.
Kathleen S. Franco, M.D., M.S.
1:30 p.m. Sessions
Advances in Medicine
Cancer Control in 21st Century 
Challenges and Opportunities
1:30 p.m. - 3:00 p.m.
Room 701 A, Level 700, South Building








Value of Comparative Effectiveness 
Research in Improving Mental Health 
Outcomes
1:30 p.m. - 3:00 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Grayson S. Norquist, M.D., M.P.H.
Speakers:
Romana Hasnain-Wynia, M.S., Ph.D.
David Hickam
Grayson S. Norquist, M.D., M.P.H.
I Wish I Learned That in Residency: 
Preparing Future Psychiatrists for the 
Future of Psychiatry
11:00 a.m. - 12:30 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Sharat P. Iyer, M.D., M.S.
Matthew D. Erlich, M.D.
Speakers:
Sharat P. Iyer, M.D., M.S.
Matthew D. Erlich, M.D.
Andres Barkil-Oteo, M.D., M.Sc.
Barney R. Vaughan, M.D.
Michael J. Yao, M.D., M.P.H.
No Poster? No Publication? No 
Problem. A Step-by-Step Guide to Get 
You Started in the Scholarly Activity 
Process
11:00 a.m. - 12:30 p.m.






M. Pilar Trelles, M.D.
Cristina Montalvo, M.B.B.S., M.D.
Varieties of Religion and Spirituality: 
What Should Clinicians Know?
APA Caucus of Religion, Spirituality and 
Psychiatry
11:00 a.m. - 12:30 p.m.




Rama Rao Gogineni, M.D.
Speakers:
John R. Peteet, M.D.
Shridhar Sharma, D.P.M., M.B.B.S., M.D.
Driss Moussaoui, M.D.
Steven Moffic, M.D.
Psychotherapy Update 2015: 
Promoting Evidence-Based Practice
11:00 a.m. - 12:30 p.m.
Room 105, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Priyanthy Weerasekera, M.D., M.Ed.
John Manring, M.D.
To Treat or Not to Treat: Is That 
the Question? The Evaluation and 
Treatment of Mood Disorders in Case 
Examples of Pregnant Women
11:00 a.m. - 12:30 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Kara E. Driscoll, M.D.
Speakers:
Katherine L. Wisner, M.D., M.S.
Kara Brown, M.D.
Marley Doyle, M.D.
Mefloquine Intoxication in Clinical and 
Forensic Psychiatry
5
11:00 a.m. - 12:30 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chairs:
Remington L. Nevin, M.D., M.P.H.
Elspeth C. Ritchie, M.D., M.P.H.
Pre-Exposure Prophylaxis for HIV: The 
Science, Psychology, and Implications 
for Clinical Practice
5
11:00 a.m. - 12:30 p.m.
Room 711, Level 700, South Building






All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
!
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 











A Cognitive Behavioral Approach to 
Weight Loss and Maintenance
1:30 p.m. - 3:00 p.m.
Room 101, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Judith Beck, Ph.D.
Deborah Beck Busis, L.C.S.W.
Weeding Through the Hype: 
Understanding Adolescent Cannabis 
Use
APA Council on Children, Adolescents and 
Their Families
2
1:30 p.m. - 3:00 p.m.
Rooms 103 A-B, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Kara Bagot, M.D.
Sharon L. Hirsch, M.D.
Speakers:




Christopher J. Hammond, M.D.
Kara Bagot, M.D.
Scientific and Clinical 
Reports
Substance Use and Misuse: Illicit 
Drugs and Prescribed Medications
 1
1:30 p.m. - 3:00 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Godfrey D. Pearlson, M.D.
1. Initial Response as a Predictor of 
12-Week Buprenorphine-Naloxone 
Treatment Response in a Prescription 
Opioid-Dependent Population
Roger D. Weiss, M.D.
1
2. Heroin Is Most Effective Treatment for 
Improving Retention Among Opioid-
Dependent Patients, But Are We 
Ready for It?
Brittany B. Dennis, B.A.
1




4. Mediation and Moderation of Religion 
Substance Abuse Relationships by 
Genotype
Rachel E. Dew, M.D., M.H.Sc.
1
Lectures
How Science Can Inform the 
Diagnosis, Prevention, and Treatment 
of Alcohol Use Disorders
U.S. National Institute on Alcohol Abuse 
and Alcoholism
6
1:30 p.m. - 3:00 p.m.
Exhibit Hall A, Level 300, North Building
Metro Toronto Convention Centre
Lecture Chair:
Jeffrey A. Lieberman, M.D.
Lecturer:
George Koob, Ph.D.
Mind Over Disaster: Overcoming 
the Challenges of Mental Health 
Plan Implementation in Low Income 
Countries
APF George Tarjan Award Lecture
1:30 p.m. - 3:00 p.m.
Room 801 B, Level 800, South Building
Metro Toronto Convention Centre
Lecture Chairs:
Nyapati R. Rao, M.D., M.S.
Fructuoso R. Irigoyen-Rascon, M.D., P.A.
Lecturer:
Marie-Claude Rigaud, M.D.
George Koob, PhD, is Director of the National Institute on Alcohol Abuse and Alcoholism 
(NIAAA) as of January 27, 2014. As NIAAA Director, Dr. Koob oversees a wide range of alcohol-
related research, including genetics, neuroscience, epidemiology, prevention, and treatment.
As an authority on alcoholism, drug addiction and stress, he has contributed to our 
understanding of the neurocircuitry associated with the acute reinforcing effects of alcohol 
and drugs of abuse and the neuroadaptations of the reward and stress circuits associated 
with the transition to dependence. Dr. Koob has published over 650 peer reviewed papers 
and several books, including the Neurobiology of Addiction, a comprehensive treatise on 
emerging research in the field, and a textbook for upper division undergraduates and gradu-
ate students called Drugs, Addiction and the Brain. He has mentored 11 Ph. D students and 
over 75 post-doctoral fellows.
He received his Ph.D. in Behavioral Physiology from Johns Hopkins University in 1972. 
He spent much of his early career at the Scripps Research Institute as the Director of the 
Alcohol Research Center, and as Professor and Chair of the Scripps’ Committee on the 
Neurobiology of Addictive Disorders. He has also served as a researcher in the Department 
of Neurophysiology at the Walter Reed Army Institute of Research and the Arthur Vining 











The Many Faces of Narcissism
1:30 p.m. - 3:00 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chair:
Glen O. Gabbard, M.D.
Speaker:
Holly Crisp-Han, M.D.
Arts-Based Workshop: “Wilderness,” 
an Award-Winning, 10-Minute Film 
About a Mother’s Struggle to Seek 
Mental Health Care for Her Son
1:30 p.m. - 3:00 p.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chair:




Elizabeth M. Ward, R.N.
Body Dysmorphic Disorder: Clinical 
Features, Neurobiology, and Treatment
1:30 p.m. - 3:00 p.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Katharine A. Phillips, M.D.
Speakers:
Katharine A. Phillips, M.D.
Jamie D. Feusner, M.D.
Moral Treatment in Psychiatry: 
Reflection on European Roots and the 
Influence of Moral Therapy on Early 
American Psychiatry
APA Ethics Committee and Penn-
Scattergood Ethics Program
1:30 p.m. - 3:00 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
David Roby, M.D.
Louis C. Charland, Ph.D.
Speakers:
Louis C. Charland, Ph.D.
David Roby, M.D.
You Be the Neurologist: Diagnosis and 
Treatment of Mild Traumatic Brain 
Injury in a Case Study Format
1:30 p.m. - 3:00 p.m.
Room 104 A, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
David B. FitzGerald, M.B.A., M.D.
Josepha A. Cheong, M.D.
Speakers:
David B. FitzGerald, M.B.A., M.D.
Josepha A. Cheong, M.D.
Medical Complications of Anorexia 




1:30 p.m. - 3:00 p.m.
Room 104 B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Philip S. Mehler, M.D.
Speaker:
Philip S. Mehler, M.D.
Marie-Claude Rigaud, MD is a Distinguished Life Fellow of the American Psychiatric 
Association (APA) and a former delegate of the American Medical Association (AMA) House 
of Delegates. She is a Lecturer and Adjunct Professor at the University of Illinois at Chicago. 
Throughout her professional career, Dr Rigaud has maintained active participation in, and 
contributed to International Medical Graduates (IMG) groups and organizations. She has 
a great interest and extensive knowledge in Global Psychiatry and is active in international 
health affairs. She served as President and Board Chair of the Association of Haitian Physi-
cians Abroad (AMHE) and is a current member of the Board of Trustees.
She was elected to and served on the American Medical Association (AMA) Governing 
Council (GC) of International Medical Graduates (IMG) and was the IMG Delegate to the AMA 
House of Delegates for 4 years. She is the past president of the APA IMG Caucus and until 
2014 represented IMGs on the APA Council on Minority Mental Health and Health Disparities.
After Dr Rigaud’s homeland Haiti was hit by a devastating earthquake, she reached out 
to APA to identify and develop programs aimed at prevention and addressing mental disor-
ders triggered or aggravated by the traumatic event. With the assistance of APA, Dr Rigaud 
started a working group of international mental health professionals and planned the first 
Haitian Mental Health Task Force. She funded and devoted her time and efforts to lead, along 
with mental health colleagues, in the development of Rebati Sante Mentale (rebatisantemen-
tale.org) an organization whose ultimate objectives are working with Haiti’s Health Depart-
ment to build the capacity of mental health services for Haitians in Haiti and in the Diaspora.
Dr. Rigaud is the recipient of several academic as well as community awards and recog-










Frontal-Subcortical Networks and 
Neuropsychiatric Concepts for General 
Psychiatrists
American Neuropsychiatric Association
2:00 p.m. - 5:00 p.m.
Room 718 B, Level 700, South Building




1. Introduction to Clinical Neuroscience 
Education for Psychiatrists
Sheldon Benjamin, M.D.
2. A Users Guide to the Frontal Lobes: Why 
Prefrontal Executive Function Matters
Sheldon Benjamin, M.D.
3. Fronto-Limbic-Subcortical Disorders 
of Motivation
David Silbersweig, M.D.
4. Neuroanatomy and Neural Circuitry 
of Neurobehavioral Changes After 
Traumatic Brain Injury
Thomas W. McAllister, M.D.
5. Treating Parkinson’s Disease and 
Other Neuropsychiatric Disorders: The 
Advantages of Combined Training in 
Neurology and Psychiatry
John F. Sullivan, M.D.
Symposia
Mobile Mental Health Apps: What 
Clinicians Need to Know
2:00 p.m. - 5:00 p.m.
Room 104 C, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Michael Van Ameringen, M.D.
1. Mental Health Apps: Where to Start?
Michael Van Ameringen, M.D.
2. Apps: Safety, Privacy and Ethical 
Issues
Simon A. Rego, Psy.D.
3. Practical Applications of Mental 
Health Apps
Michelle A. Blackmore, Ph.D.
4. Mental Health Professionals attitudes 
Towards the use of Mental Health 
Mobile Applications (apps) in Clinical 
Practice
Keren Grosman Kaplan, M.D.
Advances in Series
Test Your Knowledge With the Experts: 
An Interactive Advances in Series on 
Personality Disorders, Mentalizing and 
Network Therapy
American Psychiatric Publishing Editorial 
Board
2:00 p.m. - 5:00 p.m.
Room 105, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Philip R. Muskin, M.D.
Anna L. Dickerman, M.D.
1. Personality Disorders: Categorical or 
Dimensional?
John M. Oldham, M.D.
2. Network Therapy for Alcohol and Drug 
Addiction
Marc Galanter, M.D.
3. Mentalizing in Psychotherapy
Stuart C. Yudofsky, M.D.
Forum
Psychiatrists as Leaders
2:00 p.m. - 5:00 p.m.
Room 718 A, Level 700, South Building




Darrell G. Kirch, M.D.
Herbert Pardes, M.D.
Peter F. Buckley, M.D.
Robert N. Golden, M.D.
Media Workshops
What’s Art Got to Do With It?
2:00 p.m. - 5:00 p.m.
Ballroom A-B, Lower Level
InterContinental Toronto Centre
Chair:
Isabel Fryszberg, B.Sc., O.T.
Speakers:
Isabel Fryszberg, B.Sc., O.T.
Linda Monteith, B.A.
Janet Parsons
You re Ready to Practice...Now What?
3
1:30 p.m. - 3:00 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Kristen Lambert, J.D., M.S.W.
Speakers:
Kristen Lambert, J.D., M.S.W.
Moira K. Wertheimer, B.S.N., J.D., R.N.
Multimedia Interactive Teaching 
Methods in Psychiatric Education, 
Enabling Deeper Levels of Learning: 
An International Perspective
1:30 p.m. - 3:00 p.m.








Janet Young, B.A., O.T.
Michael Crook
Women of a Certain Age Share 
Surprising Special Experiences
1:30 p.m. - 3:00 p.m.
Caledon and Oakville, Main Level
InterContinental Toronto Centre
Chairs:
Leah J. Dickstein, M.A., M.D.
Elissa P. Benedek, M.D.
Speakers:
Carol C. Nadelson, M.D.
Esther Roberts, M.D.
Malkah T. Notman, M.D.
2:00 p.m. Sessions
Poster Sessions
New Research Poster Session 2
2:00 p.m. - 4:00 p.m.
Exhibit Halls D-F, Level 800, South Building
Metro Toronto Convention Centre
All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 












2. Educational Needs of the Integrated 
Care Consulting Psychiatrist
Anna Ratzliff, M.D., Ph.D.
3. Collaborative Mental Health Care in 
Canada: Psychiatry-Family Medicine 
Partnerships
Nick Kates, M.B.B.S.
4. Training Primary Care Providers to 
Work Effectively in the Community 
Mental Health Center Environment
Lori E. Raney, M.D.
5. Panel Discussion: Integrated Care Edu-
cation: A Multidisciplinary Perspective
Kari A. Stephens, Ph.D.
Cori Green, M.D.
H. Clifton McKnight, Jr., M.D.
Bipolar Disorder: An Update on 
Diagnosis and Treatment
2:00 p.m. - 5:00 p.m.
Rooms 206 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
S. Nassir Ghaemi, M.D., M.P.H.
Michael J. Ostacher, M.D., M.P.H.
Discussant:
Frederick K. Goodwin, M.D.
1. Anticonvulsants in Bipolar Disorders
Terence A. Ketter, M.D.
2. Review of Efficacy Data With 
Neuroleptics in Bipolar Depression 
and Mixed States
Roger S. McIntyre, M.D.
3. Antidepressants in Bipolar Disorder: 
An Update
S. Nassir Ghaemi, M.D., M.P.H.
4. Efficacy and Effectiveness: How the 
Newest Trials Can Inform Current 
Prescribing of Lithium for Bipolar 
Disorder
Michael J. Ostacher, M.D., M.P.H.
Treatment-Resistant Depression in 
Late-Life: Results of the Incomplete 
Response in Late Life Depression: 
Getting to Remission Randomized 
Placebo-Controlled Trial
 4
2:00 p.m. - 5:00 p.m.
Room 701 B, Level 700, South Building





Charles F. Reynolds III, M.D.
Academic Psychiatry 101: A Toolkit for 
Educators
Association for Academic Psychiatry
2:00 p.m. - 5:00 p.m.
Rooms 202 A-B, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Sarah B. Johnson, M.D.
1. Part 1.  Introduction and Pearls and 
Pitfalls of Negotiating Your First Job
John Luo, M.D.
2. Educator Bootcamp 101
Joan M. Anzia, M.D.
3. The Future of Academic Psychiatry
Robert Boland, M.D.
Dissociative Subtype of Posttraumatic 
Stress Disorder (PTSD): Neural, 
Epigenetic and Clinical Aspects
 5
2:00 p.m. - 5:00 p.m.
Rooms 203 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
David Spiegel, M.D.
1. Distinct Intrinsic Connectivity Patterns 
of PTSD Hyperarousal
Ruth A. Lanius, M.D., Ph.D.
2. Development of a DSM-5 Based 
Clinician Administered Dissociative 
Subtype Scale to PTSD
Eric Vermetten, M.D., Ph.D.
3. Emerging Biological Evidence for the 
Dissociative Subtype
Rachel Yehuda, Ph.D.
4. Brain Regions Involved in Hypnosis and 
Dissociation: Therapeutic Implications
David Spiegel, M.D.
Educating Psychiatrists for Work 
in Integrated Care: Focus on 
Interdisciplinary Collaboration
APA Council on Medical Education and 
Lifelong Learning
2:00 p.m. - 5:00 p.m.
Rooms 205 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Deborah Cowley, M.D.
Lori E. Raney, M.D.
Discussant:
Jurgen Unutzer, M.D., M.P.H.
1. How Psychiatry Residency Programs 
Are Educating Their Residents in Inte-
grated Care: National Survey Results 
and Recommendations for Educators
Claudia L. Reardon, M.D.
Outcome Assessments, the New 
Generation, and the Challenges of the 
Implementation
7
2:00 p.m. - 5:00 p.m.
Room 107, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Victor J.A. Buwalda, M.D., Ph.D.
William Narrow, M.D., M.P.H.
Discussant: 
Thomas E. Smith, M.D.
1. Routine Outcome Monitoring (ROM) 
in Dutch Psychiatry: Measurement 
Instruments, Implementation and 
Outcome
Victor J.A. Buwalda, M.D., Ph.D.
2. Use of Outcome Measurements in 
Clinical Practice: How Specific Should 
One Be?
M. Annet Nugter, Ph.D.
3. ROM in Addiction Care in the 
Netherlands
Gerdien H. de Weert-van Oene, Ph.D.
4. Use and Outcomes of ROM for 
Patients Undergoing Short-Term 
Treatment in a Large Urban Institution
Stasja Draisma, Psy.D.
5. Dimensional Assessments in DSM-5
William Narrow, M.D., M.P.H.
Borderline Personality Disorder (BPD) 
and Comorbid Disorders: When to 
Prioritize Treatments for Each
2:00 p.m. - 5:00 p.m.
Rooms 201 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chair:
John G. Gunderson, M.D.
Discussant:
Anthony Bateman, M.D.
1. BPD and Bipolar Disorder
Mark Zimmerman, M.D.
2. Posttraumatic Stress Disorder and 
BPD
Judith L. Herman, M.D.
3. BPD and Major Depressive Disorder
John G. Gunderson, M.D.
4. BPD and Anxiety Disorders
Alex S. Keuroghlian, M.D.









Two-Year Results of a Comprehensive 
Care Model in First Episode 
Schizophrenia: The Recovery After an 
Initial Schizophrenia Episode Early 
Treatment Prgram (RAISE ETP)
2:00 p.m. - 5:00 p.m.
Room 801 A, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
John M. Kane, M.D.
Robert K. Heinssen, Ph.D.
Discussant:
Robert K. Heinssen, Ph.D.
1. The RAISE-ETP Study Design and 
Implementation Model
Nina R. Schooler, Ph.D.
2. Overview and Implementation of 
the RAISE-ETP Study Psychosocial 
Treatment Model: The NAVIGATE 
Program
Kim T. Mueser, Ph.D.
3. Assisting Prescribers Efforts to 
Optimize Pharmacotherapy for First- 
Episode Schizophrenia
Delbert Robinson, M.D.
4. RAISE ETP:NAVIGATE Versus Usual 
Care- Two-Year Outcomes
John M. Kane, M.D.
Enhancing Capacity to Address Mental 
Health Needs of Veterans and Their 
Families: The Welcome Back Veterans 
(WVB) Initiative
2:00 p.m. - 5:00 p.m.






John F. Greden, M.D.
1. WBV Southeast Initiative: Brave 
Heart’s Outreach and Partnership 
With Star Behavioral Health Providers
Barbara Rothbaum, Ph.D.
2. Valenstein: Buddy-to-Buddy: A Peer 
Outreach Program for National Guard 
Soldiers
Marcia Valenstein, M.D.
3. Overcoming Barriers to Care 
for Returning Veterans With 
Posttraumatic Stress Disorder and 
Traumatic Brain Injury With a Veteran 
Outreach Team
Naomi Simon, M.D.
2. Oxytocin and Vasopressin: The State 
of Research on Social Bonding
C. Sue Carter, Ph.D.
3. Movement and Breathing Practices: 
Research, Clinical Applications, and 
Neurophysiological Models
Patricia L. Gerbarg, M.D.
4. Breath-Body-Mind Experiential
Richard P. Brown, M.D.
APA Assembly as APA Members’ 
Voice and Center of Planning for Their 
Professional Future
APA Caucus of International Medical 
Graduates
2:00 p.m. - 5:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:





1. The Evolution of the APA Assembly 
1953-2003
John S. McIntyre, M.D.
2. Is There a Role for the Assembly in 
the 21st Century?
Jenny l. Boyer, M.D.
3. The Assembly Comes of Age
Roger Peele, M.D.
Traumatic Brain Injury (TBI) and 
Mental Health Comorbidities in the 
U.S. Military: Lessons Learned From 
War
 5
2:00 p.m. - 5:00 p.m.
Room 717 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
David A. Williamson, M.D.
Louis French, Psy.D.
1. Mild TBI and Co-Morbidities in 
Military Populations
Louis French, Psy.D.
2. Multidisciplinary TBI Screening in a 
Military Trauma Center
Wendy A. Law, Ph.D.
3. Overview of Neuropsychiatric 
Complications of TBI in Military 
Populations; Lessons Learned
David A. Williamson, M.D.
4. Complex Partial Seizures Presenting 
With Psychiatric Symptoms in TBI 
Patients
Adam L. Hunzeker, M.D.
1. Epidemiology and Current Evidence-
Based Treatment Options for Treat-
ment-Resistant Depression in Late Life
Daniel M. Blumberger, M.D.
2. The IRL-GRey Clinical Trial of 
Aripiprazole Augmentation for 
Treatment-Resistant Depression in 
Late Life: Tolerability and Safety
Benoit Mulsant, M.D.
3. The IRL-GRey Clinical Trial of Aripiprazole 
Augmentation for Treatment-Resistant 
Depression in Late Life: Efficacy Results
Eric Lenze, M.D.
4. Future Directions for the Pharma-
cotherapy of Treatment-Resistant 
Depression in Late Life: The Role of 
the Opioid System and Opioid Agents
Jordan F. Karp, M.D.
Global Mental Health
APA Council on International Psychiatry
 5
2:00 p.m. - 5:00 p.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Dilip V. Jeste, M.D.
Anne E. Becker, M.D., Ph.D.
Discussant:
Dinesh Bhugra, M.D., Ph.D.
1. Geriatric Psychiatry Across the Globe: 
Bad News and Good News
Dilip V. Jeste, M.D.
2. Expanding Youth Mental Health Care 
Access in Low- and Middle-Income 
Countries: Lessons From School-
Based Studies in Fiji and Haiti
Anne E. Becker, M.D., Ph.D.
3. Addictions Psychiatry in Africa
Solomon Rataemane, M.D.
4. Rethinking Global Suicides
Michael R. Phillips, M.D., M.P.H.
Polyvagal Theory, Oxytocin, Bonding, 
and Mind-Body Methods to Balance 
the Autonomic Nervous System and 
Restore Connectedness
2:00 p.m. - 5:00 p.m.
Room 715 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Patricia L. Gerbarg, M.D.
Richard P. Brown, M.D.
1. Connectedness as a Biological Imper-
ative: Understanding Bonding Through 











Scientific and Clinical 
Reports
Depression: Treatment and Resistance 
and Functionality
3:30 p.m. - 5:00 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Svetlana Milenkovic, M.D.
1. Training and Education 
Recommendations for Primary Care 
Physicians in Metro and Urban 
Communities in India: Findings of a 
Needs Assessment From India
Amresh K. Shrivastava, M.D.
2. Pattern of Psychiatric Illness 
Among Women Attending a Private 
Psychiatric Consultation Service in a 
Rural Area of Bangladesh
M.M. J. Uddin, M.D.
3. Brief Culturally-Adapted Cognitive 
Behavioral Therapy for Depression: 
A Randomized Controlled Trial From 
Pakistan
Farooq Naeem, M.B.B.S., M.Sc., Ph.D.
4. Culture and Psychotherapy: A 
Psychosocial Framework for Analysis
Constantine D. Della, M.D.
Interactive Sessions
Child and Adolescent 
Psychopharmacology: Current 
Controversies and Hot Topics
2
3:30 p.m. - 5:00 p.m.
Rooms 103 A-B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Barbara Coffey, M.D., M.S.
Lectures
Delivering on the Promise of 
Translation in Psychiatry: From Novel 
Therapies to Enhanced Public Health
APA Distinguished Psychiatrist Lecture 
Series
3:30 p.m. - 5:00 p.m.
Room 102 (Theatre), Level 100, North 
Building
Metro Toronto Convention Centre
Lecture Chairs:
Jerrold F. Rosenbaum, M.D.
Iqbal Ahmed, M.D.
Lecturer:
Scott L. Rauch, M.D.
4. Lester UCLA Welcome Back Veterans 
Family Resilience Center: Innovations 
in Family Centered Behavioral Health 
Care for Veterans
Patricia Lester, M.D.
5. Treatment of Military Sexual Trauma 
Outside of the Veterans Administration 
System - Challenges and Opportunities
Niranjan Karnik, M.D., Ph.D.
3:30 p.m. Sessions
Advances in Medicine
Modulating Neurological and Psychi-
atric Brain Circuits With Deep Brain 
Stimulation
3:30 p.m. - 5:00 p.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Kenneth R. Silk, M.D.
Gregory W. Dalack, M.D.
Speaker:
Andres M. Lozano, M.D., Ph.D.
Forum
A Co-Resident s Suicide: Grieving 
Together and Rethinking Trainee 
Mental Health
3:30 p.m. - 5:00 p.m.
Room 101, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Matthew L. Goldman, M.D., M.S.




Carol A. Bernstein, M.D.
Scott L Rauch, MD is President, Psychiatrist in Chief, and The van Otterloo Chair of Psy-
chiatry at McLean Hospital, as well as Chair of Psychiatry & Mental Health for the Partners 
Health Care System, and Professor of Psychiatry at Harvard Medical School (HMS). He is an 
international expert in neuroimaging and the neurobiology of depression & anxiety disorders.
Dr. Rauch received his BA in Neuroscience from Amherst College and his MD from the 
University of Cincinnati. He completed his Psychiatry residency and a Radiology Fellowship 
at Massachusetts General Hospital (MGH)/HMS. During his 15 years on the MGH faculty, he 
founded the Psychiatric Neuroimaging Research Program and the Psychiatric Neuroscience 
Division. He was appointed to his current leadership roles at McLean and Partners in 2006.
He has contributed over 400 publications and serves on the editorial boards of several 
journals. He has won numerous honors, including awards for outstanding research from 
ACNP and MPS and for outstanding mentoring from the APA/AACDP and HMS.
Bio
All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
!
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 










Transgender Care in the Bible Belt: 
Challenges of Family and Societal 
Nonacceptance
5
3:30 p.m. - 5:00 p.m.
Humber Room, Main Level
InterContinental Toronto Centre
Chairs:
Daena L. Petersen, M.A., M.D., M.P.H.
McLeod F. Gwynette, M.D.
Speakers:
Dan H. Karasic, M.D.
Nathaniel Sharon, M.D.
The Role of the Psychiatrist in 
Treating College Students: Historical 
Perspectives, Challenges, and Current 
Innovations
3:30 p.m. - 5:00 p.m.










5:15 p.m. - 6:15 p.m.
Room 106, Level 100, North Building
Metro Toronto Convention Centre
7:00 p.m. Sessions
Media Workshops
“Lars and the Real Girl”: The Power 
of Erotomanic Delusions: A Case and 
Media Study Highlighting the Personal 
and Social Impacts
7:00 p.m. - 10:00 p.m.







Civil Commitment: Assessment of 
Statutes of Area 7 States and Native 
Sovereign Nations
3
3:30 p.m. - 5:00 p.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Monica Taylor-Desir, M.D., M.P.H.
Roland Segal, M.D.
Mood, Art, and Politics: Abraham 
Lincoln, Vincent Van Gogh and Sylvia 
Plath - Resilience and Creativity in the 
Face of Great Odds
3:30 p.m. - 5:00 p.m.
Room 801 B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
John P. O’Reardon, M.D.
Speakers:
John P. O’Reardon, M.D.
Michelle Landy, M.D.
The Challenges and Potential 
Solutions of Teaching Residents 
Evidence-Based Assessment and 
Management of Violence Within 
Inpatient Psychiatry Settings
3:30 p.m. - 5:00 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Keith A. Hermanstyne, M.D., M.P.H.
Christina Mangurian, M.D.
Speakers:
Paul S. Appelbaum, M.D.
Marvin Swartz, M.D.
Integrated and Collaborative 
Training for Psychiatrists and Nurse 
Practitioners: Meeting the Needs of 
Underserved Patient Populations
3:30 p.m. - 5:00 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Laura F. Marrone, M.D.
Speakers:
Lawrence Malak, M.D.
Steve Koh, M.D., M.P.H.
Workshops
Current Procedural Terminology 
Coding and Documentation Update
APA Committee on RBRVS, Codes and 
Reimbursement
3:30 p.m. - 5:00 p.m.
Room 104 B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Ronald Burd, M.D.
Psychiatrists Who Have Survived the 
Suicide Death of a Loved One: Their 
Insights
3:30 p.m. - 5:00 p.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Michael F. Myers, M.D.
Speakers:
Akshay Lohitsa, M.D.
Anna Halperin Rosen, M.D.




Aberrant Opioid-Prescribing Behavior: 
Two Sides of the Same Coin
5
3:30 p.m. - 5:00 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Kenneth M. Certa, M.D.
William Jangro, D.O.
Speakers:
Mitchell J. Cohen, M.D.
Christopher R. Martin, M.D.
Psychiatric Innovations of 21st 
Century Combat: How Extended 
Combat Improved Our Ability to 
Effectively Treat Veterans
3:30 p.m. - 5:00 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chairs:
David M. Oliver, M.D.
Elspeth C. Ritchie, M.D., M.P.H.
Speakers:
Paul S. Hammer, B.S., M.D.
Jeffrey Millegan, M.D., M.P.H.





































































The Role of Psychiatry in Acquired 
Brain Injury Treatment
5
9:00 a.m. - 10:30 a.m.
Rooms 103 A-B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
David A. Williamson, M.D.
Speakers:
Gary Goldberg, M.D.
Kathleen T. Bechtold, Ph.D.
David A. Williamson, M.D.
Interpersonal Psychotherapy (IPT) for 
Postpartum Depression
5
9:00 a.m. - 10:30 a.m.
Room 104 A, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Paula Ravitz, M.D.
Sophie Grigoriadis, M.A., M.D., Ph.D.
Integrating Mental Health and Primary 
Care: The Canadian Experience
9:00 a.m. - 10:30 a.m.
Room 104 B, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Nick Kates, M.B.B.S.







A Translational Research Approach to 
the Responsible Conduct of Research
APA Ethics Committee and Penn-
Scattergood Ethics Program
9:00 a.m. - 10:30 a.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Dominic Sisti, Ph.D.
Donald S. Kornfeld, M.D.
Speakers:
Mark S. Davis, Ph.D.
Brian C. Martinson, Ph.D.




9:00 a.m. - 10:30 a.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Julio Licinio, M.D.
1. Are Antidepressants Associated With 
Increased Risk of Poor Outcome in 
Patients With Bipolar Disorder?
John W. Goethe, M.D.
2. Cannabis Withdrawal in Adults With 
Depression or Bipolar Disorder
David A. Gorelick, M.D., Ph.D.
1
3. Role of Botulinum Toxin in Depression: 
A Systemic Review and Meta-Analysis
Ajay Parsaik, M.D., M.S.
4. Predictive Values of Screening 
Questions for Lifetime and Past-




Tackling Financial Health at a 
Community Mental Health Center
9:00 a.m. - 10:30 a.m.
Room 101, Level 100, North Building






Marc I. Rosen, M.D.
9:00 a.m. Sessions
Case Conference
These sessions are open to 
APA members only. A blue 
registration badge or an APA 
membership card are required for 
admittance.
!
The Troubling Relationship Between 
Mood Disorders and Dementia in 
Older Adults
4
9:00 a.m. - 10:30 a.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Kenneth I. Shulman, M.D.
Nathan Herrmann, M.D.
Speakers:
Kenneth I. Shulman, M.D.
Nathan Herrmann, M.D.
Interactive Sessions
A Conversation With Resident Fellow 
Members and Paul Summergrad, 
M.D., APA President
For Residents Only
9:00 a.m. - 10:30 a.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Paul Summergrad, M.D.
S E S S I O N  T R A C K S
1 Addiction Psychiatry







 APA Meeting on Demand
!
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 













The Athlete, Civilian, and Soldier With 
Traumatic Brain Injury (TBI): What 
They Share and How They Differ
9:00 a.m. - 12:00 p.m.
Room 107, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Michele T. Pato, M.D.
1. TBI and Issues of Comorbidity and 
Treatment
Michele T. Pato, M.D.
2. Potential Risk Factors Related to 
Types of TBI and Treatment Issues
David Baron, D.O., M.Ed.
3. Difference and Similarities in Risk 
and Outcome for TBI Suffered by 
Those in the Military
Patricia I. Ordorica, M.D.
Neurodevelopmental Disorder 
Associated With Prenatal Alcohol 
Exposure (ND-PAE): Society’s 
Preventable Mental Health Epidemic
 1
9:00 a.m. - 12:00 p.m.
Rooms 201 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Susan D. Rich, M.D., M.P.H.
Discussant:
Roger Peele, M.D.
1. Exposure to Ethanol During Early 
Gestation: Brain, Behavior, and 
Genetic Susceptibility in a Mouse 
Model of Fetal Alcohol Spectrum 
Disorders
Scott E. Parnell, Ph.D.
2. Better Safe Than Sorry - Alcohol and 
Unprotected Sex Don’t Mix!
Sydnie Butin
3. Basic Science Strategies for Studying 
ND-PAE: The Tipping Point for a 
Paradigm Shift to Prevention and 
Treatment
Sarah E. Cavanaugh, Ph.D.
4. The Hidden Cost of ND-PAE
Susan D. Rich, M.D., M.P.H.
Media Workshops
“The Hundred-Foot Journey”: From 
Culture Clash to Collaboration
APA Council on Minority Mental Health 
and Health Disparities
9:00 a.m. - 12:00 p.m.




Nyapati R. Rao, M.D., M.S.
Speaker:
Francis G. Lu, M.D.
God Loves Uganda: Faith, 
Homosexuality, and American 
Evangelicals
9:00 a.m. - 12:00 p.m.
Niagara/Ontario Rooms, Lower Level
InterContinental Toronto Centre
Chairs:
Mary E. Barber, M.D.
Eric Yarbrough, M.D.
Symposia
Caring for Clergy and Religious 
Professionals: Psychiatric, 
Vocational, and Family 
Considerations
APA Caucus of Religion, Spirituality and 
Psychiatry
4
9:00 a.m. - 12:00 p.m.
Room 104 C, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Mary L. Dell, D.Min., M.D.
1. Professional Support of Clergy: 
Attending to Physical, Developmental, 
Spiritual Arenas in a Minister’s Life
Mark Biddle, Ph.D.
2. Professional Assessment of Clergy: 
Fitness for Duty and Psychological 
Health
Holly Crisp-Han, M.D.
3. Clergy Kids: Living in the Post modern 
Fishbowl
Mary L. Dell, D.Min., M.D.
4. Letting Go and Recovery of Loves at 
the End of a Calling
James Lomax, M.D.
Do Same-Sex Marriages Differ From 
Straight Marriages?
9:00 a.m. - 10:30 a.m.
Rooms 202 C-D, Level 200, North Building





Integrative Medicine: Comprehensive 
Patient Recovery at Both the National 
Intrepid Center of Excellence and Fort 
Belvoir Addictions Treatment Center
5
9:00 a.m. - 10:30 a.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chairs:
Robert L. Koffman, M.D., M.P.H.
Frances I. Stewart, M.D.
Speakers:
Melissa S. Walker, M.A.
Rick Yount, B.S., M.S.
Roger Duda, M.D.
Forensic Primer for Community 
Psychiatrists
3
9:00 a.m. - 10:30 a.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Cathleen A. Cerny, M.D.
Speakers:
Cathleen A. Cerny, M.D.
Megan Testa, M.D.
Delaney Smith, M.D.
Susan Hatters Friedman, M.D.
Being a Part of the Solution: A 
Systematic, Effective, and Customized 
Way to Reduce Aggression, 
Seclusions, and Restraints
9:00 a.m. - 10:30 a.m.





Steven Sharfstein, M.D., M.P.A.
Robert P. Roca, M.D., M.P.H.
Antonio DePaolo, Ph.D.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 












Translating the Rapidly Expanding 
Basic and Clinical Knowledge Base 
of Cannabinoid Medicine Into the 
Holistic Treatment of Neuropsychiatric 
Disorders
9:00 a.m. - 12:00 p.m.
Room 701 B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
David G. Ostrow, M.D., Ph.D.
Discussant:
Phillipe Lucas, M.A.
1. Translating Cannabinoid Science 
Into Integrative and Holistic Wellness 
Oriented Medicine
David G. Ostrow, M.D., Ph.D.
2. Cannabis for Therapeutic Purposes in 
a Mental Health Framework: From the 
Human Endocannabinoid System to 
Public Health
Zach Walsh, Ph.D.
3. The Integration of Cannabis-Based 
Therapies Into the Neuropsychiatric 
Aspects of HIV/AIDS and Other Brain 
Syndromes
Karl Goodkin, M.D., Ph.D.
4. Cannabinoids in Acute and Chronic 
HIV: Insights From Basic Research 
and Trajectory Modeling
Dana Gabuzda, M.D.
5. Cannabis, Brain Cancer, and 
Redefining Clinical Trials With 
Botanical Medicines
Jahan P. Marcu, Ph.D.
Trauma-Centered Psychotherapy: 
Applying Evidence-Based Techniques 
Within a Psychotherapeutic Frame
American Psychiatric Publishing Editorial 
Board
9:00 a.m. - 12:00 p.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Hadar Lubin, M.D.
1. Principles of Trauma-Centered 
Psychotherapy
Hadar Lubin, M.D.
2. Conducting an Intensive, Detailed 
Trauma Inquiry
David R. Johnson, M.D.
3. Clinical Examples of Trauma-Centered 
Psychotherapy With Extremely 
Challenging Patients
Christine Mayor, M.A.
Terrorism in Pakistan - A Behavioral 
Sciences Perspective
 3
9:00 a.m. - 12:00 p.m.
Rooms 205 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Mir N. Mazhar, M.D.
Tariq Munshi, M.B.B.S.
1. Terrorism in Pakistan Controversies
Fareed A. Minhas, M.R.C.
2. Evolution of Terrorism in Pakistan
Mowadat H. Rana, M.R.C.
3. Terrorism in Pakistan Psychosocial 
Perspective
Tariq Hassan, M.B.B.S.
4. Terrorism in Pakistan Religious 
Perspective
Asad T. Nizami
Improving Engagement of Ethnic and 
Racial Minorities Through Integrated 
Care: Innovative Approaches From the 
Field
9:00 a.m. - 12:00 p.m.
Rooms 206 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Justin Chen, M.D., M.P.H.
Albert Yeung, M.D.
Discussant:
Laurence J. Kirmayer, M.D.
1. Effectiveness of Telepsychiatry-Based 
Culturally Sensitive Collaborative 
Treatment for Depressed Chinese-
American Immigrants
Albert Yeung, M.D.
2. Impact of a Culturally Focused 
Psychiatric Consultation on 
Depressive Symptoms Among Latinos 
in Primary Care
Nhi-Ha Trinh, M.D., M.P.H.
3. A Group Intervention for Diabetes 
Treatment Adherence and Depression 
in Hispanics
Trina Chang, M.D., M.P.H.
4. Collaborative Care Treatment for 
Depression in Pregnancy in S√£o 
Paulo, Brazil
Hsiang Huang, M.D., M.P.H.
5. A Group-Based Stress Management 
Intervention for Depressed Chinese 
Immigrant Patients at South Cove 
Community Health Center
Justin Chen, M.D., M.P.H.
TWITR (Telemedicine Wellness, 
Intervention, Triage, and Referral): A 
Pilot Project to Promote School Safety
 2
9:00 a.m. - 12:00 p.m.
Rooms 202 A-B, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Manish R. Aligeti, M.D., M.H.A.
1. TWITR Project: Introduction
Deepti Vats, M.D.
2. TWITR Project: A Success Story
Ankit A. Parmar, M.D., M.H.A.
3. TWITR Project: Challenges and 
Training
Manish R. Aligeti, M.D., M.H.A.
Body-Focused Repetitive Behaviors 
(BFRBs): New Understanding, Better 
Treatment
9:00 a.m. - 12:00 p.m.
Rooms 203 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Margaret A. Richter, M.D.
Mark Sinyor, M.D.
1. Using Neurobiology to Improve 
Medication Treatment of BFRBs
Jon Grant, M.D.
2. The Familiality of Hair Pulling and Its 
Relation to Other Mood and Anxiety 
Disorders
David L. Pauls, Ph.D.
3. The Examination of Five-Factor Model 
Personality Traits and Cognitive 
Dimensions in CBT Treatment 
Response for DSM-5 Trichtollomania, 
Excoriation, and Hoarding Disorder
Neil Rector, Ph.D.
4. Psychotherapy for Trichotillomania: 
A Pilot Study of the Comprehensive 
Behavioral (ComB) Model Applied in a 
Group Setting
Mark Sinyor, M.D.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 














All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 
Category 1 Credits™, except for 
Poster Sessions.
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 APA Meeting on Demand
!
Lost in Transition: Improving Safety, 
Quality, and Recovery Through 
Transitions of Care
APA Council on Quality Care
9:00 a.m. - 12:00 p.m.
Room 718 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Yad M. Jabbarpour, M.D.
Discussant:
Ken Duckworth, M.D.
1. Key Challenges Across the Health 
Care Continuum and Foundations for 
Success
Tracy Collander, L.C.S.W.
2. Routine Discharge Planning on 
Behavioral Health Inpatient Units: 
What’s Happening, and Does It Work?
Thomas E. Smith, M.D.
3. Bridging the Gaps and Connecting 
the Physical and Psychiatric Health 
Domains: A Recovery-Oriented Peer 
Perspective
Lisa Halpern, M.P.P.
4. The Role of Collaborative Care in 
Improving Patient Tracking and 
Follow-up
Lori E. Raney, M.D.
Integrating Mental Health and Primary 
Care Services: Experiences in Three 
Countries
American Society of Hispanic Psychiatry
 5
9:00 a.m. - 12:00 p.m.
Room 801 A, Level 800, South Building
Metro Toronto Convention Centre
Chair:
Javier I. Escobar, M.D.
1. Medical Home Model, an Avenue for 
Effective Mental Health Programs
Alfred Tallia, M.D.
2. Integration of Mental Health and 
Primary Care: The Experience in 
Colombia
Hernan G. Rincon-Hoyos, M.D., M.P.H.
3. Integration of Treatment of 
Depression in Women in the Primary 
Care Level in Chile
Graciela Rojas, M.D.
3. Understanding Immune-Inflammatory 
Mechanisms Relevant to the 
Treatment and Prevention of Brain 
Disorders
Roger S. McIntyre, M.D.
4. Anti-Inflammatory and Antidepressant 
Effects in Older Adults With Chronic 
Stress and Mood Disorders
Helen Lavretsky, M.D.
5. Sleep Disturbance and Inflammation 
Reciprocally Contribute to Depression: 
Implications for the Treatment and 
Prevention of Depression in Older 
Adults
Michael Irwin, M.D.
6. Inflammation as a Putative Biomarker 
of Mood and Cognition Among 
Adolescents With Bipolar Disorder
Benjamin Goldstein, M.D., Ph.D.
It’s About Time! Improving Physical 
Health Outcomes in Young People 
Prescribed Antipsychotic Medications
 2
9:00 a.m. - 12:00 p.m.
Room 717 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Philip B. Ward, B.Sc., Ph.D.
David Shiers
1. Antipsychotic-Related Risk for Weight 
Gain and Metabolic Abnormalities 
During Development
Christoph U. Correll, M.D.
2. Young People With Schizophrenia: 
A High-Risk Group for Diabetes: 
Opportunities for Prevention and Early 
Intervention From an Endocrinological 
Perspective
Katherine Samaras, M.B.B.S., Ph.D.
3. Results From the National Institute 
of Mental Health-Funded Metabolic 
Effects of Antipsychotics in Children 
Study
John W. Newcomer, M.D.
4. Early Lifestyle Intervention Attenuates 
Antipsychotic-Induced Weight Gain in 
First-Episode Psychosis
Jackie Curtis, M.D.
DSM and Psychiatric Diagnosis: Past, 
Present, Future
 7
9:00 a.m. - 12:00 p.m.
Room 715 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
S. Nassir Ghaemi, M.D., M.P.H.
Discussant:
Paul McHugh, M.D.
1. DSM-5 in the Context of the History of 
Psychiatry: Pluses and Minuses
Edward Shorter, Ph.D.
2. The 1980 Revolution in American 
Psychiatry: Need for Better Diagnosis 
or Responding to Outside Threats?
Hannah Decker, Ph.D.
3. DSM Revisions in the Context of 
Medicine, Culture, and Science
S. Nassir Ghaemi, M.D., M.P.H.
4. DSM-5: Its Past and Future
Jan Fawcett, M.D.
Beyond Inflammation: Diverse 
Immune and Metabolic Dysfunctions 
in Clinical Depression
9:00 a.m. - 12:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Bernhard T. Baune, M.D., Ph.D.
Roger S. McIntyre, M.D.
1. A Dynamic Phase-Specific Model 
of Immune Dysfunction in Clinical 
Depression
Bernhard T. Baune, M.D., Ph.D.
2. Neurobiology of Chemokines: 
Mechanistic Studies and a Clinical 
Meta-Analysis in Major Depression
Bernhard T. Baune, M.D., Ph.D.
This session will be captured 
as part of APA Annual 
Meeting on Demand, subject to 
speaker permission. Visit the APA 
on Demand Sales Booths in 











4. Statewide Hospital Quality 
Improvement Collaborative for 
Reducing Psychiatric 30-Day 
Readmissions: Strategies Used by 
High-Performing Hospitals
Kate M. Sherman, L.C.S.W., M.S.W.
Molly Finnerty, M.D.
Workshops
Integrating Care: Practical Steps in 
Implementing a Primary Care Clinic at 
a Community Mental Health Center
5
11:00 a.m. - 12:30 p.m.
Room 101, Level 100, North Building






Robert A. Cole, M.H.S.
Michael Sernyak, M.D.
Frequent Users of theEmergency 
Department for Mental Health and 
Addictions: A Canadian Perspective on 
a Complex Issue
1
11:00 a.m. - 12:30 p.m.
Rooms 103 A-B, Level 100, North Building






Cognitive Remediation to Promote 
Recovery: Innovative Models From 
Canada, France, and the New York 
State Office of Mental Health
11:00 a.m. - 12:30 p.m.
Room 104 A, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Matthew D. Erlich, M.D.
Speakers:
Christopher Bowie, Ph.D.
Isabelle Amado, M.D., Ph.D.
Matthew D. Erlich, M.D.
Master Courses
Course Descriptions are 
available in the Course 
Brochure. You can pick up a 
Course Brochure and purchase 
a course ticket in the Course 
Enrollment Area located in the 
Sheraton Centre Toronto or in 
Registration, Exhibit Halls D-E 
in the Metro Convention Centre. 
Admission to all courses, including 
Master Courses is by ticket only.
!
Update on Pediatric 
Psychopharmacology
2
9:00 a.m. - 4:00 p.m.
Room 718 B, Level 700, South Building




John T. Walkup, M.D.
Karen D. Wagner, M.D., Ph.D.
Christopher J. McDougle, M.D.
11:00 a.m. Sessions
Scientific and Clinical 
Reports
Child and Adolescent and Hospital 
Psychiatry
 2
11:00 a.m. - 12:30 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Chetana A Kulkarni, B.Sc., M.D.
1. Impact of a Mental Health Curriculum 
for High School Students on 
Knowledge, Attitudes, and Help-
Seeking Efficacy: A Randomized 
Controlled Trial
Robert P. Milin, M.D.
2
2. The Project Quixote: The Psychosocial 
Care Center for “Street Children” and 
Strategies of “Crackland” Approach
Ligia Florio, M.D.
2
3. Six Core Strategies in Reducing 
Restraints and Seclusions in Inpatient 
Child and Adolescent Settings
Muhammad W. Azeem, M.D.
2
Innovating and Supporting Dementia 
Care Across the Setting Continuum
4
9:00 a.m. - 12:00 p.m.
Room 801 B, Level 800, South Building




1. Safe Patients/Safe Staff: Geriatric 
Psychiatry C/L Innovations to Optimize 
the Care of Hospitalized Elderly With 
Comorbid Dementia
Lesley Wiesenfeld, M.D.
2. Reaching the Homebound Population: 
Home Visits and Telemedicine 
Outreach for Cognitively Impaired 
Frail Elderly and Their Care Providers
Sarah Colman, M.D.
3. To Medicate or Not to Medicate: 
Controversies and Cultural Shifts in 
the Management of the Behavioral 
Symptoms of Dementia in Long-Term 
Care
Andrea Iaboni, D.Phil., M.D.
4. The Dilemma of End-of-Life Decision 
Making in Severe Dementia
Ron Keren, M.D.
Implementing Mental Health 
Interventions in Low-Income Contexts: 
Strategies, Stages, and Supports From 
Implementation to Scale
APA Council on International Psychiatry
9:00 a.m. - 12:00 p.m.
Room 803 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Sean A. Kidd, Ph.D.
Kwame J. McKenzie, M.D.
1. CREATE: A New Paradigm for 
Recovery From Serious Mental Illness 
in Low-Resource Settings
Arlene MacDougall, M.D.
David M. Ndetei, M.D., Ph.D.
2. KIDS: A Whole-School Approach to 
Improving Mental Health in a Low-
Income Country
Kwame J. McKenzie, M.D.
David M. Ndetei, M.D., Ph.D.
3. Unpacking Social Impact: Examining 
the Scalability of Top-Tier Social 
Innovators in Mental Health












4. A Pilot Study to Determine the Safety 
and Efficacy of H-Coil Transcranial 




Evidence-Based Approaches to 
Refractory Obsessive-Compulsive 
Disorder
1:30 p.m. - 3:00 p.m.
Rooms 103 A-B, Level 100, North Building






Debunking Stigma Towards 
Electroconvulsive Therapy in Special 
Populations: Children, Adolescents, 
Autistic/Developmentally Delayed 
Persons, and Pregnant Women
2
1:30 p.m. - 3:00 p.m.
Room 104 A, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Shanti Mitchell, M.D.
William C. Wood, M.D.
Speakers:
Neera Ghaziuddin, M.D.
Lee E. Wachtel, M.D.
Shanti Mitchell, M.D.
Edward Shorter, Ph.D.
A Checklist for Checklists: Take-Home 
Tools to Improve Care and Reduce 
Risk in Psychiatric Practice
1:30 p.m. - 3:00 p.m.
Room 104 B, Level 100, North Building





Psychiatry Review With Axis (PRAXIS) 
Assessment
5
11:00 a.m. - 12:30 p.m.
Room 711, Level 700, South Building





Tom E. Draschil, M.D.
Nabil Siddiqi, M.D.
Practical Privacy Issues
11:00 a.m. - 12:30 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Zebulon Taintor, M.D.
Paul S. Appelbaum, M.D.
Speakers:
Paul S. Appelbaum, M.D.




Scientific and Clinical 
Reports
Treatment Strategies in Psychiatry 
and Neuropsychiatry
 5
1:30 p.m. - 3:00 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Steve Koh, M.D., M.P.H.
1. Cognitive and Behavioral 
Improvement After Prolonged 
Treatment With Zopiclone in 
Neurocognitive Disorders and 
Electroencephalogram Abnormalities
Alfonso Ceccherini-Nelli, M.D.
2. A Systematic Review and Meta-
Analysis of Active Versus Sham Deep 
Brain Stimulation for Obsessive-
Compulsive and Depressive Disorders
Steve Kisely, M.D., Ph.D.
3. Efficacious Ultra-Long-Term 
Treatment of Panic Disorder With 
Clonazepam or Paroxetine Might 
Not Prevent Relapse After Drug 
Withdrawal
Antonio E. Nardi, M.D., Ph.D.
5
Risk Management: Overcoming 
Barriers to Implementation in 
Telepsychiatry
3
11:00 a.m. - 12:30 p.m.
Room 104 B, Level 100, North Building
Metro Toronto Convention Centre
Chair:
Kristen Lambert, J.D., M.S.W.
Speaker:
Kristen Lambert, J.D., M.S.W.
Advances in Physician Health: Data 
From the Physician Health Programs
APA Ethics Committee and Penn-
Scattergood Ethics Program
1
11:00 a.m. - 12:30 p.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Philip J. Candilis, M.D.
Luis T. Sanchez, M.D.
Speakers:
Doris C. Gundersen, M.D.
Charles P. Samenow, M.D., M.P.H.
What Every Psychiatrist Should Know 
About Epilepsy
5
11:00 a.m. - 12:30 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Rochelle Caplan, M.D.





Elia M. Pestana-Knight, M.D.
Posttraumatic Stress Disorder 
Treatment in the Military: The Impact 
of the IOM Report
11:00 a.m. - 12:30 p.m.
Room 204 (Summit), Level 200, North 
Building
Metro Toronto Convention Centre
Chair:
Christopher H. Warner, M.D.
Speakers:
Carl A. Castro, Ph.D.
Elspeth C. Ritchie, M.D., M.P.H.
Christopher Ivany, M.D.
Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 












Patient Suicide in Residency Training: 
The Ripple Effect
2:00 p.m. - 5:00 p.m.
Rooms 203 A-D, Level 200, North Building







1. Losing a Patient to Suicide: The 
Ripple Effect
Michael F. Myers, M.D.
2. Investigating the Use of “Collateral 
Damages” to Enhance Patient Suicide 
Curricula During Residency Training
Deepak Prabhakar, M.D., M.P.H.
3. Emotional and Cognitive Responses of 
Clinicians to Patient Suicide
Joan M. Anzia, M.D.
4. Experiencing Patient Suicide as a 
Psychiatry Intern
Daphne C. Ferrer, M.D.
5. Impact of Patient Suicide During 
Residency Training
Alexis A. Seegan, M.D.
6. A Resident’s Perspective on Patient 
Suicide
Brenda Bye, D.O.
Mineral-Vitamin Combinations as 
Primary Treatment of Psychiatric 
Symptoms
APA Caucus on Complementary and 
Alternative Medicine
2:00 p.m. - 5:00 p.m.
Rooms 205 A-D, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Charles Popper, M.D.
Barbara L. Gracious, M.D.
1. Scientific Rationale for Broad-
Spectrum Micronutrient Treatments of 
Brain Function
Charles Popper, M.D.
2. Treatment of Aggression, Mood, 
Attention-Deficit/Hyperactivity 
Disorder, and Addictions With 
Multinutrient Formulas: The Evidence 
to Date
Julia J. Rucklidge, Ph.D.
3. Treatment of Anxiety and Stress With 
Multinutrient Formulas
Bonnie J. Kaplan, Ph.D.
2:00 p.m. Sessions
Symposia
What Are Psychiatric Systems Doing 
to Improve? Utilizing Performance 
Improvement Methods to Advance 
Psychiatric Care
2:00 p.m. - 5:00 p.m.
Room 104 C, Level 100, North Building




Steven Sharfstein, M.D., M.P.A.
1. Lean Behavioral Health: The Kings 
County Hospital Story
Joseph P. Merlino, M.D., M.P.A.
2. Lean Techniques in Support of 
Integration and Access: Preparing 
for Necessary Care Delivery System 
Redesign
Jill Bowen, Ph.D.
3. Teaching High-Value Care and 
Engaging Residents in Quality 
Improvement Strategies
Melissa Arbuckle, M.D., Ph.D.
4. The Role of an Industrial Engineer in a 
Psychiatric Setting
Antonio DePaolo, Ph.D.
5. Creating a Culture of Improvement at 
a Large Psychiatric Health System
Sunil Khushalani, M.D.
Everything You Needed to Know About 
Peritransplant, Psychosocial, and 
Neuropsychiatric Issues Affecting 
Outcome
 5
2:00 p.m. - 5:00 p.m.
Rooms 201 A-F, Level 200, North Building
Metro Toronto Convention Centre
Chairs:
Yelizaveta I. Sher, M.D.
José R. Maldonado, M.D.
1. Pretransplant Psychosocial Risk Factors
Renee M. Garcia, M.D.
2. Everything You Needed to Know About 
Peritransplant, Psychosocial, and 
Neuropsychiatric Issues Affecting 
Outcome
Andrea Ament, M.D.
3. Posttransplant Neuropsychiatric 
Complications
Yelizaveta I. Sher, M.D.
4. Special Neuropsychiatric Issues Asso-
ciated With Artificial Heart Technologies
José R. Maldonado, M.D.
Food Addiction and the Metabolic 
Syndrome: From Insulin Resistance to 
Neurocognitive Decline and Beyond
1
1:30 p.m. - 3:00 p.m.
Room 104 D, Level 100, North Building







Dynamic Therapy With Self-
Destructive Borderlines: An Alliance 
Based Intervention for Suicide
1:30 p.m. - 3:00 p.m.
Rooms 202 C-D, Level 200, North Building
Metro Toronto Convention Centre
Chair:
Eric Plakun, M.D.
Clinical Outcomes in Army Behavioral 
Health Care Using the Behavioral 
Health Data Portal
1:30 p.m. - 3:00 p.m.
Room 204 (Summit), Level 200, North 
Building





Experts by Experience: Exploring 
Effective Methods for Involving 
Clients and Families as Teachers in 
Psychiatric Education
1:30 p.m. - 3:00 p.m.
Room 711, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Sacha Agrawal, M.D., M.Sc.
David Wiljer, Ph.D.
Speakers:
Ivan Silver, M.D., M.Ed.
Sean A. Kidd, Ph.D.
Carmen E. Wiebe, M.D.
Thomas E. Ungar, M.D., M.Ed.
All scientific sessions listed in 
the Annual Meeting Program 
Book are designated for AMA PRA 














Program changes are printed 
each day in the Daily Bulletin 
which can be picked up in the 
Metro Convention Centre. A 
mobile application will also be 
available.
!
2. Clinical Highlight: Catatonia and the 
Physical Exam
Pierre Azzam, M.D.
3. Neurocognitive Disorders: 
Neuropsychiatric Testing and the 
Bedside Exam
Sarah Faeder, M.D., Ph.D.
4. Medical Care of the Psychiatric 
Patient
Neil Puri, M.D.
Bridging the Gap Between Intimate 
Partner Violence (IPV) and Mental 
Health Services
3
2:00 p.m. - 5:00 p.m.
Room 716 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chairs:
Mayumi Okuda, M.D.
Obianuju “Uju” J. Obi, M.D., M.P.H.
Discussant:
Elizabeth Fitelson, M.D.
1. Incidence of Psychiatric Disorders in 
Victims of IPV
Mayumi Okuda, M.D.
2. Collaborative Efforts Between the 
IPV Community and the Psychiatric 
Community
Obianuju “Uju” J. Obi, M.D., M.P.H.
3. IPV Outcomes in Women With 
Posttraumatic Stress Disorder and 
Substance Use: A Secondary Analysis 
of National Institute on Drug Abuse 
Clinical Trials Network Women and 
Trauma Multisite Study
Denise Hien, Ph.D.
4. The Women’s Recovery Group: 
Tailoring Group Therapy for Women 
With Substance Use Disorders
Shelly Greenfield, M.D., M.P.H.
5. New York City Family Justice Centers 
of the Mayor’s Office to Combat 
Domestic Violence
Margarita Guzman, J.D.
The Child Refugee Crisis on the U.S. 
Border: Mental Health Factors and 
Consequences
American Association for Social 
Psychiatry
 2
2:00 p.m. - 5:00 p.m.
Room 714 A-B, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Andres J. Pumariega, M.D.
Discussants:
Pedro Ruiz, M.D.
Andres J. Pumariega, M.D.
1. Impact of the Central American 
Refugee Crisis on the Lower Rio 
Grande Valley Region
Francisco Fernandez, M.D.
2. The Central American Child Refugee 
Crisis: Southern California and 
Historical Perspectives
William Arroyo, M.D.
3. Psychological Aspects of the 1960s 
Pedro Pan Exodus 1994 Cuban 
Balsero Crisis: Lessons Learned
Eugenio Rothe, M.D.
4. Can Social Psychiatry Help Address 
the Reaction of Host Countries to 
Immigrants?
Kenneth Thompson, M.D.
Physical Examination in Psychiatric 
Practice
 5
2:00 p.m. - 5:00 p.m.
Room 715 A-B, Level 700, South Building




1. Physical Examination in Psychiatry: 
An Overview of Clinical Scenarios
Priya Gopalan, M.D.
4. Clinical Approach to Use of 
Multinutrient Formulas: Prioritizing 
Safety
Barbara L. Gracious, M.D.
Intimate Partner Violence (IPV) and 
Mental Health
2:00 p.m. - 5:00 p.m.
Room 701 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Donna Stewart, M.D.
1. IPV in Adults
Nadine Wathen, Ph.D.
2. Sexual Violence in Intimate Partners
Simone Vigod, M.D.
3. National Clinical/Policy Guidelines 
on IPV and Sexual Violence Against 
Women in Latin America and 
Caribbean Pan-American Health 
Organization Member Countries
Donna Stewart, M.D.
4. Children’s Exposure to IPV
Harriet MacMillan, M.D.
Cheating, Personality Disorders and 
Sports Psychiatry
International Society for Sport Psychiatry
2:00 p.m. - 5:00 p.m.
Room 701 B, Level 700, South Building




1. Psychology of Infamous Sports 
Scandals in History
Thomas Newmark, M.D.
2. Cheating, Personality Issues, and the 
Role of the Sports Psychiatrist on the 
College Level
Eric D. Morse, M.D.
3. Psychodynamic Diagnosis and 
Treatment of Athletes With Personality 
Disorders Who Cheat
Dan Begel, M.D.
4. Can We Treat the Cheat?
Ira Glick, M.D.
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2. The National Action Alliance Suicide 
Attempt Survivor Task Force Presents 
Guidance From Research and Lived 
Experience
DeQuincy A. Lezine, Ph.D.
3. Working With People Who Have Been 
Suicidal via Social Media
Dese’Rae L. Stage, B.S.
4. Social Media and Suicidal Talk
Cara Anna, B.A.
3:30 p.m. Sessions
Scientific and Clinical 
Reports
A Sampling of the Various Topics That 
Psychiatry Encompasses
 1
3:30 p.m. - 5:00 p.m.
Room 713 A-B, Level 700, South Building
Metro Toronto Convention Centre
Moderator:
Chetana A Kulkarni, B.Sc., M.D.
1. NextGenU.org: Democratizing 
Psychiatric and Other Health Sciences 
Education With the World’s First Portal 
to Free, Accredited Higher Education
Randall F. White, M.D.
1
2. Anorexia and the Endocannabinoid 
System: Report of a Case With 33 
Years of Cannabis Treatment
Denis J. Petro, M.D.
3. Physician-Assisted Suicide and the 
Professional Role of Psychiatrists. 
A Medical Ethical Analysis
Jochen Vollmann, M.D., Ph.D.
4. Tai Chi Treatment for Depressed 




Update on Somatic Symptom 
Disorders
5
3:30 p.m. - 5:00 p.m.
Rooms 103 A-B, Level 100, North Building




Women’s Issues in Minority and 
Underrepresented Groups
2:00 p.m. - 5:00 p.m.
Room 801 A, Level 800, South Building
Metro Toronto Convention Centre
Chairs:
Gail E. Robinson, M.D.
Stephen A. McLeod-Bryant, M.D.
1. African-American Women With History 
of Abuse and Incarceration
Rahn Bailey
2. Femininization of Poverty and Mental 
Health
Ludmila De Faria, M.D.
3. Enduring Native Women
Linda Nahulu, M.D.
4. Lesbian, Gay, Bisexual, and 
Transgender Women
Mary E. Barber, M.D.
5. Ways That School-Based Clinics Can 
Address Mental Health Disparities 
Faced by African American Teenage 
Girls
Ulrick Vieux Jr., D.O., M.S.
National Action Alliance for Suicide 
Prevention: Recommendations for 
Prevention From the Suicide Attempt 
Survivors Task Force Report
2:00 p.m. - 5:00 p.m.
Room 803 A-B, Level 800, South Building









and Assessment of a Clinical 
Telepsychiatry Program in an 
Academic Medical Center
2:00 p.m. - 5:00 p.m.
Room 717 A-B, Level 700, South Building




1. Initiation of a Clinical Telepsychiatry 
Program in Pennsylvania: The 
Situation and Challenges
Jack Cahalane, M.P.H., Ph.D.
2. A Clinical Partnership With a Managed 
Care Organization
James Schuster, M.B.A., M.D.
3. Implementation of Best Practices in 
Setting Up a Telepsychiatry Clinic
Joseph Pierri, M.D.
4. Assessing Patient and Practitioner 
Experience
Shabana Khan, M.D.
5. Telepsychiatry in Residency Training: 
Learning Clinical Practice Through the 
Graphical User Interface
Joseph T. Kelley Victor, M.D.
Faith and Major Depressive Disorder: 
DSM-5, the Cultural Formulation Inter-
view, and Tradition-Based Responses
APA Caucus of Religion, Spirituality and 
Psychiatry
2:00 p.m. - 5:00 p.m.
Room 718 A, Level 700, South Building
Metro Toronto Convention Centre
Chair:
Abraham M. Nussbaum, M.D.
1. Mental Illness Not A Spiritual 
Weakness: Depression in Muslim 
Communities
Farha Z. Abbasi, M.D.
2. Evidence-Based Depression Care in 
African-American Churches
Sidney Hankerson, M.B.A., M.D.
3. “And You Shall Rejoice on Your 
Festival and Be Only Joyful”: 
Depression in Traditional Jewish 
Communities
Marta Herschkopf, M.D.
4. “When Sorrows Like Sea Billows 
Roll”: Depression in Evangelical 
and Fundamentalist Christian 
Communities
Warren A. Kinghorn, M.D.
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Can Early Career Psychiatrists Provide 
Psychotherapy in Today’s Health Care 
Environment?
American College of Psychoanalysts
3:30 p.m. - 5:00 p.m.
Room 802 A-B, Level 800, South Building
Metro Toronto Convention Centre
Chair:





Resident Wellness Today: Current 
Challenges, Programs, and 
Recommendations for Tomorrow’s 
Trainees
3:30 p.m. - 5:00 p.m.
Room 204 (Summit), Level 200, North 
Building






Leon Tourian Jr., M.D., M.R.C.
Richard Montoro, M.D.
The Ultimate Balancing Act: Medicine, 
Marriage, Motherhood, and Me
3:30 p.m. - 5:00 p.m.
Room 104 D, Level 100, North Building
Metro Toronto Convention Centre
Chairs:
Sarah B. Johnson, M.D.
Sarah M. Fayad, M.D.
Speakers:
Almari Ginory, D.O.
Kathy Vincent, M.D., M.S.
Do Firearms Restrictions Prevent 
Suicide and Violence in People With 
Serious Mental Illness?
3:30 p.m. - 5:00 p.m.
Rooms 202 C-D, Level 200, North Building





Joshua M. Horwitz, J.D.
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Abuse and Neglect Victims
Poster Sessions
International Poster Session 1 . . . . . . . . . . . .  101
International Poster Session 2 . . . . . . . . . . . .  105
New Research Poster Session 1 . . . . . . . . . .  123
New Research Poster Session 2 . . . . . . . . . .  142
Young Investigator Poster Session 1 . . . . . . .  118
Scientific and Clinical Reports
The Association Between Child 
Maltreatment and Adult Mental Health 
Problems in a Large Birth Cohort: More 
Complex Than Retrospective Data Suggest . .  122
Symposia
Early Life Adversities and Physicians’ 
Resilience and Risk for Negative 
Professional Outcomes . . . . . . . . . . . . . . . . .  127
Factors That Enhance Resilience in At-Risk 
Groups That Have Experienced Family 
Violence (FV) . . . . . . . . . . . . . . . . . . . . . . . . .  135
Intimate Partner Violence (IPV) and Mental 
Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  155
Neurodevelopmental Disorder Associated 
With Prenatal Alcohol Exposure (ND-PAE): 
Society’s Preventable Mental Health Epidemic   149
Workshops
Detection and Treatment of Bullying-
Related Morbidity: A Public Health Need . . . .  108
Sexual Assault Response Behaviors: 
Scientific, Procedural, and Ethical Challenges . .  82
Academic Psychiatry  
and Psychiatric Education
Courses
Exploring Technologies in Psychiatry . . . . . . .  110
Forum
Globalization of Psychiatry: APA and WPA 
Perspectives . . . . . . . . . . . . . . . . . . . . . . . . .  132
Psychiatrists as Leaders  . . . . . . . . . . . . . . . .  142
Interactive Sessions
The National Neuroscience Curriculum 
Initiative: Bringing Neuroscience Into the 
Clinical Practice of Psychiatry  . . . . . . . . . . . .  111
Media Workshops
Lars and the Real Girl: The Power of 
Erotomanic Delusions: A Case and Media 
Study Highlighting the Personal and Social 
Impacts  . . . . . . . . . . . . . . . . . . . . . . . . . . . .  146
Reviewing (Mental) Disorders With a 
Reverent Understanding of the Macabre 
(REDRUM)  . . . . . . . . . . . . . . . . . . . . . . . . . .  108
Poster Sessions
International Poster Session 1 . . . . . . . . . . . .  101
New Research Poster Session 2 . . . . . . . . . .  142
Young Investigator Poster Sessions 2  . . . . . .  137
Presidential Symposia
One Dream, Three Perspectives: The Place 
of the Dream and Dreaming in Clinical 
Practice and Training . . . . . . . . . . . . . . . . . . .  114
Scientific and Clinical Reports
Cannabis Withdrawal in Adults With 
Depression or Bipolar Disorder  . . . . . . . . . . .  148
NextGenU.org: Democratizing Psychiatric 
and Other Health Sciences Education With 
the World’s First Portal to Free, Accredited 
Higher Education  . . . . . . . . . . . . . . . . . . . . .  156
The Epidemic of Resident Physician 
Burnout: Contributors and Potential 
Interventions to Take Care of Our Own  . . . . . .  88
Seminars
How to Give More Effective Lectures: 
Punch, Passion, and Polish . . . . . . . . . . . . . . .  83
Symposia
Academic Psychiatry 101:  
A Toolkit for Educators  . . . . . . . . . . . . . . . . .  143
LGBT and Differences of Sex Development 
Patient Care Competencies: Taking 
Psychiatry Into the Next Era of Sex, 
Sexuality, and Gender Sensitive Care  . . . . . .  117
Novel Philosophies in Mental Health Education . .  80
















What Are Psychiatric Systems Doing 
to Improve? Utilizing Performance 
Improvement Methods to Advance 
Psychiatric Care  . . . . . . . . . . . . . . . . . . . . . .  154
Workshops
A Novel Educational Intervention to 
Increase Clinical Scholarship Among 
Faculty and Trainees . . . . . . . . . . . . . . . . . . .  120
Behavioral Health Services Within an 
Immigrant Community: A Population 
Health Perspective From a Student-Run 
Free Clinic . . . . . . . . . . . . . . . . . . . . . . . . . . .  128
Development and Implementation of 
Interprofessional and Integrated Clinical 
Treatment and Training Programs at a VA 
Medical Center . . . . . . . . . . . . . . . . . . . . . . .  123
Empathy: To Teach, to Learn, to Practice  . . . .  78
Experts by Experience: Exploring Effective 
Methods for Involving Clients and Families 
as Teachers in Psychiatric Education . . . . . . .  154
Follow the Yellow Brick Road: The 
McMaster Competency-Based Framework 
for Residency Training in Psychiatry . . . . . . . .  120
Interactive Training and Dissemination of 
Tobacco Cessation in Psychiatry:  
An Rx for Change . . . . . . . . . . . . . . . . . . . . .  134
I Wish I Learned That in Residency: 
Preparing Future Psychiatrists for the 
Future of Psychiatry  . . . . . . . . . . . . . . . . . . .  139
Maintenance of Certification Part 4 – 
Performance in Practice: Making It Work in 
Your Practice  . . . . . . . . . . . . . . . . . . . . . . . . .  78
Multimedia Interactive Teaching Methods 
in Psychiatric Education, Enabling Deeper 
Levels of Learning: An International 
Perspective . . . . . . . . . . . . . . . . . . . . . . . . . .  142
No Poster? No Publication? No Problem.  
A Step-by-Step Guide to Get You Started 
in the Scholarly Activity Process  . . . . . . . . . .  139
Practical Guide to Preparing Psychiatric 
Trainees to Practice in Integrated Primary 
Care and Mental Health Settings . . . . . . . . . .  120
Practical Strategies to Decrease Cognitive 
Bias in the Diagnosis of Medical Conditions 
Mimicking Psychiatric Disorders  . . . . . . . . . .  134
Psychiatry Review With Axis (PRAXIS) 
Assessment  . . . . . . . . . . . . . . . . . . . . . . . . .  153
The American Journal of Psychiatry 
Residents’ Journal: How to Get Involved . . . .  102
The Teaching of Psychotherapy 
Interventions in the Psychiatric Emergency 
Center During Residency Training  . . . . . . . . .  100
U.S. and Low- and Middle-Income 
Countries Models of Education and 
Training on Global Mental Health . . . . . . . . . . .  78
Addiction Psychiatry/Substance 
Use and Addictive Disorders
Advances in Series
Advances in Substance Abuse Treatment  . . . .  78
Test Your Knowledge With the Experts: 
An Interactive Advances in Series on 
Personality Disorders, Mentalizing and 
Network Therapy  . . . . . . . . . . . . . . . . . . . . .  142
Case Conference
The N-BOMb Strikes Again. A Case of 
Self-Injurious Behavior While Under the 
Influence of a Novel Psychedelic Drug . . . . . .  121
Courses
Buprenorphine and Office-Based 
Treatment of Opioid Use Disorder  . . . . . . . . . .  76 
Street Drugs and Mental Disorders: 
Overview and Treatment of Dual Diagnosis 
Patients  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  97
Forum
Youth Alcohol and Marijuana Use and 
Substance Use Policy . . . . . . . . . . . . . . . . . . .  88
Interactive Sessions
Let’s Talk About Marijuana . . . . . . . . . . . . . . . .  98
The Behavioral Addictions . . . . . . . . . . . . . . . .  99
Lectures
How Science Can Inform the Diagnosis, 
Prevention, and Treatment of Alcohol Use 
Disorders  . . . . . . . . . . . . . . . . . . . . . . . . . . .  140
Innovative Pharmacological Strategies to 
Treat Alcohol Use Disorder  . . . . . . . . . . . . . . .  88
Media Workshops
Screening and Discussion of the Film 
“Anonymous People”  . . . . . . . . . . . . . . . . . .  103







































International Poster Session 1 . . . . . . . . . . . .  101
International Poster Session 2 . . . . . . . . . . . .  105
New Research Poster Session 1 . . . . . . . . . .  123
New Research Poster Session 2 . . . . . . . . . .  142
Young Investigator Poster Session 1 . . . . . . .  118
Young Investigator Poster Sessions 2  . . . . . .  137
Presidential Symposia
Marijuana in 2015: State of the Policy and 
Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . .  84
Scientific and Clinical Reports
Heroin Is Most Effective Treatment for 
Improving Retention Among Opioid-De-
pendent Patients, But Are We Ready for It? . .  140
Initial Response as a Predictor of 12-
Week Buprenorphine-Naloxone Treatment 
Response in a Prescription Opioid-
Dependent Population  . . . . . . . . . . . . . . . . .  140
Opioid Addiction Resulting From 
Legitimate Medical Prescriptions . . . . . . . . . .  140
Symposia
Advances in Medications Development 
to Treat Alcohol Use Disorder and Co-
Occurring Psychiatric Disorders . . . . . . . . . . . .  79
Alcohol Use Disorders and PTSD: New 
Findings, New Challenges . . . . . . . . . . . . . . . .  86
Youth Interrupted: Alcohol Use Disorders 
and Adolescents . . . . . . . . . . . . . . . . . . . . . .  125
Workshops
Aberrant Opioid-Taking Behavior/Aberrant 
Opioid-Prescribing Behavior: Two Sides of 
the Same Coin  . . . . . . . . . . . . . . . . . . . . . . .  146
Helping Patients Who Drink Too Much: 
Using the NIAAA’s Clinician’s Guide . . . . . . . .  108
Interactive Training and Dissemination of 
Tobacco Cessation in Psychiatry:  
An Rx for Change . . . . . . . . . . . . . . . . . . . . .  134
Medications for the Treatment of Alcohol 
Use Disorders and Related Comorbidities: 
A Brief Guide  . . . . . . . . . . . . . . . . . . . . . . . .  113
Weeding Through the Hype: 
Understanding Adolescent Cannabis Use  . . .  140
ADHD
Courses
Advanced Assessment and Treatment of 
ADHD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  110
Attention-Deficit/Hyperactivity Disorder in 
Adults: From Clinical Science to Clinical 
Practice  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  76
Essentials of Assessing and Treating 
Attention-Deficit/Hyperactivity Disorder in 
Adults and Children . . . . . . . . . . . . . . . . . . . . .  81
Poster Sessions
International Poster Session 1 . . . . . . . . . . . .  101
New Research Poster Session 1 . . . . . . . . . .  123
Young Investigator Poster Session 1 . . . . . . .  118
Young Investigator Poster Sessions 2  . . . . . .  137
Symposia
Advances in the Neurobiology of Attention 
Deficit Hyperactivity Disorder (ADHD)  . . . . . . .  96
Impact of Unrecognized Attention-Deficit/
Hyperactivity Disorder on Treatment of 
Anxiety and Depressive Disorders . . . . . . . . .  136
Administrative Psychiatry  
(Public, Private and University)
Poster Sessions
International Poster Session 1 . . . . . . . . . . . .  101
Young Investigator Poster Sessions 2  . . . . . .  137
Scientific and Clinical Reports
Developing a Diversified Psychiatric 
Workforce for the 21st Century: Research 
and Policy Considerations . . . . . . . . . . . . . . . .  88
Workshops
Administrative Psychiatry in the U.S.: 
Current Perspectives . . . . . . . . . . . . . . . . . . . .  82
Being a Part of the Solution: A Systematic, 
Effective, and Customized Way to Reduce 
Aggression, Seclusions, and Restraints . . . . .  149
Counties as Psychiatric Service Providers . . .  103
















Developing a Citywide System of Care 
in Acute Psychiatry: The Toronto Mental 
Health and Addictions Acute Care Alliance  . .  108
Skills in Extreme Negotiation Within the 
Work Environment . . . . . . . . . . . . . . . . . . . . .  123
Advocacy, Stigma,  
and Patients’ Rights
Media Workshops
Screening and Discussion of the Film 
“Anonymous People”  . . . . . . . . . . . . . . . . . .  103
Poster Sessions
International Poster Session 1 . . . . . . . . . . . .  101
New Research Poster Session 2 . . . . . . . . . .  142
Scientific and Clinical Reports
Attitudes Toward Dementia, Awareness of 
Dementia Services, and Impact of a Short 
Film on Dementia Stigma in a Chinese-
American Community  . . . . . . . . . . . . . . . . . . .  77
Impact of a Mental Health Curriculum for 
High School Students on Knowledge, 
Attitudes, and Help-Seeking Efficacy: A 
Randomized Controlled Trial  . . . . . . . . . . . . .  152
Symposia
Society Unfair, Society Unwell: Addressing 
the Social Determinants of Mental Health  . . . .  86
Workshops
Breaking Down Barriers to Care: Stigma 
and Other Obstacles . . . . . . . . . . . . . . . . . . .  134
Debunking Stigma Towards 
Electroconvulsive Therapy in Special 
Populations: Children, Adolescents, 
Autistic/Developmentally Delayed Persons, 
and Pregnant Women . . . . . . . . . . . . . . . . . .  153
Introduction to Media Writing: A Hands-
On, Interactive Experience for Psychiatry 
Trainees and Early Career Psychiatrists . . . . .  128
Use of Social Media and the Internet 
to Educate the Masses: Increasing 
Awareness and Decreasing the Stigma of 
Psychiatry Amongst Minority Populations  . . . .  77
Aggressive Behaviors: Etiology, 
Assessment, and Treatment
Case Conference
Emergency Psychiatry Case Conference: 
The Psychiatrist is Assaulted . . . . . . . . . . . . . .  83
Interactive Sessions
Helping Kids in Crisis  . . . . . . . . . . . . . . . . . .  102
Poster Sessions
International Poster Session 1 . . . . . . . . . . . .  101
New Research Poster Session 1 . . . . . . . . . .  123
New Research Poster Session 2 . . . . . . . . . .  142
Symposia
Interacting With Demanding, Suicidal and 
Aggressive Patients: Avoiding Interpersonal 
Crash and Combustion . . . . . . . . . . . . . . . . .  135
Workshops
Being a Part of the Solution: A Systematic, 
Effective, and Customized Way to Reduce 
Aggression, Seclusions, and Restraints . . . . .  149
But They’re Just Kids! Assessing the Risk 
of Violence in Youth . . . . . . . . . . . . . . . . . . . .  100
Don’t Get Hit: How to Manage the Agitated 
Soldier or Patient  . . . . . . . . . . . . . . . . . . . . .  130
AIDS and HIV
Poster Sessions
International Poster Session 1 . . . . . . . . . . . .  101
New Research Poster Session 1 . . . . . . . . . .  123
Symposia
Comprehensive HIV Neuropsychiatry Update . .  105
The Role of Addictions in the HIV 
Treatment Cascade . . . . . . . . . . . . . . . . . . . . .  79
Workshops
Pre-Exposure Prophylaxis for HIV: The 
Science, Psychology, and Implications for 
Clinical Practice  . . . . . . . . . . . . . . . . . . . . . .  139








































The Latest Research and Clinical 
Information Regarding Major Psychiatric 
Disorders  . . . . . . . . . . . . . . . . . . . . . . . . . . .  113
Case Conference
Complexity, Comorbidity, and Challenges 
to Treatment . . . . . . . . . . . . . . . . . . . . . . . . . .  76
Lectures
The Role of Psychodynamic Treatments in 
Anxiety Disorders: A Relatively Neglected 
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Poster Sessions
International Poster Session 1 . . . . . . . . . . . .  101
International Poster Session 2 . . . . . . . . . . . .  105
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Symposia
Impact of Unrecognized Attention-Deficit/
Hyperactivity Disorder on Treatment of 
Anxiety and Depressive Disorders . . . . . . . . .  136
The Athlete, Civilian, and Soldier With 
Traumatic Brain Injury (TBI): What They 
Share and How They Differ  . . . . . . . . . . . . . .  149
The Place of Benzodiazepines in Treatment 
of Anxiety Disorders: Are We Ignoring the 
Evidence? . . . . . . . . . . . . . . . . . . . . . . . . . . . .  86
Workshops
Psychopharmacology Algorithm for 
Management of Generalized Anxiety Disorder  .  84
Arts and Humanities  
(Includes Historical Issues)
Lectures
Impromptu Man: J.L. Moreno and the 
Origins of Psychodrama, Encounter 
Culture, and the Social Network  . . . . . . . . . .  127
Media Workshops
“I”: A Viewing and Discussion of the Film.  . . . .  89
What’s Art Got to Do With It?  . . . . . . . . . . . .  142
Poster Sessions
International Poster Session 1 . . . . . . . . . . . .  101
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The Mind and Music of Chopin  . . . . . . . . . . . .  89
Symposia
DSM and Psychiatric Diagnosis:  
Past, Present, Future  . . . . . . . . . . . . . . . . . .  151
Workshops
Arts-Based Workshop: “Wilderness,” an 
Award-Winning, 10-Minute Film About a 
Mother’s Struggle to Seek Mental Health 
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Changes in Psychiatry and Changing 
Styles of Practice: Views From Senior and 
Early Career Psychiatrists  . . . . . . . . . . . . . . .  120
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Resilience and Creativity in the Face of 
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Autism Spectrum Disorders
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Autism Spectrum Disorders: Diagnostic 
Considerations, Genetic Research, and 
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Poster Sessions
International Poster Session 2 . . . . . . . . . . . .  105
Young Investigator Poster Session 1 . . . . . . .  118

















Current Procedural Terminology Code Set: 
The Old, the New, and the Ugly!  . . . . . . . . . .  103
Biological Psychiatry
Forum
A Preview of Breaking New Research on 
Adolescent Drinking, Schizophrenia and 
Suicide From the American Journal of 
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Epigenetic Processes Mediating the 
Impact of Social Environments on Mental 
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Understanding Resilience in the Face of 
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Scientific and Clinical Reports
Altered Default Mode Network Connectivity 
in Patients With Late-Life Depression  . . . . . . .  77
Inflammatory and Immunologic Cytokines: 
Relationships With Hurricane Exposure, 
Ethnicity, Gender and Psychiatric Diagnoses . .  82
Seminars
Neuroanatomy of Emotions . . . . . . . . . . . . . .  121
Symposia
Between Temperament and Mental 
Disorders: Assessing the Continuum . . . . . . . .  85
Personalized Medicine in Mood and 
Anxiety Disorders: The Future is Bright  . . . . . .  80
Physical Examination in Psychiatric Practice . .  155
The Relevance of Circadian Rhythm 
Disturbances and Treatment to Psychiatric 
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P2-111
Effects of Olfactory Stimulation 
with Scents Commonly Used in 
Aromatherapy on Brain Wave Activity
Ann Etim, M.D.
P2-112
Methylphenidate in Attention Deficit 
Disorder with Hyperactivity (ADHD): 
Indiscriminate Use and Adverse Effects
Fernanda M. Faria
P2-113
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in a Large Sample of Depressed 
Patients in General Practice
Pierre Michel Llorca
P3-049
Long-Term Work Continuation Rates in 
Patients on Depression-Related Sick 




Thyroid Stimulating Hormone (TSH) 
and Serum, Plasma, and Platelet 
Brain-Derived Neurotrophic Factors 
(BDNF) During a Three Month Follow-
up in Patient




BDNF Gene Polymorphism 
(VAL66MET) is Associated With 
Response To Escitalopram in Severe 
Depression
Wissam El-Hage, M.D., Ph.D.
P3-053
Cortisol Levels Before and After 
Antidepressant Fluoxetine Treatment 








Dutch Tea (Ayahuasca)-Induced 
Psychosis























Rapid Tranquillisation and Clinician 
Preferences: A Trans-Atlantic 
Comparison
Pallavi S. Nadkarni, M.B.B.S., M.D.
P3-057
Risk Management of Frequent Accident 
and Emergency Attenders With 
Suspected Mental Health Conditions
Itoro I. Udo, M.R.C. Psych, M.B.B.S.
P3-058
Prevalence and Risk Factors for 




Association Between Early Adversities 
and Suicidality During Childhood and 
Adolescence
Bruno M. Mendonça Coêlho, M.D.
P3-060
The Influence of Parental 
Psychopathology on Offspring Suicidal 
Behavior Across the Lifespan
Geilson L. Santana Jr., M.D.
P3-061
Prevalence of Psychiatric Disease of 
Adults Under Probation in Korea
Junseok Ahn, M.D.
P3-062
Physicians’ Attitude Towards 
Interaction With the Pharmaceutical 
Industry
Fahad D. Alosaimi, M.D.
P3-063
Healthcare Behaviors and Psychosocial 
Adjustments Among Individuals With 








Prader Willi Syndrome With Psychosis: 
A Case Report
Muhammed Puri, M.D., M.P.H.
P3-066




Ekbom´s Syndrome in Elderly Patients
Marta Gutierrez Rodriguez
P3-068
What Are the Benefits of a MBSR-
Inspired, Mindfullness-Based 




A New Approach to an Old Problem: 




Characterization of Primary Care-




Pains of Military Psychiatry Trainees 
Receiving Behavioral Health Care
Alyssa Soumoff, M.D.
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Metro Toronto Convention Centre
P4-001
Profile of Mental Health Laws in the 
United Arab Emirates
Ghanem Al Hassani, M.B.B.S., M.Sc.
P4-002
Radiologic Findings Among Psychiatric 
Inpatients in the United Arab Emirates
Ossama T. Osman, M.D.
P4-003
Adding Fifty Private Beds For a Year: 




Contraceptive Intentions Among 
Christian Women In India IN: A Multi-
Stage Logit Model Analysis
Mahesh N. Singh, Ph.D.
P4-005
Acute Hypothyroidism Induced by 
Lithium: A Case Report and Review
Ana Luisa Almada
P4-006
Telomere Length Unrelated with 
Depression: A Cohort Study, a 
Meta-Analysis, and a Mendelian 
Randomization Study
Marie K. Wium-Andersen, M.D.
P4-007
Correlation between the Serum S100B 
Protein and the Oxidative Stress in 




Is Head Size Nuisance in the 
Cortical Thickness Study for Alcohol 
Dependence With Korean Middle-Aged 
Male Population?
Siekyeong Kim, M.D., Ph.D.
P4-009
Reducing the Symptomatology of 
Panic Disorder: The Effects of a Yoga 
Program Alone and in Combination 
With Cognitive Behavioral Therapy
Camila F. Vorkapic, Ph.D.
P4-010
Beyond the Wounds of War: “A ONE 
STOP,” Unique Services Approach for 
Caring for Military Wounded Warriors’ 
Families and Children
Ryo Sook Chun, M.D.
P4-011
Identification of Genes for Autosomal 
Recessive Intellectual Disability or 
Autism in Consanguineous Families
John B. Vincent, Ph.D.
P4-012
Refractory Psychosis in a Young Male 






















Interactive Effects of Early Onset 




Adapting Game Theory to Model 




Allocation of Attentional Resources 
During Cognitively Demanding Tasks Is 
Altered in Job Burnout
Laura Sokka, M.A.
P4-016
Clinical Transcranial Magnetic 
Stimulation (TMS) for Major 
Depression with Melancholia in an 




Differences in ECT Application Rates 
Among the Different Regions and 
Provinces in Spain. Results of a 
National Survey (2013-2014)
Ernesto J. Verdura Vizcaíno, M.Psy., Ph.D.
P4-018
Indication Criteria of ECT in Spain (Age 
and Sex). Results of a National Survey 
(2013-2014).
Ernesto J. Verdura Vizcaíno, M.Psy., Ph.D.
P4-019
Challenges and Managment 
Alternatives in Severe Obsessive-
Complusive DIisorder Resistant to 
Conventional Guidelines of Treatment: 
A Case Report
Suhey G. Franco Cadet, M.D.
P4-020
Symptom Profiles of Patients with 
Schizophrenia and Obsessive 
Compulsive Disorder and Patients with 
Pure Obsessive Compulsive Disorder
Oguz Karamustafalioglu, M.D.
P4-021
Incidence and Severity of Psychotic 
Symptoms in the Context of a 
Preceding Traumatic Event
Suhey G. Franco Cadet, M.D.
P4-022
Examination of Burden, Depression, 
and Anxiety Level in the Caregivers 




Reorganizing a Psychiatric Service: the 
Snakes and the Ladders
Ankur Gupta, M.B.A., M.B.B.S.
P4-024








Metabolic Parameters In Major 




Efficacy of Haloperidol Versus 
Levosulpiride Injection in Patients 
With Acute Psychosis: A Randomized 
Double-Blind Study
Sagar Lavania, D.p.m., M.D.
P4-028
Development of Acute Psychosis 
After the Remission of Tuberculosis 
Meningitis: A Case Report
Ayse F. Maner, M.D.
P4-029
Case Report: Clozapine-Induced 
Myocarditis, Is Mandatory Monitoring 
Warranted for Its Early Recognition?
Tariq Munshi, M.B.B.S.
P4-030
Use of Evidence Based Treatment With 
few Psychopharmacological Options 
and Financial Constraints in the 




Lithium toxicity - inicdence, clinical 
course and associated risk factors
Ursula Werneke
P4-032
Dysregulation of Hypothalamic 
Modulation in Antipsychotics Induced 
Weight Gain in Rats
Tulin Yanik, Ph.D.
P4-033
Associations of Help-Seeking 
Behaviour With Depression 
and Anxiety Disorders Among 
Gastroenterological Patients in Riyadh, 
Saudi Arabia
Fahad D. Alosaimi, M.D.
P4-034




Acute Mania Associated With Ectopic 
Adrenocorticotropic Hormone 
Secreting Small Cell Lung Carcinoma: 
A Case Report and Literature Review
Nuria J. Thusius, M.D.
P4-036
Causes and Outcomes of 
Acetaminophen Overdoses: The Mayo 
Clinic Experience, 2004-2010
Nuria J. Thusius, M.D.
P4-037
Clinical Course and Prognosis of 
Depression by Patients With Lung 
Cancer: A 1-Year, Follow-Up Study




Communication in Health Care: Factors 
That Interfere in the Medical-Patient 
Relationship
Guillermo Rivera Arroyo, M.D., M.P.H., 
Ph.D.
P4-040
Proposal for a New (Anxiety) Disorder 




Can Intrinsic Religiosity Impact 
Brain Neuroplasticity in Depressed 
Inpatients?























Psychiatric Morbidity in Churches: A 
Comparative Study of Syncretic and 
Pentecostal Congregations in Ilupeju, 
Lagos, Nigeria
Mbong A. Tangban, M.B.B.S.
P4-043
Twitter Addiction and Personality 
Traits in Medical Students
Ahmad Alhadi, M.D.
P4-044
Workforce Migration Across Europe - 
View From the Trainees
Mariana Pinto da Costa, M.D.
P4-045
UTI as a Cause of Worsening 
Psychosis: Prompt Diagnosis and 
Treatment May Reduce the Length of 




Genetic Susceptibility for 




The Role of Novel Allosteric Modulator, 
PAOPA, in Preventing and Reversing 





in Patients with Schizophrenia and 
It’s Correlation with Functionality 
Preliminary Results
Juliana S. Cunha, M.D.
P4-049
Treatment Retention and Clinical and 
Rehabilitation Outcomes of Patients 
With Severe Schizophrenia: A 6-Year 
Follow Up
Juan J. Fernandez-Miranda, M.D., Ph.D.
P4-050
Differential Biomarkers in 
Schizophrenia
Leticia García-Álvarez, Ph.D., Psy.D.
P4-051
Severe Mental Disorders 
(Schizophrenia AND Bipolar Disorder) 
Can Be Viewed as Multi-System 
Inflammatory Disease
María Paz García-Portilla, M.D., Ph.D.
P4-052
Comorbid Obsessive Compulsive 
Disorder and Social Function in 
Patients with Chronic Schizophrenia
Suk-hoon Kang, M.D.
P4-053
The Assocıatıon of Traumatıc 
Experıences wıth Anxıety Symptoms, 




Thyroid Hormones and Schizophrenia
Sara Malta Vacas
P4-055
Paliperidone Palmitate in Outpatients 
with Schizophrenia: a 30 Months Study
Samuel Leopoldo Romero Guillena
P4-056
Nicotine Use and Cognitive 
Performance in Patients Diagnosed 
with Schizophrenia
Pilar A. Saiz, M.D., Ph.D.
P4-057
Long Acting Injectable Antipsychotic 
Treatments: Antipsychotic 
Monotherapy is More Probably With 
Them?
Selman F. Salonia, M.D.
P4-058
Lack of Exposure to Natural Light is 
Associated to Bad Quality of Sleep in 
the Workspace
Maria Paz L. Hidalgo, Ph.D.
P4-059
The Sleep Quality and Occupational 
Stress of Shift-Working and Regular-
Working Nurses
Seung-Chul Hong, M.D., Ph.D.
P4-060
How Do Drugs of Misuse Affect Our 
Sleeping Pattern?
Pardeep S. Kundi, M.R.C. Psych, M.D.
P4-061
Patient Involvement in Clinical Decision 
Making in Community Outpatient 




Caring for the Caregiver: Recognition 




Systematic Overview of Non-
Pharmacological Interventions for 
Deliberate Self Harm (and Attempted 
Suicide) in Adolescents and Adults
Ghulam M. Soomro, M.B.B.S., M.Sc.
P4-064
DSM-V and Women’s Mental Health
Sokratis Karaoulanis, Ph.D.
P4-065
The Relationship Between 
Reproductive Factors and Depression 
in Korean Postmenopausal Women: 
Korean National Health and Nutrition 
Survey 2012
Beomwoo Nam, M.D., Ph.D.
P4-066
Major Depressive Episode With 
Psychotic Features Following 
Hysterectomy and Bilateral 
Oophorectomy During Reproductive 
Stage: A Case Report
Faruk Uguz
P4-067
Antidepressants in Pregnancy: 
Prescription Trends in Women 
Presenting to a Specialist Australian 
Perinatal Psychiatry Service
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Toronto Convention Centre
P5-001
The Chrysalis Project: Identifying and 
Treating At-Risk Young Women and 
Improving Graduation Rates in Oregon
Marisol Toliver-Sokol, M.D.
P5-002
Exploring the Biobehavioral 
Mechanisms of Baclofen in Reducing 




Severe Nitrous Oxide Toxicity Resulting 




How Do Psychiatrists Recommend 




Altered Prefrontal Cognitive Control 
Over Emotional Interference in 




Drug Information Systems for 
the Prevention of Drug Misuse, 




Alcohol & Intellectual Disability:A 
London-Wide Survey into the Extent of 
Alcohol Related Risk & Harm Among 
People with Intellectual Disabilities
Rupal Patel, M.D.
P5-008
Quality of Alcohol Withdrawal 
Treatment: Monitoring Symptoms 




Evaluation of the Development of 
Children Whose Mother is Under 
Methadone Maintenance Treatment 
During Pregnancy
Lien-Chung Wei, M.D., M.P.H.
P5-010
Atomoxetine Associated With Mania
Gulay Tegin, M.D.
P5-011
The Change of Autonomic Nervous 
System in Anxiety Disorder After Given 
Physical or Psychological Stress
Minkyung Cho
P5-012




Prevalence of Dermatological Illness in 
Patients with Anxiety Disorder
Amy Yang, M.D.
P5-014




Efficacy of Pro-Social Game Play for 
Enhancing Social Communication 








Acute Psychotic and Non Psychotic 
Depressive Episodes in Bipolar 
Disorder Type I: An Inpatient Chart 




The Association Between Smoking 
Tobacco and Psychosis in Bipolar I and 
Schizoaffective Bipolar Disorder
Elena Estrada, B.A., B.Sc.
P5-019
Patient and Caregiver Personality 
Pathology Impacts Therapy Mode 
Selection in Bipolar Disorder
Tasnia Khatun, B.A.
P5-020
Coping Styles and Disability in Persons 
with Bipolar Disorder and their 
Caregivers
Mona M. Maaty, B.A., M.D.
P5-021
Bipolar Disorder: Age at Time of 
Diagnosis and Mortality Over an 18-
year Period
Clara R. Medici, M.S.
P5-024
Biological Correlates and Clinical 
Characteristics of Early Life Stress 
in Bipolar Disorder According to a 
Staging Model
Juliana B. Moraes, M.D.
P5-025
Valproic Acid-Induced 
Hyperammonemia and Minimal Hepatic 




Self-Reported Reasons for Cannabis 
Use and Related Severity of Symptoms 
in Bipolar, Depressed, and Psychotic 
Individuals
Maria F. Roccisano, M.D.
P5-027

























Effect of Trauma History and 
Attachment Style in Patient and 




Current Irritability Robustly Related to 




Effectiveness of Antidepressant 
Medications for Symptoms of 
Irritability and Disruptive Behaviours in 
Children and Adolescents
Khrista Boylan, M.D., Ph.D.
P5-031
Aberrant Cerebrocerebellar Circuits 
in Individuals at Ultra-High Risk for 
Psychosis: A Resting-State FMRI Study 
Minji Bang, M.D.
P5-033
Repetitive Transcranial Magnetic 
Stimulation on Supplementary Motor 
Area in the Children and Adolescents 




Study of Lead Time to Presentation of 
PANDAS in an Outpatient Setting
David Neger
P5-035
Fragile X Syndrome and Increasing 
Impulsivity with Age
Kalliopi S. Nissirios, M.D.
P5-036
Development of Depression Among 
Asian Adolescents: Management 
Options, Need for Increased 
Awareness, and Need for Early 
Detection of Symptoms
Kalliopi S. Nissirios, M.D.
P5-037
The Clinical Relationship Between 
Atypical Antipsychotic Use and Weight 




Childhood Adversity and Cognitive 
Style in Mood Disorders
David A. Benrimoh
P5-039
Comparison of Aripiprazole versus 
Bupropion Augmentation for the 
Treatment of Female Patients With 
Major Depressive Disorder
Eun-Jin Cheon, M.D., Ph.D.
P5-040
Oral Ketamine in the Treatment of 
Refractory Depression: A Case Series
Sarah A. Jillani, M.D.
P5-041
Social Avoidance as a Feature 




Prognosis of Depressive Disorders in 
the General Population in the 11-year 
Follow-Up: Results from the Finnish 
Health 2011 Survey
Niina Markkula, M.D., M.Sc.
P5-043
Use of Web-Based Tool to Understand 
Neurobiology of Major Depressive 
Disorder: Findings from Stanley 




Relation Between Severity of 
Depression with Thyroid Hormone 
Status
Tanjir R. Soron, M.B.B.S., M.P.H.
P5-045
A Patient with Comorbid Depression 









Parental Behavior Influences on 
the Onset and Severity of Anorexia 
Nervosa and Bulimia Nervosa
Jung Eun Lee
P5-048
The Viewpoints of Transgenders 
toward Gender Reassignment Policy in 
Taiwan – A Qualitative Study
Chih-yun Hsu, M.D.
P5-049
The Relationships Between Vascular 




Cognitive Remediation for Older 
Patients with Schizophrenia: A Pilot 
Study
Angela C. Golas, M.D.
P5-051
Identification of Behavioral and 
Sleep Problems in Dementia Patients 
Admitted to MIHS from Jan 2013 to 
June 2014.
Maryam H. Hazeghazam, M.D., Ph.D.
P5-052
Driving and White Matter 
Hyperintensity: A Clinical Research 




BDNF Promoter Methylation and 




The Effects of Stressors on Subjective 
Well-Being Among the Korean Elderly
Seong Ju Kim, M.D.
P5-055
Cognitive Effects of ECT and Other 
Brain Stimulation Techniques in 




Cerebrovascular Pathology in MCI is 
Associated with Decreased Amyloid-B 
Species, but not with Amyloid-B42/
B40 Ratio or [18] F-Flutemetomol 
Uptake
Daniel Lindqvist, M.D., Ph.D.
P5-057
Mastery Moderates the Relationship 
Between Anticipated Stigma and 
Depressive Symptoms Among Older 
Adults in a Primary Care Setting





















Self-Harm: A Study to Find the 
Association Between Perceived 
Health and Various Predictor and 




Deep Transcranial Magnetic 




BDNF Val66Met Polymorphism 
and Plasma Levels in Chinese Han 
Population with Obsessive-Compulsive 




Amygdala Response Predicts Clinical 
Symptom Reduction in Patients with 
Borderline Personality Disorder
Dirk Geurts, M.A., M.D.
P5-062
Diagnostic Stability and Mortality Rate 




Lipid Profile, Beck-D, Beck-A and 
Suas Scales Correlations in Female 
Borderline Personality Disorder 
Croatian Patients
Antonia Puljic, M.D., Ph.D.
P5-064
Risk Factors for Non-Completion of 
Evidence-Based Therapy for Combat-
Related PTSD
Michael L. Jacobs, M.D.
P5-065
Doxazosin XL Reduces Post-Traumatic 
Stress Disorder (PTSD) Checklist-
Military-Scored (PCL-M) Ratings in 
Veterans with Military Related PTSD
Christopher Rodgman, M.D.
P5-066
Interplay Between Spirituality and 
Religiosity on the Physical and Mental 
Well-Being of Cancer Survivors Post-
Treatment
Anthony J Cannon, M.D.
P5-068
A Meta-Analysis of Placebo-
Controlled Trials of Omega-3 Fatty 
Acid Augmentation in Schizophrenia: 
Possible Stage-Specific Effects
Alexander T. Chen, B.A.
P5-069
Language Analysis of Schizophrenia 




Sedentary Behaviour Among 
Individuals with Schizophrenia: A 
Systematic Review
Markus J. Duncan, B.Sc., M.Sc.
P5-071
Biomarkers in Patients with Psychotic 




Unconjugated Bilirubin in 
Schizophrenia, Schizoaffective and 
Bipolar Disorders: A Retrospective 
Observational and Controlled Study
João Gama Marques, M.D.
P5-073
The Influence of Cognition on Impaired 
Insight into Illness in Schizophrenia 
Across the Adult Lifespan
Philip Gerretsen, M.D., M.S.W.
P5-074
Insight in Inpatients with 
Schizophrenia: Relationship to 
Symptoms and Neuropsychological 
Functioning
Hongbo He, M.D., Ph.D.
P5-075
Cognitive Performance Related to 
Driving Ability in Schizophrenia 
Patients Treated with Antipsychotics
Euihyeon Na, M.D.
P5-076
BDNF Val66Met Polymorphism in 
Schizophrenic Patients Evaluated with 
MATRICS Consensus Cognitive Battery
Rodrigo Nieto, M.D., Ph.D.
P5-078
Genetic Association Between CACNA1A 




Substance Induced Psychotic Disorder 
Secondary to “Love Potion No. 9”
John A. Pesavento, M.D.
P5-080
Domain-Specific MCCB-Assessed 
Cognitive Associations to Symptoms 
of Metabolic Syndrome in Patients 




Cognitive and Neurologic 
Developmental Problems Predictive 
of Increased Neuropsychological 
Impairment in Schizophrenia
Andrew D. Snyder, M.S.
P5-082
Predictive Value of Negative Symptoms 




Comparison of Using Clozapine 
Monotherapy and Using Combination 




Sleep Irregularity in the Previous Week 








Risk Factors that are Commonly 
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P6-001
Quality of Life Results in Children and 
Adolescents with ADHD: Pivotal Data 
on a New Formulation of Extended-
Release Methylphenidate Capsules
Ann C. Childress, M.D.
P6-002
Atomoxetine monotherapy compared 
with combination therapy for treatment 




Estimating the Prevalence of DSM-
5 Attention Deficit/Hyperactivity 




Comparison of Quality of Life, 
Productivity and Functioning Between 





Predicting Attention Deficit 
Hyperactivity Disorder and 
Posttraumatic Stress Disorder in 
Patients with a Concussion History
Melissa Furtado, B.Sc.
P6-006
Examining Asthma and Its Relation 
to Social Anxiety, Agoraphobia, and 
Attention Deficit Hyperactivity Disorder
Melissa Furtado, B.Sc.
P6-007
Dasotraline for the Treatment of 
Attention-Deficit/Hyperactivity 
Disorder: A Randomized, Double-Blind, 
Placebo-Controlled Trial in Adults
Kenneth S. Koblan, M.D.
P6-008
Assessment of Human Abuse 
Potential of Dasotraline Compared 
to Methylphenidate and Placebo in 
Recreational Stimulant Users
Kenneth S. Koblan, M.D.
P6-009
A Phase III, 6-Week, Open-Label, 
Dose Optimization Study of HLD200 
in Children with Attention-Deficit 
Hyperactivity Disorder
Mary Ann A. McDonnell, M.S.N., Ph.D.
P6-010
Randomized, Double-Blind, Active- 
and Placebo-Controlled Trials of 





Gender Differences in the Impact of 
ER Dexmethylphenidate and Mixed 
Amphetamine Salts at Different 
Dosages on the Sleep of Children with 
ADHD
Jose A. Santisteban, M.B.B.S., M.Sc.
P6-012
Classic ADHD, or is it? Impact of 
Immune and Inflammatory Dysfunction 
On Attention - A Case Report
Christina Shayevitz, M.D.
P6-013
Pooled Analysis of Two Double-Blind, 
Placebo-Controlled, Randomized 
Atomoxetine Trials in Adults with ADHD 
Treated for Up to 6 Months
Linda Wietecha, B.S.N., M.S.
P6-014
Framingham Risk Score for Stroke 
is Associated with Neurocognitive 
Impairment in Older Adults with HIV 
Disease
Alan T. Rodríguez Penney, B.S.
P6-015
New Onset Anxiety Disorder 




Effects of Vilazodone on Sexual 
Function in Patients With Generalized 
Anxiety Disorder: A Pooled Analysis of 
3 Randomized Controlled Trials
Anita H. Clayton, M.D.
P6-017
Onychophagy (Nail Biting ):A New 
Approach to Chronic Nail and Skin 
Biting as Part of Anxiety Spectrum 
Disorders: 5-HTP as a Compulsion 
Control Factor
Cristian Y. Herrera, M.D., Ph.D.
P6-018
Post Hoc Analyses of Anxiety 
Measures in Adult Patients With 




Efficacy of a Mindfulness-Based 
Intervention for Social Anxiety Disorder 




Twelve-Month Prevalence and 
Correlates of Anxiety Disorders in 
Finnish Population - An Eleven-Year 
Follow-up of the Health 2000-2011 
Survey
Suoma E. Saarni, M.D., Ph.D.
P6-021
Vilazodone in Patients With 





A Double-Blind, Randomized, 
Placebo-Controlled, Flexible-Dose 
Study of Vilazodone in Patients With 
Generalized Anxiety Disorder
David Sheehan, M.B.A., M.D.
P6-023
Intolerance of Uncertainty in 
Generalized Anxiety Disorder And 
Major Depressive Disorder Comorbid 
With Generalized Anxiety Disorder
Sohel Shivji, B.A., B.S.
P6-024
The Relationship Between Self-Esteem 






















Impulsivity in Bipolar Disorder Types I, 
II and Major Depressive Disorder
Tamara Cassis, B.Sc.
P6-026
Childhood Adversity Linked to Insecure 




An 8-Week, Double-Blind, Placebo-
Controlled Study of Cariprazine 




Early Onset Robustly Escalates Prior 
Suicide Attempt Rate in Bipolar II 
Disorder
Kathryn C. Goffin, B.A.
P6-029
Biomarkers in Bipolar Disorder and 
Cardiovascular Disease: Clinical 




The Value of Early Improvement as 
a Predictor of Short-Term Response 
During Treatment of Bipolar 
Depression with Lurasidone
Dan V. Iosifescu, M.D., M.Sc.
P6-031
Risk Factors for Suicide Attempts in 
Bipolar Patients: A Study with the 








Remission and Recovery in 




Improving Management of Depression 




Efficacy and Safety of Asenapine 5 
mg BID and 10 mg BID in Adults With 
a Manic or Mixed Episode Associated 
With Bipolar I Disorder
Roger S. McIntyre
P6-036
Patterns of Improvement in Patients 
With Acute Depressive Episodes 
of Bipolar I Disorder and Bipolar II 
Disorder
Jamie A. Mullen, M.D.
P6-037
The Association Between Lipid Levels 
and Neurocognitive Performance in 
Adolescents with Bipolar Disorder
Melanie Naiberg, B.Sc.
P6-038
Inflammation and Cognitive 
Dysfunction in Adolescents with 
Bipolar Disorder
Dwight F. Newton, B.Sc.
P6-039
Metabolic Profile of Cariprazine in 
Patients With Acute Mania Associated 
With Bipolar I Disorder
Gary S. Sachs, M.D.
P6-042
Light Therapy for Bipolar Depression: 




Early Sleep Symptoms Predicted Non-
Remission in Patients Treated with 
Citalopram for Depression in STAR*D
Cynthia Siu, Ph.D.
P6-044
Using Multi-Criteria Decision 
Analysis (MCDA) to Evaluate Patient 
Preferences for Atypical Antipsychotic 
Treatment of Bipolar Disorder
Shawn X. Sun, Ph.D.
P6-045
The Effect of Personality Disorder 




Efficacy of Cariprazine in Subgroups of 
Bipolar Patients With Manic Episodes, 
Mixed Episodes, and With or Without 
Psychotic Symptoms
Eduard Vieta, M.D., Ph.D.
P6-047
Healthcare Resource Use and 
Expenditures for Bipolar Disorder 




Response and Remission Rates 
and Number Needed to Treat With 
Cariprazine in Patients with Bipolar 
Mania: Analyses from 3 Phase II/III 
Trials
Lakshmi N. Yatham, M.B.B.S., M.R.C.
P6-049
Categorical Improvement Across 
Mania Symptoms: Pooled Analyses of 
Cariprazine Phase II/III Trials
Stephen R. Zukin, M.D.
P6-050
Mother, Father, and Teacher 
Agreement on Victimization and 
Bullying in Children with Psychiatric 
and Neurodevelopmental Disorders
Raman Baweja, M.D., M.S.
P6-051
Stability of Irritable-Angry Mood 
and Temper Outbursts throughout 
Childhood and Adolescence in a 
General Population Sample
Raman Baweja, M.D., M.S.
P6-052
A Follow-up Investigation of 
Restitutional Forgiveness and Anger-
Related Emotions
Shih-Tseng T. Huang, Ph.D.
P6-053
Prevalence and Clinical Correlates of 
Non-Suicidal Self Injury in Adolescents 
with Bipolar Disorder
Adam Iskric, B.A., M.Sc.
P6-054
Characteristics of Adolescent 
Substance Use Disorders in a 
Community Hospital setting
Dilip Mohan Velu, M.D.
P6-055
Factors associated with Obstetrical 

























Outcomes of Clozapine Use Among 
27 Youth With Treatment- Refractory 




Correlates of Cigarette Smoking 




Exploring the Relation Between 
Symptoms of Borderline Personality 
Disorder and Depression in a Clinical 
Sample of Self-Harming Female 
Adolescents
Victoria E. Stead, B.A.
P6-059
The Impact of Smartphone Overuse 
in Adolescents in Taiwan- A Cross-
Sectional Study
Chen-Ying Wu, M.D., M.P.H.
P6-060
Cross-Sectional Age Analysis of DMDD 
Symptoms (Irritable-Angry Mood and 
Temper Outbursts) in Psychiatric and 
General Population Samples
Raman Baweja, M.D., M.S.
P6-061
Problem Gambling One Year Later: The 
Combined Risk of Race and Obesity
Eric W. Leppink, B.A.
P6-062
An Empirical Study of Trauma, 
Dissociation, Fantasy Proneness, 
and Deliberate Self-Harm in an Adult 
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Right Amount of Family Involvement 
are Associated with Increased Patient 
Satisfaction in Psychiatric Inpatients
Cheryl A. Kennedy, M.D.
P8-077
Medicaid Managed Care and Drug 
Utilization for Patients with Serious 
Mental Illness
Jacqueline Pesa, M.P.H., Ph.D.
P8-078
Use of Peer Navigators in Engaging 
Consumers suffering from Co-
Occuring Substance Use Disorders
Manish Sapra, M.D.
P8-079
Psychosocial Predictors of Multivita-
min Adherence After Bariatric Surgery
Supreet Sunil, B.Sc., M.B.A.
P8-080
Improving Access to Children’s Mental 
Health Care: A Collaborative Care 
Model of Child Psychiatry and Primary 
Care Pediatrics
Mary T. Gabriel, M.D.
P8-081
Preliminary Results from an 
I.M.P.A.C.T. Model Implementation in a 
Four Specialty Training Clinic






















Cognitive and Cardiovascular Fitness 
in Patients with Schizophrenia
Helene Speyer, M.D.
P8-083
Relationship of Vitamin D in Depressed 
Adolescents, Adolescents With 
Fractures and Normal Controls
Sarosh Khalid-Khan
P8-084
Social Support Moderates the 
Relationship Between Pain and Anxiety 
in a Veteran Sample
Randy A. Boley, B.A.
P8-085
Dextromethorphan Quinidine for 
Pseudobulbar Affect Secondary to 
Alzheimer’s Disease/Dementia: Effect 
on Mood Symptoms in PRISM-II 
Dementia Cohort
Andrew J. Cutler, M.D.
P8-086
Association of StarD6 Gene 
Polymorphisms and Alzheimer’s 
Disease in Korean Population
Young Jong Kim, M.D.
P8-087
Evaluation of Sentence Comprehension 
in Dementia and MCI and the Relation-
ship Between Language Deficit, Sever-
ity of Cognitive Decline and BPSD
Maria Kralova, M.D., Ph.D.
P8-088
Cross-Sectional Study of Prescribing 
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Improved Treatment Acceptance and 
Adherence Following the Diagnosis of 
Multiple Malformations of Cortical De-




Simulations of Dosing Windows 
and Missed Doses of Paliperidone 
Palmitate 3-Month Formulation in 
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Srihari Gopal, M.D., M.H.S.
P8-093
Switching Scenarios for Paliperidone 
Palmitate 3-Month Formulation 
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Pharmacokinetic Simulation-Based 
Evaluation
Mahesh N. Samtani, Ph.D.
P8-094
Stiff Person Syndrome or Catatonic 
Schizophrenia: A Case Report
Ahmad Hameed, M.D.
P8-095
RTMS Using a Two Coil 
Electromagnetic Array: Efficacy for 
Treatment Resistant Major Depressive 
Disorder
Scott T. Aaronson, M.D.
P8-096
Treatment of Unipolar, Non-
Psychotic MDD with Transcranial 
Magnetic Stimulation: Effects of 




Trends In ECT Utilization in the 




Identification of Risk Factors for 
Suicide Amongst Psychiatric Patients: 
Can Structured Measurement Tools Be 
More Specific?
Amresh K. Shrivastava, M.D.
P8-099
Recruitment, Ideology, and Strategic 




Psychiatrist as Communicator: Putting 
the ‘L’ Back in CL Psychiatry
Jamey B. Adirim, B.A., M.B.B.S.
P8-101
Predicting Help Seeking Behaviors 




Impact of Implementing Novel Level of 
Care Criteria for Group Homes
Cynthia L. Arfken, Ph.D.
P8-103
A Journey to Recovery
Felicia Iftene, M.D.
P8-104




Exploring Genetic Variability at 
PI, GSK3, HPA and Glutamatergic 
Pathways in Lithium Response: 




A Double Blind Trial of Divalproex 
Sodium for Affective Lability and 




Antidepressants and Congestive Heart 
Failure - a Population Based Nested 
Case-Control Study
Robert Boden, M.D., Ph.D.
P8-108
Baseline State but Not Drug Exposure 
Predicts Putative Side Effects 2 Weeks 
After Starting Olanzapine in Psychotic 
Depression
Simon J.C. Davies, D.M., M.B.B.S., M.Sc.
P8-109
Brexpiprazole Shows Antidepressant 
and Anxiolytic-Like Effects in the Rat 
Forced Swim and Vogel Conflict Test
Linda Lerdrup, Ph.D.
P8-110
Genetic Polymorphisms and 






















Randomized, Proof-Of-Concept Trial 
of Low Dose Naltrexone for Patients 
with Breakthrough Symptoms 
of Major Depressive Disorder on 
Antidepressants
David Mischoulon, M.D., Ph.D.
P8-112
Aripirazle as Add on for the Treatment 
of Hyperprolactinaemia Induced 
Paliperidone Palmatate Injectection 
Side Effect.
Hellme Najim, M.D., M.R.C.
P8-113
Effects of Food on the 
Pharmacokinetics and Bioavailability 




Effects of Chronic Aripiprazole Adminis-
tration on Serotonin and Glutamate Re-
ceptors: Comparison With Cariprazine
Frank I. Tarazi, M.B.A., M.B.B.S., Ph.D.
P8-115
Incidence of Serotonin Syndrome 
with concomitant Use of Serotonergic 
Agents in the U.S. Veteran Population
Lin Xie, M.A., M.S.
P8-116
“Morgellons Disease, the Controversy: 
A Dermatological Disorder or a Psychi-
atric Disorder in the Age of Internet”
Taylor Burns, M.D.
P8-117
Can Diabetes Health Beliefs in Patients 




Comorbidity of Anxiety With Heart Dis-
ease Among Adults Seen in Emergency 
Departments in a Large Asian-Ameri-
can and Pacific Islander Population
June C. Lee, D.O.
P8-119
Cancer Patients’ Hope and its 
Impact on their Own and Caregivers’ 
Emotional States
Rathi Mahendran, M.B.B.S., M.Ed., M.Med.
P8-120
Systematic review of the effectiveness 
of Consultation Liaison Psychiatry
Anne P.F. Wand, M.B.B.S.
P8-121
Outcomes in Patients with Bipolar 
Disorder who Underwent Kidney 
Transplant
I lona Wiener, M.D.
P8-122
Attachment Style and Expression of 
Jealously in Romantic Love
Borjanka Batinic, D.Phil., M.D.
P8-123
Is Rater Change Associated with 
Identical Scoring a Marker of Poor 
Data Quality?
David G. Daniel, M.D.
P8-124
Optimization of a Digital Health 
Feedback System in Psychiatry
Shashank Rohatagi, M.B.A., Ph.D.
P8-125




Prevalence of Sleep Problems and Its 
Impact on Anxiety, Depression and 
Quality of Life in Korean Fire Fighters
Sang Yeol Lee, M.D., Ph.D.
P8-127
Use of rTMS to Treat Insomnia 
Disorder: An Overview
Deepti Kaul Mughal, M.D.
P8-128
A Case of Conversion Disorder With 
Conceptual and Treatment Challenges
Furqan Nusair, M.B.B.S.
P8-129
Patient Perceptions of Community 
Mental Health Treatment and 
Community Treatment Orders (CTOs)
Arash Nakhost, M.D., M.Sc., Ph.D.
P8-130
The Wandering Mentally ill in the 
Mental Health Services of India
Gaurav H. Singh, M.D.
P8-131
Use of Prazosin for Treating PTSD 




Effects of Escitalopram on Autonomic 
Function in Posttraumatic Stress Dis-
order Among Veterans of Operations 
Enduring Freedom and Iraqi Freedom
Sriram Ramaswamy, M.D.
P8-133
Lasting Impact of Direct Exposure to 
Terrorism on Health, Mental Health 
and Posttraumatic Growth
Phebe M. Tucker, M.D.
P8-134
A Model Wellness Intervention 
Aimed at Reducing Cardiometabolic 
Syndrome Risk Associated with 
Psychotropic Medications
Raymond J. Kotwicki, M.D., M.P.H.
P8-135
Examining Patterns Of Alcohol Use In 
Burmese Refugees In Houston
Nidal Moukaddam, M.D., Ph.D.
P8-136
Hospitalization and Emergency 
Room Utilization in Patients with 
Schizophrenia Receiving Atypical 
Antipsychotics in the Outpatient Setting
Carmela Benson, M.S.
P8-137
Treatment Patterns of Schizophrenia 
Patients Treated with Long-acting 




Association Between Symptom Severity 
and Medication Adherence in Poorly 
Adherent Patients With Bipolar Disorder
Martha Sajatovic, M.D.
P8-139
Efficacy and Safety of Lurasidone in 
Older Adults with Bipolar Depression: 




Reduction in Probability of Relapse 
in Patients with Schizophrenia 


























































New Research Topic Index
Abuse and Neglect Victims
P3-042, P4-021, P5-001, P5-009, P5-024, 
P5-085, P6-026, P6-062, P8-130
Academic Psychiatry and Psychiatric 
Education
P3-001, P3-002, P3-003, P3-004, P3-062, 
P7-001, P7-002, P7-003, P8-001
Addiction Psychiatry/Substance Use and 
Addictive Disorders
P3-005 thru P3-014, P3-026, P4-008, P4-013, 
P4-060, P5-002 thru P5-009, P5-018, P5-026, 
P5-027, P5-079, P6-054, P6-065, P6-128, 
P7-010, P7-079, P8-001 thru P8-019, P8-033, 
P8-078, P8-135
Administrative Psychiatry  
(Public, Private and University)
P3-019, P7-001
Advocacy, Stigma, and Patients’ Rights
P3-020, P8-020, P8-021, P8-129
Aggressive Behaviors: Etiology, Assessment, 
and Treatment




P3-022, P3-034, P3-041, P3-051, P4-009, 
P4-040, P5-011, P5-012, P5-013, P5-029, 




P3-015, P3-016, P3-017, P3-019, P5-010, 
P6-001 thru P7-014, P7-057





P3-011, P3-037, P3-050, P4-005, P4-006, 
P4-007, P4-018, P4-028, P4-055, P5-040, 
P5-043, P5-044, P5-056, P5-071, P5-072, 
P5-076, P6-029, P6-038, P6-082, P6-123, 
P7-004, P7-005, P7-006, P7-007, P7-034, 
P7-045, P7-050, P7-051, P7-053, P8-005, 
P8-023 thru P8-028, P8-043, P8-046, P8-052, 
P8-057, P8-059, P8-071
Bipolar and Related Disorders
P3-025, P3-026, P4-031, P4-035, P4-051, 
P5-010, P5-016, thru P5-021, P5-024, P5-025 
thru P5-029, P6-024, P6-025 thru P6-039, 
P6-042 thru P6-049, P6-053, P6-055, P6-057, 
P6-117, P7-054, P7-074 thru P7-078, P8-105, 
P8-138, P8-139
Brain Imaging
P3-010, P3-012, P4-008, P5-005, P6-094, 
















New Research Topic Index
Child and Adolescent Psychiatry
P3-016, P3-021, P3-027 thru P3-031, P3-059, 
P3-060, P4-010, P5-004, P5-030, P5-033 thru 
P5-037, P6-001, P6-009, P6-037, P6-050 thru 
P6-060, P7-013, P7-072, P7-078, P7-079, 
P8-018, P8-029, P8-030, P8-080, P8-083
Clinical Case Studies (Medical Student and 
Resident Poster Competition)
P1-001 thru P1-186, P1-209, P2-135, P2-136, 
P2-137
Cognitive Behavioral and Motivational 
Therapies
P3-032, P3-033, P3-034, P3-068, P5-015, 
P8-031, P8-032
Combined Treatment (Pharmacotherapy and 
Psychotherapy)
P5-028, P7-012
Community Development and Service 
Projects (Medical Student and Resident 
Poster Competition)
P1-022, P1-187, P1-188, P1-190 thru P1-208, 
P2-104
Computers, Technology and the Internet
P2-025, P3-024, P3-035, P3-036, P4-043, 
P6-059, P7-009, P7-013, P7-070, P8-003, 
P8-032, P8-033, P8-104
Couples and Family Therapies
P3-038, P8-122
Cultural Psychiatry and Diversity
P4-039, P5-041, P6-061, P6-130, P7-012, 
P7-014, P7-015, P7-068, P7-069, P8-034
Curriculum Development and Educational 




P3-013, P3-032, P3-033, P3-037 thru P3-054, 
P4-006, P4-014, P4-016, P4-026, P4-037, P4-041, 
P4-058, P4-065, P4-066, P5-038 thru P5-045, 
P5-053, P5-057, P6-023, P6-025, P6-033, P6-034, 
P6-116, P6-126, P7-008, P7-011, P7-018, P7-021, 
P7-052, P7-075, P7-076, P8-004, P8-034, P8-036 
thru P8-066, P8-075, P8-081, P8-095, P8-096, 
P8-108, P8-109, P8-111, P8-140
Diagnosis/Assessment
P3-015, P3-055, P4-012, P5-082, P6-068, 
P6-069, P6-071, P6-088, P6-100, P7-016, 
P7-017, P7-038, P8-002, P8-013, P8-037, P8-067
Disaster Psychiatry
P8-068, P8-133
Disruptive, Impulse Control, and Conduct 
Disorders




P3-056, P3-057, P6-073, P7-025, P7-048, 
P8-069, P8-098
End of Life and Palliative Care
P3-064, P4-062
Epidemiology
P3-058 thru P3-061, P5-021, P5-038, P5-042, 
P5-062, P5-070, P6-003, P6-020, P6-103, 
P7-018, P8-009, P8-014, P8-028, P8-070, P8-071
Ethics
P3-062, P8-072
Feeding and Eating Disorders
P4-025, P5-047, P6-066, P6-068, P6-069, 
P6-071, P7-017
Forensic Psychiatry







P3-052, P3-063, P4-046, P4-047, P5-077, 
P5-078, P6-032, P7-020, P7-021, P8-073, 
P8-074, P8-075, P8-110
Geriatric Psychiatry
P3-047, P3-058, P3-064, P3-065, P3-066, 
P3-067, P5-049 thru P5-058, P6-072, P6-073, 





































New Research Topic Index
Global Mental Health and International 
Psychiatry
P3-007, P7-022, P7-023, P8-119
Group Therapies
P3-068
Health Care Financing and Reimbursement
P6-115, P8-136
Health Services Research
P3-001, P4-001, P4-002, P4-003, P4-004, 
P4-067, P5-007, P6-106, P6-129, P7-024, 
P7-025, P7-026, P7-029, P7-065, P8-017, 





Integrated and Collaborative Care
P3-044, P3-045, P3-069, P3-070, P4-033, 








Military/Veterans and Their Families
P3-003, P3-070, P4-010, P5-032, P5-064, 
P5-065, P6-080, P8-084, P8-106, P8-115
Neurocognitive Disorders
P4-011, P4-056, P4-068, P5-052, P5-074, 
P5-080, P6-014, P7-032 thru P7-035, P7-042, 
P8-085 thru P8-089
Neurodevelopmental Disorders
P6-050, P6-074, P7-036, P8-131
Neuropsychiatry
P3-028, P4-012, P4-048, P5-003, P6-091, 
P7-037 thru P7-040, P8-090, P8-091
Neuroscience
P3-009, P3-053, P4-013, P4-014, P4-015, 
P4-032, P5-031, P5-061, P5-073, P6-114, 
P7-032, P7-041 thru P7-044, P8-038, P8-049, 
P8-092, P8-093, P8-094
Non-Pharmacological Somatic Therapies 
(eg, ECT, TMS)
P4-016, P4-018, P5-033, P5-055, P7-041, 
P7-045, P7-046, P7-064, P8-095, P8-096, 
P8-097
Obsessive-Compulsive and Related Disorders
P4-019, P4-020, P4-052, P5-059, P5-060, 
P6-017, P6-077, P6-078
Patient-Oriented and Epidemiologic Studies 




P2-102, P3-017, P3-057, P4-023, P6-125, 
P7-047, P8-098
Personality Disorders
P3-046, P5-019, P5-061, P5-062, P5-063, 
P6-045, P6-058, P6-124
Political and Economic Issues (incl Human 
Rights)
P5-048, P7-019, P8-099
Posttraumatic Stress Disorder (PTSD)
P4-021, P5-064, P5-065, P6-005, P6-080, 
P8-068, P8-132
Practice Management Starting/Closing, 
Marketing
P4-003
Psychiatric Rehabilitation and Recovery
P3-049, P3-069, P4-022, P4-024, P4-049, 
P4-061, P6-081, P6-109, P8-031, P8-076
Psychiatric Services: Organization and 
Delivery
P3-023, P4-001, P4-002, P4-023, P5-008, 
P6-064, P6-118, P6-130, P7-028, P7-048, 
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P6-082, P7-005, P7-050, P7-051, P7-052, 
P8-023
Psychopharmacology
P3-014, P3-025, P3-056, P4-005, P4-026 thru 
P4-032, P4-057, P5-002, P5-025, P5-030, 
P5-075, P5-083, P6-002, P6-010, P6-011, 
P6-013, P6-035, P6-039, P6-056, P6-077, 
P6-085, P6-087, P6-089, P6-101, P6-102, 
P6-105, P6-110, P6-112, P7-036, P7-053 thru 
P7-060, P7-062, P8-016, P8-022, P8-024, 
P8-036, P8-039, P8-041, P8-047, P8-048, 
P8-050, P8-054, P8-055, P8-060, P8-064, 
P8-088, P8-105, P8-106, P8-108 thru P8-115, 
P8-132, P8-134, P8-140
Psychosocial and Biomedical Research 
Projects (Medical Student and Resident 
Poster Competition)
P1-189, P2-103, P2-105, P2-106, P2-107, 
P2-109 thru P2-134
Psychosomatic Medicine
P4-033 thru P4-038, P4-054, P5-013, P5-066, 
P6-066, P7-035, P7-040, P7-055, P7-061 thru 
P7-066, P7-071, P8-116 thru P8-121
Relational Problems
P4-015, P4-039, P8-067, P8-122
Religion, Spirituality, and Psychiatry
P4-040, P4-041, P4-042, P5-066
Research Design/Methodology
P3-043, P6-107, P8-035, P8-123, P8-124, 
P8-137
Resident, Fellows and Medical Student 
Concerns
P4-043, P4-044, P7-027, P7-067, P8-125
Schizophrenia Spectrum and Other Psychotic 
Disorders
P3-036, P4-020, P4-029, P4-045, P4-046, 
P4-048 thru P4-068, P5-031, P5-050, P5-068 
thru P6-091, P6-094 thru P6-115, P6-129, 
P7-020, P7-060, P8-035, P8-074, P8-091, 
P8-092, P8-093, P8-094, P8-113, P8-114, 




P3-027, P3-031, P4-058, P4-059, P4-060, 
P5-051, P5-084, P6-043, P8-126, P8-127
Social and Community Psychiatry
P4-022, P4-030, P4-061, P4-062, P7-030, 





P3-022, P3-039, P4-036, P4-053, P4-063, 
P5-006, P5-036, P5-085, P5-086, P6-028, 
P6-031, P6-113, P6-117 thru P6-125, P8-021, 
P8-042
Treatment Techniques and Outcome Studies
P3-040, P4-019, P5-001, P5-039, P5-068, 
P6-004, P6-042, P6-044, P6-108, P7-016, 





P4-059, P4-064, P5-054, P6-076, P7-023, 
P7-031, P7-067, P7-070, P7-071, P8-079, 
P8-117, P8-134
Women’s Health
P4-004, P4-064 thru P4-067, P6-072, P6-126, 
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The APA thanks our exhibitors for their sponsorship of the Exhibit Hall and for providing additional 
programs and services at the APA Annual Meeting. Their sponsorship supports the Annual Meeting 
and enriches the meeting experience for attendees. The APA deeply appreciates their support and 
encourages you to visit the Exhibit Hall.
!
Sponsorships and Support
APA Cafés and Wi-Fi: Takeda Pharmaceuticals USA, Inc. and Lundbeck, Inc.
APA Doctor’s Bag Pocket: Sunovion Pharmaceuticals Inc.
Connection Café: Janssen Pharmaceuticals, Inc.
Daily Bulletin Live: AstraZeneca Pharmaceuticals
Exhibit Hall Charging Station: AstraZeneca Pharmaceuticals
Hotel Key Cards: Alkermes; Sunovion Pharmaceuticals Inc.
Meeting Mobile App: Alkermes
Resident Poster Session: Janssen Pharmaceuticals, Inc.
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Allina Health
American Academy of Addiction Psychiatry
American Board of Psychiatry and Neurology, Inc.
American College of Psychiatrists
American Physician Institute for Advanced 
Professional Studies
American Professional Agency, Inc.
Armor Correctional Health Services, Inc.
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Cambridge University Press
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Cannon Design








Diamond Healthcare Recruitment Division
DR Wanted
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Hospital Corporation of America (HCA)











Johns Hopkins Healthcare Solutions
Kaiser Permanente,  
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Department of Psychiatry




Physicians for a National Health Program
PracticeLink.com
Providence Health and Services
Psychiatric Times












Royal College of Psychiatrists
Rutgers Center of Alcohol Studies
Rx Concepts, LLC
SAGE/MD Conference Express












U.S. Department of State,  
Office of Medical Services
U.S. Department of Veterans Affairs (HRMO)
U.S. Psychiatric & Mental Health Congress
Universal Health Services, Inc.
University of Florida, Department of Psychiatry























The APA exhibits program is an integral component of the 
overall Annual Meeting and provides an excellent opportunity for 
meeting registrants to obtain the latest information on products and 
services related to the psychiatric profession.
The meeting would not be possible without the generous 
support of our exhibitors, so please allow adequate time in your daily 
schedule to visit the exhibits, which are located in Exhibit Halls D-E, 
Level 800, South Building, in the Toronto Convention Centre. When 
you explore the exhibits, you will have the opportunity to participate in 
interactive computer programs and speak with the representatives of 
companies who provide services and products related directly to your 
professional and personal interests.
To assist in locating a particular company or product, a floor plan 
of the Exhibit Hall is included in this section, along with:  
1) alphabetical list of exhibitors with product/service description;  
2) exhibitors listed by product/service; and  
3) exhibitors listed numerically by booth number.
!
Hospitality Lounges
Two APA Cafés, serving compli-
mentary coffee (Locations #140 
and #1945) are located in the 
rear of the Exhibit Hall. Please 
utilize these areas to relax and 
network with colleagues. Charg-
ing stations for cell phones and 
laptops, as well as free Wi-Fi, are 
also available in each café.
Publishers’ Book Fair
Major publishers and book sellers, 
including American Psychiatric 
Publishing, are located in this des-
ignated area. Participating compa-
nies are selling and taking orders 
for new and current professional 
books in the field of psychiatry.
Career Fair
Exhibitors in this area include: 
government agencies, hospitals, 
locum tenens, mental health 
clinics, psychiatric facilities, and 
recruiters seeking psychiatrists to 
fill open positions. Find the APA 
JobCentral, The Career Hub for 
Psychiatry, the ultimate recruitment 
tool for employers and job-seekers 
alike, located in the APA Member 
Center, next to the American Psy-
chiatric Publishing Bookstore.
Exhibit Dates and Hours
SATURDAY, MAY 16
American Psychiatric Publishing 
(APP), APA Member Center, 
Publishers’ Book Fair, and Career 
Fair open:
9:00 a.m. – 4:00 p.m.
All commercial and educational 
exhibits, the International Meeting 
Pavilion along with American 
Psychiatric Publishing, APA 
Member Center, Publishers’ Book 
Fair, Career Fair open:
SUNDAY, MAY 17
10:00 a.m. – 4:00 p.m.
MONDAY, MAY 18
10:00 a.m. – 4:00 p.m.
TUESDAY, MAY 19
10:00 a.m. – 4:00 p.m.
International 
Meeting Pavilion
This area in the Exhibit Hall 
is comprised of international 
organizations and associations 
which will be holding international 
meetings outside of the U.S.
Endorsements
Products and services displayed 
in the Exhibit Hall occur by the 
contractual arrangement between 
the American Psychiatric 
Association and participating 
companies. This arrangement 
does not constitute or imply an 
endorsement by the American 
Psychiatric Association of these 
products or services.
Exhibit Hall Food Voucher
Save money and use your $10 food 
voucher (attached to your meeting 
badge for paid attendees only) re-
deemable for food/beverage at the 
concession areas in the Exhibit Hall 
only. Note: There is no cash value/
cash back, no replacement on 
vouchers, and they are for one-time 
use only, Sunday, May 17–Tuesday, 
May 19 during Exhibit Hall hours.
Exhibit Hall Activities
All Exhibit Hall activities will take 
place in Exhibit Halls D-E, Level 
800, South Building, Toronto 
Convention Centre.
 X APA Cafés with daily coffee 
service, along with free Wi-Fi, 
and charging stations for cell 
phones and laptops.
 X Check the schedule in the 
Program Guide and plan to 
attend Poster Sessions which 
will be held Saturday–Tuesday 
and Product Theaters which 
will be held Sunday–Tuesday.
 X The APP Bookstore, APA 
Member Center, Publishers’ 
Book Fair, and Career Fair will 
open on Saturday, May 16.
 X Commercial and educational 
exhibits and the International 







































The Sunshine Act and 
How It Affects You
The Physician Payment Sunshine 
Act is a federal law that requires 
pharmaceutical and device manu-
facturers under certain circum-
stances to publicly report any 
complimentary gift, food, beverage, 
non-CME certified education or 
other items of value given to physi-
cians. Some of the food, product 
theaters, and trinkets that may be 
available to you at this meeting 
have been sponsored by compa-
nies that may be required to report 
your receipt of that gift. APA rec-
ommends that you ask the person 
providing the complimentary item 
whether your name will be reported 
under the Act before accepting 
complimentary products or food so 
that you can make an independent 

























APA Product Theaters are for informational and promotional 
purposes only and do not offer CME credit. Seating is limited 
to 250 and is on a first-come, first-served basis. The 60-minute 
sessions are held Sunday, May 17 – Tuesday, May 19, with three 
sessions each day at 11:00 a.m., 12:00 p.m., and 1:00 p.m. Only 
registered meeting participants may attend the presentations, and 
your meeting badge is required. Boxed lunches and beverages 
are provided by the APA for the programs. Supporters of these 
sessions include: Actavis Pharma Inc., Alkermes, Assurex, Forum 
Pharmaceuticals, Otsuka America Pharmaceutical, Inc. and 
Lundbeck, Takeda Pharmaceuticals, U.S.A., Inc. & Lundbeck, 
Millennium Health, and Sunovion Pharmaceuticals Inc. Plan to attend! 
These sessions are covered by the Physician Payment in the 
Sunshine Act and physicians attending will be required to provide 
their identifying information for public reports.
!
SUNDAY, MAY 17
11:00 am – 12:00 pm
Supported by Otsuka America 
Pharmaceuticals, Inc. and Lundbeck
Neurocircuitry of Schizophrenia as 
It Relates to Current and Emerging 
Treatment Paradigms
Presenters:
Rakesh Jain, M.D., MPH, Clinical 
Professor, Department of 
Psychiatry and Behavioral 
Sciences, Texas Tech University 
School of Medicine, Midland, TX
Vladimir Maletic, M.D., MS, Clinical 
Professor of Neuropsychiatry and 
Behavioral Science, University of 
South Carolina School of Medicine, 
Columbia, SC; Consulting 
Associate, Division of Child and 
Adolescent Psychiatry, Department 
of Psychiatry, Duke University 
Medical Center, Durham, NC
Locations/Schedule
Exhibit Halls D-E, South, 
Level 800, Toronto 
Convention Centre
Sunday – Tuesday
Product Theater 1  
(Booth #111)
11:00 a.m.– 12:00 p.m. & 
1:00 p.m. – 2:00 p.m.
Product Theater 2  
(Booth #1911)
12:00 p.m.–1:00 p.m.
APA product theaters 
are for informational and 
promotional purposes only, and 
do not offer CME credit. The 
information presented is provided 
by the supporting companies 
and does not represent any 
endorsement by the American 
Psychiatric Association of any 
company or product.
!
12:00 pm – 1:00 pm
(Two, 30-minute presentations)
Supported by Actavis Pharma Inc.
Managing MDD in Adults: A Review 
of FETZIMA® (levomilnacipran 
extended-release capsules)
Presenter:
Adam Keller Ashton, M.D., MS, 
Clinical Professor of Psychiatry, 
State University of New York 
at Buffalo, Buffalo, NY; Private 
Practice, Suburban Psychiatric 
Associates, Amherst, NY
SAPHRIS® (asenapine) Sublingual 
Tablets: A Focus on the Acute 
Treatment of Manic or Mixed 
Episodes Associated With Bipolar I 
Disorder in Adults
Presenter:
Roger S. McIntyre, M.D., FRCPC, Pro-
fessor of Psychiatry and Pharma-
cology, University of Toronto, Head 
of the Mood Disorders Psychophar-
macology Unit at the University 
Health Network Co-chair, Canadian 
Network for Mood and Anxiety 
Treatments Task Force on the Treat-
ment of Comorbidity in Adults with 
Major Depressive Disorder or Bipo-
lar Disorder, Toronto, ON, Canada
1:00 pm – 2:00 pm
Supported by Otsuka America 
Pharmaceuticals, Inc. and Lundbeck
Discover a Long-Acting Injectable 
for the Treatment of Schizophrenia
Presenter:
Steven G. Potkin, M.D., Professor of 
Psychiatry, Psychiatry and Human 
Behavior, University of California, 
Irvine, Irvine, CA
MONDAY, MAY 18
11:00 am – 12:00 pm
Supported by Takeda Pharmaceuticals 
U.S.A., Inc. & Lundbeck
Insights Into a Major Depressive 
Disorder Treatment 
Presenter
Gustavo Alva, M.D., DFAPA, Medical 







































12:00 pm – 1:00 pm
(Three presentations)
Supported by Alkermes
Unraveling the Complexities of 
Schizophrenia Care 
Heterogeneity of Schizophrenia: 
Implications for Clinical Care
Presenter:
Henry A. Nasrallah, M.D., The 
Sydney W. Souers Endowed 
Chair Professor and Chairman, 
Department of Neurology and 
Psychiatry, Saint Louis University 
School of Medicine
Substance Use Disorders in 
Schizophrenia
Presenter:
Andrew Chambers, M.D., Assistant 
Professor of Psychiatry, Indiana 
University School of Medicine
The Spectrum of Adherence 
Challenges in Schizophrenia
Presenter:
Peter J. Weiden, M.D., Professor of 
Psychiatry, University of Illinois at 
Chicago
1:00 pm – 2:00 pm
Supported by Forum Pharmaceuticals
Cognitive Impairment and Poor 
Functioning in Schizophrenia: 
Relationship and Neurobiology
Presenters:
Philip D. Harvey, Ph.D., Leonard M. 
Miller Professor of Psychiatry and 
Behavioral Sciences, Director, 
Division of Psychology, University 
of Miami Miller School of 
Medicine, Miami, FL
Anil K. Malhotra, M.D., Professor 
of Psychiatry and Molecular 
Medicine, Hofstra North Shore-LIJ 
School of Medicine, Hempstead, 
NY; Director, Division of Psychiatry 
Research, The Zucker Hillside 
Hospital, Glen Oaks, NY
TUESDAY, MAY 19
11:00 am – 12:00 pm
Supported by Sunovion 
Pharmaceuticals, Inc.
Addressing Treatment Challenges 
in Mental Illness: A Clinical Expert 
Seminar
Presenters:
Leslie Citrome, M.D., Clinical 
Professor, Department of 
Psychiatry and Behavioral 
Sciences, New York Medical 
College, Valhalla, NY; Attending 
Physician, Department of 
Psychiatry, Good Samaritan 
Hospital, Suffern, NY; Consultant 
of Sunovion Pharmaceuticals Inc.
Roger S. McIntyre, M.D., FRCPC, 
Professor of Psychiatry and 
Pharmacology, University of 
Toronto, Head, Mood Disorders 
Psychopharmacology Unit, 
University Health Network, 
Toronto, ON Canada; Consultant of 
Sunovion Pharmaceuticals Inc.
12:00 pm – 1:00 pm
Supported by Assurex
Next Generation Pharmacogenomics: 
Moving Beyond Mendel
Presenter:
Chris Bojrab, M.D., President, Indiana 
Health Group, Indianapolis, IN
1:00 pm – 2:00 pm
Supported by Millennium Health
Pain, Depression and Anxiety – 
Improving Safety, Response and 
Medication Efficacy
Presenter:
Steven D. Passik, Ph.D., Kelly L. 
Olson, Ph.D., and Charles S. Price, 
M.D., Board Certified in Psychiatry, 
Clinical Appointment in Psychiatry 
at the University of Nevada. 

















Therapeutic Updates will be held on Sunday, May 17, and 
Monday, May 18. These updates are informational programs 
supported by Shire U.S., Inc., and Avanir Pharmaceuticals, Inc. 
These promotional programs are being held as an extension of the 
Exhibit Hall. Seating is limited to 500 and is on a first-come, first-
served basis. They feature presentations by thought leaders in 
therapeutic areas. CME credit is not provided for these sessions. 
Plan to attend! 
These sessions are covered by the Physician Payment in the 
Sunshine Act and physicians attending will be required to provide 
their identifying information for public reports.
!
SUNDAY, MAY 17
7:30 pm – 9:30 pm
Canadian Room, Convention Floor
Supported by Shire, U.S. Inc.
Shire, U.S. Inc. Therapeutic Update
Presenter:
Leslie Citrome, M.D., MPH, Clinical 
Professor of Psychiatry and 
Behavioral Sciences, New York 
Medical College, Valhalla, NY
Location
Royal York Hotel
Food service begins at 
7:00 p.m.
Session Times  
7:30 p.m. – 9:30 p.m.
The Therapeutic Update 
is two hours in length 
and is a supported promotional 
presentation. Attendees must 
be registered for the Annual 
Meeting, and the meeting badge 
is required for admittance.
!
The APA Therapeutic 
Update is for informational 
and promotional purposes only 
and does not offer CME credit. 
The information presented is pro-
vided by the supporting compa-
nies and does not represent any 
endorsement by the American 




7:30 pm – 9:30 pm
Concert Hall, Convention Floor
Supported by Avanir Pharmaceuticals, Inc.
Is it Depression or Something Else? 
Detection, Diagnosis, and Treatment 
of Pseudobulbar Affect
Presenters:
Henry A. Nasrallah, M.D., The Sydney 
Souers Professor and Chairman, 
Department of Neurology and 
Psychiatry, Saint Louis University 
School of Medicine, St. Louis, MO
Jason P. Caplan, M.D., FAPA, FAPM, 
Chair of Psychiatry, Creighton 
University School of Medicine, 








































830 Crescent Centre Drive, Suite 610
Franklin, TN 37067
www.acadiahealthcare.com
Please visit the Acadia Healthcare exhibit for more 
information about products, services, and job op-
portunities that will be of interest to you.
ACADIA Pharmaceuticals
Booth #1419
11085 Torreyana Road, Suite 100
San Diego, CA 92121
www.acadiapharm.com
ACADIA Pharmaceuticals is a biopharmaceutical 
company focused on the development and commer-
cialization of innovative medicines to address unmet 







Actavis is a global pharmaceutical leader focused 
on developing, manufacturing, and commercial-
izing high-quality, affordable, generic, and innova-
tive branded pharmaceutical products for patients 
around the world. The company has nearly 25,000 
employees worldwide and maintains global head-
quarters in Dublin, Ireland. For more information, 
please visit our website.
ACUTE Center for Eating Disorders
Booth #1610
777 Bannock Street, MC8105
Denver, CO 80204
www.denverhealth.org/acute
The ACUTE Center for Eating Disorders at Denver 
Health is the country’s only specialized medical 
stabilization program for adults with severe eating 
disorders. Led by renowned expert, Philip S. Mehler, 
M.D., ACUTE is uniquely tailored to help both males 
Exhibitors with Product/Service 
Descriptions
and females, ages 17 and older, who cannot seek 
care in a traditional inpatient or residential treatment 
setting due to the severity of their weight loss and/
or other medical complications (i.e., less than 70% of 
their ideal body weight or BMI less than 14, severe 
malnutrition and risk for the potentially fatal refeed-
ing syndrome, electrolyte/fluid problems, multi-organ 
failure, cardiac irregularities, gastrointestinal complica-
tions). ACUTE is contracted with most major insur-
ance companies and uses the patient’s medical insur-
ance benefit for stabilization. We offer an intensive 
care unit, direct hospital-to-hospital transfers, and a 
24/7 air ambulance available as needed. For more 







Please visit the Alkermes Medical Education 
booth for information about products and ser-







For more information about Alkermes and its 
innovative medicines designed to help people 
living with serious, chronic diseases, including 
addiction disorders, please visit our website.
Allina Health
Booth #503
2925 Chicago Avenue # MR10703
Minneapolis, MN 55407-1321
www.allina.com
For more than 30 years, Allina Mental Health has 















Exhibitors with Product/Service Descriptions
work through times when the troubles of life interfere 
with their ability to function or cope. We serve people 
at hospitals and clinics throughout the Twin Cities 
and greater Minnesota. Stop by our booth or visit 
our website for information about our urban, subur-
ban, and rural mental health practice opportunities.
American Academy of Addiction Psychiatry
Booth #1708
400 Massasoit Avenue, Suite 307
East Providence, RI 02914-2012
www.aaap.org
The American Academy of Addiction Psychiatry is 
the professional membership organization for learn-
ing and sharing about the art and science of addic-
tion psychiatry research and clinical treatment.
American Board of Psychiatry 
and Neurology, Inc
Booth #1602
2150 East Lake Cook Road, Suite 900
Buffalo Grove, IL 60089-1875
www.abpn.com
The American Board of Psychiatry and Neurology 
(ABPN) serves the public interest and the profes-
sions of psychiatry and neurology by promoting 
excellence in practice through certification and 
maintenance of certification processes for psychiatry, 
addiction psychiatry, child and adolescent psychiatry, 
forensic psychiatry, geriatric psychiatry, hospice and 
palliative medicine, pain medicine, psychosomatic 
medicine, brain injury, and sleep medicine. Please 
visit the ABPN booth for answers to your questions.
American College of Psychiatrists
Booth #1606
122 South Michigan Avenue, Suite 1360
Chicago, IL 60603-6185
www.acpsych.org
The American College of Psychiatrists is an honorary 
psychiatric association. The College develops and 
administers PRITE (for psychiatry residents) and PIPE, 
an online preparatory tool for recertification, which 
also fulfills ABPN's self-assessment requirement.
American Physician Institute for 
Advanced Professional Studies
Booth #1941
125 Windsor Drive, Suite 111
Oak Brook, IL 60523-4081
www.americanphysician.com
American Physician Institute (API) provides dynamic 
medical education, CME, and self-assessment cred-
its to thousands of physicians every year. Founded in 
2002 by Dr. Jack Krasuski, API creates high-quality 
board exam prep courses across the medical spec-
trum, including psychiatry. The goal of each course is 
to provide high-yield, laser-focused medical informa-
tion to physicians for the purpose of effectively pre-
paring for and passing their board exams or to keep 
up-to-date on the latest advances in their respective 
medical fields. Courses are offered in live and online 
versions to match the physician’s personal learning 
style and schedule. In addition, API offers solutions 
for multiple board course purchases that can be 
utilized by individuals and small or large groups such 
as a medical practice, residency program, or health-
care network. Board review courses are covered by 
API’s renowned triple trust guarantee. If a physician 
does not pass their board exam, they receive a full 
tuition refund, a 10% additional payment, plus a free 
repeat course until they pass.
T





Our company is a leading provider of psychiat-
ric medical professional liability insurance. Our 
program is endorsed by the American Psychiat-
ric Association and sponsored by the American 
Academy of Child and Adolescent Psychiatry. 
Our partner, Allied World, a global insurance 
company, provides comprehensive coverage 
and unparalleled risk management expertise. 
Our policyholders have access to a hotline 
24/7 should an emergency arise. Our caring 
customer service representatives welcome the 
opportunity to provide additional information and 





































Exhibitors with Product/Service Descriptions
Armor Correctional Health Services, Inc
Booth #401
4960 Southwest 72nd Avenue, Suite 400
Miami, FL 33155
www.armorcorrectionaljobs.com
Armor Correctional Health Services, Inc., is a physi-
cian and minority-owned enterprise that provides 
comprehensive medical, dental, and mental health 
services exclusively for patients in jails and prisons. 
The level of health care expertise throughout Armor 
is unparalleled within the correctional health care 
arena. Armor has contracts in Florida, Georgia, Ne-
vada, New York, Oklahoma, South Dakota, Virginia, 
and Wisconsin. Armor employs professionals who 
are passionate about putting patients first.






The AGLP is a professional organization of psychia-
trists, psychiatry residents, and medical students, 
which serve as a voice for the concerns of lesbians 
and gay men within the psychiatric community. The 
Association is committed to fostering an accurate 
understanding of homosexuality, opposing discrimi-
natory practices against gay men and lesbians, and 
promoting supportive, well-informed psychiatric 
care for lesbian and gay patients. The organization 
provides opportunities for affiliation and collaboration 
among psychiatrists who share these concerns.
Assurex Health
Booth #939
6030 South Mason Montgomery Road
Mason, OH 45040-3706
www.assurexhealth.com
Assurex Health is the leading personalized medicine 
company dedicated to helping healthcare provid-
ers determine the right medication for patients with 
behavioral health conditions and chronic pain. We 
help people achieve mental wellness with advanced 
genomics technology providing individualized treat-






AstraZeneca is a global, innovation-driven biophar-
maceutical business with a primary focus on the 
discovery, development, and commercialization of 
prescription medicines for gastrointestinal, cardio-
vascular, neuroscience, respiratory and inflammation, 
oncology, and infectious disease. AstraZeneca oper-
ates in over 100 countries and its innovative medi-




3305 W Forest Home Avenue
Milwaukee, WI 53215-2843
aurora.org/doctor.com
Aurora Health Care is the largest integrated 
health system in Wisconsin providing patient 
care in 90 communities. Nationally recognized 
as a leader in quality health care and innovation, 
our integrated delivery model allows our physi-
cians to support their patients, connect with 







The Austen Riggs Center holds patient authority 
and its completely open, voluntary, and therapeutic 
community setting as core values in the treatment 
of psychiatrically complex adults. Austen Riggs is a 
not-for-profit, private residential treatment program 
and psychiatric hospital with a continuum of care. 
Patients receive individual psychotherapy four times 
weekly with a doctoral level clinician, supported by 
an interdisciplinary treatment team. Visit our website 
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T
Avanir Pharmaceuticals, Inc,  
Medical Affairs
Booth #1151
20 Enterprise, Suite 200
Aliso Viejo, CA 92656
www.avanirmedinfo.com
Avanir Pharmaceuticals, Inc. is a biopharmaceu-
tical company focused on acquiring, developing, 
and commercializing novel therapeutic products 
for the treatment of central nervous system dis-
orders. Avanir Medical Information responds to 
unsolicited inquiries to help facilitate appropriate 
therapeutic utilization of Avanir medications. We 
strive to provide the highest-quality service to 
healthcare practitioners through the timely provi-







Bassett Medical Center, located in beautiful Cooper-
stown, NY, is seeking well-trained, BC/BE adult-
psychiatrists to join our progressive multidisciplinary 
team. The Department of Psychiatry has a ten-bed, 
inpatient unit and an outpatient facility. Practice op-
portunities include a director of inpatient psychiatry 
and outpatient psychiatrist positions. Visit us at our 
website.
Brain & Behavior Research 
Foundation/NARSAD Artworks
Booth #1513
90 Park Avenue, Floor 16
New York, NY 10016-1301
www.bbrfoundation.org
The Brain & Behavior Research Foundation is com-
mitted to alleviating the suffering caused by mental 
illness by awarding grants that will lead to advances 
and breakthroughs in scientific research. Since 1987 
the Brain & Behavior Research Foundation awarded 
more than $320 million to fund 4,769 NARSAD grants 






Brainsway offers an effective, safe, and noninvasive 
treatment for psychiatric and neurological disorders. 
Brainsway’s revolutionary deep TMS (transcranial 
magnetic stimulation) is indicated by the Food and 
Drug Administration for treatment of depressive 
episodes in adult patients diagnosed with major de-
pressive disorder, who failed to achieve satisfactory 
improvement from antidepressant medication in the 
current episode. Brainsway’s unique technology is 
based on patents registered by the National Institute 
of Health and by the company.
Brookhaven Retreat
Booth #948
1016 Ic King Road
Seymour, TN 37865-3150
www.brookhavenretreat.com
Please visit the Brookhaven Retreat, LLC exhibit for 
more information about The Lily Program®, an indi-
vidualized mental health program for women.
T
California Correctional Health 
Care Services (CCHCS)
Booth #615
Post Office Box 588500
Elk Grove, CA 95758
www.changingprisonhealthcare.org
We are improving our organization’s health 
care services measurably by hiring exceptional, 
dedicated clinicians like you. Our psychiatrists 
have rewarding careers providing top-rate men-
tal health care to inmate-patients in each of our 
35 institutions. Please visit us at exhibit booth 
#615 for additional information on our great 
pay and benefits, qualification requirements, 
and the application process. While there, ask 
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Cambridge University Press
Booth #519
32 Avenue of the Americas
New York, NY 10013-2473
www.cambridge.org
Cambridge University Press is a leading publisher 
of professional books and journals in psychiatry. 
With dozens of new books in the past year, includ-
ing important new titles from Dr. Stephen M. Stahl, 
author of Stahl’s Essential Psychopharmacology. 
Cambridge has cutting-edge material for all mental 
health professionals and is pleased to announce 
the reconfiguration and relaunch of the journal CNS 
Spectrums, with Dr. Stahl as its Editor-in-Chief.
Canadian ADHD Resource 
Alliance (CADDRA)
Booth #1713
3950 14th Avenue, Suite 604
Markham, ON L3R 0A9, Canada
www.caddra.ca
CADDRA (Canadian ADHG Resource Alliance) is 
an independent, multi-disciplinary alliance of health 
professionals working in the field of ADHD. CAD-
DRA produces the internationally-renowned Ca-
nadian ADHD Practice Guidelines, now in its 3rd 
edition, which includes an ADHD assessment toolkit. 
CADDRA is a non-profit organization that provides 
training and education for health professionals on 
best practice ADHD diagnosis, assessment, and 
treatment of ADHD. The 11th Annual CADDRA 
ADHD Conference will take place in Vancouver, Brit-




Grand Island, NY 14072-2091
www.cannondesign.com
Cannon Design has advancing design solutions to 
the greatest challenges facing our clients and society 
and is ranked among the leading international firms 
in planning and design for healthcare, education, 
corporate, and government clients. At present, the 
firm employs a staff of over 1,000, delivering services 
across a global network of offices.
The Center for Eating Disorders 
at Sheppard Pratt
Booth #1509
6501 N Charles Street
Baltimore, MD 21204-6819
www.eatingdisorder.org
The Center for Eating Disorders at Sheppard Pratt 
offers comprehensive care for children, adolescents, 
and adults with eating disorders. A national leader in 
evidence-based treatment since 1989, we provide 
highly specialized individual, group, family, occupa-
tional, art, and nutritional therapies. Our continuum 
of care includes an inpatient program, partial hospital 
program, intensive outpatient program, and free sup-




765 East Route 70, Bldg A-100
Marlton, NJ 08053-2341
www.cfghealthnetwork.com
CFG Health Network is a broad based healthcare 
provider that is dedicated to increasing access to 
care through innovative applications of technology, 
like telepsychiatry and virtual environments. In addi-
tion to running its own clinics, CFG provides hospi-
tal-based programs, including inpatient psychiatric 
services, education evaluations, psychiatric crisis 
center intervention, medical/surgical floor consults, 
school-based programs, partial hospitalization pro-
grams, and residential treatment services.
Clinical Psychiatry News
Booth #1512
7 Century Drive, Suite 302
Parsippany, NJ 07054-4609
www.clinicalpsychiatrynews.com
Clinical Psychiatry News is an independent news-
paper that provides the practicing psychiatrist with 
timely and relevant news and commentary about 
clinical developments in the field and about the 






















Community Health Systems, Inc., is one of the 
nation’s leading operators of general acute care hos-
pitals. The organization’s affiliates own, operate, or 
lease 207 hospitals in 29 states with approximately 
31,100 licensed beds. Affiliated hospitals are dedi-
cated to providing quality healthcare for local resi-
dents and contribute to the economic development 
of their communities. Based on the unique needs of 
each community served, these hospitals offer a wide 
range of diagnostic, medical, and surgical services in 
inpatient and outpatient settings.
Compulink Business Systems, Inc
Booth #1632
2645 Townsgate Road
Westlake Village, CA 91361-2708
www.compulinkadvantage.com
A proven leader for over 30 years, Compulink is a 
recognized leader in ONC-certified, EHR, and prac-
tice management systems for psychiatry. Offering 
the industry’s most flexible, most complete, and best 
supported system, our Psych Advantage is designed 
to help improve patient care and practice profitability.
CooperRiis Healing Community
Booth #511
101 Healing Farm Lane
Mill Spring, NC 28756-5808
www.cooperriis.org
CooperRiis Healing Community serves adults with 
mental health challenges including schizophrenia, 
schizoaffective disorder, bipolar disorder, major 
depression, or anxiety disorders. Some experience 
borderline personality disorder, and a third have a 
history of substance abuse. Our program is based 
on a person-centered recovery model that ad-
dresses the mind, body, and spirit. We combine the 
best of modern psychiatry, psychology, addictions 




7 Century Drive, Suite 302
Parsippany, NJ 07054-4609
www.currentpsychiatry.com
Sign up for a complimentary subscription to Current 
Psychiatry. Edited by Henry A. Nasrallah, M.D., Cur-
rent Psychiatry provides peer-reviewed, up-to-date, 
practical advice by leading authorities to commonly 
seen clinical problems. Published as an educational 
partnership with Saint Louis University’s Department 
of Psychiatry, this journal is free to psychiatric prac-







Fuji Cyber Relax is No. 1 in massage chairs. Visit our 
booth for a special 50% discount to APA attendees. 





Diamond Healthcare Corporation is a Richmond, 
Virginia-based behavioral healthcare consulting and 
contract management firm. We work with a variety 
of clients in 28 states in the area of psychiatric and 
addiction service development and management. 
Whether you are just starting out or have many years 
of practice experience, physicians of all backgrounds 




950 East Paces Ferry Road NE, Suite 2160
Atlanta, GA 30326-1384
www.drwanted.com
DR Wanted is a national leader in the locum tenens 
industry. Our areas of focus include jobs in primary 
care hospital, emergency medicine, and anesthesi-
ology, as well as allied health. We offer A++ mal-
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benefits! Best-of-Class technology and an individual 
high-touch philosophy, these are the cornerstones of 
the DR Wanted recruitment process. Our seasoned 
team of staffing professionals provide a personal, 
and unique search experience with an obsessive 
devotion to finding the right fit. At DR Wanted, we fo-
cus on shortening the search process while also pro-
viding a precise match for both client and candidate 
every time. Contact us today to find out more about 
the resources and candidates currently available.
Eating Recovery Center
Booth #1815
7351 E. Lowry Boulevard, Suite 200
Denver, CO 80230
www.eatingrecoverycenter.com
Eating Recovery Center is an international center 
providing comprehensive treatment for anorexia, 
bulimia, EDNOS, and binge eating disorder. Un-
der the leadership of Drs. Kenneth Weiner, Craig 
Johnson, Emmett Bishop, Philip Mehler, and Ovidio 
Bermudez, programs provide a full spectrum of ser-
vices for children, adolescents, and adults through 
inpatient, residential, partial hospitalization, intensive 
outpatient, and outpatient services. Our compas-
sionate, multidisciplinary treatment team collabo-
rates with treating professionals and loved ones 
to cultivate lasting behavioral change. To increase 
patient access to care, Eating Recovery Center 
provides five additional centers of excellence for the 
treatment of eating disorders across the country: 
California, Texas, Washington, Illinois, and Ohio.
Electromedical Products International, Inc
Booth #1902
2201 Garrett Morris Pkwy
Mineral Wells, TX 76067-9034
www.alpha-stim.com
Overwhelmed by patients with mood and sleep 
disorders? Alpha-Stim® can help you melt away 
their anxiety, depression, and insomnia so they can 
experience life again. Alpha-Stim is supported by 
more research than any other prescription device in 
its class. Read over 55 studies and reviews reveal-
ing robust effect sizes at our website. Side effects 
are rare, minor, and self-limiting. Pocket-sized 
Alpha-Stim medical devices work through ear clip 
electrodes that send a weak current directly into the 
brain for 20-minute sessions. This alters the EEG by 
increasing Alpha frequencies and decreasing Delta 
frequencies. Electromedical Products International, 
Inc., was founded in 1981 and is the world leader 
in cranial electrotherapy stimulation. Come by our 
booth to try it for yourself. You will be amazed at 
how good you will feel. Psychiatrists who would 
like to try Alpha-Stim in practice can request a free 
60-day loan by visiting our website for prescribing 
information, to read research studies, professional 
endorsements, media articles and see Alpha-Stim on 
TV and radio news programs. You can also contact 
us by email at info@alpha-stim.com or at 1-940-
328-0788 to request a comprehensive practitioner’s 
information kit, loan, or a visit from one of our highly 
trained and friendly customer service representatives 
(onsite visits not available in all areas).
Elsevier, Inc
Booth #629
1600 John F Kennedy Boulevard, Suite 1800
Philadelphia, PA 19103-2398
www.elsevierhealth.com
Elsevier is a world-leading provider of information 
solutions that enhance the performance of science, 
health, and technology professionals, empowering 
them to make better decisions, deliver better care, 
and sometimes make groundbreaking discoveries 
that advance the boundaries of knowledge and hu-
man progress. Elsevier provides web-based, digital 
solutions–among them ScienceDirect, Scopus, 
Elsevier Research Intelligence, and ClinicalKey—and 
publishes nearly 2,200 journals, including The Lancet 
and Cell, and over 26,000 book titles, including a 
number of iconic reference works. The company 
is part of Reed Elsevier Group PLC, a world lead-
ing provider of professional information solutions in 
the science, medical, legal, and risk and business 
sectors, which is jointly owned by Reed Elsevier PLC 
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Evoke Neuroscience
Booth #1800
1133 Broadway, Suite 412
New York, NY 10010
www.evokeneuroscience.com
Evoke Neuroscience is a medical neuroscience com-
pany that designs and develops devices that simplify 
data collection and analysis of human physiology 
along with easy-to-use intervention tools. Evoke has 
delivered its FDA registered device, eVox, to physi-
cians nationwide since 2012 and transformed the 
way doctors assess and treat their patients’ symp-
toms and conditions. The eVox uses multi-modal 
applications, including brain health (EEG), brain 
processing speed (ERP), heart health (EKG), and 
emotional health to assess the patient and provide a 




1711 Ashley Circle, Suite 6
Bowling Green, KY 42104-5801
www.fcspsy.com
Helping psychiatrists find a place to call home for 
over 30 years, FCS, Inc. is the leader in psychiatric 
recruitment, and is quickly becoming the primary 
source for psychiatry locum tenens assignments.
Focus: The Journal of Lifelong 
Learning in Psychiatry
Booth #1605
1000 Wilson Boulevard, Suite 1825
Arlington, VA 22209-3924
www.psychiatry.org
Focus: The Journal of Lifelong Learning in Psychiatry 
is the complete system for lifelong learning, mainte-
nance of certification, self-assessment, performance 




1550 Soldiers Field Road
Boston, MA 02135-1105
www.forumpharma.com
At FORUM Pharmaceuticals, every mind mat-
ters. We are focused on developing innovative 
medicines to defeat the most challenging and 
serious brain diseases, including schizophrenia, 
Alzheimer’s disease, and frontotemporal de-
mentia. FORUM’s lead compound, encenicline 
(EVP-6124), is currently being evaluated in sepa-
rate ongoing Phase 3 clinical trial programs to 
improve cognition in patients with schizophrenia 
and Alzheimer’s disease. For more information, 




Surrey, BC V3T 0H1
Canada
www.physicians.fraserhealth.ca
Located in the Metro Vancouver and Fraser Valley 
region of British Columbia, Fraser Health has 20 
culturally and geographically diverse communities—
from urban to rural. As the fastest-growing region 
in the province, we provide health services to 1.6 
million people with 12 acute care hospitals, tertiary 
teaching hospitals and services in public health, 
home health, mental health, and residential care fa-
cilities. Fraser Health’s mental health and substance 
use program provides a range of services including 
child, youth/adolescent, adult, geriatric psychiatry 
at eight of our 12 University of British Columbia af-
filiated hospitals, and through 12 community mental 
health teams. Successful applicants will have their 
FRCPC designation (or equivalent) and be eligible 
for licensure with the College of Physicians and Sur-
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Genomind
Booth #1409
100 Highpoint Drive, Suite 102
Chalfont, PA 18914-3926
www.genomind.com
Genomind is a personalized medicine company 
comprised of innovative researchers and expert 
leaders in psychiatry and neurology. The Genecept™ 
Assay, Genomind’s core product, is a simple to use 
saliva-based test for understanding genetic and bio-
logical markers that best inform response to different 
psychiatric treatments. For more information or to 
order a test kit, visit our website.
Global Medical Staffing
Booth #614
3995 South 700 East, Suite 100
Salt Lake Cty, UT 84107
www.gmedical.com
We offer extraordinary locum tenens assignments 
that last a few days, to a month, to a year, or longer 
in locations around the globe. We handle all the 
details so you are free to treat patients, free to boost 
your expertise, free to earn a competitive living, and 
enjoy practicing medicine—without worrying about 
the business of medicine. Let us help you find your 






GoodLux Technology provides the SunSprite solu-
tion, a wearable, app light management solution 
engaging patients to self-manage depression by 
effectively using bright light therapy (BLT). Our team 
of doctors, engineers, physicists and healthcare 
experts, utilizes its science background to create 
tangible solutions for value-driven healthcare. For 
more information, visit our website.
Group Health Physicians
Booth #604
320 Westlake Avenue N
Seattle, WA 98109-5232
www.grouphealthphysicians.org
Group Health Physicians is one of the nation’s larg-
est and most honored multispecialty medical groups. 
This group of more than 1,400 doctors and clini-
cians is responsible for clinical quality and care at 
Group Health, a consumer-governed health system 
in Washington State and North Idaho with more than 
600,000 plan members. In 2010, Group Health Phy-
sicians received the prestigious American Medical 
Group Association’s Acclaim Award for physician-led 
innovations that have transformed care at Group 
Health Medical Centers. As a practitioner at Group 
Health Physicians, you will join a collaborative team 
in a professionally satisfying, patient-centered envi-
ronment. Please come by our booth to learn more 




370 7th Avenue, Suite 1200
New York, NY 10001-3982
www.guilford.com
Visit our booths for new and bestselling titles: DBT® 
Skills Training Manual, 2nd edition and DBT® Skills 
Training Handouts and Worksheets, 2nd edition 
(Linehan); Handbook of Psychodynamic Approaches 
to Psychopathology (Luyten); DBT® Skills Manual 
for Adolescents (Rathus); Practicing Psychodynamic 
Therapy (Summers); Clinician’s Guide to Bipolar 
Disorder (Miklowitz); Motivational Interviewing in the 
Treatment of Psychological Problems, 2nd edition 
(Arkowitz); Mindful Way Through Stress (Alidina); 
Clinical Textbook of Addictive Disorders, 4th edition 
(Mack); Emotional Schema Therapy (Leahy); DSM-5 
Made Easy (Morrison); Essentials of Psychiatric Diag-






















Harrington HealthCare, Southbridge, is a regional 
health care organization located in south/central 
Massachusetts consisting of Harrington Hospital, a 
114-bed, nonprofit acute care community hospital; 
and Harrington Physician Services, Inc., a nonprofit, 
multispecialty medical group. Services consist of 
behavioral health services, such as inpatient psychi-
atric care, outpatient, emergency psychiatric, and 
substance abuse services for adults, adolescents, 
children, and families. Integrated services are avail-
able on the main campus and at outpatient offices 
located throughout our service area.
Hogrefe Publishing Corp
Booth #624
38 Chauncy Street, Suite 1002
Boston, MA 02111-2318
www.hogrefe.com
Hogrefe Publishing has been publishing books, pe-
riodicals, and assessment tools in the fields of psy-
chiatry, medicine, and psychology for over 60 years. 
We will be presenting the new 21st edition of the 
Clinical Handbook of Psychotropic Drugs, the new 
3rd edition of the Clinical Handbook of Psychotropic 
Drugs for Children and Adolescents, as well as new 
titles in our Advances in Psychotherapy book series 




Guelph, ON N1E 6K9
Canada
www.homewoodhealth.com
Homewood Health is Canada’s leader in mental 
health and addiction services. Our complete con-
tinuum of services includes organizational wellness, 
assistance programs, assessments, outpatient and 
inpatient treatment, recovery management, return 
to work, and family support services customized 




1965 Lakepointe Drive, Suite 100
Lewisville, TX 75057-6424
www.horizonhealth.com
Founded in 1981, Horizon Health Behavioral Health 
Services is the leading manager and provider of 
hospital-based behavioral health programs. We have 
provided services in 47 states, working with hospi-
tals of all types and sizes to manage their behavioral 
health programs, providing an additional revenue 
stream, and helping to ease the strain on their emer-
gency departments.
Hospital Corporation of America (HCA)
Booth #600
3 Maryland Farms, Suite 250
Brentwood, TN 37027-5053
www.practicewithus.com
Hospital Corporation of America (HCA) owns and 
operates 165 healthcare facilities in 20 states with 
opportunities coast to coast. HCA was one of the 
nation’s first hospital companies. We are commit-
ted to the care and improvement of human life, and 
we strive to deliver quality healthcare that meets the 
needs of the communities we serve.
HSHS Medical Group, Inc
Booth #613
3215 Executive Park Drive
Springfield, IL 62703
www.yourcareourmission.org
HSHS Medical Group is recruiting adult and child/
adolescent psychiatrists to provide general out-
patient and inpatient care for a very successful 
and busy behavioral health services program at 
St. Mary’s Hospital in Decatur, IL. St. Mary’s Hos-
pital, situated on beautiful Lake Decatur, is a fully 
accredited, modern health care facility minister-
ing to the growing Decatur community. St. Mary’s 
board certified physicians and nursing staff ranks 
the highest in the nation in patient satisfaction. An 
employed position with HSHS Medical Group offers 
a competitive salary and comprehensive benefits 
package including health, life, dental, and disability 
insurance, malpractice with tail coverage, relocation 
assistance, retirement plans, paid CME, time off, and 
much more! The HSHS Medical Group has approxi-
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in partnership with HSHS hospitals to give providers 
the support they need to provide the highest level of 
patient care possible. 
Infinite Trading, Inc
Booth #1608
3651 Lindell Road, Suite D120
Las Vegas, NV 89103
www.hidow.com
Please visit the Infinite Trading exhibit for more infor-




300 East Lombard Street, Suite 1610
Baltimore, MD 21202-3210
www.ingenuityhealth.com
Ingenuity Health is a service of Ameritox, Ltd., and is 
the nation’s leader in medication monitoring, offer-
ing laboratory services, and practice management 
tools to help clinicians coordinate and optimize the 
care of patients. Ameritox was originally founded in 
1996 as Universal Toxicology Laboratories, a feder-
ally certified urine drug testing facility and medical 
examiner toxicology laboratory. Ameritox is now 





36 South State Street, Floor 21
Salt Lake City, UT 84111-1630
www.physicianjobsintermountain.org
Please visit Intermountain Healthcare’s booth to 
learn about exciting job opportunities in Utah. 
Intermountain Healthcare is a Utah-based, 
nonprofit system of 22 hospitals, 185 clinics, 
a medical group with over 1,000 employed 
physicians, a health plan division called Select 
Health, and other health services. Intermountain 
is widely recognized as a leader in clinical quality 
improvement and efficient healthcare delivery. 
For more information, please visit our website.
International Congress on Dual 





Please visit the International Congress on Dual Disor-
ders and Dual Pathology exhibit for more information 




Level 6, West Tower, 608 Saint Kilda Road
Melbourne, 3004 Australia
www.imrmedical.com
International Medical Recruitment (IMR) provides 
a permanent solution for consultant specialist and 
trainee psychiatry doctors interested in opportunities 
in Australia and New Zealand. IMR has over 15 years 
of medical recruitment experience and our psychiatry 
recruitment team are experts in assisting our doctors 
with the complete process from application to com-





North Hollywood, CA 91602-1856
www.hospitalist.com
IPC Healthcare is the nation’s leading physician 
group practice company focused on the delivery of 
hospitalist and facility-based services. IPC's clini-
cians and affiliated providers practice in hospitals, 
and other inpatient facilities including acute, post-
acute, and long-term care settings.
Jackson & Coker
Booth #1724
3000 Old Alabama Road, Suite 119-608
Alpharetta, GA 30022-8555
www.jacksoncoker.com
Whether you seek a position for a day or a lifetime, 
trust Jackson & Coker to put our three decades of 
experience to work for you. Our dedicated team of 
experienced recruiters assists psychiatrists seeking 
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Visit our psychiatry team at booth #1724. Providing 
thorough, personalized service is our passion, and 
we are only satisfied with a placement when you are. 




330 North Wabash Avenue, Suite 39300
Chicago, IL 60611
www.jamanetwork.com
Building on a tradition of editorial excellence, The 
JAMA Network brings JAMA together with 10 
specialty journals to offer enhanced access to the 
research, viewpoints, and medical news shaping 
medicine today and into the future. JAMA Oncology, 






Janssen Pharmaceuticals, Inc., a pharmaceuti-
cal company of Johnson and Johnson, provides 
medicines for an array of health concerns in several 
therapeutic areas, including diabetes, mental health, 
pain management, and cardiovascular disease.
Johns Hopkins Healthcare Solutions
Booth #1607
1300 Thames Street, Suite 200
Baltimore, MD 21231-3608
www.hopkinsguides.com
The Johns Hopkins POC-IT Guides are evidence-
based, clinical decision resources. Trusted content 
in the ABX, diabetes, HIV, and psychiatry guides is 
easily accessed, promptly applied, and frequently 
updated. The Johns Hopkins Guides from Unbound 
Medicine can be downloaded to iOS (iPhone®, iPod 
touch®, iPad™), Android™, and Windows Phone® 
devices for instant access, even when internet is not 
readily available. The apps are optimized for each 
platform and feature superior navigation, so answers 
are easy to find at the bedside or anywhere they are 
needed.
Kaiser Permanente, The Permanente 
Medical Group, Inc
Booth #515
1800 Harrison Street, Floor 7
Oakland, CA 94612-3466
www.physiciancareers.kp.org
Within the Permanente Medical Groups, physicians 
find recognition, stability, opportunity, and indepen-
dence. Through our leadership in the use of advance 
technology, creation of innovative solutions, and our 
influence on health policy and reform efforts, Kaiser 
Permanente is helping to shape the future of health 
care in the nation. Contact us today to discover how 





London, NW1 7BY United Kingdom
www.thelancet.com
The Lancet Psychiatry launched in June 2014 and is 
an international, multidisciplinary, general psychiatry 
journal which promotes the improvement of, and ad-
vocacy for, mental health throughout the life course 
through the dissemination of high-quality review, 
original research, and opinion. The journal delivers 
comprehensive, clinically focused coverage on the 
psychopharmacology, psychotherapy, and psycho-
social approaches to all psychiatric disorders. The 
Lancet is a publication of Elsevier, a world-leading 
provider of information solutions that enhance the 
performance of science, health, and technology pro-






Locum Leaders is a national locum tenens recruiting 
firm specializing in hospitalist jobs, emergency med-
icine jobs, surgery jobs, urgent care jobs, primary 
care jobs, anesthesiology/CRNA jobs, and psychia-
try jobs. We match qualified physicians and CRNAs 
to temporary jobs at client healthcare facilities. Visit 











































Founded in 1995, LocumTenens.com is a full-service 
staffing firm serving physicians, advanced practice 
professionals, and healthcare facilities looking to 
solve employment shortages. The operator of the 
largest online job board for the locums industry, 
LocumTenens.com provides job-seeking providers 
direct access to thousands of jobs, in all specialties, 
posted directly by facilities and agencies nationwide.
Luminello Inc
Booth #1814
870 Market Street #1009
San Francisco, CA 94102
www.luminello.com
Luminello.com is the secure site where busy profes-
sionals run and grow their practice. Developed by a 
psychiatrist, Luminello increases high-yield referrals, 
makes handling daily administrative tasks more ef-
ficiently, is fully HIPAA compliant, and will feature an 
electronic medical record soon. For full details, visit 




Carmarthenshire, SA34OHR United Kingdom
www.magstim.com
Magstim manufactures a complete line of TMS 
devices for all of your research needs. Visit our booth 
to see the Rapid2 rTMS Device.
MagVenture, Inc
Booth #1619
303 Perimeter Center North, Suite 300
Atlanta, GA 30346-3401
www.magventure.com
Magventure offers a complete line of magnetic 
stimulation instruments and accessories for a broad 
range of research and clinical applications.
Maxim Physician Resources
Booth #848
5001 LBJ Freeway, Suite 900
Dallas, TX 75244-6151
www.maximphysicians.com
Maxim Physician Resources (MPR) is an industry 
leader in nationwide physician staffing services, 
specializing in placing physicians in locum tenens 
opportunities. Maxim realizes the key to quality is in 
the details, and as such, MPR focuses on the unique 
needs that are inherent to physician staffing. Maxim 
handles the recruitment, screening, credentialing, 
and the eventual placement of highly-qualified physi-
cians in various clinical environments.
Mayo Clinic
Booth #1401
200 First Street SW
Rochester, MN 55905-0002
www.mayoclinic.org/psychiatry
The Mayo Clinic mission is to inspire hope and con-
tribute to health and well-being by providing the best 
care to every patient through integrated clinical prac-
tice, education and research. Our neuroscience and 
genomic research in mood and addictive disorders 
continues to guide cutting edge progressive clinical 
care to meet the need of our patients. Multidisci-
plinary teams are constantly seeking innovation in 
clinical care and sharing it with the psychiatric com-
munity. Visit booth #1401 to meet our psychiatrists 























McLean Hospital is an international center 
for psychiatric treatment, teaching, research, 
and education. McLean offers state-of-the-art 
diagnostic and treatment services across a full 
continuum that includes inpatient, residential, 
partial hospital, and outpatient care. McLean is 
also home to an expanded array of specialized 
academic programs for children and adoles-
cents as well as dedicated services for older 
adults with Alzheimer’s and other dementias. 
McLean houses the largest research program of 
any private psychiatric hospital in the world and 
as a major teaching affiliate of Harvard Medical 
School, McLean educates the best and bright-
est mental health providers.
MECTA Corporation
Booth #1701
19799 SW 95th Avenue, Suite B
Tualatin, OR 97062-7584
www.mectacorp.com
For over 40 years, MECTA has set the standard for 
unparalleled innovation, based on research through 
four generations of ECT devices used for the treat-
ment of depression. New optimized ECT includes 
new, more efficient parameters, resulting in greater 
efficacy and the minimization of cognitive side ef-
fects. This, combined with the newest, easy-to-use 
optimized titration methodology, utilizes the new 
Ultrabrief ECT and near ultrabrief ECT. The new 
MECTA EMR stores treatment data and monitoring 
that can be saved onto hospital servers and EHRs 
as pdfs! Up to 700 data points can be viewed in 
clinician offices and exported into spreadsheets. 
Choose the only consistent platform for ECT across 
all EHR programs! MECTA–Evidence Based ECT! 
Medical Search
Booth #514
23 Vreeland Road, Suite 110
Florham Park, NJ 07932-1510
www.medsearchint.com
Medical Search is a premier locum tenens and 
permanent placement agency, specializing in plac-
ing all levels of medical professional into the most 
opportunistic assignments nationwide. The psychia-
try division is solely dedicated to their clients and 
physicians to ensure the highest level of quality and 
service in the industry.
Medicus Healthcare Solutions
Booth #606
7 Industrial Way, Unit 5
Salem, NH 03079-2817
www.medicushcs.com
Medicus Healthcare Solutions provides nationwide 
locum and permanent career opportunities for physi-
cians, CRNAs, and advanced practitioners. We offer 
our providers opportunities to work as consultants, 
interim leaders, and specialists on teams assembled 
for projects such as new program launches. For 
healthcare facilities and groups, Medicus provides 
permanent placement, supplemental physician staff-
ing and locum tenens management services.
Medley Pharmaceutical Ltd
Booth #1451




Please visit the Medley Pharmaceutical Ltd. exhibit 
for more information about products and services 






The Menninger Clinic, Houston, is a specialty psy-
chiatric hospital for assessment and treatment of 
adolescents and adults with difficult-to-treat brain 
and behavioral disorders, as well as co-occurring 
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and biopsychosocial therapies with rehabilitation. 
Addiction treatment occurs simultaneously with 
psychiatric treatment. Menninger trains mental health 
professionals, conducts collaborative research, and 
is affiliated with Baylor College of Medicine.
Merck and Co
Booth #649
2000 Galloping Hill Road
Kenilworth, NJ 07033
www.merck.com
Today's Merck is working to help the world be well. 
Through our medicines, vaccines, biologic therapies, 
and consumer and animal products, we work with 
customers and operate in more than 140 countries 






Metabolic Maintenance, the parent company of 
MethylPro®, has been a pioneer in the field of 
personal nutrition for over 30 years by collaborating 
with healthcare professionals and delivering quality 
supplements. With a foundation in medical research, 
good manufacturing practices, and personalized 
customer service, we are proud to offer custom 
formulas, a complete supplement line, and the Meth-




1593 Spring Hill Road, Suite 610
Vienna, VA 22182-2249
www.mhm-services.com
MHM Services contracts with state and local govern-
ments nationwide to provide healthcare services to 
correctional facilities, state psychiatric hospitals, and 
other community settings. Today we employ more 
than 3,000 healthcare professionals in 14 states.
MHS, Inc
Booth #1515
3770 Victoria Park Avenue
Toronto, M2H 3M6 Canada
www.mhs.com
MHS publishes and distributes assessment tools 
which assist in diagnosing a variety of concerns 
including ADHD, depression, anxiety, emotional and 
social development, executive function, and visual-
motor development. Assessments are available in a 
range of formats including online, software, and print. 
Millennium Health
Booth #1939
15330 Avenue of Science
San Diego, CA 92128
www.millenniumhealth.com
Millennium Health is a leading health solutions com-
pany that delivers accurate, timely, clinically action-
able information to inform the right treatment deci-
sions for each patient at the right time. Millennium 
offers a comprehensive, Suite of services to better 





Stevens Point, WI 54481-3114
www.ministryhealth.org
Ministry Health Care is an integrated system of hos-
pitals and clinics serving patients across Wisconsin. 
We are widely recognized as a top-rated health care 
system with 15 hospitals, 47 clinics, and more than 
650 physicians and advanced practice clinicians. We 
are actively seeking both adult and child/adolescent 
psychiatrists in both metropolitan and rural areas. 
We invite you to explore our opportunities today by 
visiting our website.




Santa Cruz, CA 95060
www.maps.org
The Multidisciplinary Association for Psychedelic 
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and educational organization working to develop 
psychedelics and marijuana into prescription treat-
ments for specific medical uses, and to educate the 
public honestly about their risks and benefits. Since 
its founding in 1986, MAPS has disbursed over $20 
million for psychedelic therapy and medical marijua-
na research and education, all donated by individu-
als, businesses, and family foundations. MAPS' 
current top-priority project is obtaining FDA approval 
for MDMA-assisted psychotherapy as a treatment 








The TMS market leader, the NeuroStar TMS 
Therapy® System is a breakthrough in neuro-
modulation for major depressive disorder. With 
the largest clinical data set of any TMS treat-
ment, NeuroStar transcranial magnetic stimula-
tion is proven effective for patients who have not 
benefited from prior antidepressant medication. 
For product information and to learn more, visit 
our exhibit booth or contact us at our website or 
at 1-877-600-7555.
Neuroscience Education Institute
1930 Palomar Point Way, Suite 101
Carlsbad, CA 92008-5579
www.neiglobal.com
The Neuroscience Education Institute (NEI) provides 
interactive learning to mental health clinicians world-
wide. CNS Spectrums is a journal of NEI through a 
partnership with Cambridge University Press. NEI's 
fast-growing Global Psychopharmacology Congress 
and its many web-based CME activities simplify 
complex concepts for ease of learning. Visit our 
booth to discuss the online resources available to 





525 East 68th Street #51
New York, NY 10065-4870
www.nyp.org
The Departments of Psychiatry at New York-
Presbyterian Hospital are recognized leaders 
in the full continuum of psychiatric care for 
children, adolescents, adults, and the elderly. 
Expert diagnostic and treatment services are 
available for personality disorders, autism 
spectrum disorders, eating disorders, geriatric 
psychiatry, anxiety and mood disorders, and 
psychotic disorders, with extensive inpatient and 
outpatient, partial hospital, and day treatment 
programs. In addition, the programs feature sig-
nificant basic, translational, and clinical research 
initiatives, as well as education and training 
programs. NewYork-Presbyterian Hospital has 
academic affiliations with two of the nation’s 
leading medical colleges: Weill Cornell Medi-




1382 Valencia Avenue, Suite F
Tustin, CA 92780-6472
www.nexalin.com
Please visit the Nexalin Technology exhibit for more 
information about products and services that will be 
of interest to you.
Northern Light Technologies
Booth #1425
8971 Henri Bourassa West
St. Laurent, QC H4S1P7
Canada
www.northernlighttechnologies.com
Produced in North America, the 10,000 Lux North-
ern Light Desk Lamp, the Travelite, Flamingo Floor 
Lamp, Boxelite, ceiling track-mounted Showoff, 
the Luxor, and the New Mini-Luxor table lamp are 
preferred by thousands of healthcare professional. 
We are the supplier of choice for affordable, versa-
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are UV-clean, flicker-free, and operate on a 110V to 




8275 South Eastern Avenue, Suite 121
Las Vegas, NV 89123-2544
www.omegabrite.com
The mission of OmegaBrite is to develop natural 
products of the highest quality that promote health 
and well-being based on scientific evidence. We are 
proud of the overwhelming positive, response we 
have received for our flagship product, OmegaBrite 
100% Natural Advance Omega-3 Formula.
T
Oregon Health and Science University, 
Department of Psychiatry
Booth #603
3181 SW Sam Jackson Park Road #UHN80
Portland, OR 97239-3079
www.ohsu.edu/psychiatry
Oregon Health and Science University has the 
only hospital in Oregon to be nationally ranked in 
U.S. News and World Report’s “Best Hospitals”. 
It is an acclaimed academic health center. We 
invite you to stop by our exhibit in the Career 
Fair for more information about career opportu-
nities in psychiatry in the beautiful Northwest.
T
Otsuka America Pharmaceutical, Inc
Booth #1139
1 University Square Drive
Princeton, NJ 08540-6492
www.otsuka-us.com
Otsuka America Pharmaceutical, Inc. (OAPI) is 
an innovative, fast-growing healthcare company 
that commercializes Otsuka-discovered and 
in-licensed products in the U.S. With a strong 
focus on neuroscience, oncology, cardio-renal 
and medical device, OAPI is dedicated to im-
proving the health and quality of human life. For 




New York, NY 10016
www.oup.com/us
Oxford University Press is proud to publish some 
of the world's premier books, journals, and online 
resources in psychiatry. Visit our booth for a discount 
on new and classic titles, free journal samples, and 






Pacific Grove Hospital, located in Riverside, CA, 
provides inpatient and outpatient psychiatric and 
substance abuse treatment for adults and senior 
adults. Our highly trained staff provides personal-
ized care designed to meet the unique needs of our 
patients. Located on a serene, five-acre campus, 
Pacific Grove Hospital's private courtyards, beauti-
fully landscaped grounds, and caring staff create 








Pfizer Inc., is one of the world’s leading biopharma-
ceutical companies. Our diversified health care port-
folio includes some of the world’s best known and 
most prescribed medicines and vaccines. Pfizer has 
a well-recognized portfolio of medical health medica-
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Physicians for a National Health Program
Booth #1705
29 East Madison Street, Suite 602
Chicago, IL 60602-4406
www.pnhp.org
Physicians for a National Health Program is a nonprof-
it research and education organization of 19,000 phy-
sicians, medical students, and health professionals 






Physicians searching for their first or next practice 
rely on PracticeLink—The Career Advancement Re-
source for Physicians. PracticeLink helps physicians 
find the practice opportunities that best suit their 
personal and professional needs and provides help-
ful career development and job-search information. 
Find your next practice by visiting our website.
Providence Health & Services
Booth #611
1201 NE Lloyd Boulevard, Suite 510
Portland, OR 97232
www.providence.org/providerjobs
Providence Health & Services, rated among the 
most integrated health systems in the nation, recruits 
nearly 1,000 physicians and advanced practice pro-
viders each year into its network of hospitals, medi-
cal groups, and private practice partners in Alaska, 
California, Montana, Oregon, and Washington. Join 
us and help create healthier communities together.
Psychiatric Times
Booth #533
535 Connecticut Avenue, Suite 300
Norwalk, CT 06854-1713
www.psychiatrictimes.com
For over 17 years, Psychiatric Times has provided 
accurate, objective, and unbiased coverage of the 
most clinically relevant issues in psychiatry. Each 
issue features a special report, a collection of several 
physician authored articles on a topic of broad inter-
est, as well as an article providing readers the oppor-
tunity to earn continuing medical education credits. 
Read more about these hot topics on our website.
Psychiatry Section, Christian 





Christian Medical Association, Psychiatry Section 
is a ministry of the Christian Medical & Dental As-
sociations. We are a 15,000 member organization 
providing resources, networking, education, and 
a public voice for Christian healthcare profession-
als and students. The Psychiatry Section offers a 
forum for the interface of psychiatric practice and 
the Christian faith. APA participants are welcome to 







PsychU is a new online community and knowledge 
center dedicated to understanding, sharing, and 
evolving best practices in mental health treatment. 
Through the exchange of information, experience, 
and ideas, PsychU members aim to shift the current 
trajectory of mental health care and improve the 
future outlook for individuals with mental illnesses. 
The PsychU community brings together physicians, 
clinicians, care managers, nurses, recovery coaches, 
pharmacists, payers, advocates, researchers, and 
all professionals involved in providing, financing, or 
regulating mental health services. The PsychU online 
community and website is managed by Open Minds.
QTC Management
Booth #1604
8001 Kaureen Garden Place
Tampa, FL 33615
www.qtcm.com
We are the largest private provider of government-
outsourced occupational health, injury, and disability 
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Quotient - ADHD System by Pearson
Booth #1250
239 Littleton Road, Suite 6A
Westford, MA 01886
www.quotient-adhd.com
The Quotient® System accurately measures micro-
motion and analyzes shifts in attention state to quan-
tify the severity of neural control deficits associated 
with ADHD symptoms. Follow-up assessments help 
you to refine the right treatment plan. Objective data 
makes conversations with patients more productive 




2014 Holland Avenue #374
Port Huron, MI 48060-1406
www.psychler.com
Rapid Psychler Press produces textbooks and 
presentation graphics that incorporate humor as an 
educational enhancement. We have new books and 
images for 2015. Please come and have a look!
Reckitt Benckiser Pharmaceuticals
Booth #1531
10710 Midlothian Boulevard, Suite 430
Richmond, VA 23235
www.indivior.com
Reckitt Benckiser Pharmaceuticals is at the forefront 
of providing educational resources and treatment 
options to physicians and patients dealing with opi-
oid dependence. Please visit the company’s medical 
booth where Reckitt Benckiser Pharmaceutical’s 
medical personnel will be standing by to assist you.
Reflections at Dominion Hospital
Booth #1609
2960 Sleepy Hollow Road
Falls Church, VA 22044
www.reflectionsed.com
Reflections at Dominion Hospital provides excep-
tional, evidence-based care to males and females 
ages 11 to adult struggling with eating disorders. 
Our comprehensive, therapeutic program provides 
medical, nutritional, and emotional support. With 
eight inpatient beds, we are able to provide 24-hour 
care to patients in need of constant support. Our 
12-hour day, partial hospitalization program allows 
patients who do not need 24-hour support to have 
comprehensive meal and therapeutic support. As 
one of only three programs in the country to be 
disease specific certified by the Joint Commission, 
Reflections provides unparalleled individualized care.
Rhino Medical Services
Booth #1612
2000 East LaMar Boulevard, Suite 250
Arlington, TX 76006-7358
www.rhinomedical.com
Rhino Medical Services is a behavioral health locum 
tenens. Please visit our booth for more information 






Wisconsin-based Rogers Behavioral Health System 
is a private, not-for-profit system nationally recog-
nized for its specialized psychiatry and addiction 
services. Anchored by Rogers Memorial Hospital, 
Rogers offers multiple levels of evidence-based 
treatment for adults, children, and adolescents with 
depression and mood disorders, eating disorders, 
addiction, obsessive-compulsive and anxiety disor-
ders, and posttraumatic stress disorder in multiple 
locations. For more information, visit our website.
Routledge/CRC Press
Booth #732
711 Third Avenue, Floor 8
New York, NY 10017-9209
www.routledgementalhealth.com & www.crcpress.com
Routledge and CRC Press publish a comprehensive 
portfolio of textbooks, professional books, mono-
graphs, and journals on psychiatry, clinical psychol-
ogy, and more. Visit our websites to keep up-to-date 
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Routledge Journals
Booth #730
530 Walnut Street, Suite 850
Philadelphia, PA 19106-3619
www.tandfonline.com
Routledge Journals, a division of Taylor and Fran-
cis, is a leading international publisher of scholarly 
research in behavioral science and mental health. 
Visit the Routledge Journals booth to learn about our 
wide range of products and services and to request 
free sample copies of our essential publications in 
the field of psychiatry.
Royal College of Psychiatrists
Booth #626
21 Prescot Street
London, London E1 8BB
United Kingdom
www.rcpsych.ac.uk
Overseas psychiatrists can become an International 
Associate of the Royal College of Psychiatrists (the 
professional body for psychiatrists in the United 
Kingdom). Please visit us to find out about this 
membership option. Our journals include the British 
Journal of Psychiatry (BJPsych), BJPsych Advances 
and, to be launched later in 2015, BJPsych Open. 
Come by to take free journal sample copies, get a 
10% discount off book prices, and learn more about 
the College’s wide range of activities at our website.





The Rutgers Center of Alcohol Studies publishes the 
Journal of Studies on Alcohol and Drugs, the oldest 
substance-related journal in the U.S. (est. 1940). 
The Center’s education and training division offers 
cutting-edge education for health, mental health, and 
public health professionals working in the addictions 
field. All programs, including the historic summer 
school, offer practical, evidence-based education 




3314 E. 46th Street, Suite 202
Tulsa, OK 74135
www.rxconceptsok.com
Rx Concepts, LLC wants to open a pharmacy in 
your practice setting. Please visit the Rx Concepts, 
LLC exhibit and let us show you how an on-site 




Thousand Oaks, CA 91320-2234
www.sagepub.com
Founded 50 years ago by Sara Miller McCune to 
support the dissemination of usable knowledge and 
educate a global community, SAGE publishes jour-
nals, books, and library products spanning a range 
of subject areas. SAGE remains majority-owned by 
our founder, who has assured that the company will 
remain permanently independent.MD Conference 
Express, a division of SAGE, fills the gap between 
live presentation and publication in academic litera-
ture by applying the rigorous standards of peer re-
view to the creation of medical conference highlights 
reports. Influential opinion leaders trust MD Confer-
ence Express to deliver authoritative, balanced, and 
insightful reports of conference news. Please visit 
www.mdconferencexpress.com.
Sheppard Pratt Health System
Booth #1507
6701 North Charles Street
Baltimore, MD 21204-6893
www.sheppardpratt.org
Sheppard Pratt Health System is dedicated to im-
proving quality of life through mental health, special 
education, and addiction services for children, ado-
lescents, and adults. Our patient-centered treat-
ment approach, combined with our legacy of clinical 
excellence, sets us apart from other health systems 
on a national level. We have been ranked among 
the nation's top psychiatric hospitals for 24 years by 











































Shire enables people with life-altering conditions to 
lead better lives. Our strategy is to focus on develop-
ing and marketing innovative specialty medicines to 
meet significant unmet patient needs. We provide 
treatments in neuroscience, rare diseases, gastroin-
testinal, internal medicine, and regenerative medi-
cine. We are also developing treatments for symp-
tomatic conditions treated by specialist physicians in 
other targeted therapeutic areas.
Somatics LLC
Booth #1427
910 Sherwood Drive, Suite 23
Lake Bluff, IL 60044-2233
www.thymatron.com
Somatics is the manufacturer of the Thymatron® 
ECT instrument, which is faster and easier than ever 
to use. Unique benefits include maximum ultrabrief 
response, age-based stimulus titration, EEG sei-
zure intensity and duration, higher stimulus current, 
greater cerebral stimulation, best seizure generaliza-
tion, and efficacy by peak heart rate. Unique features 
include EctoBrain™ Stimulus Assurance Analyzer, 
remote treat handle, automatic optimal stimulus se-
lection at 0.3 and 0.5 ms, 4-channel monitor-printer, 
postictal suppression index, automatic EEG seizure 







Sooma Oy is a medical device company developing 
non-invasive brain stimulation devices for treat-
ment of neurological and psychiatric disorders. We 
offer Sooma tDCS, an attractive treatment option 
for treatment of major depressive disorder (MDD) in 
adults. Sooma tDCS is CE approved and available 
in the EU. In the U.S. or Canada, Sooma tDCS is an 
investigational device. The treatment with Sooma 
tDCS is well tolerated and painless. The treatment 
can be used simultaneously with other ongoing 
treatments such as psychotherapy, pharmaceuticals, 
and other neuromodulation treatments. There are no 
serious adverse effects associated with the treat-
ment. Visit our website for more information. 
Spartanburg Regional Healthcare System
Booth #607
101 E. Wood Street
Spartanburg, SC 29303
www.spartanburgregional.com
Spartanburg Regional booth will be recruiting board 
certified and/or board eligible psychiatrists for Spar-
tanburg Medical Center (SMC), located in Spartan-
burg, SC. SMC was recently named the #1 hospital 
in the state of South Carolina.
Springer Science+Business Media
Booth #628
233 Spring Street, Floor 6
New York, NY 10013-1578
www.springer.com
Springer Science+Business Media is a leading global 
scientific, technical, and medical publisher offering 
high-quality products across all media. Springer pub-
lishes more than 2,000 journals and 8,000 new books 
per year and is home to the world’s largest STM 
eBook collection as well as the most comprehensive 
portfolio of open access journals. Make sure to visit 







Sunovion is a leading pharmaceutical company 
dedicated to discovering, developing, and com-
mercializing therapeutic products that advance 
the science of medicine in the psychiatry, 
neurology, and respiratory disease areas and 
improve the lives of patients and their families. 
Sunovion, an indirect, wholly-owned subsidiary 
of Sumitomo Dainippon Pharma Co., Ltd., is 
headquartered in Marlborough, MA. More infor-
mation about Sunovion Pharmaceuticals Inc. is 























Please visit our booth to discuss a treatment for 






Teva is working every day to make quality healthcare 
accessible. As a manufacturer of specialty and ge-
neric pharmaceuticals, Teva provides both new and 
innovative therapies and greater access to affordable 




One Gateway Center, Suite 2600
Newark, NJ 07102
www.theramanager.com
Visit the Theramanager exhibit for more information 
about practice management/EHR software and rev-
enue cycle management for behavioral health.
Tourette Syndrome Association
Booth #1712
4240 Bell Boulevard, Suite 205
Bayside, NY 11361-2874
www.tsa-usa.org
The Tourette Syndrome Association (TSA) is the only 
national, non-profit organization serving individuals 
affected by Tourette Syndrome. TSA disseminates 
educational materials to health care and education 
professionals, coordinates support services, and 
funds research to improve treatments and find the 
cause of TS. Free educational resources, including 
articles, CDs, and DVDs for medical professionals, 




Los Alamitos, CA 90720-2105
www.tovatest.com
T.O.V.A. (Test of Variables of Attention) is a comput-
erized assessment that measures inattention, impul-
sivity, response time, variance of response time, and 
d prime. LD and languages do not confound results. 
Its objective and accurate data can provide impor-
tant necessary information for evaluations and moni-
toring of treatments of attention related disorders.
US Department of State, 
Office of Medical Services
Booth #706
2401 E Street, NW, Room L101
Washington, DC 20522-0001
www.careers.state.gov
The Office of Medical Service in the Department of 
State maintains and promotes the health of em-
ployees and their accompanying family members 
who represent U.S. government agencies abroad. 
The Department assigns regional medical officer/
psychiatrists (RMOP) to the selected posts overseas. 
The RMOP is responsible for providing mental health 
care to members of the official American community 
within a geographic area.
US Department of Veterans Affairs
Booth #608
1250 Poydras Street, Suite 1000
New Orleans, LA 70113-1810
www.vacareers.va.gov
Please visit the U.S. Department of Veterans Affairs 
exhibit for more information about products and 
services that will be of interest to you.
US Psychiatric & Mental Health Congress
Booth #1627
83 General Warren Boulevard, Suite 100
Malvern, PA 19355-1252
www.uspsychcongress.com
The U.S. Psychiatric & Mental Health Congress 
(Psych Congress) is the nation’s largest independent, 
cross-discipline, educational conference for men-
tal health and primary care clinicians who seek to 





































Exhibitors with Product/Service Descriptions
related to psychopharmacology, psychotherapy, and 
wellness. The 28th Annual Psych Congress is being 
held September 10-13, 2015, in San Diego, CA.
Universal Health Services, Inc
Booth #1523
3295 River Exchange Drive, Suite 190
Norcross, GA 30092
www.uhsinc.com
Universal Health Services, Inc. (UHS) is the larg-
est facilities based behavioral health provider in 
the country. Our nearly 200 facilities operate inde-
pendently offering services that touch more than 
350,000 lives each year–from youth and adult 
programs to dedicated services for military person-
nel and their families. In addition to our behavioral 
health facilities we operate 25 acute care hospitals, 
and three surgery centers. We have locations in 37 
states, the District of Columbia, Puerto Rico, the 
U.S. Virgin Islands and the United Kingdom, and 
employ more than 68,000 people. UHS is actively 
recruiting psychiatrists nationwide for practice op-
portunity positions at our behavioral health facilities.
T







The University of Florida Department of Psychia-
try operates programs to treat addiction, eating 
disorders, and mood disorders in an inpatient 
setting at their free-standing, 81-bed psychiatric 
hospital. The addiction and eating disorders also 
have long-term, residential facilities. The neuro-
modulation program provides ET, TMS, DTMS, 
and DBS services.
Uskudar University Npistanbul 
Neuropsychiatry Hospital
Booth #1502




Please visit to Uskudar University Npistanbul Neu-
ropsychiatry Hospital exhibit for more information 




2033 6th Avenue, Suite 500
Seattle, WA 98121-2591
www.valant.com
Valant’s integrated EHR and practice management, 
Suite empowers behavioral health professionals to 
provide quantifiable patient outcomes while also 
streamlining billing and administration. Our easy-to-
use, cloud-based, software-as-a-service solution 
reduces the time spent on documentation so you 
can increase patient flow, grow your billable hours, 




2200 Pennsylvania Avenue, NW, Suite 300E
Washington, DC 20037-1754
www.vandapharma.com
Vanda Pharmaceuticals, Inc., is a biopharmaceutical 
company focused on the development and commer-
cialization of medicines to address unmet medical 
needs. Vanda is committed to providing education 
and awareness for schizophrenia and non-24-hour, 
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Vanderbilt Behavioral Health
Booth #1700
1601 23rd Avenue South
Nashville, TN 37212-3133
www.vanderbiltbehavioralhealth.com
Vanderbilt Behavioral Health is comprised of Vander-
bilt Psychiatric Hospital, an 88-bed inpatient facility, 
adult and adolescent partial hospitalization pro-
grams, psychiatry outpatient clinics which provide 
more than 60,000 outpatient visits annually, the 
neuromodulation program which includes transcra-
nial magnetic stimulation (TMS), electroconvulsive 
therapy (ECT), and deep brain stimulation (DBS). In 
addition, the Center of Excellence provides services 
for children in state custody or who are at risk of a 
custodial situation. As a part of Vanderbilt University 
Medical Center, we provide world-class care for our 
patients, setting the standard for excellence while 
advancing our field through education and research. 
VISTA Staffing Solutions, Inc
Booth #413
275 East 200 South
Salt Lake City, UT 84111-2002
www.vistastaff.com
VISTA Staffing Solutions plays an active role in help-
ing physicians shape truly satisfying careers through 
locum tenens, permanent, and international opportu-
nities. VISTA provides career-enhancing experiences 
based on a physician’s immediate needs and future 







Wiley is the leading society publisher. We publish 
on behalf of more societies and membership as-
sociations than anybody else and offer libraries and 
individuals 1,250 online journals, thousands of books 
and e-books, reviews, reference works, databases, 
and more. For more information, visit our website 
or our online resource at www.onlinelibrary.wiley.
com. Stop by our booth to learn about what is new 
at Wiley and receive 20% off your order and request 






Wolters Kluwer Health is a global provider of in-
formation, business intelligence, and point-of-care 
solutions for the healthcare industry. Major brands 
include Lippincott Williams and Wilkins, Lippincott 
Solutions, medical books, journals, and electronic 
media. Please visit our booth to browse our compre-
hensive product selection including the newly pub-
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